Title (News Shots),Categories,Date
?GSK to Collaborate with Pfizer to Build a Consumer Healthcare Joint Venture,Biosimilars|Biotech,13-11-2020
Celltrion's Bevacizumab Biosimilar (CT-P16) Enters into Global Phase III Clinical trial for Treating Colorectal Cancer,Biosimilars|Pharma,#N/A
JHL Biotech's Trastuzumab Biosimilar (JHL1188) Receives CHMP Positive Scientific Advice to Treat Breast Cancer,Biosimilars|Pharma,#N/A
Celltrion's Herzuma (Herceptin biosimilar) Receives Marketing Approval in Australia,Biosimilars|Pharma,#N/A
"Pfizer receives EU approval for Trazimera(Trastuzumab), the First Oncology Biosimilar",Biosimilars|Pharma,#N/A
Dr. Reddy Launched Hervycta (biosimilar Trastuzumab) in India,Biosimilars|Pharma,#N/A
Novartis divests part of Sandoz US Genercis as well as US dermatology business to Aurobindo Pharma for $0.9B,Biosimilars|Pharma,#N/A
Allergen Announces Acquisition of Bonti for its Two Aesthetic and Therapeutic Products,M&A|Pharma,#N/A
Mylan Receives EU Marketing Approval for Adalimumab Biosimilar “Hulio”,Biosimilars|Biotech|Regulatory,#N/A
Amicus Therapeutics Acquires Celenex for its Ten Gene Therapy Programs,Biosimilars|M&A,#N/A
Sandoz's Biosimilar Pegfilgrastim Receives CHMP Approval for Febrile Neutropenia,Biosimilars|Regulatory,#N/A
Samsung Bioepis' BLA for SB5 Adalimumab Biosimilar Accepted for Review by the US FDA,Biosimilars|Biotech|Regulatory,#N/A
"Celltrion and Teva Announces Approval Recommendations for CT-P10's (rituximab, biosimilar) BLA from the US FDA ODAC",Biosimilars|Regulatory,#N/A
Mundipharma Acquires Cinfa Biotech for Expansion of its Biosimilar Portfolio,Biosimilars|M&A,#N/A
Sandoz Signs a Non-Exclusive License Agreement with AbbVie for IPR of its Humira (adalimumab) for Major EU Countries,Biosimilars|Biotech,#N/A
Merck Terminates Development and Commercialization Deal with Samsung Bioepis for Lusduna Nexvue (insulin glargine),Biosimilars|Pharma,#N/A
"Amgen Launches Amgevita (adalimumab, biosimilar) in EU to Treat Inflammatory Diseases post EMA Approval in Feb 2017",Biosimilars|Biotech,#N/A
"Samsung Biogen Launches Imraldi (adalimumab, biosimilar) in EU for 14 Autoimmune Conditions",Biosimilars|Biotech,#N/A
Novartis to Acquire Endocyte for Expansion of its Investigational Radioligand Therapy (RLT) Platform,M&A,#N/A
Axsome Therapeutics Receives FDA's Orphan Drug Designation for AXS-12 (reboxetine) to Treat Narcolepsy,Regulatory,#N/A
Allergan Announces Completion of UBR-MD-04 &amp; 3110-105-002 Study for Treatment of Migrane,Pharma,#N/A
Eiger Pharmaceuticals Reports Results of Lambda in P-II LIMT (Lambda MonoTx) Study in Hepatitis Delta Virus (HDV) Infection,Biotech,#N/A
Janssen Pharmaceuticals (J&amp;J) Receives Health Canada's Approval for Invokana (canagliflozin) in MACE Reduction,Regulatory,#N/A
Mylan Launches MPA Injectable Suspension for Prevention of Pregnancy in the US,Biotech,#N/A
Abbott Receives FDA's Approval for its HeartMate 3 Left Ventricular Assist Device (LVAD) in Patients with Advance Heart Failure,MedTech,#N/A
Roche Reports Results of P-III IMpower130 study of Tecentriq (atezolizumab) for 1L Treatment in Advance NSCLC,Biotech,#N/A
AstraZeneca &amp; Merck Reports P-III SOLO-1 Trial Results of Lynparza (olaparib) for 1L+ Treatement in Advance BRCAm Ovarian Cancer at ESMO18,Biotech,#N/A
Biogen and UCB Reports Results of Dapirolizumab Pegol (DZP) in A P-IIb study for Systemic Lupus Erythematosus (SLE),Pharma,#N/A
Novartis Reports Publication of P-IIIb LIBERTY study's Results of Aimovig (erenumab) in The Lancet,Pharma,#N/A
Astrazeneca Expands Existing Deal with Innate Pharma to Strengthen its Oncology Pipeline,Pharma,#N/A
Lilly Reports Results of Taltz (ixekizumab) in P-III COAST-V and COAST-W trials for Ankylosing Spondylitis (AS),Biotech,#N/A
Alcon (Novartis Division) Plans to Develop SMART Suite Equipment for Improved Cataract Surgery,DigiHealth,#N/A
Omeros' OMS721 Receives FDA's ODD to Treat Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (HSCT-TMA),Regulatory,#N/A
"Takeda Globally Signs Licensing, Co-Development &amp; Co-Promotion Agreement with Enterome for its EB8018 Candidate",Pharma,#N/A
LEO Pharma Signs License and Research Collaboration with Zymeworks to Develop Novel Bispecific Abs,Pharma,#N/A
"Amgen Collaborates with Orion for Commercialization of Amgevita (adalimumab, biosimilar) in Finland",Biosimilars|Biotech,#N/A
Orion's Darolutamide Achieves 1EP in P-III ARAMIS study in Men with Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC),Biotech,#N/A
Pfizer Reports Improved Results of P-III OA (A4091056) Study of Tanezumab in Patients with Osteoarthritis (OA),Biotech,#N/A
"Axovant Reports Dosing of its First Patient in AXO-Lenti-PD study for Parkinson's Disease at NIHR, UCLH",Biotech,#N/A
AstraZeneca Reports Results of Lokelma (sodium zirconium cyclosilicate) in P-III HARMONIZE trial in Patients with Hyperkalaemia,Pharma,#N/A
"Seattle Genetics Reports Multiple Results of Adcetris (Brentuximab Vedotin) in P-III ECHELON-1, P-I/II, P-II and P-III AETHERA study in Patients with Hodgkin Lymphoma at ISHL 2018",Biotech,#N/A
Esperion Reports Results of Bempedoic Acid in P-III Study 2 or 1002-047 for Patients with ASCVD or HeFH,Biotech,#N/A
Novartis &amp; Pfizer Enter into a Clinical Development Collaboration to Treat Non-Alcoholic Steatohepatitis (NASH),Pharma,#N/A
ProQR Signs Exclusive Worldwide License Agreement with Ionis for IONIS-RHO-2.5 Candidate (now QR-1123),Biotech,#N/A
Jazz Receives FDA Approval for Xyrem's (sodium oxybate) sNDA to Treat Cataplexy or Excessive Daytime Sleepiness in Pediatric Patients with Narcolepsy,Regulatory,#N/A
AstraZeneca Divests Rights of its Nexium and Vimovo Product to Grunenthal,Pharma,#N/A
Astellas' Xtandi (enzalutamide) Receives EU's Approval for Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC),Pharma,#N/A
"Gilead Reports Results of Biktarvy (Bictegravir, Emtricitabine, Tenofovir Alafenamide) in P-III Study 1490 for Patients with HIV-1",Pharma ,#N/A
Mirati Therapeutics Announces IND Submission of MRTX849 to Treat NSCLC &amp; CRC,Pharma,#N/A
Roche Licenses Halozyme's ENHANZE Technology for ~$190M for the Development of Therapeutic Targets,Biotech,#N/A
Janssen's (J&amp;J) Invokana (canagliflozin) Receives FDA Approval for MACE events in Adults with T2D,Regulatory,#N/A
"Biocardia, CellProThera &amp; SlngXpand Collaborates to Develop and Commercialize CD34+ Stem Cells in Singapore for Myocardial Infarction",Biotech,#N/A
"Lupin Recalls its 6,752 Testosterone Bottles from the US market",Pharma,#N/A
Coherus' Udenyca (pegfilgrastim-cbqv) Receives the US FDA Approval for Patients Receiving Myelosuppressive Chemotherapy,Biosimilars|Regulatory,#N/A
"Boehringer Ingelheim (BI) &amp; Eli Lilly Reports RWE Results of Jardiance (empagliflozin) in EMPRISE study, Presented at AHA 2018",Pharma,#N/A
Abeona Signs Exclusive License Agreement with Regenxbio to Develop and Commercialize NAV AAV9 vector,Biotech,#N/A
"Merck Signs a Clinical Trial Collaboration with FLX Bio, for a Combination Therapy",Pharma,#N/A
"Regeneron and Sanofi Reports Results of Praluent (alirocumab) in ODYSSEY OUTCOMES study in Patients with MACE events, Presented at AHA 2018",Biotech,#N/A
AstraZeneca Announces Acceptance of Priority Review of Lynparza's (olaparib) sNDA by FDA in Patients with BRAC-Mutated Advance Ovarian Cancer,Biotech,#N/A
Merck's Keytruda (pembrolizumab) Receives FDA Approval for the Treatment of Hepatocellular Carcinoma (HCC),Regulatory,#N/A
Roche Reports Acceptance of sBLA from FDA for its Tecentriq (atezolizumab) + Abraxane (nab-paclitaxel) for 1L Metastatic Triple- Negative Breast Cancer (TNBC),Biotech,#N/A
BioTime Acquires Asterias Biotherapeutics with Two of its Clinical Stage Cell Therapy Candidates,M&A,#N/A
BioTime Acquires Asterias Biotherapeutics with Two of its Clinical Stage Cell Therapy Candidates,Biotech,#N/A
Merck Reports Initiation of BLA Filling for V920 (rVSV?G-ZEBOV-GP) Under FDA for Ebola Zaire,Biotech,#N/A
Ferring Signs an Exclusive License Agreement with Invo for its INVOcell Intravaginal Culture (IVC) System in the US,Pharma,14/11/2018
Wugen Enters into License Agreement with Washington University for its CAR-T Therapy Technologies,Biotech,14/11/2018
Merck Reports Improved Overall Survival Results of Keytruda (pembrolizumab) vs Chemotherapy in KEYNOTE-181 Study,Biotech,15/11/2018
"Grunenthal Acquires Averitas Pharma for its Peripheral Neuropathic Pain Product, Qutenza (capsaicin)",M&A,15/11/2018
Lilly Files Lasmiditan to FDA for Acute Treatment of Migrane,Biotech,15/11/2018
Bristol-Myers Squibb Receives CHMP Recommendation for Opdivo (nivolumab) + Low-Dose Yervoy (ipilimumab) in 1L RCC Based in P-III CheckMate-214 study,Biotech,16/11/2018
"Ipsen's Cabometyx (cabozantinib, as monothx) Receives EU Approval for the Treatment of 2L Advance HCC",Regulatory,16/11/2018
"Pfizer to Raise Prices of its 41 Drugs in the US, in January 2019",Pharma,19/11/2018
Novartis' Kisqali (ribociclib) (as a Combination Therapy) Receives CHMP's Expanded Label Recommendation for HR+/HER2- Locally Advanced or Metastatic Breast Cancer,Biotech,19/11/2018
Gilead's Vemlidy (Tenofovir Alafenamide) Receives NMPA (CFDA) Approval for Chronic Hepatitis B Virus (HBV) Infection",Regulatory,19/11/2018
AstraZeneca Reports Results of Imfinzi (durvalumab) &amp; Tremelimumab in Global P-III MYSTIC Trial for Stage IV Non-Small Cell Lung Cancer (NSCLC),Biotech,19/11/2018
Genentech Collaborates with Immunocore to Co-develop IMC-C103C for MAGE-A4 (Melanoma-Associated Antigen A4),Pharma,20/11/2018
Leidos Collaborates with GeoVax for the Development of Immunotherapies for Cancer,Biotech,20/11/2018
"Sandoz and Pear Therapeutics Launches reSET Medical Mobile APP, for Patients with Substance Use Disorder (SUD)",DigiHealth,20/11/2018
Verily (Alphabet's Division) Holds its Smart Lens Project,MedTech,20/11/2018
Boston Scientific Acquires BTG with its Interventional Medicine Portfolio,M&A,21/11/2018
OrthroXel's Apex Femoral Nailing System Receives CE Mark Clearance in EU,MedTech,21/11/2018
"Mylan Recalls 15 Batches of Valsartan Globally, for the Treatment of Hypertension",Pharma,21/11/2018
Leo Pharma Collaborates with PellePharm for the Development of Drug Candidate for Gorlin Syndrome and Basal Cell Carcinoma (BCC),Pharma,21/11/2018
Genentech's Venclexta (venetoclax) Receives FDA's Accelerated Approval for Patients with Newly-Diagnosed Acute Myeloid Leukemia (AML),Biotech,22/11/2018
Pfizer and Zenith Epigenetics Collaborates to Evaluate ZEN-3694 &amp; Talazoparib for TNBC,Biotech,22/11/2018
Evotec and Immuneering Collaborates to Develop Novel Candidates for Rare Hereditary Metabolic Diseases,Biotech,22/11/2018
Medtronic to Acquire Nutrino Health Along with its AI-Based Continuous Glucose Monitoring (CGM) Technology,M&A,22/11/2018
Indivior Receives Health Canada Approval for Sublocade (SC) (Buprenorphine Extended-Release) in Patients with Moderate to Severe Opioid Use Disorder(OUD),Pharma,26/11/2018
"Mundipharma Receives EU Approval for Pelmeg (Pegfilgrastim, Biosimilar)",Biosimilars|Regulatory,26/11/2018
Novartis Receives EU Approval for Gene Therapy Luxturna (voretigene neparvovec) in Patients with Rare Inherited Retinal Disease,Regulatory,26/11/2018
Bristol-Myers' Opdivo and Yervoy Combination Couldn't Meet OS as Maintenance Therapy in esSCLC Patients Post 1L Chemo,Biotech,27/11/2018
RegenxBio and Rocket Signs Exclusive Worldwide License Agreement for NAV AAV9 Vector,Biotech,27/11/2018
Sandoz's Ziextenzo (pegfilgrastim) Receives EU Approval for Reduction in Duration of Neutropenia,Biosimilars|Regulatory,27/11/2018
"Genentech's ACTpen Receives FDA's Approval for Actemra (tocilizumab) to Treat Rheumatoid Arthritis (RA), Giant Cell Arteritis (GCA) and Two Forms of Juvenile Arthritis",MedTech,27/11/2018
Loxo's Vitrakvi (larotrectinib) Receives the US FDA Approval for the Treatment of Solid Tumors in Adults and Pediatric Patients,Biotech,28/11/2018
Novo Nordisk Reports Improved Results of Oral Semaglutide in PIONEER 9 Study in Patients with Type-2 Diabetes (T2D),Biotech,28/11/2018
Beigene Signs Exclusive License and Development Agreement with Zymeworks (ZW),Biotech,28/11/2018
Mesa Biotech's Accula RSV Test Receives FDA's 510(K) Clearance and CLIA Waiver for Respiratory Infections,MedTech,28/11/2018
Genentech Acquires Jecure Therapeutics for its Preclinical Stage NLRP3 inhibitors,M&A,29/11/2018
Merck's Delstrigo (doravirine / lamivudine / tenofovir disoproxil fumarate) &amp; Pifeltro (doravirine) Receives EU's Approval for the Treatment of HIV-1 Infection,Pharma,29/11/2018
Q BioMed Acquires Rights of Metastron from GE Healthcare,Pharma,29/11/2018
"ElectroCore's gammaCore (nVNS) Receives FDA's 510(k) Approval, a Novel Therapy for Cluster Headache in Adults",MedTech,29/11/2018
Astellas' Xospata (gilteritinib) Receives FDA ‘s Approval for 1L R/R Acute Myeloid Leukemia (AML) in Adults,Regulatory,30/11/2018
Vertex's Kalydeco (ivacaftor) Receives FDA's Expanded Label Approval for Cystic Fibrosis (CF) Aged 12 to &lt; 24 Months,Regulatory,30/11/2018
NTU SingaporeTTSH Develops AI based Smart Medical Device for Early Detection of Congestive Heart Failure,MedTech,30/11/2018
Shire's Takhzyro IV (lanadelumab) Receives EU's Approval for Hereditary Angioedema,Pharma,2018-03-12
Bluebird Bio and Celgene Reports Results of bb21217 in P-I (CRB-402) study for 3L+ r/r Multiple Myeloma,Biotech,2018-03-12
Pfizer Reports Results of PF-05280586 (rituximab biosimilar) in REFLECTIONS B328-06 study for CD20-Positive Non-Hodgkin Lymphoma,Biosimilars|Biotech,2018-03-12
GSK to Acquire Tesaro for its Zejula (niraparib) for $5.1B (£4.0 billion),M&A,2018-03-12
Cilag Acquires Exclusive Worldwide Rights of Argenx's Cusatuzumab (ARGX-110) for $1.6B,Pharma,2018-04-12
"Kite Reports Results of Yescarta (axicabtagene ciloleucel) in ZUMA-1 trial for Refractory Large B-Cell, Lymphoma, Presented at ASH 2018",Biotech,2018-04-12
Crown Laboratories Acquires Rights for GSK's Five OTC Drugs,Pharma,2018-04-12
Roche Reports Results of Kadcyla (trastuzumab emtansine) in P-III KATHERINE Study for HER2-positive Early Breast Cancer (eBC),Pharma,2018-06-12
Domain Therapeutics Signs Research and License Agreement with Boehringer Ingelheim (BI) for G-Protein Coupled Receptors (GPCRs),Biotech,2018-05-12
Roche Collaborates with Icagen for the Development of Drug Candidates for Neurological Disorders,Pharma,2018-06-12
Subtle an AI based Medical Device SubtlePET Receives FDA's 510(K) Clearance,MedTech,2018-06-12
Novartis Reports Results of BYL719 (alpelisib) + fulvestrant in P-III SOLAR-1 trial for HR+/HER2- Advanced Breast Cancer,Biotech,2018-07-12
Biogen Exercises Exclusive Worldwide Option to Develop &amp; Commercialize Ionis's BIIB067 (IONIS-SOD1RX) for Amyotrophic Lateral Sclerosis (ALS),Biotech,2018-07-12
Novartis Expands its Cell Therapy Collaboration with Intellia Therapeutics for CRISPR/Cas9-Based Therapy,Biotech,2018-07-12
"Gilead's Descovy (Emtricitabine, Tenofovir Alafenamide) Receives NMPA ‘s (CFDA) Approval for HIV-1 Infection",Biotech,2018-05-12
Innovate and Massachusetts General Hospital Collaborates to Develop Larazotide for Alcoholic Liver Disease,Pharma,2018-05-12
"Celltrion Reports Results of CT-P10 (rituximab, biosimilar) in P-III for Advance Follicular Lymphoma (AFL)",Biosimilars|Biotech,2018-05-12
NeuroPace Reports Positive Results of Next-Gen RNS System for Refractory Epilepsy in the US,MedTech,2018-05-12
"Genentech's Tecentriq Receives FDA Approval a Combination Therapy, for mNon-Sq NSCLC with No EGFR or ALK Genomic Tumor Aberrations",Pharma,2018-07-12
Daiichi Reports Results of [Fam-] Trastuzumab Deruxtecan (DS-8201) in P-I study for HER2 Low Expressing Metastatic Breast Cancer,Pharma,2018-10-12
Merck Licenses Cyclica's In-Silico Artificial Intelligence (AI) based Ligand Express Platform,Biotech,2018-10-12
AstraZeneca Reports Imfinzi (durvalumab) &amp; tremelimumab Results in P-III EAGLE trial for Advanced Head and Neck Cancer,Biotech,2018-10-12
Bristol-Myers (BMS) Collaborates with Vedanta Biosciences to Develop Combination Therapy for Advanced or Metastatic Cancers,Biotech,2018-11-12
Novartis Reports Results of Kisqali (ribociclib) + Endocrine Therapy in P-III MONALEESA trials for (HR+/HER2-) Advanced Breast Cancer,Biotech,2018-11-12
Shionogi Signs a Research Collaboration with UBE Industries for the Development of Anti-RS Virus Drug Candidates,Pharma,2018-11-12
"Sandoz Receives FDA's Clearance for reSET-O, a Medical Mobile App for Opioid Use Disorder (OUD)",DigiHealth,2018-11-12
"Astellas to Launch Xospata (gilteritinib) for R/R Acute Myeloid Leukemia (AML) with FLT3 Mutation, in the US",Pharma,2018-12-12
Circassia Plans to Exercise Option for the US Commercialization Rights for Tudorza (aclidinium) From AstraZeneca,Pharma,2018-12-12
Johnson&amp;Johnson (J&amp;J) Signs a Research Collaboration with Apple for Atrial Fibrillation (AFib),Biotech,18/1/2019
BioMed X and Boehringer Ingelheim (BI) Collaborates for Neurology Disorders,Pharma,18/1/2019
Ironwood Pharmaceuticals' Linzess (linaclotide) Receives NMPA (CMPA) Approval for Irritable Bowel Syndrome with Constipation (IBS-C),Pharma,16/1/2019
"FitBit and National Institutes of Health (NIH) Launches a Digital Health Project, Fitbit Bring-Your-Own-Device (BYOD)",DigiHealth,17/1/2019
AstraZeneca Signs an Exclusive Promotion Agreement with Luye Pharma for its Xuezhikang in China,Pharma,17/1/2019
"Roche Launches uPath Enterprise Software, a Digital PathologyTechnology",Biotech,17/1/2019
Abbott Exercises its Option to Acquire Cephea Valve Technologie,M&A,17/1/2019
Boehringer Ingelheim (BI) and Bioharmony Therapeutics Collaborates to Develop Bacteriophage Lysins,Biotech,16/1/2019
Beigene's Zanubrutinib (BGB-3111) Receives the US FDA's Breakthrough Therapy Designation for Mantle Cell Lymphoma (MCL),Regulatory,16/1/2019
Sanofi Licenses Biomunex Pharmaceuticals' BiXAb Technology to Develop Bi- and Multi-Specific Antibodies,Biotech,16/1/2019
"Abbott's Amplatzer Piccolo Occluder Receives FDA Approval, a Medical Device for Premature and Newborns with Patent Ductus Arteriosus (PDA)",Regulatory,15/1/2019
"Cipla Signs an Exclusive License Agreement with Bio-Thera for its BAT1706 (bevacizumab, biosimilar)",Biosimilars|Biotech,15/1/2019
Array Biopharma Reports Results of Triplet Combination Therapy in P-III BEACON CRC Trial for BRAF-Mutant Metastatic Colorectal Cancer (mCRC),Pharma,15/1/2019
Exelixis' Cabometyx (cabozantinib) Receives FDA Approval for Previously Treated Hepatocellular Carcinoma (HCC),Regulatory,15/1/2019
Bristol-Myers Squibb's (BMS) Opdivo (nivolumab) + Low-Dose Yervoy (ipilimumab) Receives EU Approval for 1L Intermediate- and Poor-Risk Advanced RCC,Biotech,15/1/2019
Ascletis Signs an Exclusive License Agreement with Alphamab for its KN035,Biotech,14/1/2019
Chiesi Farmaceutici Licenses Tum Bio's NCE401 for $74M,Pharma,14/1/2019
Knight Therapeutics Signs an Exclusive License Agreement with Puma Biotechnology for its Nerlynx (neratinib),Pharma,14/1/2019
RFPi's iCertainty Receives FDA 510(k) Clearance Approval for Blood Flow in Surgeries,MedTech,2019-11-01
Rafael Pharmaceuticals' Devimistat (CPI-613) Receives EMA's ODD for R/R Acute Myeloid Leukemia (AML) and Metastatic Pancreatic Cancer (mPC),Regulatory,2019-11-01
Yuhan Signs an Exclusive License Agreement with Glenmark for its Ryaltris,Pharma,2019-11-01
Sumitomo Dainippon Reports Results of Lurasidone Hydrochloride (lurasidone) in P-III JEWEL Study in Patients with Schizophrenia,Pharma,2019-11-01
Empatica's Embrace an AI Smartwatch Receives FDA's 510(K) Clearance Approval in Pediatric Patients Aged =6 yrs.,DigiHealth|Regulatory,2019-10-01
Elevian and Insilico Medicine Collaborates to Develop Therapies Targeting Aging,Biotech,2019-10-01
"Sanofi Reports Results of Cablivi (caplacizumab) in P-III HERCULES Study in Patients with Rare Blood Clotting Disorder, Published in NEJM",Pharma,2019-10-01
ImmunoGen to Sell Residual Royalty Rights for Kadcyla (ado-trastuzumab emtansine) to OMERS,Pharma,2019-09-01
Janssen (J&amp;J) Reports Filing of Stelara's (ustekinumab) in Group Type II Variation Application to EMA for Moderately to Severely Active Ulcerative Colitis (UC),Biotech|Regulatory,2019-09-01
Exelixis and Daiichi Sankyo's Minnebro (Esaxerenone) Receives MHLW Marketing Approval In Patients With Hypertension In Japan,Regulatory,2019-09-01
Astellas and Amgen Astellas' Evenity (romosozumab) Receives MHLW Approval for Patients with Osteoporosis at High Risk of Fracture in Japan,Regulatory,2019-09-01
3SBio Signs a License Agreement with Samsung Bioepis for its Biosimilars,Biosimilars|Biotech,2019-08-01
Eli Lilly to Acquire Loxo Oncology for $8B,M&A,2019-08-01
Novartis's SEG101(crizanlizumab) Receives FDA's Breakthrough Therapy(BT) Designation for Sickle Cell Disease,Regulatory,2019-08-01
Merck Exercises its Option to License NGM's NGM313 (MK-3655) for NASH and Type 2 Diabetics,Pharma,2019-04-01
Vanderbilt Center for Neuroscience Drug Discovery (VCNDD) to Collaborate with Boehringer Ingelheim(BI) for Neuropsychiatric Disorders,Pharma,2019-04-01
"Daiichi Signs an Exclusive License Agreement with Esperion, for $1.2B",Pharma,2019-04-01
"Merck's Keytruda(pembrolizumab) Receives 5 Approvals from PMDA, Japan across 3 Indications",Regulatory,2019-03-01
Bristol-Myers Squibb (BMS) to Acquire Celgene for $74B,M&A,2019-03-01
Progenics Signs Exclusive License Agreement with Curium for the Development of PyL in EU,MedTech,2019-03-01
"Celgene Licenses Aprinoia's APN-1607 an Imaging Tracer, for Neurodegenerative Diseases",MedTech,2019-03-01
Bristol-Myers Squibb Receives FDA's Approval for Sprycel (dasatinib) + CT in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL),Regulatory,2019-03-01
Teva's ProAir Digihaler (Albuterol Sulfate 117 mcg) Inhalation Powder Receives FDA Approval for Asthma &amp; COPD Patients Aged 4 Years or Older,Regulatory,31/12/2018
Betta Pharma Licenses Inventisbio's D-0316 to Treat Non-Small Cell Lung Cancer (NSCLC),Pharma,31/12/2018
"FDA Approves Elzonris (tagraxofusp), the First Treatment for Blastic Plasmacytoid Dendritic Cell Neoplasm and First CD123-Targeted Therapy",Regulatory,31/12/2018
Sanofi and Merck Receives FDA Approval for Vaxelis in Pediatric Patients,Regulatory,29/12/2018
Horizon Pharma's Ravitchi (Glycerol Phenylbutyrate) Receives FDA Approval for Expansion of Age Range for in Patients with Urea Cycle Disorder (UCD),Regulatory,28/12/2018
Innovent Biologics and Eli Lilly's Tyvyt (Sintilimab injection) Receives NMPA (CFDA) Approval for Classical Hodgkin's Lymphoma (cHL) Patients,Regulatory,28/12/2018
JHL Biotech Reports Randomization of Patients in P-III Study of JHL1101 for Diffuse Large B-Cell Lymphoma,Biosimilars|Biotech,28/12/2018
Merck and Pfizer Reports Results of Avelumab in P-III JAVELIN Ovarian 100 study for Previously Untreated Advanced Ovarian Cancer,Pharma,28/12/2018
"AbbVie Licenses Lupin's MALT1 Inhibitor Program, for $977M",Pharma,27/12/2018
Alexion's Ultomiris (Ravulizumab-Cwvz) Receives FDA Approval in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH),Biosimilars|Regulatory,27/12/2018
Zydus' Doxycycline Hyclate Delayed-Release Tablets USP and Febuxostat Tablets Receives FDA's Approval,Pharma,27/12/2018
Merck's Keytruda (pembrolizumab) Receives FDA's Approval for LA or Metastatic Merkel cell carcinoma (MCC),Pharma,20/12/2018
Bristol-Myers (BMS) Divests its UPSA Consumer Health Business to Taisho,Pharma,20/12/2018
AstraZeneca and Merck's Lynparza (olaparib) Receives FDA's Approval for 1L BRCA-Mutated Advanced Ovarian Cancer,Regulatory,20/12/2018
Albireo's A4250 Receives EU Orphan Drug Designation (ODD) for Biliary Atresia,Regulatory,19/12/2018
Puma Biotechnology Reports Results of Neratinib (PB272) in P-III NALA Trial for 3L HER2-Positive Metastatic Breast Cancer,Pharma,19/12/2018
Alcon to Acquire Tear Film Innovations for its iLux Medical Device,MedTech,19/12/2018
Eli Lilly Collaborates with Aduro Biotech for its cGAS-STING Pathway Inhibitor Program to Develop Immunotherapies,Biotech,19/12/2018
Amgen Signs an Immuno-Oncology Agreement with Molecular Partners' for its MP0310,Pharma,19/12/2018
Bristol-Myers' Sprycel (dasatinib) Receives CHMP Recommendation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (ALL),Regulatory,18/12/2018
Ligand Purchases Palvella's Royalty Rights and Milestone Payments of PTX-022 for Pachyonychia Congenita,Regulatory,18/12/2018
Merck's Keytruda (pembrolizumab) Receives EU Approval for Resected Stage III Melanoma in Adults,Regulatory,18/12/2018
Lilly Acquires Hydra Biosciences with its Pre-Clinical Pain Program for Chronic Pain Syndromes,Biotech,17/12/2018
Merck Acquires Antelliq Group with its Digital Animal Health Technology,M&A,17/12/2018
Amgen's Nplate (Romiplostim) Receives FDA's Approval for Immune Thrombocytopenia Aged 1 year and Older,Regulatory,17/12/2018
Novartis' Xolair (omalizumab) Receives EU's Approval for Severe Allergic Asthma (SAA) and Chronic Spontaneous Urticaria (CSU),Regulatory,14/12/2018
Vertex‘s Orkambi (lumacaftor/ivacaftor) Receives Health Canada Approval for Cystic Fibrosis (CF) Aged 2 to 5 yrs.,Regulatory,14/12/2018
Axovant Sciences Licenses Two Gene Therapy Programs from University of Massachusetts for Rare and Fatal Neurodegenerative Genetic Disorders,Biotech,14/12/2018
Eli Lilly's Olumiant (baricitinib) Receives FDA's Fast Track Designation for Systemic Lupus Erythematosus (SLE),Regulatory,14/12/2018
AstraZeneca and AVEO Oncology Enter into an Immuno-Oncology Clinical Collaboration,Pharma,13/12/2018
Lilly Collaborates with AC Immune (AC) to Develop Candidates for Neurodegenerative Diseases,Pharma,13/12/2018
Merck Collaborates with Instituto Butantan to Develop Vaccines for Dengue,Pharma,13/12/2018
Oxford BioTherapeutics Licenses WuXi Biologics' WuXiBody Platform for Five Bispecific Antibodies,Biotech,13/12/2018
CorMedix Reports Results of Neutrolin in P-III LOCK-IT-100 Study for Patients with Hemodialysis,Pharma,18/1/2019
Thyas Signs an Exclusive License Agreement with iPS Academia Japan (iPS-AJ) to Develop Autologous Immunotherapies,Biotech,18/1/2019
"Samsung Bioepis' Biosimilar Transtuzumab Ontruzant (transtuzumab,dttb), Receives US FDA Approval for Oncology Indications",Biosimilars|Biotech,21/1/2019
Vertex Pharmaceuticals' Orkambi (lumacaftor+ivacaftor) Receives EU Approval for Cystic Fibrosis (CF) with Mutation in CFTR gene in Children Aged 2 to 5,Pharma|Regulatory,21/1/2019
Celgene Signs an Exclusive WW License Option with Obsidian for DDs Technology,Pharma,21/1/2019
"Sandoz's Erelzi (etanercept, biosimilar) Receives Health Canada Approval for Psoriatic Arthritis (PsA) in Adults",Biosimilars|Biotech,22/1/2019
Verily‘s Study Watch Receives FDA's 510 (k) Clearance for Cardiovascular Disorders,MedTech|Regulatory,22/1/2019
"Eli Lilly Reports Results of Cyramza (ramucirumab) in P-III REACH 2 study for 2L AFP-High HCC, Published in The Lancet",Biotech,22/1/2019
ProBioGen and CRISPR Therapeutics Signs a Multi-Year Research Collaboration for In Vivo Delivery Therapies,Biotech,22/1/2019
Eli Lilly Reports Results of Lartruvo (olaratumab) in ANNOUNCE P-III Study for Advanced or Metastatic Soft Tissue Sarcoma (STS),Biotech,22/1/2019
Amgen's Blincyto (blinatumomab) Receives EU Expanded Indication Approval for Ph- CD19 Positive B-cell Precursor Acute Lymphoblastic Leukemia (ALL),Biotech,23/1/2019
Albireo's A4250 Receives FDA's Orphan Drug Designation (ODD) for Biliary Atresia,Pharma,23/1/2019
Purdue Pharma Signs Exclusive License Agreement with Klaria for its KL-01401,Pharma,23/1/2019
Taiwan Liposome's TLC178 Receives EMA's ODD for Soft Tissue Sarcoma (STS),Pharma,23/1/2019
Abbott's TactiCath Contact Force Ablation Catheter Receives FDA's Approval for Atrial Fibrillation (AFib),MedTech,23/1/2019
B-MoGen Biotechnologies and CytoSen Therapeutics Sign an Agreement for the Development of Gene-Modified Therapies,Biotech,24/1/2019
Athersys Reports Results of Multistem Cell Therapy (IV) in Patients with Acute Respiratory Distress Syndrome (ARDS),Biotech,24/1/2019
Grifols Signs a License and Commercialization Agreement with Rigel Pharmaceuticals for Fostamatinib,Pharma,24/1/2019
23andMe's MAP Report Receives FDA's 510(k) Clearance for Hereditary Colorectal Cancers,Regulatory,24/1/2019
"Philogen Collaborates with Johnson&amp;Johnson (J&amp;J), Novartis and Celgene",Biotech|Pharma,24/1/2019
"Indian Government to Set Trade Margins of 50 Orphan Drugs, Treatments for Cancer and Rare Diseases",Pharma,25/1/2019
Mannin Research Signs a Collaboration with Mcmaster University for MAN-01,Pharma,28/1/2019
Vertex Signs an Exclusive License Agreement with Merck KGaA for its Two DNA-PK Inhibitor,Pharma,28/1/2019
Medtronic to Acquire EPIX Therapeutics for its Cardiovascular Technologies,M&A,28/1/2019
Clovis Oncology's Rubraca (Rucaparib) Receives EU Approval for Maintenance Treatment of Relapsed Ovarian Cancer (OC) in Adults,Pharma,25/1/2019
Dr. Reddy's Tosymra (sumatriptan nasal spray) 10mg Receives the US FDA Approval for Acute Treatment of Migraine,Regulatory,28/1/2019
Amgen's Repatha (evolocumab) Receives NMPA (CFDA) Approval for Reduction of Cardiovascular Risks in China,Regulatory,24/1/2019
Roche and Basilea Sign a Research Collaboration to Evaluate Derazantinib + Tecentriq (atezolizumab) in Patients with Urothelial Cancer (UC),Pharma,25/1/2019
"Amgen and Allergan Report Results of ABP 798 (rituximab, biosimilar) in P-I/III (NCT02792699) for Moderate-To-Severe Rheumatoid Arthritis (RA)",Biosimilars|Biotech,24/1/2019
Zimber Biomet's Rosa Knee System Receives the US FDA's 510(k) Clearance for Robotically-Assisted Surgeries,Regulatory,28/1/2019
"AbbVie's Imbruvica (ibrutinib) + Gazyva (obinutuzumab) Receives FDA's Approval, First CT Free Treatment for 1L+ CLL/SLL",Regulatory,28/1/2019
Alexion Reports Results of Ultomiris (ravulizumab-cwvz) in P-III Study in Patients with Atypical Hemolytic Uremic Syndrome (AHUS),Biotech,29/1/2019
Purdue Pharma Signs an Agreement with Alivio Therapeutics for its ALV-107,Pharma,29/1/2019
"Innovent Biologics Reports Acceptance of BLA for IBI-305 (bevacizumab, biosimilar) from NMPA (CFDA) to Treat NSCLC",Biosimilars|Biotech,29/1/2019
Vertex's Kalydeco (ivacaftor) Receives Health Canada's Approval for Cystic Fibrosis (CF) with CFTR Gene Mutation in Children Aged 12 to,Regulatory,29/1/2019
Medtronic Launches Mazor X Stealth Edition for Spine Surgery in the US,MedTech,29/1/2019
"Zai Lab Receives Priority Review for Zejula's (niraparib) NDA from NMPA (CFDA), in China",Pharma,29/1/2019
Pfizer and Eli Lilly Report Results of Tanezumab in P-III OA study (A4091057) for Moderate-To-Severe Osteoarthritis (OA) Pain,Pharma,30/1/2019
Takeda Reports Results of TAK-003 in P-III TIDES (DEN-301) Trial for Dengue,Pharma,30/1/2019
Sumitomo Dainippon's Latuda (lurasidone HCl) Receives NMPA's (CFDA) Approval for Schizophrenia,Pharma,30/1/2019
"EMA Shifts its Headquarters from London to Amsterdam, The Netherlands",Regulatory,30/1/2019
Neurocrine and Voyager Collaborate to Develop and Commercialize VY-AADC &amp; VY-FXN01 for Parkinson's &amp; Friedreich's Ataxia Disease,Biotech,30/1/2019
Roche Discontinues P-III CREAD-1 and 2 Trials of Crenezumab in Patients with Early Alzheimer's Disease (AD),Biotech|Pharma,31/1/2019
AstraZeneca's Lumoxiti Receives FDA approval for the Treatment of R/R 2L+ Hairy Cell Leukemia in patients,Pharma,14/9/2018
Genentech Receives FDA approval for Actemra SC for the Treatment of Active Systemic JIA in patients aged =2 yrs.,Pharma,14/9/2018
Ipsen's Cabometyx Receives Health Canada's Approval for the Treatment of Advanced Renal Cell Carcinoma (RCC) in Adults,Pharma,20/9/2018
Merck's Delstrigo and Pifeltro Receives CHMP Approval for the Treatment of HIV-1 Infection in EU,Regulatory,21/9/2018
Coherus Biosciences' Udenyca (Pegfilgrastim Biosimilar) Receives EU Marketing Approval for Febrile Neutropenia,Biosimilars|Regulatory,26/9/2018
Anaeropharma Science and Astellas Pharma Collaborates to Develop Novel Anti-Tumor Drugs Using i-DPS Technology,M&A,26/9/2018
I-Mab Biopharma Expands Collaboration with Wuxi Biologics for three more Antibody Programs,Pharma,27/9/2018
Sanofi's Libtayo Receives the US FDA approval for Metastatic Cutaneous Squamous Cell Carcinoma (mCSCC),Regulatory,2018-01-10
Kite and HiFiBio Signs a Research &amp; License Agreement for Neoantigen-Reactive T Cell Receptors (TCRs),Biotech,2018-03-10
Novo Nordisk's Tresiba Receives Health Canada Approval for Type 1 Diabetes in patients Aged =2 years,Regulatory,2018-03-10
Eagle Pharmaceuticals and USAMRICD Signs an Agreement for Ryanodex (dantrolene sodium),Pharma,2018-04-10
Xbrane Biopharma Reports Results of Xlucane Compared to Lucentis from In-Vivo Study,Biosimilars|Biotech,2018-04-10
MeiraGTx Acquires Vector Neurosciences to Strengthen its Neurology Portfolio,M&A,2018-10-10
Celgene to Present Results of Two P-III Trial SUNBEAM and RADIANCE Part B for Ozanimod to Treat RMS at ECTRIMS 2018,Biotech,2018-11-10
Myriad and Pfizer Signs a Service Agreement for Testing of BRCA-Mutated Triple Negative Breast Cancer,Pharma,2018-12-10
"Therapiva Private Acquires Dr. Reddy's API Manufacturing Unit Jeedimetla, Hyderabad",M&A,15/10/2018
Themis Biosciences Signs an Exclusive License Agreement with Max-Planck-Innovation for Oncolytic Virotherapies,Biotech,15/10/2018
AbbVie Announces FDA's Acceptance of sNDA for PR for Imbruvica (ibrutinib) + Gazyva (Obinutuzumab),Biotech,17/10/2018
"Mylan Launches Hulio (adalimumab, biosimilar) in EU for Autoimmune Diseases",Biosimilars|Biotech,22/10/2018
"Mylan &amp; Biocon Receive CHMP Recommendation to Ogivri (trastuzumab, biosimilar) for HER-2 Breast Cancer",Biosimilars|Regulatory,22/10/2018
"At ESMO'18, Pfizer Presents Results of PALOMA-3 Trial Results of Ibrance and Fulvestrant",Biotech,22/10/2018
Novartis Reports Results of Extended Follow-up P-III COMBI-AD Trial of Tafinlar (dabrafenib) + Mekinist (trametinib) during ESMO18,Biotech,22/10/2018
UCB Reports Improved Results of Extended P-IIb BE ACTIVE study for Bimekizumab in Patients with Psoriatic Arthritis (PsA) Patients,Pharma,24/10/2018
Roche's Xofluza (baloxavir marboxil) Receives FDA Approval for Influenza in Patients Aged =12 yrs.,Pharma,25/10/2018
Medtronic's Valiant Navion(TM) Thoracic Stent Graft System Receives FDA Approval for Aortic Diseases,MedTech,26/10/2018
Regeneron's Eylea (aflibercept) Achieves 1EP &amp; 2EP in P-III PANORAMA trial in Patients with Non-Proliferative Diabetic Retinopathy (NPDR),Biotech,26/10/2018
Esperion Reports Completion of Bempedoic Acid in Global P-III LDL-C Development Program for Patients with ASCVD or HeFH,Biotech,29/10/2018
Lilly Signs a Global Research and License Collaboration with Dicerna for ~$550M,Biotech,29/10/2018
Henry Ford Health System Signs Development and Commercialization Agreement with G3 Pharma for its Galectin-3 inhibitors,Biotech,31/10/2018
Gilead Signs Global Research Collaboration with Tango to Develop &amp; Commercialize Targeted Immuno-Oncology Therapies,Biotech,2018-01-11
Sandoz's Hymiroz (adalimumab-adaz) Receives the US FDA Approval for Treatment of Chronic Autoimmune Diseases,Biosimilars|Regulatory,2018-01-11
Roche Reports Results of Venclexta/Venclyxto plus Gazyva/Gazyvaro in P-III CLL-14 study for CLL patients,Biotech,2018-01-11
Roche Receives EU Approval for Venclyxto (venetoclax) plus MabThera (rituximab) to Treat Adults with CLL,Biotech,2018-01-11
Sanofi and Denali Therapeutics Collaborates to Develop &amp; Commercialize Clinical Candidates for Neurology and Inflammatory Disorders,Biotech,2018-01-11
Vertex Receives EU's MAA for Symkevi (tezacaftor/ivacaftor) + Kalydeco (Ivacaftor) to Treat Patients with CF aged =12yrs. with Mutations in CFTR gene,Regulatory,2018-02-11
Aileron Therapeutics &amp; Dana-Farber/Boston Children's Cancer and Blood Disorders Center Enters into a Clinical Collaboration to Treat Pediatric Patients with Cancer,Biotech,2018-02-11
"AbbVie Exercises its Option to License Agreement for BioArctic's Alpha-Synuclein Antibody Portfolio, Signed in 2016",Pharma,2018-02-11
Illumina Acquires Pacific Biosciences for ~$1.2B with its Sequel SMRT Technology,M&A,2018-02-11
Sage Reports Voting Results from FDA Advisory Committees for Zulresso (brexanolone) to Treat Postpartum Depression (PPD),Biotech,2018-05-11
Eli Lilly and NextCure Signs a Multi-Year Collaboration to Develop Novel Immuno-Oncology Therapies,Biotech,2018-06-11
"Amgen to Present Long-Term Safety-Efficacy Data of Repatha (evolocumab) in Multiple studies, at AHA 2018",Pharma,2018-06-11
Amgen Out-Licenses its AMG 714 (PRO-015) Candidate to Provention to Treat Celiac Disease,Biotech,2018-05-11
Eisai Reports Results of Lenvima (Lenvatinib) + Keytruda (pembrolizumab) to Treat Metastatic NSCLC Metastatic Melanoma and Metastatic Urothelial Carcinoma,Biotech,2018-12-11
Amgen Reports Safety &amp; Efficacy Results of Repatha (evolocumab) in OSLER-1 Five-Year Extension Study,Biotech,13/11/2018
Novartis' Gilenya (fingolimod) Receives EU's Approval for Relapsing-Remitting Forms of Multiple Sclerosis (RRMS),Regulatory,30/11/2018
Janssen (J&amp;J) Reports Results of Erleada (apalutamide) in P-III TITAN Study for Metastatic Castration-Sensitive Prostate Cancer (mCSPC) #ASCO2019,Pharma,31/1/2019
Merck's V114 Receives FDA's Breakthrough Therapy Designation to Prevent Invasive Pneumococcal Disease,Pharma,31/1/2019
Columbia's Zuckerman Institute Develops an AI-based Brain-Computer Interface (BCI) for People with Aphasia &amp; Amyotrophic Lateral Sclerosis (ALS),Biotech,31/1/2019
Eli Lilly's Alimta (pemetrexed) + Keytruda (pembrolizumab) Receives FDA's Expanded Label Approval for 1L Metastatic Nonsquamous Non-Small Cell Lung Cancer (NSCLC),Pharma,31/1/2019
Janssen(J&amp;J) Signs an Exclusive Worldwide License Agreement with MeiraGTx for its Gene Therapy Candidates,Biotech,2019-01-02
Bayer Signs an Exclusive License Agreement with Kyoto University for Pulmonary Disorders,Biotech,2019-01-02
Alexion Collaborates with Caelum Biosciences for its CAEL-101 to Treat Light Chain (AL) Amyloidosis,M&A,2019-01-02
Audentes Reports Next Phase Development of AT132 for X-linked Myotubular Myopathy (XLMTM) with RMAT Designation,Pharma,2019-01-02
ONO Signs a Research Collaboration with Repare Therapeutics for its Pol? Inhibitor Program,Pharma,2019-01-02
?Roche Recalls Lots of Coaguchek Xs Pt Test Strips with FDA's Class I Warning,Pharma,2019-04-02
Evolus' Jeuveau (prabotulinumtoxinA-xvfs) Receives FDA Approval for Moderate-to-Severe Glabellar Lines in Adults,Regulatory,2019-04-02
?Novartis' Kymriah Receives NICE Approval for R/R Diffuse Large B-cell lymphoma (DLBCL) in Adults,Regulatory,2019-04-02
Merck's KEYTRUDA (pembrolizumab) Receives CHMP Recommendation for 1L Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC),Pharma,2019-04-02
Argenx Signs a Worldwide License Agreement with Halozyme for its ENHANZE Technology,Biotech,2019-05-02
Eli Lilly Reports Results of Olumiant (baricitinib) in P-III BREEZE-AD1 and BREEZE-AD2 study for Moderate-to-Severe Atopic Dermatitis (AD),Pharma,2019-05-02
?BioLineRX's BL-8040 Receives FDA's Orphan Drug Designation (ODD) for Pancreatic Cancer,Pharma,2019-05-02
?Eisai and Purdue Report Result of Lemborexant in P-III SUNRISE 2 Study for Insomnia in Adults,Pharma,2019-05-02
AstraZeneca's MEDI8897 Receives FDA's Breakthrough Therapy Designation (BTD) &amp; EMA's PRIME Designation for Lower Respiratory Tract Infection (LRTI) in Infants,Regulatory,2019-05-02
Novartis to Acquire AveXis with its Gene Therapy Clinical Candidates,M&A,2018-09-04
Celgene to Acquire Juno for its Cellular Immunotherapy &amp; Hematology Portfolio,M&A,2018-06-02
?Sanofi to Acquire Bioverativ to Treat Hemophilia,M&A,22/1/2018
FDA to Refuse Celgene for Filling Ozanimod's NDA for the Treatment of Relapsing Multiple Sclerosis,Pharma,27/2/2018
"GSK to Acquire 36.5% Stake in Consumer Healthcare Joint Venture, Established with Novartis",M&A,22/4/2018
Genentech Signs a Development and Commercialization Agreement with Xencor for its IL-15 &amp; XmAb24306 Programs,Pharma,2019-06-02
?Lilly Reports Negative Results of Solanezumab in P-III EXPEDITION Studies in Patients with Alzheimer Disease,Biotech,2018-06-12
"Novo Nordisk, Genentech and Sanofi to cut off jobs in 2018",Biosimilars|Pharma,2018-03-11
?Kyowa Kirin Signs an Exclusive Commercialization Agreement with Hisamitsu for its HP-3000,Pharma,2019-06-02
?Top Pharma Companies Appointed Their New CEOs in 2018,Pharma,2018-06-09
?Merck Reports Acceptance of NDA from FDA for Its (Imipenem/Cilastatin) + (Relebactam) for Complicated Urinary Tract and Intra-Abdominal Infections in Adults,Regulatory,2019-06-02
?GSK to Collaborate with Pfizer to Build a Consumer Healthcare Joint Venture,M&A,19/12/2018
Sanofi Report Results of Isatuximab in P-III ICARIA-MM Study for Patients with Relapsed/Refractory Multiple Myeloma (MM),Pharma,2019-06-02
"Pfizer's Retacrit (epoetin alfa-epbx, biosimilar) Receives FDA Approval for Anemia ?",Biosimilars|Biotech,15/5/2018
"Pfizer's Nivestym (filgrastim-aafi, biosmilar) Receives the US FDA Approval for Neutropenia",Biosimilars|Biotech,15/7/2018
Celltrion's Truxima (rituximab-abbs) Receives FDA's Approval for Three on-Hodgkin's Lymphoma Indications,Biosimilars|Biotech,29/11/2018
"?Celltrion and Teva's Herzuma (trastuzumab-pkrb, Herceptin biosimilar) Receives FDA's Approval for HER2-Overexpressing Breast Cancer",Biosimilars|Biotech,14/12/2018
"Amgen and Allergan's Mvasi (bevacizumab, biosimilar) + Combination Therapy Receives EU's MAA Approval for Treatment of Certain Types of Cancer",Biosimilars|Biotech|Regulatory,18/1/2019
"Celltrion's Herzuma (Trastuzumab Biosimilar, CT-P6) Receives EMA Approval for Breast Cancer, Metastatic Breast Cancer and Metastatic Gastric Cancer",Biosimilars|Regulatory,14/2/2018
"Amgen and Allergan's ABP 980 (biosimilar, Herceptin) Receives CHMP Recommendation for Three Types of Cancer?",Biosimilars|Regulatory,23/3/2018
"Sandoz's Zessly (infliximab) Receives EU Approval for Gastroenterological, Rheumatological And Dermatological Diseases",Biosimilars|Regulatory,24/5/2018
Sandoz's Hyrimoz (adalimumab) Receives EU Approval for Autoimmune Disorders,Biosimilars|Regulatory,27/7/2018
"Biocon and Mylan Fulphila (pegfilgrastim, Neulasta biosimilar) Receives CHMP (EMA) Recommendation for Neutropenia",Biosimilars|Regulatory,21/9/2018
Mylan and Biocon's Semglee Receives EU Approval for Patients with Diabetes,Regulatory,28/3/2018
"GSK Signs a Worldwide Development &amp; Commercialization Collaboration with Merck KGaA, for $4.2B",Pharma,2019-06-02
?Sanofi's Cablivi (caplacizumab-yhdp) Receives FDA's Approval for Acquired Thrombotic Thrombocytopenic Purpura (aTTP) in Adults,Regulatory,2019-07-02
"?Paratek's Reports Results of Nuzyra (Omadacycline) in P-III OPTIC and OASIS-1 Studies for Pneumonia and Skin Infections in Adults, Published in NEJM",Regulatory,2019-07-02
Recordati Licenses Exclusive Commercialization Rights of Juxtapid (lomitapide) from Aegerion Pharmaceuticals ?,Pharma,2019-07-02
AstraZeneca's Fasenra Receives Orphan Drug Designation (ODD) For Hypereosinophilic Syndrome (HES),Regulatory,2019-07-02
P&amp;G to Acquire "This is L." for its Feminine Care Products in the US ?,M&A,2019-07-02
?Medtronic's Pipeline Flex Embolization Device Receives FDA's Expanded Indication Approval for Intracranial Aneurysms (IAs),Regulatory,2019-08-02
BioMarin Reports Results of Brineura (cerliponase alfa) for Patients with CLN2 Disease Aged 3 to 16 yrs.,Pharma,2019-08-02
?Genagon Signs a Worldwide License Agreement with Ligand for its Omniab Technology,Biotech,2019-08-02
Orthofix Medical's M6-C Artificial Cervical Disc Receives FDA's Approval for Cervical Disc Degeneration,MedTech|Regulatory,2019-08-02
Galapagos Signs a Worldwide Development &amp; Commercialization Agreement with Evotec for Fibrotic Diseases,Pharma,2019-08-02
C-Bridge Capital Signs a Development &amp; Commercialization Agreement with Samsung Bioepis for Biosimilars in China,Biosimilars|Biotech,2019-11-02
Regeneron Reports Results of Eylea (aflibercept) in P-III PANORAMA Trial for Diabetic Retinopathy (DR),Pharma,2019-11-02
?Pfizer Recalls Lots of Ambaro (valsartan and amlodipine besylate salt) for its Carcinogenic Effects in Japan,Pharma,2019-11-02
Finch Therapeutics' CP101 Receives FDA's Breakthrough Therapy Designation (BT) for Recurrent Clostridium Difficile (C. difficile) Infection,Regulatory,2019-11-02
?Bristol-Myers Reports Results of Opdivo (nivolumab) + Yervoy (ipilimumab) in P-III CheckMate-214 study in Patients with Advanced or Metastatic RCC,Pharma,2019-12-02
Astellas Reports Results of Xtandi (enzalutamide) in P-III ARCHES Trial for Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) in Men,Pharma,2019-12-02
?Bayer Signs an Exclusive License Agreement with Moberg Pharma for MOB-015 in EU,Pharma,2019-12-02
Takeda's Adcetris (brentuximab vedotin) + AVD Receives EU Approval for CD30+ Stage IV Hodgkin Lymphoma (HL) in Adults,Regulatory,2019-12-02
Genmab's Darzalex (daratumumab) Split Dosing Regimen Receives the US FDA Approval for Multiple Myeloma,Regulatory,2019-12-02
?Gilead Reports Results of Selonsertib in P-III STELLAR-4 study for Compensated Cirrhosis (F4) due to Nonalcoholic Steatohepatitis (NASH),Pharma,13/2/2019
?AbbVie Signs a Partner and Option to Acquire Agreement with TeneoOne for its TNB-383B,Pharma,13/2/2019
Janssen (J&amp;J) Reports Voting Results from FDA Advisory Committees for Spravato (esketamine) in Adults with Resistant Depression,Pharma,13/2/2019
Almirall Signs an Option to License Agreement with Dermira to Develop and Commercialize Lebrikizumab in EU for Atopic Dermatitis ?,Pharma,13/2/2019
ITROM Pharmaceutical Signs an Exclusive License &amp; Commercialization Agreement with Mithra for 20 years,Pharma,13/2/2019
Novartis' Egaten (triclabendazole) Receives FDA's Approval for Fascioliasis in the US,Regulatory,14/2/2019
?Johnson &amp; Johnson to Acquire Auris Health for its Monarch Technology for $5.7B,M&A,14/2/2019
Clinigen Licenses Commercialization Rights for Proleukin from Novartis in the US,Pharma,14/2/2019
?Amgen Signs a Multi-Target Collaboration with Abilita Bio for Enabled Membrane Proteins (EMPs),Pharma,14/2/2019
?Roche Signs a Clinical Program Agreement with Vaccibody to Evaluate VB10.16 + Tecentriq (atezolizumab) for Advanced Cervical Cancer,Pharma,14/2/2019
Bayer Reports Results of Darolutamide in P-III ARAMIS trial for Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC),Pharma,15/2/2019
Nestle Health Science (NHSc) Exercises its Exclusive WorldWide Option to License CDX-6114 from Codexis,Pharma,15/2/2019
Bristol-Myers (BMS) Reports Results of Opdivo (nivolumab) + Yervoy (ipilimumab) in P-II CheckMate -650 trial for Metastatic Castration-Resistant Prostate Cancer (mCRPC),Pharma,15/2/2019
Novartis Signs a Multi-Target Agreement with AbCellera for its Ab-Based Technology,Biotech,15/2/2019
Arvelle Therapeutics Licenses Exclusive Development &amp; Commercialization Rights for Cenobamate from SK Biopharmaceuticals in EU?,Pharma,15/2/2019
Merck Reports Results of Keytruda (pembrolizumab) + Inlyta (axitinib) in P-III KEYNOTE-426 Study in Patients with 1L Advanced Renal Cell Carcinoma (RCC),Pharma,18/2/2019
Bayer Exercises its Exclusive WW Option to License Vitrakvi &amp; BAY 2731954 with Change-In-Control Clause from Loxo Oncology,Pharma,18/2/2019
Medtronic to Recall its Dual Chamber Implantable Pulse Generators (IPGs) in the US,MedTech,18/2/2019
Medtronic Reports Results of PRODIGY Study in Patients with Opioid-Induced Respiratory Depression (OIRD)?,MedTech,18/2/2019
?Pfizer Reports Results of Bavencio (avelumab) + Inlyta (axitinib) in P-III JAVELIN Renal 101 trial for 1L Advanced Renal Cell Carcinoma (RCC),Pharma,19/2/2019
Japan Ministry of Health Approves Use of Induced Pluripotent Stem Cells (iPSCs) for Spinal Injuries,Regulatory,19/2/2019
Roche's Polatuzumab Vedotin as Combination Therapy &amp; Entrectinib Receives FDA's Priority Review for r/r Diffuse DLBCL &amp; NTRK Fusion-Positive Solid Tumors,Regulatory,19/2/2019
Innovent Biosciences Collaborates with ?Chipscreen to Evaluate Chidamide in Combination with Sintilimab &amp; IBI305 in China,Biosimilars|Biotech|Pharma,19/2/2019
?AVEO Oncology Reports Results of Fotivda (tivozanib) in P-III TIVO-3 Study for Refractory Advanced or Metastatic Renal Cell Carcinoma (RCC),Pharma,19/2/2019
?Merck's Keytruda (pembrolizumab) Receives FDA's Approval for Adjuvant Treatment of Patients with Melanoma with Involvement of Lymph Node,Regulatory,20/2/2019
"Novo Nordisk Receives BLA Approval for Esperoct (turoctocog alfa pegol, N8-GP) for Patients with Haemophilia A",Regulatory,20/2/2019
Alkermes Signs a Research Collaboration with Clovis Oncology to Evaluate ALKS 4230 in Combination with Rucaparib &amp; Lucitanib,Pharma,20/2/2019
?Pfizer and Lilly Report Result of Tanezumab in P-III A4091059 Study for Chronic Low Back Pain (CLBP),Pharma,20/2/2019
Bausch + Lomb Licenses US Commercial Rights for Eton Pharmaceuticals' EM-100 to Treat Ocular Itching,Pharma,20/2/2019
?Merck Reports Results of Keytruda (pembrolizumab) in P-III KEYNOTE-240 Study for 1L Advanced Hepatocellular Carcinoma (HCC),Pharma,21/2/2019
?Mustang Bio Signs an Exclusive Worldwide Collaboration with Nationwide Children's Hospital for Glioblastoma Multiforme,Pharma,21/2/2019
?Novo Nordisk Signs Non -Exclusive Agreement with Abbott for its FreeStyle Libre Mobile App,DigiHealth|MedTech,21/2/2019
AbbVie's Humira (adalimumab) Receives Health Canada Approval for Chronic Non-Infectious Anterior Uveitis in Pediatric Patients,Regulatory,21/2/2019
Merck to Acquire Immune Design for its Technologies for $300M,M&A,21/2/2019
AbbVie &amp; Eisai's Humira (adalimumab) Receives Approval for Hidradenitis Suppurativa in Japan,Regulatory,22/2/2019
Amgen Reports Initiation of Second P-III METEORIC-HF Study of Omecamtiv Mecarbil for Patients with Heart Failure,Pharma,22/2/2019
Janssen (J&amp;J) Signs an Exclusive WW Research Collaboration with Morphic to Develop Human Integrins Therapies?,Pharma,22/2/2019
Eurofarma Signs an Exclusive Development and Commercialization Agreement with NLS-1 Pharma for its Nalazol Therapy,Biotech,22/2/2019
Mallinckrodt Reports Results of Therakos Photopheresis Therapy in P-III study for Steroid-Refractory Acute Graft-Versus-Host Disease (aGvHD),Pharma,22/2/2019
?AstraZeneca Reports Results of Brilinta (ticagrelor) in P-III THEMIS Trial for Patients with Coronary Artery Disease (CAD) and Type-2 Diabetes (T2D),Pharma,25/2/2019
? Roche to Acquire Spark Therapeutics for $4.3B,M&A,25/2/2019
Santhera Reports Results of Raxone (Idebenone) in P-III DELOS trial for Patients with Duchenne Muscular Dystrophy (DMD)?,Pharma,25/2/2019
AbbVie Signs an Exclusive Worldwide Research Collaboration with Voyager Therapeutics for Vectorized Abs,Pharma,25/2/2019
?Danaher to Acquire Biopharma Unit of GE LifeScience for $21.4B,M&A,26/2/2019
Novartis Exercises its Option to License AKCEA-APO(a)-LRx from Akcea,Pharma,26/2/2019
?Ipsen to Acquire Clementia Pharmaceuticals for $1.31B to Expand its Rare Disease Portfolio,M&A,26/2/2019
?Amgen Reports In-Favor Uphold of its Two Patents for Repatha from Delaware Jury,Biotech,26/2/2019
?Genmab Reports Results of Darzalex (daratumumab) in P-III COLUMBA Study for Patients with R/R Multiple Myeloma,Pharma,26/2/2019
?AstraZeneca and Merck Report Result of Lynparza (olaparib) in P-III POLO Trial for BRCA-Mutated Metastatic Pancreatic Cancer #ASCO2019,Pharma,27/2/2019
?Roche and Immatics Collaborate to Evaluate IMA101 + Tecentriq (atezolizumab) for Solid Cancers,Pharma,27/2/2019
?Imbrium Signs a License Agreement with TetraGenetics for its TetraExpress Technology,Biotech,27/2/2019
?Medtronic Resolute Drug-Eluting Stent (DES) Platform Receives FDA's Approval for Expanded Indication for Chronic Total Occlusion (CTO),MedTech|Regulatory,27/2/2019
Sarepta Exercises its Exclusive Option to Acquire Myngonexus Therapeutics for $165M,M&A,27/2/2019
AstraZeneca's Farxiga and Xigduo XR Receives FDA's Expanded Label Approval for Type 2 Diabetes (T2D) and Moderate Renal Impairment,Regulatory,28/2/2019
Janssen's Tremfya (guselkumab) Receives FDA's Approval for Moderate-to-Severe Plaque Psoriasis in Adults,Regulatory,28/2/2019
Novartis Signs a Research Agreement with Target PharmaSolutions for Conducting TARGET-DERM Study?,Pharma,28/2/2019
?Novartis and Blackstone Life Sciences Collaborate to Launch Anthos Therapeutics for Cardiovascular Disorders,Pharma,28/2/2019
?Amicus Therapeutics' Galafold (migalastat) Receives FDA Approval for Fabry Disease in Adult Patients,Pharma,2018-10-08
AbCellera and Denali Therapeutics Expand Collaboration to Develop Abs for Neurological Disorders,Pharma,28/2/2019
?Servier's Asparlas (calaspargase pegol-mknl) Receives FDA's Approval for Acute Lymphoblastic Leukemia (ALL),Regulatory,20/12/2018
Shire's Motegrity (prucalopride) Receives FDA Approval for Chronic Idiopathic Constipation (CIC) in Adults,Regulatory,17/12/2018
?Catalyst's Firdapse (amifampridine) Receives FDA's Approval for Lambert-Eaton Myasthenic Syndrome,Regulatory,20/10/2018
Roche's Herceptin Hylecta (trastuzumab and hyaluronidase-oysk) Receives FDA's Approval for Patients with HER2-Positive Breast Cancers,Regulatory,2019-01-03
Biogen's Spinraza (nusinersen) Receives NMPA (CFDA) Approval for Spinal Muscular Atrophy (SMA) Aged 6wks.?,Regulatory,2019-01-03
?Pfizer's Daurismo (glasdegib) Receives FDA Approval for Adults with Newly-Diagnosed Acute Myeloid Leukemia (AML),Regulatory,2018-11-10
Sobi's Gamifant (emapalumab) Receives FDA Approval for Primary Haemophagocytic Lymphohistiocytosis (HLH),Regulatory,20/11/2018
Pfizer's Lorbrena (lorlatinib) Receives FDA Approval for Patients with 1L ALK- Positive Metastatic NSCLC,Regulatory,20/11/2018
"Alvogen Expands Development and Commercialization Collaboration with Pfenex for PF708 in EU, MENA and ROW",Biosimilars|Biotech,2019-01-03
"Pfizer's Talzenna (talazoparib) Receives FDA Approval for BRCA-Mutated, HER2-Negative LA or MBC",Regulatory,2018-11-10
?Ionis' Tegsedi (inotersen) Receives FDA Approval for Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis in Adults,Regulatory,2018-05-10
Johnson &amp; Johnson (J&amp;J) Collaborates with AdoRx Therapeutics to Develop Therapies for Lung Cancer,Pharma,2019-01-03
Leadiant Biosciences Revcovi's (elapegademase-lvlr) Receives FDA Approval for Adenosine Deaminase Severe Combined Immune Deficiency (ADA-SCID) in Pediatric and Adult Patients,Regulatory,2018-05-10
Paratek Pharmaceuticals' Nuzyra (omadacycline) Receives FDA Approval for Community-Acquired Bacterial Pneumonia (CABP) and Acute Skin and Skin Structure Infections (ABSSSI) in Adults,Regulatory,2018-02-10
TaiMed Biologics' Trogarzo (ibalizumab-uiyk) Receives Approval for Multidrug Resistant (MDR)-HIV,Regulatory,2018-06-03
Paratek's Seysara (sarecycline) Receives FDA's Approval for Treatment of Moderate to Severe Acne,Regulatory,2018-02-10
?Verastem Oncology's Copiktra (duvelisib) Receives FDA Approval for r/r 2L+ Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL),Regulatory,24/9/2018
Rigel Pharmaceuticals' Tavalisse (fostamatinib disodium hexahydrate) Receives FDA Approval for Chronic Immune Thrombocytopenia (ITP) in Adults,Regulatory|Uncategorized,2018-06-03
Merck's Pifeltro (doravirine) Receives FDA Approval for Patients with HIV-1 in Appropriate Patients,Regulatory,30/8/2018
Therapeutics MD's Annovera (Segesterone Acetate/Ethinyl Estradiol) Receives FDA Approval for the Prevention of Pregnancy?,Regulatory,2018-10-08
?Tetraphase Pharmaceuticals' Xerava (eravacycline) Receives FDA's Approval for Complicated Intra-Abdominal Infections (CIAI),Regulatory,27/8/2018
?Eli Lilly's Olumiant (baricitinib) Receives FDA Approval for Moderately-to-Severely Active Rheumatoid Arthritis (RA) in Adults,Regulatory,2018-06-06
GSK's Krintafel (tafenoquine) Receives FDA Approval Preventing the Relapse of P.vivax Malaria?,Regulatory,20/7/2018
AstraZeneca's Lokelma Receives FDA's Approval for Patients with Hyperkalaemia in Adults,Regulatory,18/5/2018
Amgen's Aimovig (erenumab-aooe) Receives FDA's Approval for Prevention of Migraine in Adults,Regulatory,17/5/2018
Agios Pharmaceuticals' Tibsovo (ivosidenib) Receives Approval For R/R Acute Myeloid Leukemia (AML) and IDH1 Mutation?,Regulatory,20/7/2018
Janssen's Erleada (apalutamide) Receives FDA Approval for Non-Metastatic Castration-Resistant Prostate Cancer (NM-CRPC),Regulatory,14/2/2018
?Helsinn's (fosnetupitant + palonosetron) Receives FDA Approval for Managing Chemotherapy-Induced Nausea and Vomiting (CINV),Regulatory,20/4/2018
?SIGA Technologies' TPOXX (tecovirimat) Receives FDA Approval for Smallpox,Regulatory,13/7/2018
BioMarin's Palynziq (pegvaliase-pqpz) Receives FDA Approval for Phenylketonuria (PKU) in Adults,Regulatory,24/5/2018
Achaogen's Zemdri (plazomicin) Receives FDA Approval for Complicated Urinary Tract Infection (cUTI),Uncategorized,26/6/2018
GW Pharmaceuticals' Epidiolex (cannabidiol) Receives FDA Approval for Epilepsy for 2yrs. or older,Regulatory,25/6/2018
Medicines Development for Global Health's (MDGH) Moxidectin Receives FDA Approval for Onchocerciasis (River Blindness),Regulatory|Uncategorized,13/6/2018
?Novavax Reports Results of ResVax in P-III PREPARE Trial for Prevention of RSV Disease in Infants via Maternal Immunization,Pharma,2019-01-03
Biocodex's Diacomit (stiripentol) Receives FDA Approval for Seizures Associated with Dravet Syndrome (DS) in Patients Aged 2 Years or Older,Regulatory,2018-02-08
Sanofi's Zynquista (sotagliflozin) and Dupixent (dupilumab) Receives CHMP Recommendation for Type 1 Diabetes and Asthma?,Regulatory,2019-04-03
Novartis Reports Results of Cosentyx (secukinumab) in P-III Study in Patients with Moderate to Severe Plaque Psoriasis in China?,Pharma,2019-04-03
?Lupus Therapeutics Signs a Research Agreement with Takeda for its TAK-079,Pharma,2019-04-03
?Biogen to Acquire Nightstar Therapeutics for $800M,M&A,2019-04-03
?Verastem Oncology Reports Results of Copiktra (Duvelisib) in P-III DUO Study in Patients with R/R CLL/SLL,Pharma,2019-05-03
?Clovis Oncology Launches Rubraca (rucaparib) for Women with Relapsed Ovarian Cancer in Germany,Pharma,2019-05-03
?Ascendis Pharma Reports Results of TransCon Growth Hormone in P-III Height Study for Growth Hormone Deficiency (GHD) in Children,Pharma,2019-05-03
"Bioxcel, Nektar and Merck KGaA in a Triple Collaboration for Pancreatic Cancer",Pharma,2019-05-03
ProMab Biotechnologies Signs Worldwide License Agreement with NantKwest to Develop Ab for Multiple Myeloma,Pharma,2019-05-03
?Celgene's Fedratinib Receives FDA's Priority Review to NDA Filing for Myelofibrosis,Regulatory,2019-06-03
Genentech Announces FDA's Acceptance of sNDA for Xofluza (baloxavir marboxil) in Patients with Influenza,Regulatory,2019-06-03
?Pacira to Acquire MyoScience to Expand its Post-Surgical Portfolio,M&A,2019-06-03
Acceleron's ACE-083 Receives FDA's ODD for Charcot Marie Tooth Disease (CMT),Regulatory,2019-06-03
Pfizer Exercised its Option to License AnTolRx's Immune Tolerance Therapy for Type 1 Diabetes (T1D),Pharma,2019-06-03
?Allergan Reports Results of Rapastinel in Four P-III RAP-MD Studies for Major Depressive Disorders (MDD),Pharma,2019-07-03
?BeiGene and Ambrx Enters into a Worldwide Research and Development Collaboration to Develop Novel Biologics,Pharma,2019-07-03
Vertex Reports Positive Results of Triple Combination Therapy in P-III Studies for Cystic Fibrosis?,Pharma,2019-07-03
?Alnylam Reports Positive Result of Givosiran in P-III ENVISION Study for Acute Hepatic Porphyria (AHP),Pharma,2019-07-03
?Baxter's Eptifibatide Receives the US FDA's Approval for Cardiovascular Diseases,Regulatory,2019-07-03
?Shionogi Signs Development &amp; Commercialization Agreement with Akili for its AKL-T01 and AKL-T02 for ADHD &amp; ASD,DigiHealth|Pharma,2019-08-03
?Oncternal Therapeutics Reverse Merges with GTx,M&A,2019-08-03
?Janssen (J&amp;J) Reports Positive Results of Rilpivirine + Cabotegravir in P-III ATLAS and FLAIR Studies for HIV,Pharma,2019-08-03
Zeiss' CIRRUS HD-OCT Receives FDA's 510 (k) Clearance for Epithelial Thickness Mapping (ETM),MedTech,2019-08-03
?Bayer Submits EU's Marketing Authorization Application to EMA for Darolutamide,Regulatory,2019-08-03
Roche's Ventana PD-L1 (SP142) Receives FDA's Approval for Identifying Triple-Negative Breast Cancer (TNBC) as CDx?,MedTech|Pharma,2019-11-03
?MSD Signs a License Agreement with King's College London &amp; Wellcome's Innovations to Develop Chronic Neuropathic Pain Therapies,Pharma,2019-11-03
Almirall's Ilumetri (tildrakizumab) Receives NICE's Provisional Approval for Moderate-To-Severe Plaque Psoriasis?,Regulatory,2019-11-03
?Roche's Tecentriq + Abraxane Receive FDA's Accelerated Approval for mTNBC,Regulatory,2019-11-03
?AstraZeneca and Seres Therapeutics Enters into Research Collaboration for 3yrs.,Pharma,2019-12-03
Pfizer's Trazimera (trastuzumab-biosimilar) Receives FDA's Approval for HER-2+ Breast Cancer and m-Gastric/GEJ Cancer?,Biosimilars|Biotech,2019-12-03
Allergan Reports Acceptance of NDA from FDA for its Ubrogepant for Migraine,Pharma,2019-12-03
?Fujifilm to Acquire Biogen's Danish Biologics Manufacturing Facility for $890M,Biotech|M&A,2019-12-03
?Paige.AI Receives FDA's Breakthrough Designation for its Artificial Intelligence in Pathology,Regulatory,2019-12-03
Eli Lilly Reports Positive Results of Cyramza (ramucirumab) in P-III RELAY Study for mNSCLC?,Pharma,2019-12-03
Vertex's Symdeko (tezacaftor/ivacaftor and ivacaftor) Receives TGA's Approval for Cystic Fibrosis with CFTR Gene Mutation in Australia?,Regulatory,13/3/2019
?Secura Bio Acquires WW Commercialization Rights to Novartis' Farydak for R/R Multiple Myeloma,M&A,13/3/2019
?Akebia Therapeutics Reports Positive Results of Vadadustat in P-III J01 &amp; J03 Studies for Anemia Due to Chronic Kidney Disease (CKD) in Japan,Pharma,13/3/2019
?Exactech to Acquire XpandOrtho for its Ligament-Balancing Technology,M&A,13/3/2019
?Sun Pharma's SPARC Signs a Research Collaboration with HitGen to Develop Therapies,Pharma,13/3/2019
?Retrotope's RT001 Receives EMA's Orphan Drug Designation for Infantile Neuroaxonal Dystrophy (INAD),Regulatory,14/3/2019
?Smith &amp; Nephew to Acquire Osiris Therapeutics for $660M,M&A,14/3/2019
?Roche's Hemlibra Receives EU's Approval for Severe Haemophilia A without Factor VIII Inhibitors,Regulatory,14/3/2019
?Hoth Therapeutics Signs a License Agreement with UMB and Isoprene Pharmaceuticals,Pharma,14/3/2019
?Merck's Keytruda + Chemotherapy Receive EU's Approval for Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC),Regulatory,14/3/2019
?Merck KGaA Collaborates with Iktos for its Artificial Intelligence (AI) Technology,Biotech,15/3/2019
?Bayer Reports Results of Nifurtimox in P-III CHICO Study for Chagas Disease in Pediatric Patients,Pharma,15/3/2019
Roche's MabThera (rituximab) Receives EU's Approval for Rare Autoimmune Disease Pemphigus Vulgaris (PV),Biotech,15/3/2019
?Abbott's MitraClip Device Receives FDA's Expanded Indication Approval for Secondary Mitral Regurgitation (MR),Regulatory,15/3/2019
AbCellera ?Signs a Research Agreement with Bill &amp; Melinda Gates Foundation to Accelerate Global Health Research,Pharma,15/3/2019
BMS Reports Positive Results of Eliquis (apixaban) in P-IV AUGUSTUS Study for NVAF/ACS/PCI,Pharma,18/3/2019
Alcon to Acquire PowerVision for $285M,M&A,18/3/2019
?Novartis Reports Results of Entresto (sacubitril/valsartan) in PIONEER-HF 4-Week Extension Study for Systolic Heart Failure,Pharma,18/3/2019
?Cellesce Signs a License Agreement with Hubrecht Organoid Technology (HUB) for the Expansion of Organoids,Biotech,18/3/2019
AstraZeneca Reports Positive Results of Farxiga in P-III DECLARE-TIMI 58 Study for Type-2 Diabetes (T2D),Pharma,19/3/2019
?Baxter and BioMerieux Collaborates to Develop Biomarkers for Acute Kidney Injury (AKI),Biotech,19/3/2019
Jazz Pharmaceuticals' Sunosi (solriamfetol) Receives FDA's Approval for the Treatment of Sleep Disorders?,Regulatory,22/3/2019
Mylan Voluntary Globally Recalls 2 Lots of Levoleucovorin (250mg/25ml) Injection Used to Prevent Harmful Effects of Methotrexate,Pharma,19/3/2019
Merck Extends its Strategic Collaboration with NGM Biopharmaceuticals,Pharma,22/3/2019
Roche's Tecentriq (atezolizumab) + Chemotherapy (carboplatin and etoposide) Receive FDA's Approval for Extensive-Stage Small Cell Lung Cancer (ES-SCLC),Regulatory,19/3/2019
?Biogen and Eisai Terminate P-III ENGAGE and EMERGE Study for Alzheimer's Disease,Pharma,22/3/2019
Théa and OliX Announce Collaboration to Develop RNAi Therapies for the Treatment of AMD,Biotech,19/3/2019
Merck KGaA and Pfizer Terminates P-III JAVELIN Ovarian PARP 100 Study for Advanced Ovarian Cancer,Pharma,20/3/2019
?Celgene Collaborates with Exscientia for its AI Drug Discovery Platform,Pharma,22/3/2019
"?Novartis Announces Spin-Off of Alcon Eye Care Business on April 9, 2019",M&A,22/3/2019
AbbVie Reports FDA's Hold on All Clinical Trials Evaluating Venclexta/Venclyxto (venetoclax) for Multiple Myeloma,Regulatory,20/3/2019
?Merck KGaA Collaborates with GenScript for the Expansion of Cell and Gene Therapies in China,Biotech,20/3/2019
?Sage Therapeutics' Zulresso (brexanolone) Receives FDA's Approval for Postpartum Depression (PPD),Regulatory,20/3/2019
Evotec and GARDP Collaborates to Develop Novel Antibiotics for Antimicrobial Resistance (AMR)?,Pharma,20/3/2019
AstraZeneca Signs Development and Commercialization Agreement with Kyowa Hakko Kirin for its Fasenra (beralizumab)?,Pharma,26/3/2019
?Thermo Fischer to Acquire Brammer Bio for $1.7B,M&A,25/3/2019
?Almirall Signs a Research Collaboration with HitGen for its DNA-Encoded Technology,Pharma,26/3/2019
?Lupin and YL Biologics' Etanercept Biosimilar (YLB113) Receive PMDA's Approval for Moderate-to-Severe Rheumatoid Arthritis (RA) and Juvenile Idiopathic Arthritis (JIA) in Japan,Biosimilars|Biotech,26/3/2019
"AbbVie's Skyrizi (risankizumab) Receives Japanese Ministry of Health, Labour and Welfare (MHLW) Approval to Treat Plaque Psoriasis, Generalized Pustular Psoriasis, Erythrodermic Psoriasis and Psoriatic Arthritis in Adults",Pharma,26/3/2019
?Celgene Files NDA for Ozanimod to the US FDA for Relapsing Forms of Multiple Sclerosis (RMS),Regulatory,26/3/2019
Novartis' Mayzent (siponimod) Receives FDA's Approval for Patients with Secondary Progressive Multiple Sclerosis (SPMS)?,Regulatory,27/3/2019
?Eli Lilly Signs an Exclusive Worldwide License Agreement with ImmuNext to Develop Therapies for Autoimmune Disorders,Pharma,27/3/2019
?AstraZeneca's Forxiga (dapagliflozin) Receives MHLW's Approval for Type-1 Diabetes (T1D) in Japan,Regulatory,27/3/2019
"?Gilead's Biktarvy (Bictegravir, Emtricitabine and Tenofovir Alafenamide) Receives MHLW's Approval for HIV-1 Infection in Japan",Regulatory,27/3/2019
?Jazz Pharmaceuticals Reports Results of JZP-258 in P-III Study for Narcolepsy Patients with Cataplexy and Excessive Daytime Sleepiness,Pharma,27/3/2019
Takeda Collaborates with LegoChem Biosciences (LCB) to Develop Antibody-Drug Conjugates in Immuno-Oncology,Biotech|Pharma,25/3/2019
?Eisai Signs a Research Agreement with Cerveau Technologies for its Novel Tau Imaging Agent,Biotech,25/3/2019
AstraZeneca's Forxiga (dapagliflozin) Receives EU's Approval for Type-1 Diabetes (T1D) in Adults,Regulatory,25/3/2019
?BioLineRx Reports Engraftment Data of BL-8040 in P-III GENESIS Trial for Patients with Multiple Myeloma,Pharma,28/3/2019
?Chugai's Risdiplam Receives MHLW's Orphan Drug Designation for Spinal Muscular Atrophy (SMA),Regulatory,28/3/2019
?Ono Pharmaceutical Signs a Multi-Year Collaboration with LifeArc and Cancer Research UK to Develop Immuno-Therapies for Cancer,Pharma,28/3/2019
?Apple Launches its Watch Series 4 Enabled with ECG App and Irregular Rhythm Notification in Europe and Hong Kong,DigiHealth,28/3/2019
?Johnson &amp; Johnson (J&amp;J) Vision Launches Acuvue Oasys with Transitions Light Intelligent Technology in the US,Biotech,28/3/2019
?Bayer Signs a Non-Exclusive Licensing Agreement with ProteoNic Biotechnology for its 2G UNic Technology,Biotech,29/3/2019
?Gilead and Galapagos' Report Results of Filgotinib in P-III FINCH 3 Trial for Moderate-To-Severe Active Rheumatoid Arthritis (RA),Pharma,29/3/2019
?AstraZeneca Signs a Worldwide Development and Commercialization Agreement with Daiichi Sankyo for $6.9B,Biotech,29/3/2019
?Mitsubishi Tanabe Pharma (MTPA) Collaborates with Massachusetts General Hospital (MGH) for ALS Biomarker Study,Pharma,29/3/2019
Takeda Signs a Multi-Target Agreement with StrideBio to Develop Gene Therapies for Neurological Disorders,Biotech,29/3/2019
?Bluebird Bio's Zynteglo Receives CHMP's Positive Opinion for Conditional Marketing for Patients with Transfusion-Dependent ß-Thalassemia (TDT) without ß0/ß0 Genotype,Regulatory,2019-01-04
?Novartis to Acquire IFM Tre for its Clinical and Preclinical Portfolio of NLRP3 Inhibitors for $1.5B,M&A,2019-01-04
?Boehringer Ingelheim (BI) to Acquire ICD Therapeutics for its MacroDel Delivery Technology,Biotech,2019-01-04
?Roche Reports Result of Ipatasertib + Tecentriq (atezolizumab) in P-Ib Study for 1L Patients with Advanced Triple-Negative Breast Cancer (TNBC),Pharma,2019-01-04
?VistaGen Therapeutics Reports Positive Results of PH94B in P-III study for Social Anxiety Disorder (SAD),Pharma,2019-02-04
AveXis to Purchase Biologics Manufacturing Facility in Colorado,Biotech,2019-02-04
?Merck's Keytruda (pembrolizumab) + Chemotherapy Receive NMPA's (CFDA) Approval for 1L Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC),Regulatory,2019-02-04
Novartis' Cosentyx (secukinumab) Receives NMPA's (CFDA) Approval for Patients with Plaque Psoriasis in Adults,Regulatory,2019-02-04
Sangamo Therapeutics Signs an Option Agreement with Brammer Bio for its AAV Manufacturing Facility,Biotech,2019-02-04
Allergan and Molecular Partners Report Result of Abicipar pegol in P-III MAPLE Study for Neovascular Macular Degeneration (nAMD)?,Pharma,2019-03-04
?Astellas Signs a Research and License Agreement with Xencor for Bispecific Antibody Program in Oncology,Biotech,2019-03-04
?Encore Dermatology to Acquire US Commercialization Rights for Dr. Reddy's Three Dermatology Products,M&A,2019-03-04
?Dermelix Collaborates with EspeRare to Co-develop and Commercialize DMX-101 for XLHED,Pharma,2019-03-04
?Channel Medsystems' Cerene Cryotherapy Device Receives FDA's Approval for Heavy Menstrual Bleeding,MedTech,2019-03-04
?Liquidia Reports Results of LIQ861 in P-III INSPIRE Trial in Patients with Pulmonary Arterial Hypertension (PAH),Pharma,2019-04-04
"?Fresenius Kabi's Idacio (adalimumab, biosimilar) Receives EU's Marketing Approval in Rheumatology, Gastroenterology and Dermatology",Biosimilars|Biotech,2019-04-04
?Editas Medicine Signs a Research and Cross-Licensing Agreement with BlueRock Therapeutics for their Technologies,Biotech,2019-04-04
?Genmab and Janssen Biotech Report Initiation of P-III MMY3021 Study for Darzalex (daratumumab) in Multiple Myeloma,Pharma,2019-04-04
AstraZeneca and the US NIAID Report Results of Fasenra (benralizumab) in P-II Study for Hypereosinophilic Syndromes (HES),Pharma,2019-04-04
?Oncology Venture Signs an Exclusive Option Agreement to In-License Commercialization Rights for R-Pharm's Ixempra (ixabepilone) in EU,Pharma,2019-05-04
?Myriad Expands its Companion Diagnostic Collaboration with AstraZeneca and Merck,MedTech,2019-05-04
?Abbott Signs a Non-Exclusive License Agreement with Banyan Biomarkers for its Traumatic Brain Injury (TBI) Blood Biomarkers,Biotech|MedTech,2019-05-04
?Roivant Launches Cytovant Sciences to Collaborates with Medigene for the Development of Cellular Therapies in Asia,Biotech,2019-05-04
?Amazon Launches Alexa's Health Services for Managing Health and Handling Patients Data,DigiHealth,2019-05-04
?Novartis' Kisqali + Aromatase Inhibitor Receive FDA's Breakthrough Therapy Designation for HR+/HER2- Advanced Breast Cancer,Regulatory,2018-03-01
?Roche's Hemlibra Receives FDA's Breakthrough Therapy Designation for Hemophilia A without Factor VIII Inhibitors,Regulatory,17/4/2018
Roche's Tecentriq + Avastin Receive FDA's Breakthrough Designation as 1L Treatment for Advanced or Metastatic Hepatocellular Carcinoma (HCC),Regulatory,18/7/2018
Proteostasis' PTI-428 Receives FDA's Breakthrough Therapy Designation for Cystic Fibrosis (CF),Regulatory,2018-12-03
Novartis' Promacta Receives FDA's Breakthrough Therapy Designation for Severe Aplastic Anemia (SAA),Regulatory,2018-04-01
Seattle Genetics' Adcetris (brentuximab vedotin) Receives FDA's Breakthrough Designation for Frontline Peripheral T-Cell Lymphomas?,Pharma,15/11/2018
?Compass Pathways' Psilocybin Therapy Receives FDA's Breakthrough Therapy Designation for Treatment-Resistant Depression,Regulatory,23/10/2018
Sage Therapeutics' SAGE-217 Receives FDA's Breakthrough Designation for CNS Disorders,Regulatory,2018-07-02
?Avita Medical Reports Results of RECELL System in Investigational Device Exemption (IDE) Compassionate Use and Continued Access Studies for Third-Degree Burns in Pediatric Patients,MedTech,2019-08-04
?Celgene and Acceleron Pharma Submit Biologics License Application (BLA) to the US FDA for Luspatercept,Biotech|Regulatory,2019-08-04
?Sanofi and Alnylam Exercise Research and Option Phase Collaboration for its 2014 Deal,Biotech,2019-08-04
Xoma Purchases Royalty Rights for Aronora's Five Preclinical and Clinical Hematology Candidates,Pharma,2019-08-04
"?Regeneron Collaborates with Alnylam to Discover, Develop and Commercialize RNAi Therapeutics for Ophthalmic and CNS Disorders",Biotech,2019-09-04
ViiV Healthcare's Dovato (dolutegravir/lamivudine) Receives FDA's Approval to Treat HIV-1 Infection in Adults?,Regulatory,2019-09-04
?uniQure's AMT-130 Receives FDA's Fast Track Designation for Huntington's Disease,Regulatory,2019-09-04
?Audentes Signs an Exclusive License Agreement with Nationwide Children's Hospital (NCH) for the Expansion of its AAV Technology and Pipeline,Pharma,2019-09-04
?BeiGene Signs a Worldwide Co-Development and Commercialization Agreement with BioAtla for BA3071 and Tislelizumab,Pharma,2019-09-04
Amgen's Evenity (romosozumab-aqqg) Receives FDA's Approval for Osteoporosis in Postmenopausal Women at High Risk for Fracture,Regulatory,2019-10-04
?Xinhua Healthcare Signs an Exclusive License Agreement with ArcDia for its mariPOC Technology in China,Biotech,2019-10-04
?AstraZeneca and Merck's Lynparza (olaparib) Receive EU's Approval as a Monotherapy to Treat Germline BRCA-Mutated HER2-Negative Advanced Breast Cancer,Regulatory,2019-10-04
?­Alkermes' Reports Results of Aristada (aripiprazole lauroxil) and Invega Sustenna (paliperidone palmitate) in P-IIIb ALPINE Study to Treat Schizophrenia,Pharma,2019-10-04
Shanghai Fosun Signs an Exclusive License Agreement with ReNeuron for its CTX and hRPC Cell Therapy in China,Biotech,2019-10-04
?Astellas Collaborates with Concerto HealthAI on Real-World Evidence (RWE) Initiative for Acute Myeloid Leukemia (AML),DigiHealth,2019-11-04
?Shanghai Miracogen Signs a Non-Exclusive License Agreement with Synaffix for its ADC Technologies,Biotech,2019-11-04
Sandoz Signs a Commercialization Agreement with Shionogi for Rizmoic (naldemedine) in Europe,Pharma,2019-11-04
Cognoa Signs an Exclusive License Agreement with Stanford for its Google Glass-based Technology for Children with Autism Spectrum Disorder (ASD),Biotech,2019-11-04
?BioDelivery Sciences (BDSI) Signs a License Agreement with Shionogi to Commercialize Symproic (naldemedine) in the US,Pharma,2019-11-04
Merck's Keytruda (pembrolizumab) Receives FDA's Expanded Monotherapy Label Approval for Patients with 1L Stage III Non-Small Cell Lung Cancer (NSCLC),Pharma,2019-12-04
Evotec Signs a Research Agreement with Indivumed to Develop Precision Therapies for Colorectal Cancer (CRC),Biotech,2019-12-04
Moleculin Signs a Clinical Research Agreement with Emory University for Brain Tumor in Pediatric Patients,Pharma,2019-12-04
Gilead and Novo Nordisk Collaborate to Conduct a Combination Therapy Trial in NASH,Pharma,2019-12-04
Omron Healthcare Receives FDA's Approval for Complete a Blood Pressure Monitoring Device with ECG Facility,MedTech|Regulatory,2019-12-04
?Alnylam Reports Results of Givosiran in P-III ENVISION Study to Treat Acute Hepatic Porphyria,Biotech,15/4/2019
?Tracon Terminates its P-III TAPPAS Trial of TRC105 (carotuximab) + Votrient (pazopanib) for Advanced or Metastatic Angiosarcoma,Pharma,15/4/2019
?Dr. Reddy's to Acquire a Portfolio of 42 Abbreviated New Drug Applications (ANDA) in the US,Pharma,15/4/2019
Santhera to Present Result of DELOS &amp; SYROS Study at the 2019 MDA Clinical and Scientific Conference ?,Pharma,15/4/2019
?Generium and Selexis Launch Eculizumab Biosimilar for Paroxysmal Nocturnal Hemoglobinuria (PNH) and Hemolytic Uremic Syndrome (aHUS) in Russia,Biosimilars|Biotech,2019-09-04
Novartis Reports FDA's Acceptance of BLA for Brolucizumab (RTH258) to Treat Wet AMD,Biotech|Regulatory,16/4/2019
?Castle Creek Collaborates with Fibrocell to Develop and Commercialize FCX-007 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB),Biotech,16/4/2019
Eagle Restructured its Licensing Agreement with Teva for Bendeka (bendamustine hydrochloride),Pharma,16/4/2019
Janssen Expands Clinical Development for Tremfya(R) (guselkumab) in Familial Adenomatous Polyposis (FAP)?,Biotech,16/4/2019
Alnylam Initiates P-III ILLUMINATE-B Study of Lumasiran for Primary Hyperoxaluria Type 1 (PH1) in Pediatric Patients,Biotech,16/4/2019
Tessa Collaborates with Merck to Evaluate a Combination Therapy for Metastatic or Recurrent Cervical Cancer?,Biotech,17/4/2019
?Novartis Reports Results of Zolgensma (onasemnogene abeparvovec-xioi) in P-III STR1VE Study for Spinal Muscular Atrophy (SMA) Type 1,Biotech,17/4/2019
?FDA Orders Immediate Stop on Commercialization of Surgical Mesh for Women with Pelvic Collapse in the US,MedTech|Regulatory,17/4/2019
Thermo Fisher Collaborates with NX Prenatal to Develop Proteomics Assays for Adverse Pregnancy Outcomes,MedTech,17/4/2019
?Gilead Collaborates with Insitro to Discover and Develop Novel Therapies in Nonalcoholic Steatohepatitis (NASH) for 3yrs.,Pharma,17/4/2019
?Boehringer Ingelheim Collaborates with PureTech to Develop Immuno-Oncology Candidates for Immune Modulation,Biotech,18/4/2019
?CASI Pharmaceutical Signs an Exclusive Worldwide License Agreement with Black Belt for its TSK011010 Program,Pharma,18/4/2019
Medtronic Reports Results of VenaSeal Closure System in VeClose Extension Study for Chronic Venous Diseases,MedTech,18/4/2019
?OncoSec Signs Research Agreement with Duke University School of Medicine to Evaluate the Combination of TAVOPLUS with a HER2-Plasmid Vaccine,Pharma,18/4/2019
World Health Organization (WHO) Reports 10 Guidelines on Digital Health Interventions,Regulatory,18/4/2019
Pfizer &amp; Eli Lilly Report Results of Tanezumab in Long-Term P-III Study for Osteoarthritis,Pharma,19/4/2019
?AbbVie's Skyrizi (risankizumab) Receives Health Canada's Approval for Moderate to Severe Plaque Psoriasis,Regulatory,19/4/2019
?Mylan and TB Alliance Collaborate to Commercialize Pretomanid in Two Combination Regimens for Tuberculosis,Pharma,19/4/2019
?NICE Publishes Final Recommendation for Almirall's Ilumetri (tildrakizumab) to Treat Moderate-To-Severe Plaque Psoriasis in Adults,Regulatory,19/4/2019
?Almac Diagnostic Collaborates with Queen's University to Bring Personalized Chemotherapy for Esophageal Cancer,MedTech,19/4/2019
?Alvogen Voluntary Recalls Nationwide Two Lots of Fentanyl Transdermal System Due to Product Mislabeling,MedTech|Pharma,22/4/2019
?TELA Bio's Restella Reconstructive BioScaffolds Receives FDA's 510(k) Clearance for Reconstructive Surgery,MedTech,22/4/2019
?Lilly Signs a Global Research and Licensing Agreement with Avidity Biosciences to Develop Therapies in Immunology,Biotech,22/4/2019
Merck's Keytruda (pembrolizumab) + Inlyta (axitinib) Receive FDA's Approval as 1L Treatment for Advanced Renal Cell Carcinoma,Pharma,22/4/2019
?Lilly Reports Results of Taltz (ixekizumab) in P-III COAST-X Study for Non-Radiographic Axial Spondyloarthritis,Biotech,23/4/2019
?Roche Launches Ventana HER2 Dual ISH CDx for the Identification of Breast and Gastric Cancer,MedTech,23/4/2019
?Eli Lilly to Sell Rights for its Two Antibiotics and a Manufacturing Facility to Eddingpharm in China for $375M,Pharma,23/4/2019
?Alder BioPharmaceuticals Reports FDA's Acceptance of BLA for Eptinezumab to Prevent Migraine,Regulatory,23/4/2019
NuVasive Reports Results of Cohere Porous PEEK Implants for Degenerative Cervical Disc,MedTech,23/4/2019
BAROnova's TransPyloric Shuttle Device Receives FDA's Approval for the Treatment of Obesity in Adults,MedTech|Regulatory,24/4/2019
Teva Discontinues its P-III ENFORCE Study of Fremanezumab for Episodic Cluster Headache,Pharma,24/4/2019
?OncoSec Initiates a Triple Combination Immunotherapy Trial for Squamous Cell Head and Neck Cancer,Pharma,24/4/2019
AbbVie's Skyrizi (risankizumab-rzaa) Receives FDA's Approval for Moderate to Severe Plaque Psoriasis,Regulatory,24/4/2019
Fulcrum Therapeutics ?Signs an Exclusive Worldwide License Agreement with GSK to Develop and Commercialize Losmapimod for Facioscapulohumeral Muscular Dystrophy,Pharma,24/4/2019
?Takeda Signs a Licensing Option Agreement with Emendo Biotherapeutics for its OMNI Nuclease Program,Biotech,25/4/2019
Perelman School of Medicine Signs a Research and Development Agreement with Sensus Healthcare for its Sculptura Intraoperative Radiation Therapy System,MedTech,24/4/2019
ADC Therapeutics Signs a License Agreement with Adagene for its SAFEbody Technology,Pharma,25/4/2019
Eli Lilly Facilitates the Withdrawal of Lartruvo (olaratumab) from the Global Market for Advanced Soft Tissue Sarcoma,Pharma,25/4/2019
?B. Braun Launches its Heparin Sodium Prefilled Syringe in the US,Pharma,25/4/2019
Salix (Bausch Health) Signs an Exclusive License Agreement with Mitsubishi Tanabe for its MT-1303 (amiselimod),Pharma,26/4/2019
Merck Reports Updated Results of Keytruda (pembrolizumab) in P-III KEYNOTE-062 Study as a Monotherapy for 1L Treatment of Advanced Gastric Cancer,Pharma,26/4/2019
Takeda Files NDA for Cabometyx (cabozantinib) to MHLW for Advanced Renal Cell Carcinoma in Japan,Regulatory,26/4/2019
?Gilead Reports Results of Selonsertib in P-III STELLAR 3 Study for Bridging Fibrosis (F3) due to NASH,Pharma,26/4/2019
Novo Nordisk Files MAA for Semaglutide to the EMA for Type 2 Diabetes?,Regulatory,26/4/2019
?AstraZeneca and Merck's Lynparza (olaparib) Receive CHMP's Positive Opinion for 1L Maintenance Treatment of BRCA-Mutated Advanced Ovarian Cancer,Pharma,29/4/2019
Sanofi and Lexicon's Zynquista (sotagliflozin) Receive EU's MAA to Treat Type-1 Diabetes in Adults,Pharma,29/4/2019
Acutus Medical's AcQMap Contact Mapping Software Receives CE Mark Approval,Regulatory,29/4/2019
"?Novo Nordisk's Esperoct (turoctocog alfa pegol, N8-GP) Receives CHMP's Positive Opinion to Treat Hemophilia A in Adolescents and Adults",Regulatory,29/4/2019
Sandoz Signs an Agreement with EirGenix to Commercialize Proposed Trastuzumab Biosimilar for HER2+ Cancer Tumors,Biosimilars|Biotech,30/4/2019
ViiV Healthcare Files NDA for Cabotegravir + Edurant (rilpivirine) to the US FDA to Treat HIV-1 Infection in Adults?,Regulatory,30/4/2019
?Janssen Collaborates with Iktos for its Artificial Intelligence (AI) Technology,Biotech,30/4/2019
?AstraZeneca Collaborates with BenevolentAI to Develop Therapies for Chronic Kidney Disease and Idiopathic Pulmonary Fibrosis,Pharma,30/4/2019
Abbott Reports Results of High Sensitive Troponin-I Blood Test for Risk Assessment of Heart Diseases,MedTech,30/4/2019
Vertex's Kalydeco (ivacaftor) Receives FDA's Approval for Cystic Fibrosis in Eligible Infants Aged 6 to Less than 12 Months,Regulatory,2019-01-05
?AbbVie's Mavyret (glecaprevir and pibrentasvir) Receives FDA's Approval for All Genotypes of Hepatitis C in Pediatric Patients,Regulatory,2019-01-05
?Roche Spin-Off Nimble Therapeutics to Commercialize its Drug Development Technology,Pharma,2019-01-05
?AbbVie's Skyrizi (risankizumab) Receives European Commission's Approval for Moderate to Severe Plaque Psoriasis,Regulatory,2019-01-05
?Medtronic Launches Solitaire X Revascularization Device for Acute Ischemic Stroke in the US,MedTech,2019-01-05
?Exelixis Initiates P-III COSMIC-313 Study of Triple Combination Therapy for Advanced Renal Cell Carcinoma,Pharma,2019-02-05
Medtronic's Attain Stability Quad MRI SureScan Left Heart Lead Receives FDA's Approval for Heart Failure?,MedTech,2019-02-05
?Eisai Terminates its Worldwide Development &amp; Commercialization Agreement with Purdue Pharma for Lemborexant,Pharma,2019-02-05
?Tmunity Signs an Exclusive Research Agreement with the University of California to Advance TCR Therapies for Pediatric Cancers,Biotech,2019-02-05
Sanofi's Dengvaxia Receives FDA's Approval to Prevent Dengue in Endemic Region in the US,Pharma,2019-02-05
?AstraZeneca Signs an Exclusive Option and Research Agreement with Transgene for Oncolytic Immunotherapies,Pharma,2019-03-05
?GSK Reports Results of Trelegy Ellipta in P-III CAPTAIN Study for Asthma,Pharma,2019-03-05
?Boehringer Ingelheim Signs a Clinical Research Agreement with Amal for the Evaluation of Combination Therapy to Treat Stage IV colorectal cancer,Pharma,2019-03-05
?Celgene Collaborates with Presage to Evaluate Therapies with its CIVO Technology for Multiple Cancers,Pharma,2019-03-05
"?AstraZeneca's Qternmet XR (dapagliflozin, saxagliptin, metformin hydrochloride) Receives FDA's Approval for Type-2 Diabetes in the US",Regulatory,2019-03-05
?Roche's Kadcyla (trastuzumab emtansine) Receives FDA's Expanded Approval as an Adjuvant Treatment for HER2+ Early Breast Cancer in the US,Regulatory,2019-06-05
?Lundbeck to Acquire Abide Therapeutics for $400M,M&A,2019-06-05
?Astellas Reports Results of Mirabegron in P-IV PLUS Study to Reduce Overactive Bladder Symptoms in Men,Pharma,2019-06-05
?Pfizer's Vyndaqel (tafamidis meglumine) and Vyndamax (tafamidis) Receive FDA's Approval for Transthyretin Amyloid Cardiomyopathy,Regulatory,2019-06-05
?Eli Lilly Reports Results of Emgality (galcanezumab-gnlm) in Two P-III Studies to Treat Low- and High-Frequency Episodic Migraine,Pharma,2019-07-05
?Roche Reports Results of Risdiplam in FIREFISH and SUNFISH Studies for Spinal Muscular Atrophy,Pharma,2019-07-05
?BioMarin's Palynziq (pegvaliase injection) Receives European Commission's MAA Approval for Phenylketonuria,Regulatory,2019-07-05
Takeda Collaborates with Skyhawk Therapeutics to Develop RNA Splicing Modifiers for Neurodegenerative Diseases,Biotech,2019-07-05
?Novartis Reports Results of MS Progression Discussion Tool in a Validation Study for Patients with Multiple Sclerosis,MedTech,2019-07-05
?AstraZeneca Reports Results of Calquence (acalabrutinib) in P-III ASCEND Study for R/R Chronic Lymphocytic Leukaemia,Pharma,2019-08-05
?Roche Reports Results of Ocrevus (ocrelizumab) in Three P-III Studies for Relapsing and Primary Progressive Multiple Sclerosis,Pharma,2019-08-05
?Sanofi's Dupixent (dupilumab) Receives European Commission Approval for Severe Asthma with Type 2 Inflammation,Biotech|Regulatory,2019-08-05
?AstraZeneca and Daiichi Report Results of Trastuzumab Deruxtecan (DS-8201) in P-II DESTINY-Breast01 Study for Refractory HER2+ Metastatic Breast Cancer,Biotech,2019-08-05
?FDA Issues an Alert on Medtronic's Pacemaker or Cardiac Resynchronization Therapy Pacemaker for its Premature Battery Depletion,MedTech,2019-08-05
Pfizer to Acquire Therachon for the Expansion of its Rare Disease Portfolio,M&A,2019-08-05
?Novartis Acquires Worldwide Rights of Takeda's Xiidra (lifitegrast ophthalmic solution) for $5.3B,Pharma,2019-09-05
?Medtronic Reports Results of MiniMed 640G System in the SMILE Study for Reducing Hypoglycemia in Patients with Type 1 Diabetes,MedTech,2019-09-05
?Janssen (J&amp;J) Expands its PTG-200 Collaboration with Protagonist for Second Generation Oral IL-23 Receptor Antagonists,Pharma,2019-09-05
Gilead Collaborates with Goldfinch Bio to Develop and Commercialize Therapies for Kidney Disorders,Pharma,2019-09-05
Takeda Signs a Licensing Agreement with Curadev for Stimulator of Interferon Genes (STING) Agonist,Pharma,2019-09-05
?Ethicon Acquires Rights of Takeda's TachoSil Fibrin Sealant Patch for ~$400M,MedTech,2019-09-05
?BMS Report Results of Opdivo + Radiation in P-III CheckMate -498 Study in Patients with Newly Diagnosed MGMT-Unmethylated Glioblastoma Multiforme,Pharma,2019-10-05
?Medtronic To Acquire Titan Spine for its Portfolio of Implants and nanoLock Surface Technology,M&A,2019-10-05
?Takeda Reports FDA's Acceptance of BLA for Entyvio (Vedolizumab SC) as a Maintenance Therapy in Moderate to Severe Active Ulcerative Colitis,Regulatory,2019-10-05
?Boston Scientific to Acquire Vertiflex for its Superion Indirect Decompression System,M&A,2019-10-05
AstraZeneca Reports Results of Roxadustat in Global Phase III Programme for Cardiovascular Safety in Patients with Chronic Kidney Disease,Pharma,2019-10-05
?Eli Lilly's Cyramza (ramucirumab) Receives FDA's Approval as a Second-line Treatment in Patients with High AFP Hepatocellular Carcinoma,Regulatory,13/5/2019
"?Novartis Voluntary Nationwide Recalls Three Lots of Promacta (eltrombopag, 12.5 mg) Oral Suspension Due to Peanut Contamination",Pharma,13/5/2019
?Boston Scientific Reports Results of Emblem S-ICD System in UNTOUCHED Study to Prevent Sudden Cardiac Death,MedTech,13/5/2019
The US FDA Issues Final Guidance on Interchangeable Biosimilars,Biosimilars|Regulatory,13/5/2019
?Roche Launches Cobas MTB-RIF/INH Test for the Detection of Antimicrobial Resistance in Tuberculosis,MedTech,14/5/2019
?Regeneron's Eylea (aflibercept) Injection Receives FDA's Approval for Diabetic Retinopathy,Regulatory,14/5/2019
?Exelixis and Daiichi Report Launch of Minnebro (Esaxerenone) Tablets for Hypertension in Japan,Pharma,14/5/2019
?AliveCor's KardiaMobile 6L Receives FDA's Clearance as Six-Lead Personal ECG Device,Regulatory,14/5/2019
?HanX Biopharmaceuticals Signs a License Agreement with Onconova to Develop and Commercialize Rigosertib in Greater China,Pharma,14/5/2019
?Myovant Sciences Reports Results of Relugolix Combination Therapy in P-III LIBERTY 1 Study for Uterine Fibroids in Women,Pharma,15/5/2019
?Merck KGaA and Pfizer's Bavencio (avelumab) + Inlyta (axitinib) Receive FDA's Approval as 1L Treatment for Advanced Renal Cell Carcinoma,Regulatory,15/5/2019
?Abbott Collaborates with NIH on Brain Initiative for Advancing Research on Neurological Disorders,Biotech,15/5/2019
?Progenics Signs an Exclusive Agreement with ROTOP Pharmaka to Develop and Commercialize Imaging Agent 1404 for Prostate Cancer in Europe,MedTech,15/5/2019
?REGENXBIO Launches a Manufacturing Facility for Developing Gene Therapies Based on NAV-Technology,Biotech,15/5/2019
?Roche and AbbVie's Venclexta (venetoclax) + Gazyva (obinutuzumab) Receive FDA's Approval for Untreated Chronic Lymphocytic Leukemia,Regulatory,16/5/2019
Vertex Signs a 4 Years Agreement with Kymera to Discover and Develop Protein Degradation Therapies,Biotech,16/5/2019
?Takeda and Frazier Healthcare Collaborate to Launch a Facility Phathom Pharmaceutical for Gastrointestinal Disorders,Pharma,16/5/2019
"?NeuClone to Initiate P-I Clinical Study of Stelara (ustekinumab, biosimilar) in Australia",Biosimilars|Biotech,16/5/2019
?GSK Expands its License Agreement with Zymework to Develop and Commercialize Bi-Specific Antibodies,Pharma,16/5/2019
?Sanofi and Regeneron Report Updated Results of Libtayo (cemiplimab-rwlc) in P-II EMPOWER-CSCC-1 Study for Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma,Biotech,17/5/2019
?Thermo Fisher to Acquire Manufacturing Facility from GSK for ~$100M,Pharma,17/5/2019
?Pfizer's Fragmin (dalteparin sodium) Receives FDA's Approval for Symptomatic Venous Thromboembolism in Pediatric Patients,Regulatory,17/5/2019
?Exelixis Signs an Exclusive Option and License Agreement with Iconic Therapeutics for Advancing ADC Program,Pharma,17/5/2019
Roche Signs a Worldwide License Agreement with Parvus Therapeutics to Develop and Commercialize Navacim Platform for Autoimmune Diseases,Pharma,17/5/2019
?AbbVie Reports Results of Depatux-M (depatuxizumab mafodotin) in P-III INTELLANCE-1 Study for Glioblastoma,Biotech,20/5/2019
?Takeda Reports Results of Entyvio (vedolizumab) in P-III VARSITY Study for Ulcerative Colitis,Biotech,20/5/2019
?Ethicon (J&amp;J) Recalls Endo-Surgery Intraluminal Staplers Due to Complete Staple Line Failure,MedTech,20/5/2019
Takeda's Gattex (teduglutide) Receives the US FDA's Approval for Short Bowel Syndrome in Children,Regulatory,20/5/2019
?UCB's Nayzilam (midazolam) Receives FDA's Approval for the Treatment of Seizure Cluster in Epilepsy in the US,Regulatory,21/5/2019
?Santhera Signs a Pre-Clinical Research Agreement with Biozentrum to Advance Gene Therapy for Congenital Muscular Dystrophy,Biotech,21/5/2019
?Merck Reports Results of Keytruda (pembrolizumab) in P-III KEYNOTE-119 Study for Metastatic Triple-Negative Breast Cancer,Pharma,21/5/2019
AstraZeneca Reports Results of Symbicort Turbuhaler (budesonide/formoterol) in Novel START Study for Mild Asthma,MedTech|Pharma,21/5/2019
?Clovis Oncology Reports Results of Rubraca (rucaparib) in P-III ARIEL3 Study for Advanced Ovarian Cancer,Pharma,21/5/2019
?Merck to Acquire Peloton Therapeutics for $2.2B,M&A,22/5/2019
Verily Collaborates with Global Pharma Companies to Develop Clinical Research Program,Pharma,22/5/2019
?Array BioPharma Reports Results of Combination Therapy in P-III BEACON CRC Study for BRAF(V600E)- Mutant Metastatic Colorectal Cancer,Pharma,22/5/2019
?Abbott Reports Results of Minimally Invasive Device in TRILUMINATE Study for Tricuspid Heart Valve Leaks,MedTech,22/5/2019
Medtronic Reports Results of Symplicity Renal Denervation System in Two Studies for Hypertensive Heart Diseases,MedTech,22/5/2019
"Biocon and Mylan's Ogivri (trastuzumab, biosimilar) Receives Health Canada's Approval for HER2-Positive Breast and Gastric Cancers",Biosimilars|Regulatory,22/5/2019
?Takeda's Entyvio (vedolizumab) Receives MHLW's Approval for Moderate to Severely Active Crohn's Disease in Japan,Regulatory,23/5/2019
Santhera Signs an Exclusive License Agreement with Chiesi to Develop and Commercialize Raxone for Leber's Hereditary Optic Neuropathy,Pharma,23/5/2019
?OncoSec Reports Result of Keytruda + TAVO in P-II KEYNOTE-890 Study for Refractory Metastatic Triple Negative Breast Cancer,Pharma,23/5/2019
?Synlogic Collaborates with Roche to Evaluate the Combination of SYNB1891 and Tecentriq (atezolizumab) for Advanced Solid Tumors,Biotech,23/5/2019
?Boston Scientific Initiates OPTION Study of Watchman FLX Device for Stroke Risk Reduction Post-AF Ablation,MedTech,23/5/2019
?GSK's Shingrix Receives NMPA's Approval for the Prevention of Shingles in China,Regulatory,24/5/2019
"?Celltrion's Herzuma (trastuzumab, biosimilar) Receives ANVISA's Approval for Breast and Gastric Cancer in Brazil",Biosimilars|Regulatory,24/5/2019
?Hologic &amp; Cepheid's Diagnostic Tests Receive 510(k) Clearance for Extragenital Testing in Chlamydia and Gonorrhea,MedTech,24/5/2019
?Roche's Cobas TV/MG Test Receives FDA's 510 (k) Clearance for the Detection of Sexually Transmitted Diseases,MedTech|Pharma,24/5/2019
?BrightInsight Launches a CE-Marked Dosing Calculator for Emicizumab to Treat Patients with Hemophilia A,MedTech,24/5/2019
?Novartis' Piqray (alpelisib) + Fulvestrant Receive FDA's Approval for Patients with a PIK3CA Mutation in HR+/HER2- Advanced/Metastatic Breast Cancer,Regulatory,27/5/2019
?Pfizer Reports Results of Lyrica (pregabalin) in P-III Study for Primary Generalized Tonic-Clonic Seizures,Pharma,27/5/2019
?Novartis' Zolgensma (onasemnogene abeparvovec-xioi) Receives FDA's Approval for Spinal Muscular Atrophy in Pediatric Patients,Regulatory,27/5/2019
?Calecim Collaborates with Menarini Asia-Pacific to Expand the Worldwide Sales of its Product,Pharma,27/5/2019
?Santhera Reports Submission of Marketing Authorization Application to the EMA for Puldysa (Idebenone) in Duchenne Muscular Dystrophy,Regulatory,28/5/2019
?Matas to Acquire Kosmolet for its Make-up Brand Nilens Jord,M&A,28/5/2019
?Nanobiotix Launches Curadigm Facility with Nanoprimer Technology in France and the US,Pharma,28/5/2019
BioMarin Reports Results of Valoctocogene Roxaparvovec in P-III GENEr8-1 Study for Hemophilia A,Biotech,28/5/2019
Eli ?Lilly Signs an Exclusive Worldwide License Agreement with Centrexion Therapeutics for its CNTX-0290,Pharma,28/5/2019
?Celgene's Revlimid (Lenalidomide) + Rituximab Receive FDA's Approval for Previously Treated Follicular Lymphoma or Marginal Zone Lymphoma in Adults,Regulatory,29/5/2019
"Prestige BioPharma Reports EMA's Acceptance of Marketing Authorization Application for its Tuznue (trastuzumab, biosimilar)?",Biosimilars|Regulatory,29/5/2019
?Bayer Signs a License Agreement with Sensible Medical for its ReDS Technology in Europe,MedTech,29/5/2019
?Arvinas' ARV-110 Receives the US FDA's Fast Track Designation for Metastatic Castration-Resistant Prostate Cancer in Men,Regulatory,29/5/2019
?Ziopharm Signs an Exclusive License Agreement with NIH to Develop and Commercialize TCRs Targeting Neoantigen for Cancer,Biotech,29/5/2019
Bayer Signs a Worldwide Agreement with Roche's Foundation Medicine to Develop and Commercialize CDx for Cancer,MedTech,29/5/2019
?Novartis Reports Results of QMF149 (indacaterol acetate and mometasone furoate) in P-III QUARTZ Study for Inadequately Controlled Asthma,Pharma,30/5/2019
?Roche's Tecentriq (atezolizumab) Combination Therapy Receives Health Canada's Approval for Metastatic Non-Squamous Non-Small Cell Lung Cancer in Adults,Regulatory,30/5/2019
?Philips Reports Results of Stellarex .035 Low-Dose Drug-Coated Balloon in Two Clinical Studies for Peripheral Arterial Disease,MedTech,30/5/2019
?Medtronic's SelectSite C304-HIS Deflectable Catheter System Receives FDA's Clearance for HIS Bundle Pacing,MedTech,30/5/2019
?Janssen Reports Results of Darzalex (daratumumab) in P-III MAIA Study for Patients with Multiple Myeloma Ineligible for ASCT,Pharma,30/5/2019
?Sumitomo Dainippon Pharma Signs a Co-Promotion &amp; Commercialization Agreement with Novartis for Diabetes in Japan,Pharma,31/5/2019
?Roche and GE Healthcare Launch NAVIFY Tumor Board 2.0 for Personalized Treatment Decision in Cancer Care,DigiHealth,31/5/2019
"?Pfenex and Alvogen Report EMA's Acceptance of MAA for PF708 (biosimilar, teriparatide)",Biosimilars|Regulatory,2019-01-06
?Merck Reports Result of Keytruda (pembrolizumab) in P-III KEYNOTE-048 Study as a 1L Treatment for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma,Pharma,31/5/2019
Genmab's Darzalex (daratumumab) + Bortezomib + Thalidomide and Dexamethasone (VTd) Receive FDA's Priority Review to sBLA Filing for Frontline Multiple Myeloma?,Regulatory,31/5/2019
Novartis Reports Results of Xolair (omalizumab) in Two P-III Studies for Chronic Rhinosinusitis with Nasal Polyps in Adults,Biotech,2019-03-06
?Sanofi Reports Results of Isatuximab Combination Therapy in P-III ICARIA-MM Study for Relapsed/Refractory Multiple Myeloma #ASCO2019,Pharma,2019-03-06
?Novartis Reports Result of Kisqali (ribociclib) + Endocrine Therapy in P-III MONALEESA-7 Study for HR+/HER2- Advanced Breast Cancer #ASCO2019,Pharma,2019-03-06
Novartis Reports Results of Capmatinib in P-II GEOMETRY mono-1 Study for Non-Small Cell Lung Cancer with MET exon-14 Skipping Mutation #ASCO2019,Pharma,2019-04-06
?AstraZeneca and Merck Report Results of Lynparza (olaparib) in P-III SOLO3 Study for Platinum-Sensitive Relapsed Germline BRCA-mutated Advanced Ovarian Cancer #ASCO2019,Pharma,2019-04-06
Merck's Zerbaxa (ceftolozane and tazobactam) Receives FDA's Approval for Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia in Adults,Pharma,2019-04-06
"Fresenius Kabi Launches its Idacio (adalimumab, biosimilar) in Germany",Biosimilars|Biotech,2019-03-05
British Columbia Expands Use of Biosimilars to Explore Treatment Options,Biosimilars|Biotech,27/5/2019
The US FDA Releases Drafts Guidance Recommending on Comparative Analytical Assessment for Biosimilars,Biosimilars|Biotech|Regulatory,21/5/2019
UnitedHealthcare to Use Brand-Name for Pegfilgrastim from July'19,Biosimilars|Biotech,21/5/2019
AbbVie Resolves Humira (adalimumab) Litigation with Boehringer Ingelheim,Biotech,14/5/2019
Roche Reports Results of Xofluza (baloxavir marboxil) in P-III BLOCKSTONE Study for the Prevention of Influenza,Pharma,2019-04-06
Takeda Reports Results of Takhzyro (lanadelumab) in P-III HELP Study for the Prevention of Hereditary Angioedema Attacks,Pharma,2019-04-06
Celgene and Acceleron Report FDA's Acceptance of BLA for Luspatercept to Treat Myelodysplastic Syndromes and Beta-Thalassemia,Biotech|Regulatory,2019-04-06
Astellas and Seattle Genetics Report Results of Enfortumab Vedotin in P-II EV-201 Study for Patients with Locally Advanced or Metastatic Urothelial Cancer #ASCO2019,Biotech,2019-04-06
?Eli Lilly's Emgality (galcanezumab-gnlm) Receives FDA's Approval for Episodic Cluster Headache in Adults,Pharma,2019-05-06
Roche Reports Results of Venclexta/Venclyxto (venetoclax) in P-III CLL14 Study for Chronic Lymphocytic Leukemia #ASCO2019,Pharma,2019-05-06
Puma Biotechnology Reports Results of PB272 (neratinib) in P-III NALA Trial for Patients with 2L+ HER2+ Metastatic Breast Cancer #ASCO2019,Pharma,2019-05-06
?BioMarin's Vimizim (elosulfase alfa) Receives NMPA's (CFDA) Approval for Treatment of Morquio A Syndrome,Pharma,2019-05-06
?Bayer Signs a Research and Development Collaboration with Arvinas for its PROTAC Technology,Pharma,2019-05-06
IBM Watson Health Reports Real-World Progress of AI in Oncology in #ASCO2019,DigiHealth,2019-05-06
?Takeda Reports Results of Ninlaro (ixazomib) in P-III TOURMALINE-AL1 Study in Patients with Relapsed or Refractory Systemic Light-Chain Amyloidosis,Pharma,2019-06-06
Enzyvant Reports FDA's Acceptance of BLA for RVT-802 to Treat Pediatric Congenital Athymia,Biotech|Regulatory,2019-06-06
Oncolytics Biotech Signs a Clinical Trial Collaboration with Merck KGaA and Pfizer,Biotech,2019-06-06
Celgene Reports FDA and EMA's Acceptance of NDA for Ozanimod to Treat Relapsing Forms of Multiple Sclerosis,Pharma,2019-06-06
AstraZeneca Reports Results of Calquence (acalabrutinib) in P-III ELEVATE-TN Trial for Patients with Previously Untreated Chronic Lymphocytic Leukemia,Pharma,2019-06-06
GSK's Nucala (mepolizumab) Receives FDA's Approval for its Two New Self-Administered Methods for Patients with SEA and EGPA,Biotech,2019-07-06
Novartis Reports Histology Data of CFZ533 (iscalimab) in Kidney Transplantation for Extended Survival of Transplanted Organs,Pharma,2019-07-06
Novartis' LysaKare (arginine hydrochloride/lysine hydrochloride) Solution Receives CHMP's Positive Opinion for Reduction of Kidney Exposure to Radiation During PPRT with Lutathera,Pharma|Regulatory,2019-07-06
Vertex to Expand its Collaboration with CRISPR Therapeutics to Develop Therapies for Duchenne Muscular Dystrophy and Myotonic Dystrophy Type 1,Biotech|M&A,2019-07-06
STADA to Acquire GSK's OTC Portfolio for the Expansion of its Consumer Health Business in Europe,M&A|Pharma,2019-07-06
Eli Lilly Reports Results of Ultra Rapid Lispro (URLi) in Two P-III Studies for Type 1 And Type 2 Diabetes,Pharma,2019-10-06
?Theramex Signs an Exclusive License Agreement with Therapeutics MD to Commercialize Bijuva and Imvexxy Outside the US,Pharma,2019-10-06
?Merck To Acquire Tilos Therapeutics for ~ $773M,M&A,2019-10-06
?Medtronic and Tidepool Collaborates to Develop Interoperable Automated Insulin Pump System for Diabetes Management,DigiHealth,2019-10-06
Innovate Biopharmaceuticals Initiates P-III Clinical Study for Celiac Disease?,Pharma,2019-10-06
?Roche's Polivy (polatuzumab vedotin-piiq) Combination Therapy Receives FDA's Accelerated Approval for Relapsed/Refractory Lymphoma,Regulatory,2019-11-06
Eli Lilly Reports Results of Taltz (ixekizumab) in 5 Years P-III Study for Plaque Psoriasis #WCD2019?,Biotech,2019-11-06
?Innovative Health Solution's IB-Stim Receives FDA's Clearance for the Treatment of Functional Abdominal Pain in Irritable Bowel Syndrome,Regulatory,2019-11-06
?Abbvie Reports Two Years Data of Skyrizi (risankizumab) in P-III IMMhance Study for Moderate to Severe Plaque Psoriasis #WCD2019,Pharma,2019-11-06
Eli Lilly and Boehringer Ingelheim Report Cardiovascular Outcomes of Tradjenta (linagliptin) in CAROLINA Study for Type 2 Diabetes,Pharma,2019-11-06
?Merck's Keytruda (pembrolizumab) Receives FDA's Approval for 1L Treatment of Metastatic or Unresectable Recurrent Head and Neck Squamous Cell Carcinoma,Regulatory,2019-11-06
Janssen Reports Cardiovascular Outcomes of Invokana (canagliflozin) in P-III CREDENCE Study for Type 2 Diabetes and Chronic Kidney Disease,Pharma,2019-12-06
Janssen Signs an Exclusive Worldwide License and Option Agreement with Genmab for its HexaBody-CD38,Pharma,2019-12-06
?Biogen To Report New Data of its Biosimilar Anti-TNF Portfolio at European Congress of Rheumatology (EULAR) 2019,Biosimilars,2019-12-06
?Genentech Reports Acceptance of sBLA for Rituxan (rituximab) to Treat Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) in Children with 2 Years and Older,Biotech,2019-12-06
?Novo Nordisk Reports Cardiovascular Outcomes of Oral Semaglutide in PIONEER 6 Study for Type 2 Diabetes,Pharma,2019-12-06
?AbbVie Reports Results of Upadacitinib in Two P-III Studies for Rheumatoid Arthritis #EULAR2019,Pharma,13/6/2019
?Genentech Reports Positive Results of Rituxan (rituximab) in P-III PEMPHIX Study to Treat Patients with Moderate to Severe Pemphigus Vulgaris,Biotech,13/6/2019
?Pfizer Reports Results of Xeljanz XR (tofacitinib) in the P-IIIB/IV ORAL Shift Study for Moderate to Severe Rheumatoid Arthritis #EULAR2019,Pharma,13/6/2019
"?Celltrion Reports Results of CT-P13 SC (biosimilar, infliximab) in a Clinical Study for Rheumatoid Arthritis #EULAR2019",Pharma,13/6/2019
?Sobi Acquires Novimmune's Emapalumab with its All Related Assets to Strengthen its Focus in Hematology and Immunology,Pharma,13/6/2019
"?Amgen and Allergan's Kanjinti (biosimilar, trastuzumab) Receive the US FDA's Approval for All Approved Indications of Herceptin",Biosimilars|Regulatory,14/6/2019
?BMS Reports Results of Orencia (abatacept) in P-IV Early AMPLE Study for Moderate-to-Severe Rheumatoid Arthritis #EULAR2019,Pharma,14/6/2019
?BeiGene Reports Updated Results of Tislelizumab in P-II Study in Chinese Patients with R/R Classical Hodgkin Lymphoma #EHA2019,Biotech,14/6/2019
?Eli Lilly to Report Positive Results of Taltz (ixekizumab) in P-IIIb/IV SPIRIT-H2H Study for Active Psoriatic Arthritis #EULAR2019,Pharma,14/6/2019
?Upsher-Smith Signs an Agreement with Dr. Reddy's Laboratories to Acquire its Two Neurology Products,Pharma,14/6/2019
?AstraZeneca Reports Results of Lokelma (sodium zirconium cyclosilicate) in P-IIIb DIALIZE Study to Treat Hyperkalaemia in Patients with End-Stage Renal Disease,Pharma,14/6/2019
?Janssen Reports Results of Tremfya (guselkumab) in Two P-III DISCOVER Studies for Psoriatic Arthritis,Biotech,17/6/2019
?Immunophotonics Signs a Research Agreement with Clinical Laserthermia Clinical Laserthermia Systems for Cancer Patients with Solid Tumors,Pharma,17/6/2019
?Pfizer to Acquire Array Biopharma for ~$11.4B,M&A,17/6/2019
?AstraZeneca Reports Results of Calquence (acalabrutinib) in P-III ASCEND Study for R/R Chronic Lymphocytic Leukemia #EHA2019,Pharma,17/6/2019
?Novo Nordisk's Victoza (liraglutide) Receives FDA's Approval for Type 2 Diabetes in Children and Adolescents,Regulatory,18/6/2019
BeiGene Terminates its Worldwide Development and Commercialization Agreement with Celgene for Tislelizumab,Biotech,18/6/2019
?Roche's Rozlytrek (entrectinib) Receives MHLW's Approval for NTRK Fusion-Positive Advanced Recurrent Solid Tumors in Adult and Pediatric Patients in Japan,Pharma,18/6/2019
?AstraZeneca and MSD's Lynparza (olaparib) Receive European Commission's Approval as 1L Maintenance Treatment for BRCA-Mutated Advanced Ovarian Cancer,Regulatory,18/6/2019
?Abbott Launches Afinion HbA1c Dx (Rapid Point-Of-Care Test) to Aid the Diagnosis of Diabetes,MedTech,18/6/2019
?Merck's Keytruda (pembrolizumab) Receives FDA's Accelerated Approval as a Monotherapy for Metastatic Small Cell Lung Cancer,Regulatory,19/6/2019
?Ironwood and Allergan Report Positive Results of Inzess (linaclotide) in P-IIIb Trial for Patients with Irritable Bowel Syndrome with Constipation,Pharma,19/6/2019
?AstraZeneca's Breztri Aerosphere (PT010) and Bevespi Aerosphere Receive MHLW's Approval for Chronic Obstructive Pulmonary Disease in Japan,Pharma,19/6/2019
Roche's Hemlibra (emicizumab injection) Receives Health Canada Approval for Patients with Hemophilia A Without Factor VIII Inhibitors ?,Regulatory,19/6/2019
"?Bristol-Myers Squibb to Sell its Manufacturing Facility to Catalent in Anagni, Italy",Biotech,19/6/2019
?Sanofi Signs an Agreement with Google to Develop Virtual Innovation Lab for Transforming Healthcare Services,DigiHealth,19/6/2019
Gilead Signs an Agreement with Nurix to Develop and Commercialize Protein Degradation Therapies for Cancer and Other Disease,Biotech,20/6/2019
?Amgen Signs a Research Agreement with the University of Washington's IPD for the Development of Protein-Based Therapies,Biotech,20/6/2019
Alexa to Detect Cardiac Arrest with AI-Enabled Tool for Smart Speakers and Smartphones,DigiHealth,20/6/2019
?Resolution Bioscience Collaborates with Janssen to Develop Cell-Free DNA CDx for Niraparib to Treat Prostate Cancer,MedTech,20/6/2019
?Alexion's Ultomiris (ravulizumab) Receives MHLW's Marketing Authorization to Treat Paroxysmal Nocturnal Hemoglobinuria in Adults,Regulatory,20/6/2019
"?Novo Nordisk's Esperoct (turoctocog alfa pegol, N8-GP) Receives European Commission Approval for the Treatment of Hemophilia A",Regulatory,21/6/2019
IBRI Signs a License Agreement with Eli Lilly to Access its Fab Phage Display Library,Biotech,21/6/2019
?Valneva Terminates its Agreement with GSK for Regaining Control of Research and Development Assets,Biotech,21/6/2019
?Bayer Initiates P-III Study of Aflibercept for the Prevention of Blindness in Premature Infants with Retinopathy of Prematurity,Pharma,21/6/2019
Sanofi and Regeneron Report Results of REGN3500 in P-II Study for Asthma,Biotech,21/6/2019
Allergan's BOTOX (onabotulinumtoxinA) Receives FDA's Approval for Upper Limb Spasticity in Pediatric Patients,Regulatory,24/6/2019
Pfizer's Talzenna (talazoparib) Receives European Commission Approval for Germline BRCA-Mutated Locally Advanced or Metastatic Breast Cancer?,Regulatory,24/6/2019
"Henlius Reports EMA's Acceptance of Marketing Authorization Application for HLX02 (biosimilar, trastuzumab)",Biosimilars|Regulatory,24/6/2019
?Bristol-Myers Squibb Reports Results of Opdivo (nivolumab) in P-III CheckMate-459 Study as 1L Treatment for Patients with Unresectable Hepatocellular Carcinoma,Biotech,24/6/2019
"?Allergan's CoolTone Device Receives FDA's Clearance to Strengthen, Tone and Firm Abdominal Muscles",MedTech|Regulatory,24/6/2019
?Gilead Signs an Agreement with Carna Biosciences to Develop and Commercialize Immuno-Oncology Therapies,Pharma,25/6/2019
"Novartis to Collaborate with Glenmark to Promote, Commercialize and Distribute Three Respiratory Therapies for COPD in Brazil?",Pharma,25/6/2019
?AbbVie to Acquire Allergan for $63B,M&A,25/6/2019
Bristol-Myers Squibb to Divest Celgene's Otezla (apremilast) to Gain the US FTC's Approval on Celgene Acquisition?,Pharma,25/6/2019
C4X Discovery Signs a Neurodegeneration Drug Discovery Agreement with PhoreMost for Parkinson's Disease,Pharma,25/6/2019
?Almirall Exercises its Option to License Dermira's Lebrikizumab for Atopic Dermatitis in Europe,Biotech,26/6/2019
?Tilt Biotherapeutics Signs an Agreement with Merck KGaA and Pfizer to Investigate the Dual Combination for Solid Tumors,Pharma,26/6/2019
?Eisai Reports Results of Fycompa (perampanel) in P-III FREEDOM Study for Patients with Newly Diagnosed or Untreated Partial Onset Seizures,Pharma,26/6/2019
?Lilly Reports Results of Trulicity (dulaglutide) in P-III AWARD-11 Study for Type 2 Diabetes,Pharma,26/6/2019
?Boehringer Ingelheim and Eli Lilly's Empagliflozin Receive FDA's Fast Track Designation for Chronic Heart Failure,Pharma,26/6/2019
?Daiichi Sankyo to Return Exclusive Development and Commercialization Rights for Four Diagnostic Imaging Agents to GE Healthcare in Japan,Pharma,26/6/2019
Louisiana Department of Health Launches Innovative Payment Model with Asegua Therapeutics to Eliminate Hepatitis C in Louisiana,Pharma,27/6/2019
Regeneron and Sanofi's Dupixent (dupilumab) Receives FDA's Approval for Chronic Rhinosinusitis with Nasal Polyposis?,Biotech|Regulatory,27/6/2019
AstraZeneca Reports Results of Imfinzi (durvalumab) in P-III CASPIAN Study for 1L Extensive-Stage Small Cell Lung Cancer?,Biotech,27/6/2019
?Sanofi Reports FDA's Acceptance of BLA for MenQuadfi to Prevent Meningococcal Meningitis,Biotech|Regulatory,27/6/2019
GSK Amends its Development and Commercialization Agreement with Liquidia for Inhaled Therapies,Pharma,27/6/2019
?Janssen's Darzalex (daratumumab) in Combination with Lenalidomide + Dexamethasone Receive FDA's Approval for Transplant Ineligible Patients with Multiple Myeloma,Biotech|Regulatory,28/6/2019
?Alexion's Soliris (eculizumab) Receives FDA's Approval for Anti-Aquaporin-4 Antibody Positive Patients with Neuromyelitis Optica Spectrum Disorder,Biotech|Regulatory,28/6/2019
?Apple Disrupting the Healthcare with the Availability of One Drop Blood Glucose Monitor at its Retails Outlets in the US,DigiHealth,28/6/2019
Sanofi and Regeneron's Dupixent (dupilumab) Receive CHMP's Positive Opinion for Moderate-To-Severe Atopic Dermatitis in Adolescents?,Biotech|Regulatory,28/6/2019
"?Innovent and Eli Lilly Report NMPA's Acceptance of NDA for IBI301 (rituximab, biosimilar) for Non-Hodgkin's lymphoma",Biosimilars|Regulatory,28/6/2019
"?Pfizer's Zirabev (biosimilar, bevacizumab) Receives the US FDA's Approval for Five Types of Cancer",Biosimilars|Regulatory,28/6/2019
?Pfizer Reports Results of Revatio (sildenafil citrate) in P-III Study for Persistent Pulmonary Hypertension in the Newborns,Pharma,2019-01-07
?AstraZeneca's Forxiga and Fasenra (Prefilled Syringe and Pen) Receive EU CHMP's Positive Opinion for CV Outcomes in T2D and Asthma,Biotech|Pharma,2019-01-07
?Janssen's Imbruvica (ibrutinib) Receives CHMP Positive Recommendation for its Expanded Use in Chronic Lymphocytic Leukaemia and Waldenstrom's Macroglobulinemia in Europe,Pharma|Regulatory,2019-01-07
Roche's Tecentriq (atezolizumab) + Abraxane Receives CHMP's Recommendation for its Approval in Europe,Biotech|Regulatory,2019-01-07
?Biogen Reports Results of Spinraza (nusinersen) in P-II NURTURE Study as a Foundation of Care in Spinal Muscular Atrophy,Pharma,2019-02-07
Regeneron and Sanofi's Libtayo (cemiplimab) Receives European Commission's Approval for Advanced Cutaneous Squamous Cell Carcinoma,Biotech|Regulatory,2019-02-07
?Teva Reports Results of Fremanezumab in P-IIIb FOCUS Study for Migraine in Adults,Biotech,2019-02-07
"?Egis Pharmaceuticals Signs an Exclusive Distribution Agreement with Mundipharma for Pelmeg (biosimilar, pegfilgrastim) in Central and Eastern Europe",Biosimilars,13/6/2019
"?Amgen to Withdraw the ABP 710 (biosimilar, infliximab) MAA with European Medical Agency",Biosimilars,28/6/2019
?Boehringer Ingelheim Signs a License Agreement with Yuhan Corporation to Develop Dual Agonist for Nonalcoholic Steatohepatitis,Biotech,2019-02-07
Foundation Medicine's FoundationOne CDx Receives FDA's Approval as a CDx for Lynparza (olaparib),MedTech|Regulatory,2019-02-07
?Varian to Acquire Boston Scientific's Oncology Assets for $90M,Pharma,2019-02-07
?Genentech Reports Results of Xofluza (baloxavir marboxil) in P-III MINISTONE-2 Study for Influenza in Children,Pharma,2019-03-07
?Sandoz Launches Generic Gefitinib for Locally Advanced or Metastatic Non-Small Cell Lung Cancer in 13 European Countries,Pharma,2019-03-07
?ViiV Healthcare's Dovato (dolutegravir/lamivudine) Receives European Commission Marketing Authorization for HIV-1 Infection in Adults and Adolescents,Pharma,2019-03-07
GSK to Initiate P-III ContRAst Studies of Otilimab to Treat Moderate to Severe Rheumatoid Arthritis,Biotech|Pharma,2019-03-07
Asieris Signs a Worldwide Development and Commercialization Agreement with Photocure for Cevira,MedTech|Pharma,2019-03-07
?Samsung Bioepis and Genentech Settles Patent Dispute of Trastuzumab Biosimilar-Ontruzant,Biosimilars|Pharma,2019-04-07
Alexion's Ultomiris (Ravulizumab) Receives European Commission's Marketing Authorization for Paroxysmal Nocturnal Hemoglobinuria in Adults,Biotech|Regulatory,2019-04-07
?Karyopharm's Xpovio (selinexor) Receives FDA's Accelerated Approval for Relapsed/Refractory Multiple Myeloma,Pharma|Regulatory,2019-04-07
"Samsung Bioepis Reports EU Label Update with Extended Storage Conditions for Imraldi (biosimilar, adalimumab)",Biosimilars,28/6/2019
?Nosopharm Signs an Agreement with Evotec to Accelerate the Development of Antibiotics,Pharma,2019-04-07
?Janssen Returns its Exclusive Rights to Develop and Commercialize Hanmi's Antidiabetic Obesity Therapy,Biotech,2019-04-07
?SIFI Acquires Laboratoire Gifrer Barbezat's Dacudoses and Novoptine for $6.7M in France,Pharma,2019-05-07
Grifols' Xembify (20% SC Immunoglobulin) Receives FDA's Approval for the Treatment of Primary Immunodeficiencies?,Regulatory,2019-05-07
?Fraunhofer MEVIS' Experts Develops Intelligent Catheter Navigation System in Germany,MedTech,2019-05-07
?SDSC and Moores Cancer Center Collaboratively Work with CureMatch to Develop Machine Learning Model for the Diagnosis of Bladder Cancer,MedTech,2019-05-07
?Fresenius Kabi Voluntary Recalls Two Lots of Fluorouracil Injection Due to Potential for Glass Particulate,Pharma,2019-05-07
?BeiGene's Tislelizumab Receives NMPA's Priority Review to sNDA for Urothelial Carcinoma in China,Biotech|Regulatory,2019-08-07
?Isansys Lifecare Develops Patient Status Engine Wearable Body Patch for the Detection of Sepsis,MedTech,2019-08-07
?Novo Nordisk Reports Results of Refixia (nonacog beta pegol) in Two P-III Studies for Hemophilia B in Children,Pharma,2019-08-07
?Takeda Reports Updated Results of Adynovate in P-IIIb/IV PROPEL Study for Personalized Prophylaxis in Patients with Severe Hemophilia A,Biotech,2019-08-07
ViiV Healthcare Initiates CUSTOMIZE Study of Dual-Drug Injectable Regimen for the Treatment of HIV,Pharma,2019-08-07
?Bayer Reports Results of Xarelto (rivaroxaban) in P-III EINSTEIN-Jr. Study for Venous Thromboembolism,Pharma,2019-09-07
Roche Reports Updated Results of Hemlibra (emicizumab) in P-III HAVEN and P-IIIb STASEY Studies for Hemophilia A,Biotech,2019-09-07
?The US Department of Defense Awarded Contract to SIGA for Expanded Indication of TPOXX (tecovirimat) for $19.5M,Pharma,2019-09-07
?Merck Reports FDA's Acceptance of sBLA of Keytruda (pembrolizumab) with Six-Week Dosing Schedule for Multiple Indications,Biotech,2019-09-07
?Boehringer Ingelheim Reports Results of Pradaxa (dabigatran etexilate mesylate) for the Management of Venous Thromboembolism in Children,Pharma,2019-09-07
?Sanofi Reports FDA's Acceptance of BLA to Review Isatuximab for Relapsed/Refractory Multiple Myeloma,Biotech|Regulatory,2019-10-07
?ViiV Healthcare Reports Results of Dual-Drug Regimen in P-III TANGO Study for HIV-1 Infection,Pharma,2019-10-07
?Mirati Signs a Non-Exclusive Clinical Collaboration with Novartis to Evaluate the Combination of MRTX849 and TNO155 for Solid Tumors,Pharma,2019-10-07
?Janssen Signs an Agreement with Celsius Therapeutics to Identify Response Biomarkers for Ulcerative Colitis,Biotech|MedTech,2019-10-07
?Jazz Pharmaceuticals Acquires Redx Pharma's Pre-clinical Pan-RAF Inhibitor Program for RAF and RAS Mutant Tumors,Pharma,2019-10-07
?Sandoz Launches Pre-Filled Epinephrine Injection for Type 1 Allergic Reactions in the US,MedTech,2019-10-07
?Celgene's Pomalyst (pomalidomide)-Based Triple Regimen Receive Health Canada's Approval for Multiple Myeloma,Regulatory,2019-11-07
?Torrent Signs a Non-Exclusive License Agreement with Glenmark to Co-Commercialize Remogliflozin Etabonate for Type 2 Diabetes in India,Pharma,2019-11-07
?Takeda's Vyvanse (lisexamfetamine dimesylate) Chewable Tablet Receives Health Canada's Approval for the Treatment of Patients with Attention-Deficit/Hyperactivity Disorder Aged= 6yrs.,Pharma|Regulatory,2019-11-07
?Amazon's AI-Powered Alexa to Deliver NHS Health Advice in the UK,DigiHealth,2019-11-07
?Eli Lilly Reports Results of Emgality (galcanezumab-gnlm) in P-III Study for Episodic Cluster Headache,Biotech,2019-11-07
?I-Mab Signs an Exclusive License Agreement with MacroGenics to Develop and Commercialize Enoblituzumab in Greater China,Biotech,2019-11-07
"?Novartis, Amgen and Banner Alzheimer's Institute Terminate Two P-II/III Studies of CNP520 (umibecestat) for the Prevention of Alzheimer's Disease",Pharma,2019-12-07
Abbott's Alinity S System Receives FDA's Approval for Blood and Plasma Screening in the US?,MedTech|Regulatory,2019-12-07
?Ono Pharmaceutical Signs an Exclusive License Agreement with Forty Seven to Develop and Commercialize 5F9 in Selected Asian Countries,Pharma,2019-12-07
Valeo Launches Onstryv (safinamide tablet) for the Treatment of Parkinson's Disease in Canada?,Pharma,2019-12-07
Eli Lilly Reports Results of Emgality (galcanezumab-gnlm) in Three P-III Studies for Chronic and Episodic Migraine,Biotech,2019-12-07
?GSK Reports Results of Zejula (niraparib) in P-III PRIMA Study as 1L Maintenance Therapy for Ovarian Cancer,Pharma,15/7/2019
?Gilead to Raise Stake in Galapagos with ~$5.1B Deal,Pharma,15/7/2019
?Janssen Reports Submission of BLA to the US FDA for Darzalex (daratumumab) Subcutaneous Formulation for Multiple Myeloma,Biotech|Regulatory,15/7/2019
?AbbVie Acquires Mavupharma for its STING (STimulator of INterferon Genes) Modulators to Treat Cancer,M&A,15/7/2019
?Boehringer Ingelheim Acquires AMAL Therapeutics for its KISIMA Immunization Platform,M&A,16/7/2019
?Abbott's MitraClip G4 Receives the US FDA's Approval for the Treatment of Mitral Regurgitation,MedTech|Regulatory,16/7/2019
?Bayer's Gadavist (gadobutrol) Injection Receives the US FDA's Approval for use in CMRI in Patients with Coronary Artery Disease,Regulatory,16/7/2019
?T-CiRA Research Collaboration Initiates Clinical Study of iCART Therapies for the Treatment of Cancer,Pharma,16/7/2019
?Novartis Reports FDA's Acceptance of BLA for Crizanlizumab (SEG101) to Treat Sickle Cell Disease,Regulatory,16/7/2019
Genentech Signs an Exclusive Option and License Agreement with Skyhawk to Discover and Develop RNA Splicing Modifiers for Oncology and Neurodegenerative Diseases?,Pharma,17/7/2019
Genentech Enters into an Exclusive Worldwide Collaboration and Option to Acquire Agreement with Convelo to Discover Remyelinating Therapies,Pharma,17/7/2019
?Knight Therapeutics' Nerlynx (neratinib) Receives Health Canada Approval as Extended Adjuvant Therapy for HR+ and HER2+ Breast Cancer,Regulatory,17/7/2019
?Merck's Recarbrio (imipenem/cilastatin/relebactam) Receives the US FDA's Approval for Complicated Urinary Tract and Complicated Intra-Abdominal Bacterial Infections,Regulatory,17/7/2019
?Allergan Reports FDA's Acceptance of NDA for Bimatoprost Sustained-Release to Treat Glaucoma or Ocular Hypertension,Regulatory,17/7/2019
Genentech Signs a Research and License Agreement with Sosei Heptares to Develop GPCR Modulating Therapies,Pharma,17/7/2019
?MacroGenics Plans to Advance the Development of Flotetuzumab for Acute Myeloid Leukemia,Pharma,18/7/2019
?Novartis' Kisqali (ribociclib) + Fulvestrant Receive NICE Approval for Advanced or Metastatic Breast Cancer,Regulatory,18/7/2019
?Paragon Biosciences Launches a Facility for the Advancement of QuantX Medical Imaging AI System Diagnosing Breast Cancer,MedTech,18/7/2019
?Bayer Signs a Clinical Collaboration Agreement with BMS and Ono to Evaluate Dual Regimen for Metastatic Colorectal Cancer,Pharma,18/7/2019
Astellas Signs a License Agreement with Frequency Therapeutics to Develop and Commercialize FX-322 for Hearing Loss,Pharma,18/7/2019
Takeda and Chembio Diagnostics Collaborate to Develop Point-of-Care Diagnostic Test,MedTech,18/7/2019
Interpace Diagnostics Signs an AI-Driven Agreement with Predictive Oncology for Diagnosing Thyroid Cancer,DigiHealth,19/7/2019
Boehringer Ingelheim Signs a Worldwide License Agreement with Bridge Biotherapeutics for its BBT-877 for $1.28B,Pharma,19/7/2019
Boehringer Ingelheim Reports Results of Ofev (nintedanib) in INMARK Study for Patients with Idiopathic Pulmonary Fibrosis (IPF),Pharma,19/7/2019
Mallinckrodt Signs an Agreement with Silence Therapeutics to Develop and Commercialize RNAi Therapeutics for Complement-Mediated Diseases,Biotech,19/7/2019
Amgen and Allergan Report Availability of Mvasi (biosimilar bevacizumab) and Kanjinti (biosimilar trastuzumab) in the US,Biosimilars,19/7/2019
Gilead Signs an Exclusive Worldwide License Agreement with Novartis for its Three Preclinical Antiviral Programs,Pharma,19/7/2019
Sandoz Reports Patient Enrollment in P-I/III ROSALIA Study of Proposed Biosimilar Denosumab for Postmenopausal Osteoporosis,Biosimilars,22/7/2019
Celgene's Otezla (apremilast) Receives FDA's Approval for Oral Ulcers Associated with Behçet's Disease,Regulatory,22/7/2019
Takeda Reports Results of Entyvio (vedolizumab SC) in P-III VISIBLE 2 Study for Moderately to Severely Active Crohn's Disease,Biotech,22/7/2019
Medtronic Collaborates with Viz.ai to Facilitate Adoption of AI Software for Stroke Centers in the US,DigiHealth,22/7/2019
Gilead Signs an Exclusive Worldwide License Agreement with Durect for its HIV and Hepatitis B Products,Pharma,22/7/2019
Baxter's Myxredlin Ready-To-Use Insulin for IV Infusion Receives FDA's Approval for Diabetes Mellitus?,Regulatory,23/7/2019
Sanofi Signs an Exclusive Agreement with Roche for OTC Rights of Tamiflu (oseltamivir phosphate) in the US,Pharma,23/7/2019
ViiV Healthcare Reports Results of Fostemsavir in P-III BRIGHTE Study for HIV-1 infection,Pharma,23/7/2019
AstraZeneca Reports Inclusion of Overall Survival Data in Labelling of Imfinzi (durvalumab) in the US,Biotech,23/7/2019
Merck and Eisai's Keytruda (pembrolizumab) + Lenvima (lenvatinib) Receive FDA's Third Breakthrough Therapy Designation as 1L Therapy for Hepatocellular Carcinoma,Pharma,23/7/2019
Chiasma Reports Results of Mycapssa (octreotide) in P-III CHIASMA OPTIMAL Study as a Maintenance Therapy for Acromegaly,Pharma,23/7/2019
"Pfizer's Ruxience (biosimilar, rituximab) Receives FDA's Approval for Cancer and Autoimmune Diseases",Biosimilars,24/7/2019
"Samsung Bioepis' Hadlima (biosimilar, adalimumab) Receives FDA's Approval for Autoimmune Diseases",Biosimilars,24/7/2019
Ligand to Acquire Ab Initio Biotherapeutics for its Antigen Technology,M&A,24/7/2019
Medtronic Solicits the US FDA for Non-Adjunctive Labeling Approval of MiniMed 670G Insulin Pump Sensor,MedTech,24/7/2019
Gilead Reports Updated Results of Descovy in P-III DISCOVER Study for Pre-Exposure Prophylaxis of H,Pharma,24/7/2019
Celgene Partners with Multiple Sclerosis Association of America Bringing MS MindShift Brain Bulb Hot Air Balloon to Raise Awareness of Multiple Sclerosis and Brain Health,Pharma,24/7/2019
Synapse Signs an Agreement with Pfizer in Oncology Precision Medicine,Pharma,24/7/2019
Eli Lilly's Baqsimi (glucagon 3mg) Nasal Powder Receives FDA's Approval for the Treatment of Severe Hypoglycemia,Pharma,25/7/2019
BMS Reports Results of Opdivo (nivolumab) + Yervoy (ipilimumab) in P-III CheckMate -227 Part 1a Study for 1L Non-Small Cell Lung Cancer,Pharma,25/7/2019
Celgene Reports Update on its Collaboration with Jounce Therapeutics,Pharma,25/7/2019
Allergan Voluntary Recalls Worldwide BIOCELL Textured Breast Implants and Tissue Expanders?,MedTech,25/7/2019
Regenxbio Signs an Exclusive Development and Commercialization Agreement with Neurimmune for AAV Gene Therapies Targeting Neurodegenerative Diseases,Pharma,25/7/2019
Sanofi Enter into an Exclusive License Agreement with Verastem Oncology to Develop and Commercialize Copiktra (duvelisib) for all Oncology Indications,Pharma,26/7/2019
Boehringer Ingelheim's Ofev (nintedanib) Receives FDA's Advisory Committee Recommendation for Systemic Sclerosis Associated ILD,Regulatory,26/7/2019
Janssen Reports Results of Ponesimod in P-III OPTIMUM Study for Relapsing Multiple Sclerosis,Pharma,26/7/2019
BMS' Triple Regimen Receives Positive CHMP Recommendation for its Approval to Treat R/R Multiple Myeloma in Europe,Regulatory,26/7/2019
Roche's Tecentriq Receives EU's CHMP Recommendation for its Approval as 1L Therapy for Extensive-Stage Small Cell Lung Cancer,Regulatory,26/7/2019
Epizyme Reports FDA's Acceptance of NDA for Tazemetostat to Treat Epithelioid Sarcoma,Regulatory,26/7/2019
ViiV Healthcare Reports Submission of MAA to EMA for the Combination of Cabotegravir + Rilpivirine to Treat HIV-1 Infection,Regulatory,29/7/2019
Pfizer in Talks with Mylan to Merge its Off-Patent Drug Business ?,M&A|Pharma,29/7/2019
Pfizer's Upjohn Off-Patent Drug Business to Merge with Mylan to Form a New Pharmaceutical Company,M&A|Pharma,29/7/2019
Sanofi Reports Results of Zynquista (sotagliflozin) in P-III InSynchrony Program for Type2 Diabetes and Terminates Its Collaboration with Lexicon,Pharma,29/7/2019
Baxter Launches PrisMax Acute Care System for Acute Kidney Injury in the US,MedTech,30/7/2019
Merck Reports Results of Keytruda (pembrolizumab) + Chemotherapy in P-III KEYNOTE-522 Study for Triple-Negative Breast Cancer,Pharma,30/7/2019
Exact Sciences to Merge with Genomic Health Forming a New Cancer Diagnostics Company,M&A|MedTech,30/7/2019
Eli Lilly Reports Results of Verzenio (abemaciclib) in P-III MONARCH 2 for HR+ and HER2- Advanced Breast Cancer,Pharma,30/7/2019
Merck Receives EU's CHMP Positive Opinion for its Zerbaxa (ceftolozane and tazobactam) and Keytruda (pembrolizumab) + Inlyta (axitinib) Regimen,Regulatory,30/7/2019
Novartis' Lucentis Receive EU's CHMP Positive Opinion for Retinopathy of Prematurity in Preterm Infan,Regulatory,30/7/2019
Bayer's Nubeqa (darolutamide) Receives the US FDA's Approval for Non-Metastatic Castration-Resistant Prostate Cancer in Men,Regulatory,31/7/2019
Biogen and Alkermes Report Results of Diroximel Fumarate in P-III EVOLVE-MS-2 Study for Multiple Sclerosis,Pharma,31/7/2019
Gates Foundation Grants $13M to Lyndra Therapeutics for the Development of Once-Monthly Oral Contraceptive,Pharma,31/7/2019
Bayer's Vitrakvi (larotrectinib) Receives Health Canada Approval for Advanced Solid Tumors Harboring NTRK Gene Fusion,Regulatory,31/7/2019
Merck's Keytruda (pembrolizumab) Receives FDA's Approval as a Monotherapy for 1L+ Recurrent Locally Advanced or Metastatic Esophageal Cancer Expressing PD-L1 (CPS =10),Regulatory,31/7/2019
Pfizer Signs a License Agreement with Regenxbio for its NAV AAV9 Vector to Treat Friedreich's Ataxia,Biotech,31/7/2019
Novartis Reports Results of Kisqali in Second Phase P-III MONALEESA-3 Study for HR+/HER2- Advanced Breast Cancer in Women,Pharma,2019-01-08
Chimerix Signs an Exclusive Worldwide License Agreement with Cantex for CX-01 to Treat Acute Myeloid Leukemia,Pharma,2019-01-08
Exelixis Signs a Research Collaboration and Option to License Agreement with Aurigene to Discover and Develop Therapies for Cancer,Pharma,2019-01-08
LEO Pharma's Enstilar Foam and Taclonex Topical Suspension Receive the US FDA's Expanded Approval for Plaque Psoriasis,Regulatory,2019-01-08
Sun Pharma Reports Submission of Manufacturing and Marketing Authorization Application of Tildrakizumab in Japan,Regulatory,2019-01-08
GSK's Nucala (mepolizumab) Receives European Commission Approval for Self-Administration in Severe Eosinophilic Asthma,Regulatory,2019-02-08
Nektar and BMS Receive the US FDA's Breakthrough Designation for Bempegaldesleukin (NKTR-214) + Opdivo (nivolumab) to Treat Advanced Melanoma,Pharma,2019-02-08
Arcellx Signs a Development Evaluation and License Agreement with Pfenex for Advancing SparX Proteins,Biotech,2019-02-08
"Mylan and Biocon Launch Ogivri (biosimilar, trastuzumab) in Australia",Biosimilars,2019-02-08
Voluntis' Oleena Digital Application Receives FDA's Marketing Approval to Self-Manage Cancer Symptoms,DigiHealth|Regulatory,2019-02-08
Thermo Fisher Enters into a Collaboration with Genome Canada and OICR to Develop NGS Assays for Cancer,MedTech,2019-02-08
AbbVie's Maviret (glecaprevir/pibrentasvir) Receives European Commission Approval for Treatment-Naive Patients with Chronic Hepatitis C and Compensated Cirrhosis,Pharma|Regulatory,2019-02-08
Daiichi Sankyo's Turalio (pexidartinib) Receives the US FDA's Approval for the Symptomatic Tenosynovial Giant Cell Tumor,Pharma|Regulatory,2019-05-08
Roche Reports Results of Tecentriq in P-III IMvigor130 Study for Previously Untreated Advanced Bladder Cancer,Biotech,2019-05-08
Takeda Signs an Exclusive Multi-Target Research Agreement with Sosei Heptares to Develop and Commercialize Therapies Modulating GPCR,Pharma,2019-05-08
AstraZeneca Reports Label Update with Positive Cardiovascular Outcomes and Renal Data for Forxiga (dapagliflozin) in EU,Pharma,2019-05-08
Pfizer Reports Results of Rivipansel in P-III RESET Study for Sickle Cell Disease with Vaso-Occlusive Crisis,Pharma,2019-05-08
NUST MISIS Laboratory Develops an Ultrasound Tomography System for the Diagnosis of Cancer,MedTech,2019-05-08
"Cipla Gulf Signs an Exclusive Commercialization Agreement with Alvotech for AVT02 (biosimilar, adalimumab)",Biosimilars,23/7/2019
Coherus Biosciences Reports Winning of Pegfilgrastim Patent Dispute Against Amgen,Biosimilars,29/7/2019
"Celltrion to Initiate P-I trial for CT-P39 (biosimilar, omalizumab)",Biosimilars,15/7/2019
Eli Lilly Reports Results of Emgality (galcanezumab-gnlm) in P-III CONQUER Study for Chronic and Episodic Migraine,Pharma,2019-05-08
Chong Kun Dang and Dong-A ST Plan to Launch Nesp biosimilar in Japan,Biosimilars,21/7/2019
"Mundipharma and Prestige Enters into an Exclusive License and Supply Agreement for Tuznue (biosimilar, trastuzumab, HD201)",Biosimilars,2019-02-07
Sanofi and Regeneron's Dupixent Receives European Commission Approval for Moderate-To-Severe Atopic Dermatitis in Adolescents,Biotech|Regulatory,2019-06-08
LifeOmic Launches AI-Based LIFE Extend App to Expand Healthcare and Enable People to Adopt Five Health Pillars?,DigiHealth,2019-06-08
MannKind Enter into an Agreement with One Drop to Combine Bluetooth-Connected Inhaler with Dose Detection into the One Drop Platform,DigiHealth,2019-06-08
Innovent and Shenogen Enter into a Collaboration to Evaluate the Combination of Tyvyt (sintilimab injection) + SNG1005 for Advanced Cancer,Pharma,2019-06-08
GSK and Sabin Signs an Exclusive Agreement to Advance the Development of Ebola and Marburg Vaccines,Biotech,2019-06-08
Astellas Initiates P-III BRIGHT SKY Clinical Program for Fezolinetant in Postmenopausal Women with Vasomotor Symptoms,Pharma,2019-06-08
Allergan Reports the Acceptance of EMA's MAA for Abicipar to Treat Neovascular Age-Related Macular Degeneration,Regulatory,2019-07-08
Spring Bank Signs a Research Agreement with the University of Texas Southwestern Medical School to Evaluate STING Antagonist Compounds,Pharma,2019-07-08
AstraZeneca and MSD's Report Results of Lynparza in P-III PROfound Study for Metastatic Castration-Resistant Prostate Cancer with Homologous Recombination Repair Gene Mutation,Pharma,2019-07-08
ADC Therapeutics and Sophia Genetics Collaborate to Identify Biomarkers in Clinical Study,Biotech|MedTech,2019-07-08
NIH Launches LUCA Biologics to Develop Live Biotherapeutics for Women's Health,Biotech,2019-07-08
Newsoara Biopharma Signs a Licensing Agreement with Zenith Epigenetics for its ZEN-3694,Pharma,2019-07-08
Aevi Genomic Medicine Signs an Option and License Agreement with AstraZeneca for its MEDI2338,Pharma,2019-08-08
Stoke Therapeutics' STK-001 Receives FDA's Orphan Drug Designation for Dravet Syndrome,Regulatory,2019-08-08
Myriad to File sPMA to the US FDA of BRACAnalysis CDx as a Companion Diagnostic for Lynparza (olaparib) to Treat Metastatic Castrate-Resistant Prostate Cancer in Men,MedTech,2019-08-08
Akcea Therapeutics and Ionis Pharmaceutical Launch Waylivra (volanesorsen) for Familial Chylomicronemia Syndrome in EU,Pharma,2019-08-08
Gilead Sciences Receives the US FDA Advisory Committee's Recommendation on Approval of Descovy for PrEP,Regulatory,2019-08-08
Mitsubishi Tanabe's Edaravone Receives NMPA's Approval for Amyotrophic Lateral Sclerosis (ALS),Regulatory,2019-08-08
Bayer to Acquire BlueRock Therapeutics for its Cell Therapies,M&A,2019-09-08
Eli Lilly with Evidation Health and Apple Report Results of Digital Alzheimer's Study,DigiHealth,2019-09-08
Takeda Reports Submission of NDA to MHLW for Vedolizumab SC to Treat Moderately to Severely Active Ulcerative Colitis in Japan,Biotech|Regulatory,2019-09-08
AstraZeneca Reports Updated Positive Results of Tagrisso (osimertinib) in P-III FLAURA Study for 1L EGFR-Mutated Non-Small Cell Lung Cancer,Pharma,2019-09-08
Ziopharm Oncology's Controlled IL-12 Platform Receives EMA's COMP Positive Recommendation for Orphan Drug Designation to Treat Glioma,Regulatory,2019-09-08
"Gilead's Biktarvy (Bictegravir, Emtricitabine and Tenofovir Alafenamide) Receives NMPA's Approval for Treatment of HIV-1 Infection",Pharma,2019-12-08
SMS-Oncology Signs a Clinical Trial Collaboration with Cytovation to Treat Solid Tumors,Pharma,2019-12-08
Atricure to Acquire SentreHEART for Expansion of Therapies to Treat Atrial Fibrillation,M&A,2019-12-08
Oncologie and Merck Collaborate to Evaluate Bavituximab + Keytruda for Treatment of Advanced Gastric or Gastroesophageal Cancer,Pharma,2019-12-08
?Zai Lab and Novocure's Optune Receive NMPA's Innovative Medical Device Designation for its Tumor Treating Field Delivery System,MedTech|Regulatory,2019-12-08
Boehringer Ingelheim Signs a Multi-Year Agreement with University of Texas for the Advancement of Cancer Therapies,Pharma,13/8/2019
Baxter's PrisMax System Receives Health Canada's Approval for Maximizing Treatment in the Intensive Care Unit,MedTech,13/8/2019
Pharming Signs an Exclusive Development and Commercialization Agreement with Novartis for its CDZ173 to Treat Activated Phosphoinositide 3-kinase Delta Syndrome,Pharma,13/8/2019
Jazz Pharmaceutical to Acquire Cavion for the Expansion of its Sleep and Neurology Portfolio,M&A,13/8/2019
Eli Lilly Reports Superiority Results of Taltz (ixekizumab) in P-IV IXORA-R Study for Patients with Moderate to Severe Plaque Psoriasis,Pharma,13/8/2019
Roche's Tecentriq (atezolizumab) Receives Health Canada's Approval for 1L Extensive-Stage Small Cell Lung Cancer in Adults,Pharma,13/8/2019
Innovate Initiates its Dosing For P-III CeD LA 3001 Trial for Celiac Disease,Pharma,13/8/2019
Janssen's Imbruvica (ibrutinib) Receives European Commission Approval for Chronic Lymphocytic Leukaemia and Waldenstrom's Macroglobulinemia in Adults,Regulatory,14/8/2019
AstraZeneca's Calquence (acalabrutinib) Receives the US FDA's Breakthrough Therapy Designation for Chronic Lymphocytic Leukemia,Regulatory,14/8/2019
Leo Pharma Enters into a Sub-Licensing Agreement with Bausch Health to Develop and Commercialize Brodalumab for Moderate-to-Severe Psoriasis Outside Europe,Biotech,14/8/2019
AstraZeneca and MSD Report Results of Lynparza in P-III PAOLA-1 Study as 1L Maintenance Therapy for Advanced Ovarian Cancer,Pharma,14/8/2019
Regeneron's Eylea (aflibercept) Receives the US FDA's Approval as a Prefilled Syringe,Regulatory,14/8/2019
Regeneron Reports Positive Results of Evinacumab in P-III Study for Homozygous Familial Hypercholesterolemia,Biotech,14/8/2019
Roche's Rozlytrek (entrectinib) Receives the US FDA Approval for ROS1-Positive Metastatic Non-Small Cell Lung Cancer and NTRK Gene Fusion-Positive Solid Tumors,Pharma|Regulatory,16/8/2019
Ultragenyx Enters into a Partnership and Option to Acquire Agreement with GeneTx to Develop its GTX-102 for Angelman Syndrome,Pharma,16/8/2019
Gilead and Galapagos Reports the Validation of EMA's MAA for Filgotinib to Treat Rheumatoid Arthritis,Regulatory,16/8/2019
Baxter Collaborates with Cosmed to Commercialize Q-NRG+ Indirect Calorimetry Device to Support Global Clinical Nutrition ?,MedTech,16/8/2019
Mallinckrodt Reports Positive Results of Terlipressin in P-III CONFIRM Study for Hepatorenal Syndrome Type 1,Pharma,16/8/2019
Profound Medical's TULSA-PRO Receives the US FDA's 510(k) Clearance for Ablation of Prostate Tissue,MedTech|Regulatory,16/8/2019
AbbVie's Rinvoq (upadacitinib) Receives the US FDA's Approval for Moderate to Severe Rheumatoid Arthritis,Regulatory,19/8/2019
Celgene's Inrebic (fedratinib) Receives the US FDA's Approval for Myelofibrosis,Regulatory,19/8/2019
Alcon to Launch PRECISION1 Daily Disposable Contact Lenses in the US,MedTech,19/8/2019
CVRx's Barostim Neo Device Receives the US FDA's Approval as World's First Heart Failure Neuromodulation Device,MedTech,19/8/2019
Glenmark's Combination Therapy of Remogliflozin Etabonate + Metformin Hydrochloride Receive Approval for Type 2 Diabetes in India,Pharma|Regulatory,19/8/2019
"Dr. Reddy's Laboratories Launches Versavo (biosimilar, bevacizumab) for Multiple Cancer Indications in India",Biosimilars,20/8/2019
AstraZeneca Reports Results of Farxiga (dapagliflozin) in P-III DAPA-HF Study to Treat Patients with Heart Failure,Pharma,20/8/2019
Boston Scientific's ImageReady MRI For Vercise Gevia Deep Brain Stimulation System Receives FDA's Approval for Parkinson's Disease,MedTech,20/8/2019
Nabriva's Xenleta (lefamulin) Receives FDA's Approval for the Treatment of Community-Acquired Bacterial Pneumonia in Adults,Pharma|Regulatory,20/8/2019
Elanco To Acquire Bayer's Animal Health Business for $7.6B,M&A,20/8/2019
"Gedeon Richter Launches Terrosa (biosimilar, teriparatide) in Europe",Biosimilars,20/8/2019
Biotheus Enters into an Agreement with Alligator Bioscience to Develop Bispecific Molecules in Greater China,Biotech,21/8/2019
AstraZeneca Reports Results of Imfinzi (durvalumab) + Tremelimumab in P-III NEPTUNE Study for Stage IV Non-Small Cell Lung Cancer?,Biotech,21/8/2019
GSK Reports Submission of NDA to MHLW for Daprodustat to Treat Patients with Renal Anaemia due to Chronic Kidney Disease in Japan,Pharma,21/8/2019
BioInvent to Initiate P-I/IIa Study with BI-1206 in Combination with Merck's Keytruda (pembrolizumab) for Solid Tumors,Pharma,21/8/2019
Orexo Enters into an Agreement with GAIA to Develop and Commercialize Digital Therapy for Opioid Use Disorder?,DigiHealth,21/8/2019
Vivus Reports Results of Qsymia in Pilot Clinical Study for Patients with Laparoscopic Sleeve Gastrectomy Surgery,Pharma,21/8/2019
Pfizer to Invest $500M in State-of-the-Art Gene Therapy Facility in North Carolina,Biotech,22/8/2019
"Biocon Receives EU's GMP Certification for its Semglee (biosimilar, Insulin Glargine) Manufacturing Facility in Malaysia",Biosimilars|Regulatory,22/8/2019
Clarus Therapeutics' Jatenzo (Testosterone Undecanoate Capsules for Oral Use) (CIII) Receives FDA'S Approval for Testosterone Replacement Therapy in Certain Adult Men,Regulatory,27/3/2019
EMD Serono's Mavenclad (Cladribine) Receives FDA's Approval for RRMS and SPMS in Adults,Regulatory,29/3/2019
Johnson &amp; Johnson's Balversa (erdafitinib) Receives FDA's Approval for Locally Advanced or Metastatic Urothelial Carcinoma with Certain FGFR Genetic Alteration,Regulatory,2019-12-04
Amgen's Corlanor (ivabradine) Receives FDA's Approval to Reduce Risk of Hospitalization for Worsening Heart Failure in Patients with Chronic Heart Failure,Regulatory,15/4/2019
Bausch's Duobrii (Halobetasol Propionate and Tazarotene) Receives FDA's Approval for Topical Treatment of Plaque Psoriasis in Adults,Regulatory,25/4/2019
Janssen's Darzalex (daratumumab) Receives MHLW's Approval for Transplant Ineligible Patients with Multiple Myeloma in Japan,Pharma,22/8/2019
"Samsung Bioepis Eticovo's (etanercept-ykro, biosmilar) Receives FDA's Approval for All Eligible Indication",Regulatory,29/4/2019
Jacobus Pharmaceutical's Ruzurgi (amifampridine) Receives the US FDA's Approval for Lambert-Eaton myasthenic syndrome,Regulatory,2019-06-05
AstraZeneca Signs an Agreement with Sobi to Buy its Priority Review Voucher for $95M,Pharma,22/8/2019
Exeltis' Slynd Receives the US FDA's Approval for the Prevention of Pregnancy,Uncategorized,2019-06-06
Innovent Signs a License Agreement with Eli Lilly to Develop and Commercialize OXM3 in China,Pharma,22/8/2019
AstraZeneca and FibroGen's Roxadustat Receive NMPA's Approval for the Treatment of Anemia in Non-Dialysis-Dependent Patients with Chronic Kidney Disease in China,Regulatory,22/8/2019
"Palatin Technologies' Vyleesi (bremelanotide injection) Receives FDA's Approval for Premenopausal Women with Acquired, Generalized Hypoactive Sexual Desire Disorder",Regulatory,22/6/2019
MSD Signs an Exclusive License and Research Agreement with Themis Bioscience to Develop Vaccine Therapies,Biotech,23/8/2019
"Amgen and Allergan Report Results of ABP 798 (biosimilar, rituximab) in JASMINE Study for Non-Hodgkin's Lymphoma",Biosimilars,23/8/2019
Roche's Tecentriq (atezolizumab) Receives MHLW's Approval as the First Immunotherapy for Extensive-Stage Small Cell Lung Cancer in Japan,Regulatory,23/8/2019
Cantargia Extends Licensing Agreement with BioWa for its POTELLIGENT Technology,Biotech,23/8/2019
Novartis Signs an Option Agreement with Iconic Therapeutics for its Ophthalmology Program,Pharma,23/8/2019
OxThera's Oxabact Receives EMA's Positive Decision on Pediatric Investigational Plan to Treat Primary Hyperoxaluria,Regulatory,23/8/2019
Amgen to Acquire Celgene's Otezla (apremilast) for $13.4B,Pharma,26/8/2019
Miracor's PiCSO Impulse System Receives FDA's Breakthrough Device Designation for Treatment of Patients with STEMI,MedTech|Regulatory,26/8/2019
Zogenix to Acquire Modis Therapeutics for its MT1621,M&A,26/8/2019
Eli Lilly and Incyte Report Results of Olumiant (baricitinib) + Topical Corticosteroids in P-III BREEZE-AD7 Study for Moderate to Severe Atopic Dermatitis,Pharma,26/8/2019
Laminate Reports Results of VasQ External Support Device in a Clinical Study for Arteriovenous Fistulas in Hemodialysis Patients,MedTech,26/8/2019
Freenome Signs an Agreement with ADC Therapeutics to Develop Biomarker for its ADCT-402 (loncastuximab tesirine),MedTech,27/8/2019
Eli Lilly's Taltz (ixekizumab) Receives Third US FDA's Approval for Active Ankylosing Spondylitis (Radiographic Axial Spondyloarthritis)?,Regulatory,27/8/2019
Alcon's AcrySof IQ PanOptix Receives the US FDA's Approval as the First Trifocal Lens for Patients Undergoing Cataract Surgery in the US?,Regulatory,27/8/2019
Abbott Reports Positive Data of its Blood Test Technology Detecting Traumatic Brain Injury in Patients with Negative CT Scan,MedTech,27/8/2019
AstraZeneca's Farxiga Receives the US FDA's Fast Track Designation for Chronic Kidney Disease?,Regulatory,27/8/2019
GSK Exercises Its Option to License Ionis' Antisense Therapy for Chronic Hepatitis B Virus Infection,Biotech,27/8/2019
Everyday Health Group to Acquire Johnson and Johnson's BabyCenter a Global Digital Pregnancy and Parenting Resource,M&A,27/8/2019
BMS Signs a Research Collaboration with Presage to Evaluate Novel Cancer Therapies In Phase 0 Studies Utilizing CIVO Technology,Pharma,28/8/2019
Alexion's Soliris (eculizumab) Receives European Commission's Approval for Neuromyelitis Optica Spectrum Disorder?,Regulatory,28/8/2019
AstraZeneca Reports Results of Breztri Aerosphere in P-III ETHOS Study for Chronic Obstructive Pulmonary Disease,Pharma,28/8/2019
BMS's Triple Regimen Receives European Commission Approval for Relapse/Refractory Multiple Myeloma?,Regulatory,28/8/2019
AstraZeneca Receives the US FDA's Orphan Drug Designation for its First Respiratory Biologic Fasenra (benralizumab) to Treat Eosinophilic Esophagitis,Biotech|Regulatory,28/8/2019
Kyowa Kirin's Nourianz (istradefylline) Receives FDA's Approval as an Adjunctive Therapy in Patients with Parkinson's Disease,Pharma|Regulatory,28/8/2019
Janssen Collaborates with Arrowhead for the Initiation of REEF-1 P-IIB Study in Patients with Chronic Hepatitis B Infection,Pharma,28/8/2019
Celgene Signs an Option to License Agreement with Immatics to Develop Novel Adoptive Cell Therapies Targeting Multiple Cancers,Pharma,29/8/2019
Mitsubishi Tanabe Reports Initiation of P-III BouNDLess Trial in Patients with Fluctuating Parkinson's Disease,Pharma,29/8/2019
Roche's Tecentriq (atezolizumab) + Abraxane Receive European Commission's Approval for Patients with PD-L1-Positive Metastatic Triple-Negative Breast Cancer,Regulatory,29/8/2019
AstraZeneca Reports Results of Anifrolumab in P-III TULIP 2 Study for Patients with Systemic Lupus Erythematosus,Pharma,29/8/2019
Roche Reports Launch of First CDx VENTANA PD-L1 (SP142) Assay Identifying TNBC Patients Eligible for Treatment with Tecentriq (atezolizumab),MedTech,29/8/2019
AbbVie to Discontinue its P-III MERU Trial of Rovalpituzumab Tesirine (Rova-T) as 1L Maintenance Therapy for Patients with Advanced Small-Cell Lung Cancer,Pharma,29/8/2019
Novartis Reports Results of Ofatumumab (OMB157) in P-III ASCLEPIOS I and II Studies for Multiple Sclerosis,Biotech,30/8/2019
Sandoz Recalls Losartan Potassium and Ezetimibe Prescription Drug Bottles due to Packaging Issues?,Pharma,30/8/2019
Janssen Extends its Research and Licensing Agreement with SVI to Develop Therapies for Alzheimer's Disease,Pharma,30/8/2019
"Innovent Biologics Reports Results of IBI303 (biosimilar, adalimumab) in P-III Studies for Ankylosing Spondylitis?",Biosimilars,30/8/2019
Celltrion and Teva Report Results Updated Results of CT-P6 in P-III Study for Patients Receiving Neoadjuvant Treatment for HER2-Positive Early Breast Cancer,Biosimilars,21/8/2019
United Healthcare to Prefer Amgen's Two Anticancer Biosimilars in October 2019,Biosimilars,16/8/2019
Philips Collaborates with LindaCare for the Remote Monitoring of Patients with Cardiac Implantable Electronic Devices,DigiHealth,30/8/2019
Paratek Reports Results of Nuzyra (omadacycline) in P-III OASIS-2 Study for Skin Infections,Pharma,30/8/2019
Roche Reports Positive Results of Xofluza (baloxavir marboxil) in Two P-III MINISTONE-2 and BLOCKSTONE Studies for Influenza Infection,Pharma,2019-02-09
Novartis Reports Results of Entresto (sacubitril/valsartan) in Three P-III PARAGON-HF and P-IV PROVE-HF with EVALUATE-HF Studies for Patients with HFpEF and HFrEF,Pharma,2019-02-09
UniSA Evaluates Computer Vision Technology to Monitor Premature Babies in Neonatal Units,MedTech,2019-02-09
AstraZeneca Reports Results of Brilinta (ticagrelor) in P-III THEMIS Study for Coronary Artery Disease and Type-2 Diabetes,Pharma,2019-02-09
Chugai Files an Application to MHLW for an Additional Indication of Kadcyla (trastuzumab emtansine) as an Adjuvant Therapy for HER2-Positive Early Breast Cancer in Japan,Biotech,2019-02-09
AstraZeneca Reports Detailed Results of Farxiga (dapagliflozin) in P-III DAPA-HF Study to Treat Patients with Heart Failure?,Pharma,2019-02-09
Helsinn Enters into an Exclusive Distribution and License Agreement with Blanver and Varifarma for Pracinostat in South America,Pharma,2019-03-09
"Federal Circuit to Dismiss Halt Sales of Amgen's Mvasi (biosimilar, bevacizumab-awws) in the US",Biosimilars,16/8/2019
Polpharma Signs an Exclusive Worldwide Commercialization Agreement with Sandoz for Proposed Biosimilar Natalizumab to Treat Relapsing-Remitting Multiple Sclerosis,Biosimilars,2019-03-09
The European Society of Cardiology Recommends Bayer's Xarelto (rivaroxaban) in Combination with Aspirin for the Management of Diabetes and Chronic Coronary Syndromes,Pharma,2019-03-09
Boehringer Ingelheim and Zealand Pharma to Initiate P-II Study of BI 456906 for Obesity and Diabetes,Pharma,2019-03-09
Alytas Therapeutics Signs an Agreement with Velabs Therapeutics to Develop Novel Immune-Based Therapy for Obesity,Pharma,2019-03-09
Vertex to Acquire Semma Therapeutics for Developing Curative Cell-Based Therapies to Treat Type 1 Diabetes,M&A,2019-03-09
"Celltrion Enters into a Contract to Manufacture Agreement for its Remsima (biosimilar, infliximab) with Lonza?",Biosimilars,2019-04-09
"STADA to Launch its Movymia (biosimilar, teriparatide) to Treat Osteoporosis in 24 Countries",Biosimilars,20/8/2019
AstraZeneca's Tagrisso (osimertinib) Receives NMPA's Approval as a 1L Therapy for EGFR-Mutated Non-Small Cell Lung Cancer in China?,Regulatory,2019-04-09
Boehringer Ingelheim Enters into a Licensing Agreement with Lupin to Expand its KRAS Cancer Program,Pharma,2019-04-09
Karolinska Institutet Evaluates AsthmaTuner Self-monitoring Mobile App for Managing Uncontrolled Asthma?,DigiHealth,2019-04-09
Merck's Keytruda (pembrolizumab) in Combination with Inlyta (axitinib) Receives European Commission's Approval as a 1L Therapy for Advanced Renal Cell Carcinoma,Regulatory,2019-04-09
Janssen's Investigational Prophylactic Vaccine Receives the US FDA's Breakthrough Therapy Designation to Prevent Respiratory Syncytial Virus,Regulatory,2019-04-09
BMS Signs an Agreement with BioMotiv to Develop Therapies for Patients with Serious Disorder,Pharma,2019-04-09
Regenxbio Signs an Exclusive Worldwide Option and License Agreement with Clearside Biomedical to Evaluate its Delivery Platform for RGX-314,Pharma,2019-04-09
Mylan to Make Amendments in its 2018 License Agreement with Revance for Biosimilar of BOTOX,Biosimilars,22/8/2019
"Samsung Bioepis Initiates Recruitment of Patients in P-III Study for SB12 (biosimilar, eculizumab) to Treat Paroxysmal Nocturnal Hemoglobinuria (PNH) in India",Biosimilars,16/8/2019
Conglomerate of Rheumatology and Spondylitis Organizations Released New Updated Guidelines Against Mandatory Switching to Biosimilars,Biosimilars,22/8/2019
AstraZeneca Collaborates with Schrödinger to Utilize its Molecule-Modeling Platform for Drug Discovery,Pharma,2019-05-09
Google Collaborates with Cochlear and GN Hearing to Support Direct Phone Streaming to Hearing Aids for Patients with Hearing Loss,MedTech,2019-05-09
BioNTech Signs an Agreement with Gates Foundation to Develop Therapies for HIV and Tuberculosis,Biotech,2019-05-09
Janssen's Stelara (ustekinumab) Receives EC's Approval for its Expanded Use to Treat Moderately to Severely Active Ulcerative Colitis,Regulatory,2019-05-09
AbbVie Signs a Research Agreement with Idera Pharmaceuticals to Evaluate Combination Therapy,Pharma,2019-05-09
Novartis Signs an Exclusive Research and Option to Acquire Agreement with IFM Due to Develop Therapies Targeting cGAS/STING Pathway,Pharma,2019-05-09
Takeda Recalls Natpara (parathyroid hormone) Injection Formulation in the US,Biotech,2019-06-09
AstraZeneca Signs a License Agreement with Theragnostics for its PARP Inhibitor,Pharma,2019-06-09
SpeeDx's ResistancePlus MG FleXible Receives CE-IVD Clearance for Detection of Sexually Transmitted Infection (STI),MedTech|Regulatory,2019-06-09
BMS Reports Results of Opdivo (nivolumab) in P-III CheckMate-548 Study for Patients Newly Diagnosed with MGMT-Methylated Glioblastoma Multiforme,Pharma,2019-06-09
Roche's Tecentriq Based Combination Therapy Receives EC's Approval as 1L Treatment for Non-Squamous Non-Small Cell Lung Cancer,Regulatory,2019-06-09
OncoCyte to Acquire Razor Genomics for the Expansion of its Capabilities in Early-Stage Lung Cancer,M&A,2019-06-09
Roche's Tecentriq + Chemotherapy Receives EC's Approval as 1L Treatment for Extensive Stage Small Cell Lung Cancer,Regulatory,2019-06-09
Sumitomo Dainippon and Roivant Signs a Memorandum of Understanding to Form $3B Alliance,Pharma,2019-09-09
Eli Lilly Signs an Agreement with Thermo Fisher to Develop CDx for its Selpercatinib (LOXO-292),MedTech,2019-09-09
AstraZeneca Reports Results of Imfinzi (durvalumab) in P-III CASPIAN Study for 1L Extensive-Stage Small Cell Lung Cancer,Biotech,2019-09-09
Abbott to Initiate World's First Study to Evaluate its TriClip Transcatheter Tricuspid Valve Repair System in the US?,MedTech,2019-09-09
Allergan and Molecular Partners Report Acceptance of FDA's BLA and Validation of EMA's MAA for Abicipar Pegol,Regulatory,2019-09-09
Genmab Signs an Agreement with Tempus to Develop Novel Targets and Biomarkers for Cancer Indications,MedTech,2019-10-09
Alexion Enters into an Exclusive License Agreement with Eidos to Develop and Commercialize AG10 in Japan,Pharma,2019-10-09
Medtronic's MiniMed 670G Insulin Pump System Receives Reimbursement for Patients with T1D in Germany,MedTech,2019-10-09
BMS Reports Pooled Five Year Results of Opdivo (nivolumab) in Two P-III Studies for Advanced Non-Small Cell Lung Cancer,Pharma,2019-10-09
Mallinckrodt to Divest its Subsidiary BioVectra for $250M?,M&A,2019-10-09
Baxter to Acquire Cheetah Medical for ~$230M,M&A,2019-10-09
Sanofi Terminates its Four Years Alliance with Lexicon for Zynquista (sotagliflozin)?,Pharma,2019-11-09
Xeris' GVOKE (glucagon) Receives FDA's Approval as The First Ready-To-Use Stable Liquid Glucagon for Severe Hypoglycemia,Biotech,2019-11-09
Google Collaborates with Mayo Clinic for Healthcare Innovation Utilizing AI and Cloud Computing?,DigiHealth,2019-11-09
"Samsung Bioepis Reports the Availability of Brenzys (biosimilar, etanercept) in Brazil",Biosimilars,2019-11-09
Merck KGaA's Tepotinib Receives FDA's Breakthrough Therapy Designation for Metastatic NSCLC with METex14 Skipping Alterations,Regulatory,2019-11-09
Apple to Launch a Research App for Three Medical Studies Monitoring Health Issues,DigiHealth,2019-11-09
GSK to Acquire Sitari Pharmaceuticals for its Celiac Diseases Program,M&A,2019-12-09
"Teva Canada's Herzuma (biosimilar, trastuzumab) Receives Health Canada Approval for Multiple Cancer Indications?",Biosimilars|Regulatory,2019-12-09
Roche Reports Results of Satralizumab in Second P-III Study for Neuromyelitis Optica Spectrum Disorder,Pharma,2019-12-09
Zentiva to Acquire Sanofi's Ankleshwar Manufacturing Facility in India,M&A,2019-12-09
Janssen Reports Results of Ponesimod in P-III OPTIMUM Study for Relapsing Multiple Sclerosis in Adults,Pharma,2019-12-09
Hansoh Enters into a Collaboration with Atomwise for AI-Based Drug Discovery,Pharma,2019-12-09
Vertex Signs an Access Agreement with Scottish Government for Orkambi (lumacaftor/ivacaftor) and Symkevi (tezacaftor/ivacaftor),Pharma,2019-12-09
Aytu BioScience to Acquire Innovus Pharmaceuticals for ~$24M,M&A,13/9/2019
Roche Reports Results of Perjeta (pertuzumab) Fixed Dose SC Combination Therapy in P-III FeDeriCa Study for HER2+ve Breast Cancer,Pharma,13/9/2019
GSK's Nucala (mepolizumab) Receives the US FDA's Approval as First Biologic for Severe Eosinophilic Asthma in Children Aged 6-11yrs.,Regulatory,13/9/2019
Celgene Reports Results of CC-486 in P-III QUAZAR AML-001 Study as Maintenance Therapy for Acute Myeloid Leukemia,Pharma,13/9/2019
GE Healthcare's Critical Care Suite AI-Powered X-ray Device Receives FDA's 510(k) Clearance to Identify Pneumothorax,MedTech,13/9/2019
Eisai And Biogen to Terminate Two P-III Clinical Studies of Elenbecestat (E2609) for Early Alzheimer's Disease?,Pharma,13/9/2019
Lundbeck to Acquire Alder BioPharmaceuticals for $1.95B,M&A,16/9/2019
Sanofi and Abbott Collaborate to Assimilate Glucose Sensing and Insulin Delivery Technologies to Manage Diabetes,DigiHealth,16/9/2019
Medtronic and Novo Nordisk Collaborate to Deliver Integrated Digital Solutions Easing the Hassles of Diabetes Management,MedTech,16/9/2019
AstraZeneca's Farxiga (dapagliflozin) Receives FDA's Fast Track Designation to Treat Patients with Heart Failure,Regulatory,16/9/2019
Boehringer Ingelheim Signs an Exclusive Worldwide License Agreement with Oncoheroes Biosciences for Volasertib,Pharma,16/9/2019
Janssen Reports Submission of sBLA to the US FDA for Tremfya (guselkumab) to Treat Active Psoriatic Arthritis,Biotech|Regulatory,17/9/2019
Seattle Genetics and Astellas Report Acceptance of BLA for Enfortumab Vedotin to Treat Locally Advanced or Metastatic Urothelial Cancer?,Biotech|Regulatory,17/9/2019
Medtronic's Envision Pro Continuous Glucose Monitoring System Receives CE Mark in Europe,MedTech,17/9/2019
Acceleron to Discontinue its P-II Study of ACE-083 for Facioscapulohumeral Muscular Dystrophy?,Pharma,17/9/2019
Glenmark's GBR 1342 Receives the US FDA's Orphan Drug Designation for Multiple Myeloma,Regulatory,17/9/2019
Merck Reports Acceptance of BLA to the US FDA for V920 Ebola Virus Vaccine,Regulatory,17/9/2019
Bayer Signs a License Agreement with Informed Data Systems to Utilize its One Drop Digital Therapeutics Platform,DigiHealth,17/9/2019
Mylan Launches Generic Faslodex Injection for the Expansion of its Oncology Portfolio in the US,Pharma,18/9/2019
Generium Launches First Biosimilar of Dornase Alfa Utilizing Selexis' SUREtechnology Platform?,Biosimilars,18/9/2019
AstraZeneca Amends its Development and Commercialization Agreement with Ironwood for Linzess (linaclotide) Signed in 2012 ?,Pharma,18/9/2019
Roche's Gazyva (obinutuzumab) Receives FDA's Breakthrough Therapy Designation for Lupus Nephritis,Regulatory,18/9/2019
Regeneron and Sanofi Launch Educational Campaign Focusing on Patients Living with Moderate-To-Severe Atopic Dermatitis,Pharma,18/9/2019
The US FDA Initiates its First Step Towards Project Orbis for Concurrent Review of Cancer Therapies,Regulatory,18/9/2019
Merck's Keytruda (pembrolizumab) + Eisai's Lenvima (lenvatinib) Receives FDA's Approval for Certain Types of Endometrial Carcinoma?,Regulatory,18/9/2019
Novigenix Collaborates with BioLizard to Develop AI-Based Diagnostic Algorithm for Detecting Colon Cancer,MedTech,19/9/2019
Roche Renews its Support to the Phelophepa Healthcare Trains in South Africa Marking the 25th Anniversary,Pharma,19/9/2019
Novartis Reports Results of Galvus (vildagliptin) Combination Therapy in P-IV VERIFY Study for Type 2 Diabetes Mellitus?,Pharma,19/9/2019
Biogen to Initiate P-II/III DEVOTE Study Evaluating the Higher Doses of Spinraza (nusinersen) for Spinal Muscular Atrophy,Pharma,19/9/2019
TB Alliance's Pretomanid Combination Therapy Receives the US FDA's Approval for Highly Drug-Resistant Forms of Tuberculosis,Regulatory,15/8/2019
Harmony Biosciences' Wakix (pitolisant) Receives the US FDA's Approval for Treatment of Excessive Daytime Sleepiness in Adult Patients with Narcolepsy,Regulatory,15/8/2019
Novo Nordisk Reports Results of Tresiba (insulin degludec) in CONCLUDE Study for Type 2 Diabetes,Biotech,19/9/2019
Novartis Reports the Reimbursement of Kisqali as 1L Treatment for Metastatic Breast Cancer in Quebec,Pharma,19/9/2019
Merck KGaA Signs a License Agreement with Y-Trap to Develop Antibody-Ligand Traps for Immuno-Oncology,Biotech,20/9/2019
Roche's cobas Babesia Blood Test Receives the US FDA's Approval for Donor Screening,MedTech|Regulatory,20/9/2019
Takeda and Lundbeck's Trintellix (vortioxetine) Receives MHLW's Approval for Major Depressive Disorder in Japan?,Regulatory,20/9/2019
Eli Lilly's Trulicity (dulaglutide) Receives CHMP Recommendation for Label Update to Include Results from REWIND Study,Regulatory,20/9/2019
Astellas and FibroGen's Evrenzo (roxadustat) Receives MHLW's Approval for Anemia Associated with Chronic Kidney Disease in Dialysis Patients,Regulatory,20/9/2019
Boehringer Ingelheim Enters into an Agreement with Inflammasome Therapeutics to Co-Develop Therapies for Retinal Diseases,Pharma,20/9/2019
"PharmaShots Weekly Snapshot (September 16– 20, 2019)",Weekly Snapshot,23/9/2019
AstraZeneca's Qtrilmet Receives CHMP's Recommendation for its Approval to Treat Patients with Type-2 Diabetes in Europe,Regulatory,23/9/2019
Novo Nordisk's Rybelsus (semaglutide) Receives FDA's Approval as the First Oral GLP-1 analog for Type 2 Diabetes,Regulatory,23/9/2019
Clovis Oncology Signs a License Agreement with 3B Pharmaceuticals for FAP-Targeted Radiopharmaceutical Program,Pharma,23/9/2019
Biogen's Plegridy (peginterferon beta-1a) and Avonex (interferon beta-1a) Receive CHMP's Positive Opinion to Use During Pregnancy and Breastfeeding?,Regulatory,23/9/2019
Mallinckrodt Reports Results of StrataGraft Regenerative Tissue in P-III STRATA2016 Study for Deep Partial-thickness Thermal Burns?,Biotech,23/9/2019
"Celltrion's CT-P13 (biosimilar, infliximab) Receives CHMP's Positive Opinion for its SC Formulation to Treat Rheumatoid Arthritis?",Biosimilars,23/9/2019
MSD Collaborates with I-Mab to Evaluate Keytruda + TJC4 for Multiple Cancer Indications,Pharma,24/9/2019
Bayer's Vitrakvi (larotrectinib) Receives EMA's Approval as the First Tumor Agonist in Europe?,Regulatory,24/9/2019
Sandoz Voluntary Recalls Ranitidine Hydrochloride Capsules Due to Elevated Amount of N-Nitrosodimethylamine in the US,Pharma,24/9/2019
Bayer Collaborate with Women's Hospital and Massachusetts General Hospital to Launch Joint Lab Targeting Chronic Lung Diseases,Pharma,24/9/2019
Takeda Collaborates with Evotec to Discover Clinical Candidates for Multiple Therapeutic Areas,Pharma,24/9/2019
BMS' Opdivo (nivolumab) Receives CHMP Recommendation for Approval of its Four-Week Dosing Schedule?,Regulatory,24/9/2019
Aldeyra's ADX-2191 Receives FDA's Fast Track Designation to Prevent Proliferative Vitreoretinopathy,Regulatory,24/9/2019
Biocon Biologics Acquires Pfizer's Research Facility to Expand its Research and Development Footprint,Biotech|M&A,25/9/2019
Pfizer Expands its Collaboration with Flatiron Health to Integrate the Use of Real-World Evidence in Oncology,Pharma,25/9/2019
Amgen Reports Results of Blincyto (blinatumomab) in Two P-III Studies for Relapsed Acute Lymphoblastic Leukemia in Pediatric Patients?,Pharma,25/9/2019
Bavarian Nordic's Jynneos Vaccine Receives FDA's Approval to Prevent Smallpox and Monkeypox Disease in Adults,Regulatory,25/9/2019
Achillion's Danicopan (ACH-4471) Receives FDA's Breakthrough Therapy Designation for Paroxysmal Nocturnal Hemoglobinuria,Regulatory,25/9/2019
Ethicon Launches Echelon Circular as the First Powered Circular Stapler for Colorectal Gastric and Thoracic Surgery?,MedTech,25/9/2019
Takeda Reports Results of Vedolizumab in its First Head-to-Head Biologic Study for Ulcerative Colitis,Biotech,26/9/2019
Abbott's ARCHITECT STAT High Sensitivity Troponin-I Blood Test Receives FDA Clearance to Detect Heart Attacks Faster and Accurately,MedTech,26/9/2019
Thermo Fisher to Expand its Clinical Trials Capabilities and Collaborates with Frontier to Develop Therapy for HIV,Pharma,26/9/2019
Jazz Reports Results of JZP-258 in a P-III Study to Treat Cataplexy and Excessive Daytime Sleepiness in Patients with Narcolepsy,Pharma,26/9/2019
AstraZeneca and Innate Pharma to Advance Monalizumab in a P-III Study for Head and Neck Cancer,Biotech,26/9/2019
Medtronic to Initiate Clinical Study Evaluating Infuse Bone Graft in TLIF Spine Procedures,MedTech,26/9/2019
AbbVie's Mavyret (glecaprevir/pibrentasvir) Receives FDA's Approval for its Expanded Indication in Treatment-Naïve Patients with Chronic Hepatitis C and Compensated Cirrhosis Across All Genotypes,Regulatory,27/9/2019
Janssen's Darzalex (daratumumab) Combination Therapy Receives FDA's Approval for Frontline Multiple Myeloma?,Regulatory,27/9/2019
Medtronic Reports Results of Resolute Onyx DES in Onyx ONE Global Study for High-Bleeding Risk Patients with One-Month DAPT ?,MedTech,27/9/2019
Ieso Launches Eight Billion Minds Digital Initiative Addressing Unmet Mental Health Needs,DigiHealth,27/9/2019
Simcere Signs an Exclusive License Agreement with JW Pharmaceutical for an Anti-Gout Drug Candidate URC-102 in China?,Pharma,27/9/2019
Pfizer Reports Results of Abrocitinib in P-III JADE MONO-2 Study for Moderate to Severe Atopic Dermatitis,Uncategorized,27/9/2019
Incyte Reports Updated Results of Pemigatinib in P-II FIGHT-202 Trial for Patients with Previously Treated Advanced Cholangiocarcinoma,Pharma,27/9/2019
Sobi to Acquire Dova Pharmaceuticals for $915M?,M&A,30/9/2019
Roche's Rituxan (rituximab) Receives the US FDA's Approval for Two Rare Blood Vessel Disorders in Pediatric Patients Aged 2yrs. and Above?,Regulatory,30/9/2019
GSK Reports Results of Nucala (mepolizumab) in REALITI-A Study for Severe Eosinophilic Asthma?,Biotech,30/9/2019
Merck Reports Results of Recarbrio (imipenem/cilastatin/relebactam) in P-III RESTORE-IMI 2 Study for Patients with HABP/VABP,Pharma,30/9/2019
Celltrion Signs an Exclusive Co-Marketing Agreement with Juno in Australia,Biosimilars,30/9/2019
Fresenius Kabi to Establish R&amp;D Center for Biosimilars in Switzerland,Biosimilars,18/9/2019
Vertex Collaborates with Ribometrix to Discover and Develop up to Three RNA Targeted Candidates,Pharma,30/9/2019
Mochida Receives Marketing Authorization for Teriparatide Biosimilar in Japan,Biosimilars,20/9/2019
SymBio Signs Worldwide Exclusive License Agreement with Chimerix to Develop and Commercialize Brincidofovir,Pharma,2019-01-10
"Dr. Reddy Plans the Onset of P-III trial for DRL_RI (biosimilar, rituximab) in the Korea",Biosimilars,17/9/2019
AstraZeneca to Divest Worldwide Commercialization Rights of Losec (omeprazole) to Cheplapharm,Pharma,2019-01-10
Janssen's Invokana (canagliflozin) Receives the US FDA's Approval for Patients with Type 2 Diabetes and Diabetic Kidney Disease ?,Regulatory,2019-01-10
Roche Reports Result of Tecentriq (atezolizumab) + Platinum-Based CT in P-III IMvigor130 Study for Advanced Bladder Cancer,Biotech,2019-01-10
"Pfizer to Launch its Zirabev (biosimilar, bevacizumab) in the US by the year end 2019",Biosimilars,2019-01-10
Taisho Signs an Exclusive License Agreement with Moberg Pharma to Develop and Commercialize MOB-015 in Japan?,Pharma,2019-01-10
Eisai Signs a Research and Option Agreement with Numab to Discover and Develop Multi-Specific Antibody Immunotherapies for Cancer?,Biotech,2019-01-10
Novartis Signs a Multiyear Agreement with Microsoft to Transform Medicine with the Launch of AI Innovation Lab,DigiHealth,2019-03-10
"Biocon and Mylan Launch Semglee (biosimilar, Insulin Glargine) in Australia",Biosimilars,2019-03-10
Philips Collaborates with Air Ambulance Kent Surrey Sussex to Provide Emergency Services in the UK,Pharma,2019-03-10
Eli Lilly Reports Results of Taltz (ixekizumab) in Head-to-Head P-IV IXORA-R Study for Moderate to Severe Plaque Psoriasis,Biotech,2019-03-10
Merck's Keytruda Receives NMPA's Approval as Monotherapy for 1L Treatment of Advanced Non-Small Cell Lung Cancer with PD-L1 Tumor Expression in China?,Regulatory,2019-03-10
Eli Lilly Reports the Availability of Emgality (galcanezumab) to Prevent Migraine in Canada,Biotech,2019-03-10
Novo Nordisk Collaborates with Noom to Provide Digital Health Solutions Targeting Weight Management in Patients with Obesity,DigiHealth,2019-03-10
Takeda Signs a License Agreement with Goldfinch Bio for its GFB-024 to Treat Rare and Metabolic Kidney Diseases,Pharma,2019-04-10
Gilead's Descovy Receives the US FDA's Approval for HIV Pre-Exposure Prophylaxis ?,Regulatory,2019-04-10
AstraZeneca's Fasenra Pen (Pre-Filled Auto-Injector) Receives the US FDA's Approval for Severe Eosinophilic Asthma?,Biotech|Regulatory,2019-04-10
Silver Cloud Health Partners with Microsoft to Deploy AI for Enhancing its Digital Mental Healthcare,DigiHealth,2019-04-10
Arbutus to Discontinue its P-Ia/Ib Clinical Study of AB-506 to Treat Patients with Chronic Hepatitis B,Pharma,2019-04-10
Janssen's Niraparib Receives the US FDA's Breakthrough Therapy Designation for Metastatic Castration-Resistant Prostate Cancer,Regulatory,2019-04-10
AveXis Reports Results of AVXS-101 (Intrathecal) in P-I/II STRONG Study for Patients with SMA Type 2,Pharma,2019-07-10
Takeda Signs Multi-Target Strategic Collaboration with Prometheus to Develop Targeted Therapies for Inflammatory Bowel Disease,Pharma,2019-07-10
Eli Lilly Report Results of Cyramza (ramucirumab) in P-III RELAY Study for 1L Treatment of EGFR-Mutated Non-Small Cell Lung Cancer,Biotech,2019-07-10
"Alvogen and Pfenex's PF708 (biosimilar, teriparatide) Receives FDA's Approval for the Treatment of Osteoporosis?",Biosimilars,2019-07-10
Pfizer Signs an Exclusive Worldwide License Agreement with Akcea for its AKCEA-ANGPTL3-L(Rx),Pharma,2019-07-10
Biofourmis' Biovitals Analytics Engine Receives FDA's 510(k) Clearance for Ambulatory Physiologic Monitoring?,MedTech,2019-07-10
Innovate Merging with RDD Pharma to Form New Gastroenterology Company Focusing on Specialty Rare and Orphan Diseases,M&A,2019-08-10
Allergan to Launch Three REFRESH RELIEVA Lubricant Eye Drops Expanding its REFRESH Portfolio,Pharma,2019-08-10
MSD Signs a Research and Option to License Agreement with 4D Pharma to Develop Live Biotherapeutics for Vaccines,Biotech,2019-08-10
Medtronic Initiates Worldwide Pivotal Study to Evaluate its Extravascular Implantable Cardioverter Defibrillator System,MedTech,2019-08-10
Novartis' Beovu (brolucizumab) Receives FDA's Approval for the Treatment of Wet Age-Related Macular Degeneration,Biotech|Regulatory,2019-08-10
Gilead Reports Submission of NDA to MHLW for Filgotinib to Treat Rheumatoid Arthritis in Japan,Regulatory,2019-08-10
GSK Signs a Five Years Collaboration with Lyell to Develop Technologies Improving Cell Therapies for Cancer,Pharma,2019-09-10
AstraZeneca Canada's Calquence (acalabrutinib) Receives Health Canada Approval for Patients Previously Treated with Mantle Cell Lymphoma (MCL),Pharma,2019-09-10
Prevail Signs an Agreement with Lonza to Develop and Manufacture AAV9 Gene Therapy Programs for Patients with Neurodegenerative Diseases,Pharma,2019-09-10
Amgen Canada's EVENITY (romosozumab) Receives Health Canada Approval to Treat Osteoporosis in Postmenopausal Women at High Risk for Fracture,Pharma,2019-09-10
GE Healthcare Signs a Worldwide Development and Commercialization Agreement with Theragnostics for Late Stage PSMA Diagnostic for Prostate Cancer,Pharma,2019-09-10
"Samsung Bioepis Reports Real-World Data of Benepali (biosimilar, etanercept) in Patients with Psoriasis at EADV 2019",Biosimilars,2019-09-10
Bluebird Bio Signs a Three-Year Research Collaboration with Novo Nordisk to Develop In-Vivo Genome Editing Therapies for Hemophilia A,Biotech,2019-09-10
Mitsubishi Tanabe Signs a License Agreement with Viela Bio for its Inebilizumab,Pharma,2019-10-10
Evotec Signs an Agreement with Celmatix to Develop Pre-Clinical Candidates for Women Health,Pharma,2019-10-10
Boehringer Ingelheim Reports Results of OFEV (nintedanib) in P-III INBUILD Trial for Patients with Chronic Fibrosing Interstitial Lung Disease with Progressive Phenotype (1),Pharma,2019-10-10
Bayer Launches a LifeHub UK for the Development of AI-Enabled Imaging Solutions Enhancing Data-Driven Drug Discovery and Disease Diagnosis,DigiHealth,2019-10-10
Sun Pharma Reports Four Years Result of Ilumya (tildrakizumab-asmn) in P-III reSURFACE 1 and 2 Trials in Patients with Moderate-to-Severe Plaque Psoriasis,Pharma,2019-10-10
UCB to Acquire Ra Pharma to Improve Therapies for Patients with Myasthenia Gravis and Other Rare Diseases,M&A,2019-10-10
Reata Regains Exclusive Worldwide Rights of its Nrf2 Activator Product Platform from AbbVie,Pharma,2019-10-10
Aclaris to Divest its Rhofade (oxymetazoline hydrochloride) with all IPR Rights to EPI Health,Pharma,2019-11-10
Bayer's G4A Digital Health Partnerships Program Signs an Agreement with Eleven Digital Health Startups Transforming Digital Health Solutions,DigiHealth,2019-11-10
Boehringer Ingelheim's Ofev (nintedanib) Receives the US FDA's Breakthrough Therapy Designation for Chronic Fibrosing ILDs with a Progressive Phenotype,Pharma,2019-11-10
Biocon Biologics Signs an In-License Agreement with Just - Evotec Biologics,Biosimilars,2019-11-10
Alexion Signs an Option to Co-Develop and Commercialize Agreement with Stealth for Elamipretide,Pharma,2019-11-10
OraSure Technologies' Rapid Diagnostic OraQuick Ebola Rapid Antigen Test Receives the US FDA Marketing Approval for Detection of Ebola Virus Antigens,Regulatory,2019-11-10
?Alnylam Reports Submission of MAA to Brazilian Health Regulatory Agency for Onpattro (patisiran) to Treat Hereditary ATTR Amyloidosis with Polyneuropathy,Regulatory,2019-11-10
?ImaginAb Collaborates with Three Global Pharmaceutical Companies Focusing on the Development of its CD8 ImmunoPET Technology,Biotech,14/10/2019
Roche Reports Results of MabThera/Rituxan (rituximab) in P-III PEMPHIX Study for Pemphigus Vulgaris?,Pharma,14/10/2019
?Lilly's Reyvow (lasmiditan) Receives FDA's Approval as the First Therapy in a New Class of Acute Treatment for Migraine,Regulatory,14/10/2019
?Exact Sciences and Mayo Clinic Initiate Voyage Study Evaluating the Real-World Impact of Cologuard,MedTech,14/10/2019
?Aytu BioScience to Acquire Cerecor's Prescription Product Portfolio for $17M,Pharma,14/10/2019
?Sanofi Launches its First Digital Manufacturing Facility for Delivering Next-Generation Biologics in Massachusetts,Biotech,15/10/2019
?Takeda to Divest its Portfolio of Select OTC and Non-Core Assets to Acino for ~$200M in NEMEA Countries,Pharma,15/10/2019
?Abbott Collaborates with Omada Health to Provide Integrated Digital Health and Coaching Experience for Patients with Type 2 Diabetes,DigiHealth,15/10/2019
?Bayer and Janssen's Xarelto (rivaroxaban) Receive FDA's Approval to Prevent Venous Thromboembolism in Acutely Ill Patients,Regulatory,15/10/2019
?Kyowa Kirin Reports the Availability of Nourianz (Istradefylline) to Treat Parkinson's Disease “Off” Episodes in the US,Pharma,15/10/2019
CRISPR Therapeutics and KSQ Therapeutics Cross Licenses their IP Rights to Facilitate Cell Therapy Programs in Oncology?,Biotech,15/10/2019
?Reata Reports Results of Omaveloxolone in P-II MOXIe Registrational Study for Patients with Friedreich's Ataxia,Pharma,15/10/2019
?Abbott and Tandem Collaborate to Explore Integrated Diabetes Solutions Improving Diabetes Management,DigiHealth,16/10/2019
?Sanofi and Kaken to Terminate their Co-Marketing Agreement for Clexane by the Year End 2019,Pharma,16/10/2019
?Daiichi Sankyo Acquires Rights for Astellas' Three Therapies to Boost its Presence in Asia,Pharma,16/10/2019
?ProQR's Sepofarsen Receives FDA's Rare Pediatric Disease Designation to Treat Leber's Congenital Amaurosis 10,Regulatory,16/10/2019
Alexion to Acquire Achillion for ~$930M?,M&A,16/10/2019
Lilly Reports Results Pegilodecakin + Folfox in P-III SEQUOIA Study for Metastatic Pancreatic Cancer?,Pharma,16/10/2019
?Sandoz Terminates its Prescription Digital Therapies Agreement with Pear Therapeutics,DigiHealth,17/10/2019
?AstraZeneca Collaborates with PetaGene to Deploy PetaSuite in its Core Genomics Initiative,DigiHealth,17/10/2019
?AstraZeneca and Daiichi Report the US FDA's Acceptance of BLA for Trastuzumab deruxtecan (DS-8201) and Granted Priority Review,Regulatory,17/10/2019
Sun Pharma Launches Drizalma Sprinkle (duloxetine delayed-release capsules) for Neuro-Psychiatric and Pain Disorders in the US?,Pharma,17/10/2019
Ipsen Signs Exclusive Worldwide License Agreement with Blueprint to Develop &amp; Commercialize BLU-782 for Fibrodysplasia Ossificans Progressiva?,Pharma,17/10/2019
UCB Reports Results of Bimekizumab in P-III BE VIVID Study to Treat Moderate to Severe Chronic Plaque Psoriasis?,Biotech,17/10/2019
Fitbit Collaborates with BMS-Pfizer Alliance Focusing on Improving Atrial Fibrillation Detection?,DigiHealth,18/10/2019
?Roche's Xofluza (baloxavir marboxil) Receives the US FDA's Approval for People at High Risk of Developing Influenza-Related Complications,Regulatory,18/10/2019
Amgen and UCB's Evenity (Romosozumab) Receive CHMP Positive Opinion to Treat Severe Osteoporosis in Postmenopausal Women at High Risk of Fracture?,Regulatory,18/10/2019
Cipla to Acquire Venus Remedies' Elores to Strengthen its Critical Care Footprints in India,Pharma,18/10/2019
Merck's V920 Ebola Zaire Vaccine Receives CHMP Positive Opinion to Protect Against Ebola Virus Disease,Biotech,18/10/2019
AbbVie's Rinvoq (Upadacitinib) Receives CHMP Positive Opinion to Treat Moderate to Severe Active Rheumatoid Arthritis?,Regulatory,18/10/2019
Johnson &amp; Johnson Initiates Voluntarily Recall of a Single Lot of its Baby Powder in the US,Pharma,18/10/2019
Roche Reports Result of Tecentriq (atezolizumab) + Avastin (bevacizumab) in P-III IMbrave150 Study for Unresectable Hepatocellular Carcinoma,Biotech,21/10/2019
GSK to Divest its Rabipur and Encepur Vaccines to Bavarian Nordic for ~1B,Biotech,21/10/2019
?AstraZeneca's Farxiga (dapagliflozin) Receives the US FDA's Approval for Reducing the Risk of Hospitalization for Heart Failure in Patients with Type-2 Diabetes,Regulatory,21/10/2019
?Sartorius to Acquire Danaher's Life Science Portfolio for $750M,Pharma,21/10/2019
?Janssen's Stelara (ustekinumab) Receives the US FDA's Approval for Moderately to Severely Active Ulcerative Colitis,Regulatory,21/10/2019
?Humana and Microsoft Collaborate to Reimagine Health Leveraging Azure Cloud and AI with Voice Technologies,DigiHealth,22/10/2019
?Bayer to Terminate its JV Agreement with CRISPR Therapeutics,Pharma,22/10/2019
?Takeda Acquires Exclusive Worldwide License Rights for COUR's CNP-101 to Treat Celiac Disease,Pharma,22/10/2019
?Pfizer and OPKO Reports Results of Somatrogon in P-III Study for Children with Growth Hormone Deficiency,Biotech,22/10/2019
?Vertex's Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) Receives the US FDA's Approval to Treat the Underlying Cause of Cystic Fibrosis,Regulatory,22/10/2019
?BMS Reports Result of Opdivo (nivolumab) + Yervoy (ipilimumab) + CT in P-III CheckMate-9LA Study as 1L Therapy for Lung Cancer,Biotech,22/10/2019
"?Alvogen Signs an Exclusive Commercialization Agreement with Three Pharma Companies for PF708 (biosimilar, teriparatide)",Biosimilars,23/10/2019
?Novo Nordisk's Fiasp (insulin aspart injection) Receives the FDA's Approval for use in Insulin Infusion Pumps to Treat Type 1 or Type 2 Diabetes,Regulatory,23/10/2019
?Biogen and Eisai Plan to File BLA to the US FDA for Aducanumab to Treat Alzheimer's Disease,Biotech,23/10/2019
?BerGenBio's Bemcentinib Receives the US FDA's Fast Track Designation for Relapsed Acute Myeloid Leukemia,Regulatory,23/10/2019
?Brii Biosciences Collaborates with Qpex to Develop and Commercialize Antibiotics for Drug-Resistant Infections in China,Pharma,23/10/2019
?Biomica Signs an Agreement with Weizmann Institute of Science to Develop a Selective Treatment Against Antibiotic-Resistant Bacteria,Pharma,23/10/2019
Novartis Collaborates with Pliant Therapeutics to Develop Therapies for NASH and Fibrotic Diseases,Pharma,24/10/2019
?GSK's Zejula (niraparib) Receives FDA's Approval for Late-line Treatment in Women with Recurrent Ovarian Cancer,Regulatory,24/10/2019
Bausch Health In-Licenses Clearside's Xipere (triamcinolone acetonide suprachoroidal injectable suspension) For Macular Edema Associated with Uveitis?,Pharma,24/10/2019
?NovoCodex Collaborates with Ambrx to Develop and Commercialize its ARX305 in China,Biotech,24/10/2019
?WHO Signs MoU with IGBA for Promoting the Access to Biosimilars and Generics,Biosimilars,24/10/2019
?AbbVie Collaborate with Cystic Fibrosis Foundation to Advance CFTR Potentiator,Pharma,25/10/2019
?Allergan's BOTOX (onabotulinumtoxinA) Receives the US FDA's Approval for Pediatric Patients with Lower Limb Spasticity Excluding Spasticity Caused by Cerebral Palsy,Regulatory,25/10/2019
?Astellas' Xospata (gilteritinib) Receives EC's Approval as Monotherapy for Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation,Regulatory,25/10/2019
?Zentiva to Acquire Alvogen's Generics and OTC Business in Central and Eastern Europe,M&A,25/10/2019
?NHS England Signs an Agreement with Vertex to Access All Licensed Cystic Fibrosis Therapies,Pharma,25/10/2019
?Urology San Antonio Collaborates with Anixa Biosciences on Ccheck Prostate Cancer Study,MedTech,25/10/2019
?Gilead Collaborates with Glympse Bio to Utilize Biomarker Technology in NASH Clinical Program,Biotech,29/10/2019
?AstraZeneca Reports Results of Imfinzi (durvalumab) and Imfinzi + Tremelimumab in P-III POSEIDON Study as 1L Treatment for Stage IV Non-Small Cell Lung Cancer,Biotech,29/10/2019
?Pfizer's Bavencio (avelumab) + Axitinib Dual Regimen Receive EC's Approval as 1L Treatment for Advanced Renal Cell Carcinoma,Regulatory,29/10/2019
GSK Reports Results of M72/AS01E in P-IIb Study for the Prevention of Pulmonary Tuberculosis Disease,Pharma,29/10/2019
MorphoSys and Galapagos in Collaboration with Novartis Terminate Clinical Development of MOR106 in Atopic Dermatitis,Pharma,29/10/2019
?Astellas' ASP1128 Receives the US FDA's Fast Track Designation for Patients at High Risk of Acute Kidney Injury,Regulatory,29/10/2019
Boehringer Ingelheim Collaborates with The Defeat-NCD Partnership to Tackle the Impacts of Non-Communicable Diseases,Pharma,30/10/2019
"GSK's Benlysta (belimumab, IV) Receives EC's Approvals as the First Biologic to Treat Lupus in Children",Biotech|Regulatory,30/10/2019
AstraZeneca Divests Rights of Seroquel and Seroquel XR to Cheplapharm in Europe and Russia,Pharma,30/10/2019
Roche Reports EMA and FDA's Acceptance of Marketing Application for Satralizumab to Treat Neuromyelitis Optica Spectrum Disorder,Regulatory,30/10/2019
Novartis Reports FDA's Hold on P-I/II Intrathecal Study Evaluating Zolgensma/AVXS-101 (onasemnogene abeparvovec-xioi) for Spinal Muscular Atrophy Type 2,Biotech,30/10/2019
LEO Pharma Signs an Option Agreement with Ubiquigent to Access its Two Novel Therapies,Pharma,30/10/2019
Biogen and Alkermes' Vumerity (diroximel fumarate) Receive FDA's Approval for Multiple Sclerosis,Regulatory,30/10/2019
Pear Therapeutics Signs an Agreement with Ironwood to Assess Prescription Digital Therapeutics for GI Indications,DigiHealth,31/10/2019
Astellas Signs an Exclusive License Agreement with Pandion to Deliver Immunomodulators for Autoimmune Diseases of the Pancreas,Biotech,31/10/2019
Johnson &amp; Johnson Vision Launches TECNIS Eyhance Monofocal Intraocular Lens for Post Cataract Surgery Patients in India,MedTech,31/10/2019
AliveCor and Huami Collaborate to Bring the Next Generation ECG Wearables Devices,MedTech,31/10/2019
Roche Signs a Development and Commercialization Agreement with Dicerna for its DCR-HBVS to Treat Chronic Hepatitis B Virus Infection,Pharma,31/10/2019
Janssen's Darzalex (daratumumab) Combination Regimen Receives Health Canada Approval for Transplant Ineligible Patients with Multiple Myeloma,Regulatory,31/10/2019
Amgen Acquires Stake in BeiGene to Expand its Oncology Portfolio in China,Pharma,2019-01-11
Pfizer Reports Launch Date for its Two Anticancer Biosimilars,Biosimilars,29/10/2019
"Formycon Reports Initiation of P-I Trial for FYB202 (biosimilar, ustekinumab)",Biosimilars,28/10/2019
"Pfenex Reports Results of Human Factors Study for its PF708 Candidate (biosimilar, teriparatide)",Biosimilars,14/10/2019
"NeuClone Reports Dosing of NeuLara (proposed biosimilar, ustekinumab) in P-I Trial",Biosimilars,2019-01-11
Novartis Reports Results of Cosentyx (secukinumab) in Head to Head P-III EXCEED Study for Psoriatic Arthritis,Biotech,2019-01-11
AbbVie Reports Results of Rinvoq (upadacitinib) in P-III SELECT-PsA 2 Study for Psoriatic Arthritis,Pharma,2019-01-11
Vertex Reports Results of Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Two P-III Studies for Cystic Fibrosis,Pharma,2019-01-11
"Mundipharma's Pegfilgrastim Mundipharma (biosimilar, pegfilgrastim) Receives CHMP Positive Opinion for MAA in EU",Biosimilars,18/10/2019
Beam Therapeutics Signs Exclusive License Agreement with Prime Medicine for Prime Editing Technology,Biotech,2019-01-11
Medtronic Reports MHLW's Shonin Approval and Launches Valiant Navion Thoracic Stent Graft System in Japan,MedTech|Regulatory,2019-01-11
Google to Acquire Fitbit for ~$2.1B,DigiHealth,2019-04-11
Sanofi Reports Results of Toujeo (insulin glargine 300 Units/mL) in P-III EDITION JUNIOR Study in Children and Adolescents with Type 1 Diabetes,Biotech,2019-04-11
Janssen Collaborates with Vifor Pharma to Co-commercialize Invokana (canagliflozin) for the Treatment of Diabetic Kidney Disease in the US,Pharma,2019-04-11
Yas Holding to Acquire Stake in Alvotech and Signs an Exclusive Agreement for its Three Biosimilar Candidates,Biosimilars,2019-04-11
Halozyme to Discontinue its P-III HALO-301 Study of PEGPH20 for the Treatment of Metastatic Pancreatic Cancer,Pharma,2019-04-11
Boehringer Ingelheim and Lilly Restructure their Alliance to Emphasis Full Expertise and Investment on Jardiance,Pharma,2019-05-11
"Sandoz's Ziextenzo (biosimilar, pegfilgrastim) Receives the US FDA's Approval to Decrease the Incidence of Febrile Neutropenia",Biosimilars|Regulatory,2019-05-11
Takeda to Divest its Portfolio of Select OTC and Non-Core Assets to STADA for ~$660M,Pharma,2019-05-11
Sanofi's Fluzone High-Dose Quadrivalent (Influenza Vaccine) Receives the FDA's Approval for Adults Aged= 65yrs.,Regulatory,2019-05-11
Henlius and Ascentage Pharma Collaborate to Evaluate the Combination Therapy for Chronic Lymphocytic Leukemia in China,Pharma,2019-05-11
Stryker to Acquire Wright Medical for $5.4B,M&A|MedTech,2019-05-11
BeiGene Signs an Exclusive Worldwide License Agreement with Seattle Genetics to Advance Preclinical Candidates Treating Cancer,Pharma,2019-06-11
Takeda Signs an Exclusive License and Research Agreement with MD Anderson for CAR NK Cell Therapies,Pharma,2019-06-11
BioLineRx Reports Results of BL-8040 in Combination with Keytruda (pembrolizumab) in P-IIb Trial for Patients with Metastatic Pancreatic Cancer,Pharma,2019-06-11
Vela Diagnostics' Sentosa SQ HIV-1 Genotyping Assay Receives the US FDA's DE Novo Authorization for Detection of HIV-1 Genomic Drug Resistance Mutations (DRMs),Regulatory,2019-06-11
Evotec Collaborates with Vifor Pharma to Launch a Joint Venture to Discover and Develop Therapies for Nephrology,Pharma,2019-06-11
Eisai to Transfer Royalty Rights for Tazemetostat to Royalty Pharma Outside Japan,Pharma,2019-06-11
Regeneron Signs a Research and Option to License Agreement with Vyriad for Oncolytic Virus-Based Therapies,Pharma,2019-06-11
Biogen Signs an Exclusive Commercialization Agreement with Samsung Bioepis to Expand its Biosimilars Portfolio,Biosimilars,2019-07-11
Coherus Signs an Exclusive License Agreement with Bioeq for Biosimilar of Lucentis (ranibizumab) in the US,Biosimilars,2019-07-11
Promega Signs a Worldwide Agreement with Merck to Develop MSI Technology as CDx for Keytruda,MedTech,2019-07-11
Novo Nordisk Signs an Exclusive Worldwide License Agreement with UBE Industries for its UD-014,Pharma,2019-07-11
STADA Signs an Exclusive Commercialization Agreement with Alvotech for Seven Biosimilars in Europe,Biosimilars,2019-07-11
AstraZeneca to Invest $1B for the Transformation of Healthcare in China,Pharma,2019-07-11
"Bio Thera's QLETLI (biosimilar, adalimumab) Receives NMPA's Approval for Auto-Immune Diseases in China",Biosimilars,2019-07-11
"Teva and Celltrion Reports the Availability of Truxima (biosimilar, Rituxan) in the US",Biotech|Regulatory,2019-07-11
AstraZeneca Reports Results of Roxadustat in P-III OLYMPUS and ROCKIES Studies for Chronic Kidney Disease Patients with Anaemia,Pharma,2019-08-11
Sierra Oncology Amends its Asset Purchase Agreement with Gilead for Momelotinib Signed in 2018,Pharma,2019-08-11
Takeda Reports Results of Ninlaro (ixazomib) in P-III TOURMALINE-MM4 Study as 1L Treatment for Multiple Myeloma Patients Not Treated with Stem Cell Transplantation,Pharma,2019-08-11
Yuhan Pharmaceutical Collaborates with Cyclica to Enhance Drug Development Utilizing AI-Integrated Drug Discovery Platform,Pharma,2019-08-11
Triumvira's TAC01-CD19 Receives FDA's Fast Track Designation for R/R Diffuse Large B-Cell Lymphoma,Regulatory,2019-08-11
Janssen Reports Submission of MAA to EMA for its Investigational Ebola Vaccine Regimen to Prevent Ebola Virus Disease,Regulatory,2019-08-11
Sandoz to Acquire Aspen's Japanese Operations and Associated Assets for ~$440M,Pharma,2019-11-11
AstraZeneca Reports Pooled Cardiovascular Safety and Efficacy Analyses of Roxadustat in P-III Program for CKD Patients with Anaemia,Pharma,2019-11-11
Roche Reports Results of Risdiplam in Pivotal SUNFISH Study for Patients with Type 2 or 3 Spinal Muscular Atrophy,Pharma,2019-11-11
Celgene's Reblozyl (luspatercept–aamt) Receives FDA's Approval as the First Therapy to Treat Patients with Rare Blood Disorder,Regulatory,2019-11-11
Roche Reports Results of Gazyva (obinutuzumab) in P-II NOBILITY Study for Lupus Nephritis,Biotech,2019-11-11
Medtronic Reports Results of World's Smallest Pacemaker in MARVEL 2 Study for Patients with Atrioventricular Block,MedTech,2019-12-11
Merck's Ervebo [Ebola Zaire Vaccine (rVSV?G-ZEBOV-GP) live] Receives EC's Conditional Approval to Prevent Ebola Virus Disease,Biotech,2019-12-11
Lupin to Divest its Stake in Kyowa to Unison for ~$525M,M&A,2019-12-11
BMS Reports Acceptance of sBLA for Opdivo (nivolumab) + Yervoy (ipilimumab) for Patients with Previously Treated Advanced Hepatocellular Carcinoma,Regulatory,2019-12-11
Janssen Reports Results of Tremfya (guselkumab) in P-III DISCOVER Studies for Active Psoriatic Arthritis,Biotech,2019-12-11
Bluebird Bio Collaborates with Forty Seven to Evaluate Antibody Conditioning Regimen in Combination with Autologous Lentiviral Vector Hematopoietic Stem Cell Gene Therapy,Biotech,2019-12-11
Mylan and Pfizer Names Viatris as the New Company for Mylan-Upjohn's Combination,Pharma,13/11/2019
Celgene Amends its Existing Collaboration with Editas to Develop and Commercialize Autologous and Allogeneic T Cell Medicines for Cancer and Autoimmune Diseases,Biotech,13/11/2019
Celgene Signs an Exclusive Worldwide License Agreement with Skyhawk to Develop Therapies Modulating RNA Splicing,Pharma,13/11/2019
AbbVie Reports Results of Rinvoq (upadacitinib) in P-II/III SELECT-AXIS 1 Study for Patients with Ankylosing Spondylitis,Pharma,13/11/2019
Boehringer Ingelheim and Lilly Commence P-III EMPULSE Study to Evaluate Jardiance in People Hospitalized for Acute Heart Failure Who Have Been Stabilized,Pharma,13/11/2019
GSK Reports Results of Nucala (mepolizumab) in P-III Study for Hypereosinophilic Syndrome,Biotech,13/11/2019
Merck Acquires Calporta Therapeutics for ~$576M,M&A,14/11/2019
Pfizer Collaborates with Centogene to Access its Rare Disease Data,Pharma,14/11/2019
Shreis Scalene's Cytotron Receives the US FDA's Breakthrough Device Designation for the Treatment of Multiple Cancer Indications,MedTech,31/10/2019
Boehringer Ingelheim and Lilly Report FDA's EMDAC Outcomes for Empagliflozin (2.5mg) as Adjunct to Insulin for T1D Patients,Regulatory,14/11/2019
Takeda Expands its Collaboration with Finch Therapeutics to Develop Microbiome Therapies Utilizing Human-First Discovery Platform,Biotech,14/11/2019
Zambon Signs a License Agreement with Aquestive to Develop and Commercialize Riluzole Oral Film for Amyotrophic Lateral Sclerosis in EU,Pharma,14/11/2019
Clinuvel's Scenesse Receives the US FDA's Approval for Erythropoietic Protoporphyria (EPP),Pharma,2019-08-10
Bayer Collaborates with Dewpoint to Develop New Therapies Targeting Cardiovascular and Gynecological Diseases,Pharma,14/11/2019
Galderma's Aklief (trifarotene) Receives the US FDA's Approval for the Treatment of Acne in 20 Years,Pharma,2019-04-10
Ardelyx's Ibsrela (tenapanor) Receives the US FDA's Approval for Irritable Bowel Syndrome with Constipation (ISB-C) for Adults,Pharma,2019-12-09
Foamix's Amzeeq (topical minocycline) Receives the US FDA's Approval for Moderate to Severe Acne,Pharma,18/10/2019
Allergan Signs an Exclusive Option and License Agreement with Exicure to Discover and Develop SNA-based Therapies for Hair Loss Disorders,Pharma,15/11/2019
Metacel Pharmaceuticals' Ozobax (baclofen) Receives the US FDA's Approval for Spasticity Due to Multiple Sclerosis,Pharma,18/9/2019
AstraZeneca and MSD Report FDA's Acceptance of NDA for Selumetinib in Patients with Neurofibromatosis Type 1,Regulatory,15/11/2019
BeiGene's Brukinsa (zanubrutinib) Receives the US FDA's Accelerated Approval for Patients with Mantle Cell Lymphoma Who Received At least One Prior Therapy,Regulatory,15/11/2019
Shionogi's Fetroja (cefiderocol) Receives the US FDA's Approval for the Treatment of Complicated Urinary Tract Infections,Regulatory,15/11/2019
Sarepta Signs a License Agreement with Stride Bio to Develop In vivo AAV-Based Gene Therapies,Biotech,15/11/2019
Stanford Medicine Reports Results of Apple Heart Study for Detecting Atrial Fibrillation,DigiHealth,15/11/2019
Roche's Kadcyla (trastuzumab emtansine) Receives CHMP's Recommendation for Approval as an Adjuvant Treatment for Patients with HER2+ eBC with Residual Invasive Disease After Neoadjuvant Treatment,Biotech,15/11/2019
Roche to Acquire Promedior for $1.39B,M&A,18/11/2019
"Pfizer's Abrilada (biosimilar, adalimumab) Receives the US FDA's Approval for Rheumatoid Arthritis",Biosimilars,18/11/2019
Novartis' Adakveo (crizanlizumab) Receives the US FDA's Approval for Reducing the Frequency of VOCs in Sickle Cell Disease,Regulatory,18/11/2019
Novo Nordisk Collaborates with Dicerna to Discover and Develop RNAi Therapies for Liver-Related Cardio-Metabolic Diseases,Biotech,18/11/2019
Aerie Pharmaceuticals to Acquire Avizorex Pharma to Expand its Footprint in Ophthalmology,M&A,18/11/2019
Merck and Bayer Report Results of Vericiguat in P-III VICTORIA Study for Patients with Worsening Chronic Heart Failure,Pharma,18/11/2019
Novartis Collaborates with Biofourmis To Offer Digital Therapeutics for Managing Heart Failures,DigiHealth|M&A,19/11/2019
Alkermes to Acquire Rodin Therapeutics for $950M,M&A,19/11/2019
Santhera Reports Results of Idebenone in SYROS Study for Duchenne Muscular Dystrophy,Pharma,19/11/2019
Janssen Redefines Clinical Trial Design by Leveraging Wearable Technology,DigiHealth,19/11/2019
Vertex Collaborates with Molecular Templates to Discover and Develop Conditioning Regimens Enhancing Hematopoietic Stem Cell Transplants,Biotech,19/11/2019
"Samsung Bioepis Reports FDA's Acceptance of BLA for SB8 (biosimilar, bevacizumab)",Biosimilars,19/11/2019
Merck KGaA Collaborates with Personalis to Develop Novel Biomarkers for Cancer Therapies,MedTech,20/11/2019
CRISPR Therapeutics and Vertex Report Results of CTX001 from First Two Patients with Severe Hemoglobinopathies,Biotech,20/11/2019
Myovant Sciences Reports Results of Relugolix in P-III HERO Study for Men with Advanced Prostate Cancer,Pharma,20/11/2019
Janssen's Darzalex (daratumumab) Combination Regimen Receives EC's Approval for Transplant Ineligible Patients with Newly Diagnosed Multiple Myeloma,Regulatory,20/11/2019
BioVentrix's Revivent TC Transcatheter Ventricular Enhancement System Receives FDA's Breakthrough Device Designation for Heart Failure,MedTech|Regulatory,20/11/2019
Merck's Keytruda (pembrolizumab) Receives EC's Approval as 1L Treatment for Metastatic or Unresectable Recurrent Head and Neck Squamous Cell Carcinoma,Regulatory,20/11/2019
BMS Reports Update of Opdivo (nivolumab) + Yervoy (ipilimumab) in P-III CheckMate -915 Study for Patients with Resected High-Risk Melanoma and PD-L1,Biotech,20/11/2019
AbbVie Collaborates with Dragonfly Therapeutics to Develop Therapies for Autoimmune and Oncology Indications,Pharma,21/11/2019
Alnylam's Givlaari (givosiran) Receives the US FDA's Approval as the First Therapy for Acute Hepatic Porphyria,Regulatory,21/11/2019
Novartis Collaborates with Mila to Transform Therapies with Artificial Intelligence in Canada,DigiHealth,21/11/2019
Sanofi Collaborates with Aetion to Leverage its Evidence Platform for Advancing Regulatory Submissions,Pharma,21/11/2019
Astellas Signs a License Agreement with Welldoc to Develop and Commercialize Digital Therapies,DigiHealth,21/11/2019
"Aerie's Rhokiinsa (netarsudil ophthalmic solution, 0.02%) Receives EC's Approval for Patients with Open-Angle Glaucoma or Ocular Hypertension",Regulatory,21/11/2019
AbbVie Enters into an Exclusive Option and License Agreement for HPN217 and Expands its Existing Collaboration with Harpoon Therapeutics,Pharma,21/11/2019
Knight Therapeutics Signs an Exclusive License Agreement with Onconova for Rigosertib in Canada,Pharma,22/11/2019
AstraZeneca's Calquence (acalabrutinib) Receives the US FDA's Approval for Chronic Lymphocytic Leukemia Under the Project Orbis,Regulatory,22/11/2019
GSK and ViiV Healthcare Sign an Exclusive License Agreement with NIH for its Investigational bNAb to Treat and Prevent HIV,Biotech,22/11/2019
Medtronic's IN.PACT AV Drug-Coated Balloon Receives the US FDA's Approval for the Treatment of Arteriovenous Fistula Lesions,MedTech,22/11/2019
BioMarin Reports Submission of MAA to EMA for Valoctocogene Roxaparvovec to Treat Severe Hemophilia A,Regulatory,22/11/2019
Lupin Launches Smart Device for Metered-Dose Inhalers to Support Treatment of Respiratory Diseases in India,DigiHealth,22/11/2019
Novartis to Acquire The Medicines Company for $9.7B,M&A,25/11/2019
Roche Reports the US FDA's Acceptance of NDA for Risdiplam and Granted Priority Review to Treat Spinal Muscular Atrophy,Regulatory,25/11/2019
Takeda's Takhzyro (lanadelumab injection) Receives CADTH's CDEC Positive Opinion for the Routine Prevention of Hereditary Angioedema Attacks,Regulatory,25/11/2019
Roche Reports Results of Tecentriq (atezolizumab) + Avastin (bevacizumab) in P-III IMbrave150 for Unresectable Hepatocellular Carcinoma at ESMO Congress 2019,Biotech,25/11/2019
Takeda Reports Results of Alunbrig (brigatinib) in P-III ALTA-1L Study for Advanced Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer,Pharma,25/11/2019
Ferring and Blackstone Collaborate to Establish Joint Venture Focusing on the Development of Gene Therapy for Bladder Cancer,Pharma,26/11/2019
Zogenix Reports the US FDA Acceptance of NDA and Granted Priority Review for Fintepla (fenfluramine) to Treat Dravet Syndrome,Regulatory,26/11/2019
Bayer Reports Submission of MAA to EMA for Rivaroxaban to Treat Venous Thromboembolism in Children,Regulatory,26/11/2019
Kyowa Kirin Signs Two Agreement with Ardelyx to Expand its Existing Partnership,Pharma,26/11/2019
Yas Holding Collaborates with Alvogen to Commercialize its Generic Portfolio in MENA Region,Pharma,26/11/2019
Merck's Keytruda (pembrolizumab) + CT Receives NMPA's approval as 1L Treatment for Metastatic Squamous Non-Small Cell Lung Cancer,Regulatory,26/11/2019
Novoheart Collaborates with AstraZeneca to Develop World's First Heart-in-a-Jar Model of Heart Failure,Biotech,27/11/2019
"Biocon Report the US FDA's Approval of sBLA for Fulphila (biosimilar, pegfilgrastim) Manufactured at its New Facility in Bengaluru",Biosimilars|Regulatory,27/11/2019
"Celltrion's Remsima SC (biosimilar, infliximab) Receives EC's Approval for Rheumatoid Arthritis",Biosimilars|Regulatory,27/11/2019
Elsevier Acquires 3D4Medical for ~$50M,DigiHealth|M&A,27/11/2019
Amazon's Alexa Launches Medication Management Feature for Giant Eagle's Clients,DigiHealth,27/11/2019
Astellas' Xtandi (enzalutamide) Receives NMPA's Approval for Metastatic Castration-Resistant Prostate Cancer in Men,Regulatory,27/11/2019
Incyte Reports Acceptance and Priority Review of NDA for Pemigatinib to Treat Patients with Cholangiocarcinoma,Regulatory,27/11/2019
AbbVie UK Collaborates with NorthWest EHealth to Generate Real World Evidence for Exploring Autoimmune Conditions,Pharma,28/11/2019
Mochida Launches Teriparatide Biosimilar for the Treatment of Osteoporosis in Japan,Biosimilars,28/11/2019
Boehringer Ingelheim's Ofev (nintedanib) Receives Health Canada's Approval as the First Therapy to Treat SSc-ILD in Canada,Regulatory,28/11/2019
Chugai Launches Tecentriq Intravenous Infusion 840mg as an Optimal Formulation to Treat PD-L1+ Triple-Negative Breast Cancer in Japan,Biotech,28/11/2019
JW Pharma Acquires C&amp;C Research Laboratories a Joint Venture with Chugai,Pharma,28/11/2019
Simcere Signs an Exclusive Regional Licensing Agreement with GI Innovation for its GI-101 Candidate,Biotech,28/11/2019
Octavus Consulting Collaborates with IBCI for Delivering of Professional Educational Programs in India from 2020,Insights+,28/11/2019
Avion Signs an Exclusive License Agreement with ImmuPharma to Develop and Commercialize Lupuzor,Pharma,29/11/2019
Roche's Kadcyla (trastuzumab emtansine) Receives Health Canada's Approval for The Treatment of HER2-Positive Early Breast Cancer After Surgery,Regulatory,29/11/2019
WuXi ATU and GeneMedicine Collaborate to Develop and Manufacture Oncolytic Virus Products,Pharma,29/11/2019
AstraZeneca Reports the US FDA Acceptance of sBLA and Granted Priority Review for Imfinzi (durvalumab) to Treat Patients with Extensive-Stage Small Cell Lung Cancer,Regulatory,29/11/2019
AstraZeneca Collaborates with JVP to Invest in Digital Health Program in Israel,DigiHealth,29/11/2019
ONO Reports Submission of MAA to MHLW for Tirabrutinib Hydrochloride to Treat Waldenstrom Macroglobulinemia and Lymphoplasmacytic Lymphoma,Regulatory,29/11/2019
Roche Reports Results of Satralizumab in P-III SAkuraSky Study to Treat Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD),Pharma,2019-02-12
Y-mAbs Reports Initiation of Rolling Review of BLA for Naxitamab to the US FDA to Treat Neuroblastoma,Pharma,2019-02-12
Fosun Pharma's FN-1501 Receives the US FDA's Orphan Drug Designation for Leukemia,Pharma,2019-02-12
Chipscreen Bioscience's Epidaza (chidamide) Receives NMPA Approval for Breast Cancer Indication,Pharma,2019-02-12
Merck's Keytruda (pembrolizumab) Receives FDA's Priority Review for sBLA to Treat High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC),Pharma,2019-02-12
"Mylan and Biocon Launch Ogivri (biosimilar, trastuzumab) in the US",Biosimilars,2019-02-12
Neurocrine Signs a License Agreement with Xenon to Develop Therapies for Epilepsy,Biotech,2019-02-12
Baxter to Acquire Seprafilm Adhesion Barriers from Sanofi for $350M,M&A|Pharma,2019-02-12
Astellas to Acquire Audentes Therapeutics for $3B,M&A,2019-03-12
STADA to Acquire Biopharma's Pharmaceutical Prescription and Consumer Health Business to Expand Its Footprint in Ukraine,M&A,2019-03-12
AstraZeneca Divests Commercial Rights of Seroquel and Seroquel XR to Cheplapharm in the US and Canada,Pharma,2019-03-12
Gene Techno Science Signs an Agreement with Kishi Kasei to Co-Develop Biosimilar of Aflibercept,Biosimilars,2019-03-12
Seattle Genetics and Astellas Collaborate with Merck to Evaluate Enfortumab Vedotin + Keytruda (pembrolizumab) for Metastatic Urothelial Cancer,Pharma,2019-03-12
GE Healthcare Signs an Agreement with Affidea to Deploy Digital Imaging Technologies,MedTech,2019-03-12
Kamada Collaborates with Alvotech to Commercialize its Six Biosimilar Products in Israel,Biosimilars,2019-03-12
StemoniX Collaborates with Atomwise to Form a Joint Venture Targeting Rett Syndrome,Pharma,2019-03-12
Ethicon Launches VISTASEAL Fibrin Sealant (Human) for Sealing Off Bleeds During Surgery,MedTech,2019-04-12
Lupin Plans to Launch Two of its Biosimilars in the US,Biosimilars,28/11/2019
"Qilu Reports Initiation of P-III Trial for QL1206 (biosimilar, denosumab) in China",Biosimilars,22/11/2019
Merck KGaA and Ping An Good Doctor Collaborate to Support Health Management in China,DigiHealth,2019-04-12
Roche's Tecentriq + CT (abraxane and carboplatin) Receive the US FDA's Approval for the Initial Treatment of Metastatic Non-Squamous Non-Small Cell Lung Cancer,Regulatory,2019-04-12
Johnson &amp; Johnson Vision Launches TECNIS Toric II 1-Piece IOL as a New Monofocal Option for Cataract Patients with Astigmatism in the US,MedTech,2019-04-12
Veracyte Signs an Exclusive License Agreement with NanoString for its nCounter FLEX System,MedTech|Pharma,2019-04-12
Eris Lifesciences Acquires Novartis' Zomelis (vildagliptin) in India for $13M,Pharma,2019-04-12
BMS' Orencia (abatacept) Receive the FDA's Breakthrough Therapy Designation to Prevent Acute Graft-Versus-Host Disease After Stem Cell Transplant,Regulatory,2019-04-12
LEO Pharma Collaborates with Portal Instruments to Develop Needle-Free Drug Delivery Device,MedTech,2019-04-12
Lannett Reports Results of Biosimilar Insulin Glargine in Human Clinical Study to Treat Patients with Type 2 Diabetes,Biosimilars,2019-04-12
Novartis Collaborates with Amazon to Leverage Cloud Services for its Business Operations,DigiHealth,2019-05-12
Novartis Highlights its Blockbuster Portfolio at R&amp;D Day 2019,Pharma,2019-05-12
Takeda Collaborates with Enzyre to Develop Diagnostic Device to Regulate Coagulation Status in Patients with Hemophilia at Home,DigiHealth,2019-05-12
AstraZeneca and MSD's Lynparza (olaparib) Receive NMPA's Approval as 1L Maintenance Therapy for BRCA-Mutated Advanced Ovarian Cancer,Regulatory,2019-05-12
Philips Collaborates with Humana to Deliver Remote Monitoring Capabilities to Select Medicare Advantage Members,DigiHealth,2019-05-12
Bayer Collaborates with Children's Hospital of Philadelphia to Develop Oral Non-Replacement Therapy for the Treatment of Hemophilia,Pharma,2019-05-12
AstraZeneca Signs an Agreement with Gatehouse Bio to Identify New Therapies Targeting Respiratory and Cardiovascular Diseases,Pharma,2019-05-12
Cerecor to Acquire Aevi Genomic Medicine for ~$22.6M,M&A,2019-06-12
FDA and NIH Launch CURE ID Crowdsourcing App for Patients with Infectious Diseases,DigiHealth,2019-06-12
The US FDA Draft New Guidelines for Proposed Biosimilars and Interchangeable Insulins,Biosimilars,25/11/2019
Novartis Reports Results of QMF149 in P-III PALLADIUM Study for Patients with Uncontrolled Asthma,Regulatory,2019-06-12
Y-mAbs Reports EMA's Acceptance of Pediatric Investigation Plan for Omburtamab,Regulatory,2019-06-12
Bayer And Simulations Plus Collaborate to Advance ADMET Predictor for Improving Data Integrity in Drug Discovery,DigiHealth,2019-06-12
Bio-Thera Reports NMPA's Acceptance of IND for BAT2206 Proposed Biosimilar of Stelara (ustekinumab),Biosimilars,2019-06-12
Sage Therapeutics Reports Results of SAGE-217 in P-III MOUNTAIN Study for Major Depressive Disorders,Pharma,2019-06-12
Sanofi to Acquire Synthorx for $2.5B,M&A,2019-09-12
Janssen to Acquire XBiotech's Bermekimab for $750M,Pharma,2019-09-12
Sobi's Dova Pharmaceutical Reports Results of an Online Survey Highlighting Disease Burden and Impact for Patients with Immune Thrombocytopenia,Pharma,2019-09-12
Boehringer Ingelheim Collaborates with Healx to Identify New Treatments for Rare Neurological Diseases,DigiHealth|Pharma,2019-09-12
"Amgen's Avsola (biosimilar, infliximab) Receives the US FDA's Approval for the Same Indications as Remicade (infliximab)",Biosimilars,2019-09-12
AstraZeneca Reports Results of Calquence (acalabrutinib) in P-III ELEVATE TN Study for Previously Untreated Chronic Lymphocytic Leukemia,Pharma,2019-09-12
Merck to Acquire ArQule for $2.7B,M&A,2019-09-12
AstraZeneca Collaborates with DeepMatter for Optimization of Compound Synthesis Leveraging AI and Machine Learning,DigiHealth,2019-10-12
Roche's Accu-Chek SugarView App Receives CE Mark Approval for Non-Insulin-Dependent Patients with Type 2 Diabetes or Pre-Diabetes,DigiHealth,2019-10-12
AbbVie Signs an Exclusive Agreement with Scripps Research to Develop New Therapies Targeting Multiple Therapeutic Areas,Pharma,2019-10-12
Merck Collaborates with Seven and Eight BioPharmaceuticals to Evaluate the BDB001 + Keytruda (pembrolizumab) for Advanced Solid Tumors,Pharma,2019-10-12
AbbVie to Deploy Adaptive's clonoSEQ Assay to Assess MRD Status Across Multiple Myeloma Studies,Pharma,2019-10-12
Engitix and Morphic Collaborate to Detect ECM-Related Targets in Fibrostenotic Inflammatory Bowel Disease,Pharma,2019-10-12
Sanofi Divulges its Strategic Framework to Drive Innovation and Growth,Pharma,2019-10-12
Sanofi and Regeneron to Restructure its Collaboration for Kevzara (sarilumab) and Praluent (alirocumab),Pharma,2019-11-12
Roche and Novartis Report the US FDA's Acceptance of sBLA for Xolair (omalizumab) to Treat Nasal Polyps,Regulatory,2019-11-12
"AffaMed Therapeutics' AMT901 (biosimilar, trastuzumab) Receives NMPA's Approval to Initiate P-III Clinical Study in China",Biosimilars,2019-11-12
Vertex's Kalydeco (ivacaftor) Receives EC's Approval for Infants with Cystic Fibrosis with CFTR Gene Mutation Aged 6 to,Regulatory,2019-11-12
Amgen Reports Results of KYPROLIS (carfilzomib) and DARZALEX (daratumumab) in P-III CANDOR study for Patients with Relapsed or Refractory Multiple Myeloma,Pharma,2019-11-12
Dermira‘s Lebrikizumab Receives the US FDA's Fast Track Designation to Treat Atopic Dermatitis,Regulatory,2019-11-12
Kite and Kiniksa Collaborate to Evaluate the Combination of Yescarta (axicabtagene ciloleucel) and Mavrilimumab for R/R Large B-Cell Lymphoma,Pharma,2019-12-12
Kite Reports Submission of BLA to the US FDA for its Second CAR T Cell Therapy,Regulatory,2019-12-12
Novartis Signs Worldwide License Agreement with Forendo Pharma to Discover Therapies Targeting Chronic Liver Diseases,Pharma,2019-12-12
Almirall to Accelerate Drug Discovery Process Utilizing Iktos' AI Technology,DigiHealth,2019-12-12
Roche Reports Results of Fixed-Dose SC Combination of Perjeta (pertuzumab) and Herceptin (trastuzumab) in P-III FeDeriCa Study for HER2-Positive Breast Cancer,Biotech,2019-12-12
Amgen and UCB's Evenity (romosozumab) Receive EC's Approval to Treat Severe Osteoporosis in Postmenopausal Women at High Risk of Fracture,Regulatory,2019-12-12
AstraZeneca and Daiichi Sankyo Report Result of Trastuzumab Deruxtecan in P-II DESTINY-Breast01 Study for HER2 Positive Metastatic Breast Cancer,Biotech,2019-12-12
AstraZeneca's Imfinzi (durvalumab) Receives NMPA's Approval for Unresectable Stage III Non-Small Cell Lung Cancer,Regulatory,2019-12-12
Alvogen to Acquire Assertio's Gralise (gabapentin) for $127.5M,Pharma,2019-12-12
iTeos Therapeutics Collaborates with Merck to Evaluate EOS100850 + Keytruda (pembrolizumab) for Solid Tumors,Pharma,13/12/2019
PerkinElmer's Screening Kit Receives the FDA's Approval as the First Test to Aid in Newborn Screening for Duchenne Muscular Dystrophy,MedTech|Regulatory,13/12/2019
Roche Reports Results of Triple Combination Regimen in P-III IMspire150 Study for Previously Untreated BRAF V600 Mutation-Positive Advanced Melanoma,Biotech,13/12/2019
Equillium Expands its Exclusive Licensing Agreement with Biocon for Itolizumab,Biotech,13/12/2019
Pfizer's Xeljanz XR (tofacitinib) Receives the US FDA's Approval for Ulcerative Colitis,Regulatory,13/12/2019
SK Life Sciences' XCOPRI (cenobamate tablets) Receives the US FDA's Approval for Partial-Onset Seizures in Adults,Pharma,21/11/2019
Global Blood's Oxbryta (Voxelotor) Receives the US FDA's Accelerated Approval for Treatment of Sickle Cell Disease,Regulatory,25/11/2019
RedHill Biopharma's Talicia Received the US FDA's Approval for H. pylori in Adults,Regulatory,2019-04-11
ViiV Healthcare Reports Regulatory Submission to the US FDA and EMA for Dispersible Formulation of Tivicay (dolutegravir),Regulatory,13/12/2019
Sun Pharmaceuticals' Absorica Received the US FDA's Approval for Severe Recalcitrant Nodular Acne,Pharma|Regulatory,2019-05-11
Aquestive Therapeutics' Exservan (riluzole) Receives the US FDA Approval to Treat Amyotrophic Lateral Sclerosis (ALS),Regulatory,13/11/2019
Cumberland Pharmaceuticals' RediTrex (methotrexate) Injection Receives the US FDA's Approval for Rheumatoid Arthritis and Psoriasis,Biotech,13/12/2019
Janssen's Darzalex (daratumumab) Combination Regimen Receives CHMP's Positive Opinion for Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma,Regulatory,13/12/2019
"Pfizer's Amsparity (biosimilar, adalimumab) Receives CHMP's Positive Opinion for Inflammatory and Autoimmune Disorders",Biosimilars,13/12/2019
Roche Launches cobas Zika Blood Screening Test to Detect Zika Virus RNA,MedTech,16/12/2019
Tandem's Predictive Insulin Pump Software Receives the US FDA's Approval to Deliver Accurate Doses of Insulin in Patients Utilizing t:slim X2 Insulin Pump,MedTech|Regulatory,16/12/2019
Novartis Terminates Clinical Development of Fevipiprant (AW039) in P-III LUSTER Studies for Patients with Uncontrolled GINA 4/5 Asthma,Pharma,16/12/2019
Boehringer Ingelheim and Lilly Report Results of Jardiance (empagliflozin) in P-III EMPERIAL Studies for Chronic Heart Failure,Pharma,16/12/2019
SanBio and Sumitomo Dainippon Pharma Terminate Joint Development and License Agreement for SB623 in North America,Pharma,16/12/2019
Lilly Collaborates with DexCom to Utilize Dexcom CGM in its Personalized Diabetes Management System,MedTech,16/12/2019
Charles River to Acquire HemaCare Corporation for $380M,M&A,16/12/2019
Medtronic and ChristianaCare Collaborate to Deploy Value-Based Healthcare Initiatives in Delaware,Pharma,17/12/2019
Alexion Exercises its Option to License Dicerna's Two Additional GalXC RNAi Programs,Biotech,17/12/2019
Eagle Pharmaceuticals' Ryanodex (dantrolene sodium) Receives the US FDA's ODD for the Treatment of Organophosphate Exposure,Regulatory,17/12/2019
BeiGene Report Results of Brukinsa (zanubrutinib) in P-III ASPEN Study for Waldenström's Macroglobulinemia,Pharma,17/12/2019
Janssen's Erleada (apalutamide) Receives Health Canada's Approval for Metastatic Castration-Sensitive Prostate Cancer,Regulatory,17/12/2019
Xiangxue Signs an Exclusive License Agreement with Athenex to Expand their Existing Partnership,Pharma,17/12/2019
Sangamo Highlights its Genomic Medicine Pipeline at R&amp;D Day 2019,Pharma,17/12/2019
Medtronic Acquires Klue to Bolster its Personalized Closed Loop Technology for Diabetes Management,M&A,18/12/2019
Merck Receives the US FDA Advisory Committee's Recommendation on Approval of Keytruda (pembrolizumab) for Patients with High-Risk Non-Muscle Invasive Bladder Cancer,Regulatory,18/12/2019
Takeda Collaborates with Cerevance to Develop New Therapies for Gastrointestinal Disorders,Pharma,18/12/2019
BioInvent Collaborates with MSD to Evaluate BI-1206 in Combination with Keytruda (pembrolizumab) for Advanced Solid Tumors,Pharma,18/12/2019
AstraZeneca and Merck &amp; Co Receive the US FDA Advisory Committee's Recommendation on Approval of Lynparza (olaparib) as 1L Maintenance Treatment for Germline BRCA-Mutated Metastatic Pancreatic Cancer,Regulatory,18/12/2019
Eisai Signs a Research Collaboration with BioArctic to Characterize BAN2401's Mechanism of Action,Biotech,18/12/2019
Chondrial Therapeutics Signs a Reverse Merger Agreement with Zafgen,M&A,18/12/2019
Genentech Signs a Clinical Trial Collaboration with Arcus for Colorectal and Pancreatic Cancers,Pharma,19/12/2019
"GSK Reports Results of Benlysta (belimumab, IV) in P-III BLISS-LN Study for Patients with Active Lupus Nephritis",Pharma,19/12/2019
Specialised Therapeutics Signs an Exclusive License Agreement with Onconova Therapeutics for Rigosertib,Pharma,19/12/2019
AbbVie's RINVOQ (upadacitinib) Receives the EC's Approval for the Treatment of Adults with Moderate to Severe Active Rheumatoid Arthritis,Pharma,19/12/2019
Novartis Terminates its Agreement with Akcea for AKCEA-APOCIII-LRx,Pharma,19/12/2019
Biogen Signs an Exclusive License Agreement with Ionis for IONIS-MAPTRx,Biotech,19/12/2019
Exelixis Signs a Clinical Trial Collaboration with Roche for Patients with Solid Tumors,Pharma,19/12/2019
Genmab and CureVac Collaborate to Develop mRNA-based Antibody Therapeutics,Biotech,20/12/2019
"Amgen and Allergan Report Submission of BLA to the US FDA for its ABP 798 (biosimilar, rituximab)",Regulatory,20/12/2019
Smith Medical Recalls Medfusion 4000 Syringe Pump Due to its Software Failure,Pharma,20/12/2019
Merck's Ervebo Vaccine Receives the US FDA's Approval for Prevention of Ebola Virus,Regulatory,20/12/2019
Gilead Reports Submission of Filgotinib's NDA Under Priority Review to the US FDA for Rheumatoid Arthritis Treatment,Regulatory,20/12/2019
Novo Nordisk Signs a Five-Year Agreement with UVA Center for Diabetes Technology for Type 2 Diabetes,Pharma,20/12/2019
AstraZeneca to Sell Commercialization Rights of its Two Oncology Candidates to Juvise Pharmaceuticals,Pharma,20/12/2019
Roche Signs an Exclusive Worldwide Option and License Agreement with Rheos Medicines to Develop and Commercialize Therapies for Immunometabolism,Uncategorized,23/12/2019
Roche Signs a License Agreement with Sarepta for its Gene Therapy Candidate SRP-9001,Biotech,23/12/2019
BMS' Revlimid + Rituximab Receives EC's Approval to Treat Adults Previously Treated Follicular Lymphoma (Grade 1-3a),Regulatory,23/12/2019
Johnson &amp; Johnson to Acquire TARIS Biomedical for its Drug Delivery Technology to Treat Bladder Cancer,M&A,23/12/2019
"Gilead's Vosevi (sofosbuvir, velpatasvir and voxilaprevir) Receives NMPA's Approval for Chronic Hepatitis C Infection Who Require Re-Treatment",Regulatory,23/12/2019
Pfizer Signs a Worldwide License Agreement with Theravance BioPharma for its Pan-JAK Inhibitor Program,Pharma,26/12/2019
Gilead Signs a Co-Promotion Agreement with Eisai for Filgotinib in Japan,Pharma,26/12/2019
Allergan's Ubrelvy (ubrogepant) Receives the US FDA's Approval for Acute Treatment of Migraine with or without Aura in Adults,Regulatory,26/12/2019
AstraZeneca's Triple Combination Regimen Receives NMPA's Approval as the Maintenance Treatment for COPD in China,Regulatory,26/12/2019
Pfizer Extends its Research and License Agreement with BioInvent to Develop Ab Targeting Tumor-Associated Myeloid Cells,Pharma,26/12/2019
AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) Receive the FDA's Accelerated Approval for HER-2 Positive Unresectable/ Metastatic Breast Cancer,Regulatory,26/12/2019
OBI Pharma's OBI-999 Receives the US FDA's Orphan Drug Designation for Pancreatic Cancer,Regulatory,26/12/2019
Astellas Acquires Xyphos Biosciences for ~$665M,M&A,27/12/2019
Kadmon and Meiji Collaborate to Form JV for the Development and Commercialization of KD025 in Japan,Pharma,27/12/2019
ONO and BMS Report Submission of sBLA for Opdivo (nivolumab) + Yervoy (ipilimumab) in Japan,Biotech,27/12/2019
Chugai Receives MHLW's Approval for the Expanded Use of FoundationOne CDx as a Companion Diagnostic of Rozlytrek (entrectinib),Regulatory,27/12/2019
Immunomedics Reports the US FDA's Acceptance of BLA for Sacituzumab Govitecan to Treat Metastatic Triple-Negative Breast Cancer,Regulatory,27/12/2019
Luye Pharma Reports Submission of NDA to the US FDA for LY03005,Regulatory,27/12/2019
Pharming to Reacquire Exclusive Commercialization Rights for its Ruconest from Sobi,Pharma,30/12/2019
Eisai Reports Results of DAYVIGO (lemborexant) in P-III SUNRISE 1 Study in Patients with Insomnia Disorder,Pharma,30/12/2019
Zai Lab's Zejula (niraparib) Receives NMPA's Approval as Maintenance Therapy for Patients with Recurrent Ovarian Cancer in China,Regulatory,30/12/2019
AstraZeneca and Merck &amp; Co's Lynparza Receive the US FDA's Approval as a 1L Maintenance Treatment of Germline BRCA-Mutated Metastatic Pancreatic Cancer,Regulatory,30/12/2019
Eli Lilly Opens its P-III LIBRETTO-531 Clinical Trial for LOXO-292 (selpercatinib) to Treat RET-Mutant Medullary Thyroid Cancer (MTC) Patients,Pharma,30/12/2019
BeiGene's Tislelizumab Receives NMPA's Approval for the Treatment of 2L Classical Hodgkin's Lymphoma (cHL),Regulatory,31/12/2019
Acceleron Signs a License Agreement with Fulcrum for the Identification of Therapies to Treat Pulmonary Diseases,Pharma,31/12/2019
GenScript Signs an Agreement with Selecxine to Develop Therapies for Immuno-Oncology,Pharma,31/12/2019
"Clover Reports First Patient Dosing in P-III Trial with SCB-808 (biosimilar, etanercept) in China",Biotech,31/12/2019
MorphoSys Reports Submission of Tafasitamab's BLA to the US FDA to Treat Relapsed or Refractory Diffuse Large B Cell Lymphoma (r/r DLBCL),Regulatory,31/12/2019
Axsome Therapeutics Reports Results of AXS-07 in MOMENTUM P-III Migraine Trial in Patients with History of Inadequate Response,Pharma,2020-02-01
MappBio Collaborates with Aridis Pharmaceuticals to Develop Therapies Utilizing APEX Technology,Pharma,2020-02-01
Roche Signs an AI-Based Research Agreement with Sensyne Health,Pharma,2020-02-01
Sol-Gel Reports Results of Twyneo in Two P-III Trials for Acne Vulgaris,Pharma,2020-02-01
Amgen Signs an Agreement with BeiGene for the Expansion of its Oncology Footprints in China,Pharma,2020-03-01
Johnson &amp; Johnson Signs a License Agreement with Pulmatrix to Develop Therapies for Lung Cancer,Biotech,2020-03-01
Arena Signs a Multi-Year Agreement with Beacon Discovery to Develop Therapies for Immune and Inflammatory Diseases,Pharma,2020-03-01
Incyte Reports Results of Itacitinib in GRAVITAS-301 P-III Study for Patients with Treatment-Naive Acute Graft-Versus-Host Disease,Pharma,2020-03-01
Innate's Lumoxiti (moxetumomab pasudotox-tdfk) Receives EMA's MAA to Treat Patients with Relapsed or Refractory Hairy Cell Leukemia,Pharma,2020-03-01
RedHill Terminates its 2014 Deal with Salix Pharmaceuticals for RHB-106,Pharma,2020-03-01
BeiGene Signs an Exclusive Option and License Agreement with Leap Therapeutics for DKN-01,Pharma,2020-06-01
AstraZeneca's Farxiga (dapagliflozin) Receives the US FDA's Priority Review Voucher for the Reduction of CV Risks and Death in Patients with Type-2 Diabetes,Pharma,2020-06-01
Kyowa Kirin's Istradefylline (KW-6002) Receives EMA's MAA as an Adjunctive Treatment to Levodopa-Based Regimens in Adult with Parkinson's disease Experiencing “Off” Time,Regulatory,2020-06-01
AstraZeneca's Lokelma (sodium zirconium cyclosilicate) Receives NMPA's Approval for Patients with Hyperkalaemia,Regulatory,2020-06-01
I-Mab Reports Dosing of TJ202/MOR202 in P-II Trial for Patients with Relapsed or Refractory Multiple Myeloma,Pharma,2020-06-01
Merck &amp; Co. Signs an Exclusive Worldwide License Agreement with Taiho and Astex to Develop Targeted Therapies,Pharma,2020-06-01
InxMed Signs a Clinical Trial Collaboration with Merck &amp; Co for Patients with Pancreatic Cancer,Pharma,2020-07-01
Sorrento's Partner Mabpharm Files NDA to the NMPA for Infliximab Biosimilar in China,Regulatory,2020-07-01
Merck &amp; Co Reports Results of Keytruda in P-III KEYNOTE-604 Trial in 1L Patients with Extensive Stage Small Cell Lung Cancer (ES-SCLC),Pharma,2020-07-01
Mundipharma Signs an Exclusive Commercialization and Distribution Agreement with Biosolution in South Korea,Pharma,2020-07-01
Merck KGaA and Pfizer Report Results of Bavencio (avelumab) in P-III JAVELIN Bladder 100 Study for Patients with Locally Advanced or Metastatic Urothelial Carcinoma,Pharma,2020-07-01
Mithra Signs a License Agreement with Alvogen for its Estelle in Hong Kong and Taiwan,Pharma,2020-07-01
Evotec Expands its 2016 Agreement with Bristol-Myers Squibb,Pharma,2020-07-01
Bicycle Therapeutics Signs Clinical Development Partnership with Cancer Research UK for BT7401,Pharma,2020-08-01
MiNA Therapeutics Signs a Research Collaboration with AstraZeneca to Evaluate Therapies for Metabolic Diseases,Pharma,2020-08-01
Eagle Signs a Co-Promotion Agreement with Tyme for SM-88 to Treat Cancer,Pharma,2020-08-01
Innovent Signs a Clinical Trial Agreement with Sirnaomics to Treat Cancer and Fibrotic Diseases in the US,Pharma,2020-08-01
Abbott's HeartMate 3 Heart Pump Receives the US FDA's Approval for Patients to Avoid Open Heart Surgery,Regulatory,2020-08-01
PhoreMost Signs a Multi-Project Drug Discovery Agreement with Boehringer Ingelheim,Pharma,2020-08-01
Gilead Signs a License Agreement with Xencor for its GS-9722 to Treat HIV,Pharma,2020-08-01
Veracyte Signs a Multi-Year Agreement with AstraZeneca,Pharma,2020-09-01
Merck &amp; Co's Keytruda (pembrolizumab) Receives the US FDA's Approval for Patients with BCG-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer,Pharma,2020-09-01
Almirall Signs an In-License Agreement with 23andMe for Multiple Inflammatory Diseases,Pharma,2020-09-01
Mylan Voluntarily Recalls Nationwide Three Lots of Nizatidine Capsules USP Due to Trace Amounts of NDMA (N-Nitrosodimethylamine),Pharma,2020-09-01
Evotec Signs a Five-Year Collaboration with Bayer to Develop Therapies for Polycystic Ovary Syndrome,Pharma,2020-09-01
BioMed Collaborates with Merck &amp; Co for Autoimmune Diseases,Pharma,2020-09-01
Gilead Signs an Exclusive License Agreement with Rockefeller University for its Portfolio of HIV Abs,Pharma,2020-10-01
Kaleido Signs a Collaboration with Janssen for Microbiome Metabolic Therapies (MMT),Pharma,2020-10-01
Pfizer Signs an Exclusive Worldwide License Agreement with eFFECTOR to Develop Therapies for Cancer Indications,Pharma,2020-10-01
Immunic Exercises its Worldwide Exclusive Option to License for IMU-856 with Daiichi Sankyo,Pharma,2020-10-01
Bayer Signs a Three Year Multi Target AI-based Agreement with Exscientia to Treat Cardiovascular and Oncology Diseases,Pharma,2020-10-01
Eli Lilly to Acquire Dermira for $1.1B,M&A,2020-10-01
Nektar Therapeutics Signs a Clinical Trial Collaboration with Bristol-Myers Squibb,Pharma,2020-10-01
Iovance Signs a License Agreement with Novartis to Develop and Commercialize IOV-3001,Biotech,13/1/2020
AstraZeneca's Lynparza (olaparib) + Bevacizumab Receive the US FDA's Priority Review for 1L Treatment of Advanced Ovarian Cancers,Regulatory,13/1/2020
Incyte Signs a Worldwide License Agreement with MorphoSys for Tafasitamab,Biotech,13/1/2020
Roche Signs a Technology License Agreement with Amunix Pharmaceutical to Develop Non-Oncology Therapies,Pharma,13/1/2020
Mundipharma Collaborates with Samsung Bioepis to Commercialize Multiple Biosimilar Candidates in Hong Kong and Taiwan,Biosimilars,13/1/2020
Biogen to Acquire Pfizer's PF-05251749 to Bolster its Neurological Pipeline,Pharma,13/1/2020
BeiGene Collaborates with EUSA Pharma to Develop and Commercialize Sylvant (siltuximab) and Qarziba (dinutuximab beta) in Greater China,Biotech,13/1/2020
Coherus Signs a License Agreement with Innovent Biologics to Commercialize Biosimilar of Avastin (bevacizumab) in the US and Canada,Biosimilars,14/1/2020
MSD Signs a Multiyear Agreement with Just – Evotec Biologics for Gaining Access to J.POD Facility,Biotech,14/1/2020
Roche Collaborates with Illumina to Expand the Adoption of NGS Based Testing in Oncology,MedTech,14/1/2020
Astellas and Adaptimmune Signs Co-Exclusive Agreement for Universal Donor Cell Platform and Stem-Cell Derived Allogeneic CAR-T and TCR T-Cell Therapies,Biotech,14/1/2020
Amgen Collaborates with Guardant Health and Qiagen to Expand Molecular Testing for Patients with Non-Small Cell Lung Cancer,Pharma,14/1/2020
Axsome In-Licenses Pfizer's Reboxetine and Esreboxetine in the US,Pharma,14/1/2020
Bayer Signs an Exclusive Option to License Agreement with Dare Biosciences to Commercialize Ovaprene in the US,Pharma,14/1/2020
Takeda Collaborates with Charles River to Identify and Develop Preclinical Candidates,Pharma,14/1/2020
Genome &amp; Company Signs a Clinical Trial Agreement with Merck KGaA and Pfizer to Evaluate the Combination Therapy,Pharma,15/1/2020
Astellas' Xospata (gilteritinib) Receives Health Canada Approval for Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation,Regulatory,15/1/2020
ViiV Healthcare's Dovato (dolutegravir/lamivudine) Receives MHLW's Approval to Treat HIV 1 Infection,Regulatory,15/1/2020
Insilico Collaborates with Pfizer to Explore Novel Data and AI System for Target Discovery,Pharma,15/1/2020
JAMP Signs an Agreement with Alvotech to Commercialize Five Biosimilars in Canada,Biosimilars,15/1/2020
Alexion to Initiate P-III CHAMPION-ALS Study Evaluating Ultomiris (ravulizumab) in Amyotrophic Lateral Sclerosis,Biotech,15/1/2020
Kymera Signs a DNA-Encoded Library Based Drug Discovery Research Agreement with HitGen,Pharma,15/1/2020
BioLineRx's Motixafortide (BL-8040) Receives EC's ODD to Treat Pancreatic Cancer in Europe,Regulatory,15/1/2020
Galapagos Signs an Exclusive Option to License Agreement with Fibrocor to Expand their Existing 2019 Partnership for Fibrosis,Pharma,16/1/2020
JT Signs an Exclusive License Agreement with Dermavant to Develop and Commercialize Tapinarof in Japan,Pharma,16/1/2020
Livongo to Integrate Dexcom's G6 CGM System into its Applied Health Signals Platform,DigiHealth,16/1/2020
Wuxi Biologic to Acquire Bayer's Production Facility in Germany,Pharma,16/1/2020
UCB's Cimzia (certolizumab pegol) Receives Health Canada Approval for Non-Radiographic Axial Spondyloarthritis,Regulatory,16/1/2020
BMS Reports the US FDA Acceptance of sBLA for Opdivo (nivolumab) + Yervoy (ipilimumab) as 1L Treatment for Non-Small Cell Lung Cancer,Regulatory,16/1/2020
Sun Pharma Signs a License Agreement with Rockwell Medical for Triferic in India,Pharma,16/1/2020
"Meiji and Dong-A Socio Initiate P-I Trial for DMB-3115 (biosimilar, ustekinumab)",Biosimilars,16/12/2019
Boehringer Ingelheim Report Results of BI 695501 in P-III Trial for Patients with Crohn's Disease,Biosimilars|Pharma,17/12/2019
BioNTech To Acquire Neon to Bolster its Immunotherapy Pipeline,M&A,17/1/2020
"Celltrion Reports Results of Truxima (biosimilar, rituximab) in P-III Study for Advanced Follicular Lymphoma in the US",Biosimilars,2019-12-12
"Clover Reports Dosing of SCB-808 (biosimilar, etanercept) in P-III Trial in China",Biosimilars|Pharma,30/12/2019
"Neuclone Reports Dosing of NeuLara (biosimilar, ustekinumab) in P-I Trial",Biosimilars,30/12/2019
Samsung Bioepis Initiates P-III Trial for Ontruzant in China,Biosimilars,20/12/2019
Novo Nordisk's Ozempic (semaglutide) Receives the US FDA's Approval for Reduction in MACE in Patients with Type 2 Diabetes,Regulatory,17/1/2020
Just – Evotec Signs a Development and Manufacturing Agreement with OncoResponse for OR2805,Pharma,17/1/2020
Healthy.io Launches Digital Wound Management Solution to Treat Chronic Wounds,DigiHealth,17/1/2020
Charles River Collaborates with Fios Genomics for Bioinformatics-Driven Drug Discovery and Safety Assessment,Biotech,17/1/2020
Arena's APD418 Receives FDA's Fast Track Designation to Treat Patients with Decompensated Heart Failure,Regulatory,17/1/2020
AstraZeneca's Lynparza (olaparib) Receives the US FDA's Priority Review for HRR-Mutated Metastatic Castration-Resistant Prostate Cancer,Regulatory,20/1/2020
AstraZeneca's Imfinzi (durvalumab) + Tremelimumab Receive the US FDA's Orphan Drug Designation for Liver Cancer,Regulatory,20/1/2020
Cyclica and AUM Biosciences Collaborate to Develop Novel Cancer Therapies Under Project Nexus,Pharma,20/1/2020
CMS Signs a License Agreement with Zydus for Desidustat in Greater China,Pharma,20/1/2020
Astellas to Establish a New Manufacturing Facility for API of Prograf in Toyama Technology Center,Pharma,20/1/2020
TB Alliance Collaborates with Hongqi Pharma to Commercialize New Therapy for Highly Drug-Resistant Forms of TB in China,Pharma,20/1/2020
Novartis' Mayzent (siponimod) Receives EC's Approval to Treat Patients with Secondary Progressive Multiple Sclerosis with Active Disease,Regulatory,21/1/2020
Roche's Polivy (polatuzumab vedotin) Based Combination Regimen Receives EC's Approval for Patients with R/R Diffuse Large B-Cell Lymphoma,Regulatory,21/1/2020
Pharming Receive EMA's Approval to Establish New Facility for Manufacturing Ruconest (conestat alfa),Pharma,21/1/2020
Jazz Pharmaceuticals' Sunosi (solriamfetol) Receives EMA's MAA for Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea,Regulatory,21/1/2020
Inotrem Signs a Worldwide License agreement with Roche Diagnostic for CDx Test in Septic Shock,MedTech,21/1/2020
PhoreMost Signs Multi-Project Drug Discovery Collaboration with Otsuka Pharmaceutical to Identify Novel Targets,Pharma,21/1/2020
Janssen's Darzalex (daratumumab) Combination Regimen Receives EC's Approval for Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma,Biotech,21/1/2020
OBI Pharma's OBI-999 Receives the US FDA's Orphan Drug Designation to Treat Gastric Cancer,Regulatory,21/1/2020
MD Anderson to Acquire Bellicum's Manufacturing Facility for $15M,Biotech,22/1/2020
Fresenius Kabi Forms a Joint Venture in Collaboration with Bio-Techne and Wilson Wolf to Advance Cell and Gene Therapies,Biotech,22/1/2020
Horizon Therapeutics' Tepezza (teprotumumab-trbw) Receives the US FDA's Approval as the First Therapy for Thyroid Eye Disease,Regulatory,22/1/2020
Medtronic's Micra AV Receives the US FDA's Approval as the World's Smallest Pacemaker to Treat AV Block,MedTech|Regulatory,22/1/2020
Theramex to Acquire Commercial Rights of MSD's Zoely to Expand its Footprints,Pharma,22/1/2020
GSK's Belantamab Mafodotin Receives FDA's Priority Review for Relapsed or Refractory Multiple Myeloma,Regulatory,22/1/2020
Genialis Collaborates with Oncologie on Precision Medicine Initiative in Gastric Cancer,Biotech,23/1/2020
Roche Reports Results of Risdiplam in FIREFISH Study for Infants with Type 1 Spinal Muscular Atrophy,Pharma,23/1/2020
Bayer's Nubeqa (darolutamide) Receives MHLW's Approval for Men with Non-Metastatic Castration-Resistant Prostate Cancer,Regulatory,23/1/2020
Bayer Reports Submission of MAA to the EMA for Pre-Filled Syringe to Administer Eylea (aflibercept solution for intravitreal injection),Regulatory,23/1/2020
Evotec and Indivumed Collaborate to Develop Therapies for Patients with Non-Small Cell Lung Cancer,Pharma,23/1/2020
Merck &amp; Co's Keytruda (pembrolizumab) Receives Health Canada's Approval as 1L Treatment for Advanced Renal Cell Carcinoma,Regulatory,23/1/2020
Janssen Receives EC's Approval for the Expanded Use of Stelara (Ustekinumab) to Treat Pediatric Patients with Moderate to Severe Plaque Psoriasis,Regulatory,24/1/2020
Roche Reports Results of Tecentriq (atezolizumab) in P-III IMvigor010 Study for Patients with Muscle-Invasive Urothelial Cancer,Biotech,24/1/2020
Pfizer to Launch Two Oncology Biosimilars at Lowest Wholesale Acquisition Cost in the US,Biosimilars,24/1/2020
Evarsana Signs an Agreement with Evoke Pharma to Commercialize Gimoti in the US,Pharma,24/1/2020
Epizyme's Tazverik (tazemetostat) Receives the US FDA's Accelerated Approval as the First Therapy for Epithelioid Sarcoma,Regulatory,24/1/2020
AbbVie to Divest Allergan's Brazikumab and Zenpep (pancrelipase) to Gain the US FTC and EC's Approval on Pending Allergan Acquisition,Pharma,27/1/2020
AstraZeneca to Divest its Hypertension Therapies to Atnahs Pharma,Pharma,27/1/2020
Roche Reports Submission of sBLA to the US FDA for Tecentriq (atezolizumab) + Avastin (bevacizumab) to Treat Unresectable Hepatocellular Carcinoma,Regulatory,27/1/2020
AstraZeneca Reports Results of Brilinta (ticagrelor) in P-III THALES Study for Patients with Minor Acute Ischemic Stroke or High-Risk Transient Ischemic Attack,Regulatory,27/1/2020
Merck &amp; Co's Dificid (fidaxomicin) Receives FDA's Approval to Treat Clostridioides difficile in Children Aged Six Months and Older,Regulatory,27/1/2020
Sanofi and Regeneron Receive the US FDA's Priority Review Acceptance for Dupixent's sBLA to Treat Moderate-to-Severe Atopic Dermatitis in Children Aged 6 to 11 Years,Biotech|Regulatory,28/1/2020
GSK Out Licenses its Tuberculosis Vaccine (M72/AS01E ) to Bill &amp; Melinda Gates Medical Research Institute,Biotech,28/1/2020
Eli Lilly and Boehringer Ingelheim's Triple Regimen Receive the US FDA's Approval for Type 2 Diabetes,Regulatory,28/1/2020
Bausch + Lomb Collaborates with TerraCycle to Launch First Contact Lens Recycling Program in Canada,MedTech,28/1/2020
Ningbo NewBay Medical Technology Signs an Exclusive License Agreement with Genentech to Develop and Commercialize GDC-0570,Pharma,28/1/2020
Alkermes Reports the US FDA Acceptance of NDA for ALKS 3831 to Treat Schizophrenia and Bipolar I Disorder,Regulatory,28/1/2020
Timber Pharmaceuticals Signs a Reverse Merger Agreement with BioPharmX,M&A,29/1/2020
Takeda Report Submission of NDA to MHLW for Cabometyx (cabozantinib) to Treat Advanced Hepatocellular Carcinoma in Japan,Regulatory,29/1/2020
Kite Reports the Validation of EMA's MAA for KTE-X19 to Treat Relapsed or Refractory Mantle Cell Lymphoma,Regulatory,29/1/2020
Eli Lilly's Selpercatinib (LOXO-292) Receives Priority Review Status for the Treatment of RET-Driven Cancer Indications,Regulatory,29/1/2020
Verastem Reports Dosing of Copiktra (duvelisib) in CPSC's Chinese Study for Relapsed or Refractory Follicular Lymphoma,Pharma,29/1/2020
Akcea and Ionis Report Results of AKCEA-ANGPTL3-LRx in P-II Study for Patients with Cardiovascular and Metabolic Diseases,Pharma,29/1/2020
Johnson &amp; Johnson Initiates the Development of Vaccines Against Coronavirus,Biotech,30/1/2020
Sanofi Reports Results of Olipudase alfa in Two Studies for Acid Sphingomyelinase Deficiency in Adults and Pediatric Patients,Pharma,30/1/2020
Astellas Reports Submission of sNDA to MHLW for Evrenzo (roxadustat) to Treat Anemia Associated with Chronic Kidney Disease in Non-Dialysis Dependent Patients in Japan,Regulatory,30/1/2020
Sorrento Collaborates with Celularity to Initiate the Development of Emergency Allogeneic Natural Killer Cell Therapy for Coronavirus Infection,Biotech,30/1/2020
Janssen Receives EC's Approval for Expanded Use of Erleada (apalutamide) to Treat Metastatic Hormone-Sensitive Prostate Cancer,Regulatory,30/1/2020
Bayer Report Result of Nubeqa (darolutamide) + ADT in P-III ARAMIS Study for Non-Metastatic Castration-Resistant Prostate Cancer,Pharma,30/1/2020
Spring Bank Discontinues the Development of Inarigivir to Treat Patients with Chronic Hepatitis B Virus,Pharma,30/1/2020
Inovio Collaborates with Beijing Advaccine to Advance the Development of INO-4800 Vaccine Targeting Coronavirus in China,Biotech,31/1/2020
Abbott's Tendyne Receives CE Mark as the World's First Transcatheter Mitral Valve Implantation System in Europe,MedTech,31/1/2020
Microsoft Launches $40M AI Program to Accelerate Health Initiatives Globally,DigiHealth,31/1/2020
Accenture Collaborates with Google Cloud to Support Life Sciences Companies Advancing Research and Development of Innovative Therapies,DigiHealth,31/1/2020
ProQR's QR-421a Receives FDA's Rare Pediatric Disease Designation for Retinitis Pigmentosa,Regulatory,31/1/2020
Alnylam's Givlaari (givosiran) Receives CHMP's Positive Opinion to Treat Acute Hepatic Porphyria in Adults and Adolescents,Regulatory,31/1/2020
Eli Lilly's Fast-Acting Insulin Lispro Receives CHMP's Positive Opinion in Patients with Diabetes,Regulatory,31/1/2020
GSK Collaborates with CEPI to Develop Vaccine Against Corona Virus,Biotech,2020-03-02
Eli Lilly Launches Reyvow (lasmiditan) C-V for the Treatment of Migraine in the US,Pharma,2020-03-02
Teva Reports Results of Ajovy (fremanezumab) in Two P-II/III Clinical Studies for the Treatment of Migraine in Japan,Pharma,2020-03-02
"Pfizer's Ruxience (biosimilar, rituximab) Receives CHMP's Positive Opinion for Cancer and Autoimmune Diseases",Biosimilars,2020-03-02
"Amgen Launches Amgevita (biosimilar, adalimumab) for the Treatment of Inflammatory Diseases in Brazil",Biosimilars,2020-03-02
Danaher Receives S.Korean FTC's Conditional Approval for its $21.4B GE Biopharma Acquisition,Biotech,2020-04-02
IMIDomics Collaborates with Gossamer Bio to Develop Therapies for Treating Immune-Mediated Inflammatory Diseases,Pharma,2020-04-02
"Bio-Thera Reports Results of BAT1706 (biosimilar, bevacizumab) in P-III Trial for Patients with Non-Squamous Non-Small Cell Lung Cancer (NSCLC)",Biosimilars,2020-04-02
Kyowa Kirin Terminates its Agreement with Zeria Pharmaceuticals for ASACOL (mesalazine),Pharma,2020-04-02
CELLINK Expands its Multi-Target Collaboration with AstraZeneca for Drug Discovery,Pharma,2020-04-02
Boehringer Ingelheim Reports Real-World Data for Spiriva Respimat (tiotropium bromide) Inhalation Spray 1.25mcg in Patients with Asthma,Pharma,2020-04-02
GSK Reports EMA's Acceptance of MAA for Belantamab Mafodotin to Treat Relapsed or Refractory Multiple Myeloma,Regulatory,2020-04-02
Regeneron Expands its Existing Collaboration with HHS'BARDA to Develop Antibody Therapies for Coronavirus,Biotech,2020-05-02
BioMotiv and BMS to Launch Anteros Pharmaceuticals,Pharma,2020-05-02
AbbVie's Rinvoq (upadacitinib) Receives ANVISA's Approval for Rheumatoid Arthritis,Regulatory,2020-05-02
The US FDA Grants Emergency Use Authorization for Coronavirus Diagnostic Test,MedTech,2020-05-02
Merck &amp; Co. to Spin-Off its Non-Core Business into a New Company to Focus on its Core Therapy Areas,Biosimilars|Pharma,2020-05-02
Seqirus' Audenz Receives the US FDA's Approval as the First Adjuvanted Cell-Based Pandemic Influenza A (H5N1) Vaccine,Regulatory,2020-05-02
Navrogen and Levena Collaborate to Develop ADCs for Humoral Immuno-Suppressed Cancers,Biotech,2020-05-02
Alector's AL101 Receives FDA's Fast Track Designation to Treat Frontotemporal Dementia,Regulatory,2020-05-02
Merck &amp; Co. Collaborates with Atreca to Identify Novel Antibody Targets in Oncology,Pharma,2020-06-02
Sanofi Reports Results of SAR442168 in P-IIb Study for Relapsing Multiple Sclerosis,Pharma,2020-06-02
Fresenius Kabi Reports the Availability of Glucagon Emergency Medicine Kit to Treat Hypoglycemia in the US,MedTech,2020-06-02
Roche Reports Results of Risdiplam in SUNFISH Part 2 Study for Patients with Type 2 Or 3 Spinal Muscular Atrophy,Pharma,2020-06-02
Nestle Health Science Signs a Worldwide Exclusive Agreement with VALBIOTIS to Develop and Commercialize TOTUM-63 for Reducing the Risk of T2D,Pharma,2020-06-02
Bridge Biotherapeutics Signs a License Agreement with Konkuk University for its Back-Eye Disease Therapy,Pharma,2020-06-02
Almirall Collaborates with Plug and Play to Offer Digital Solutions in Dermatology,DigiHealth,2020-07-02
Roche Reports Results of Tecentriq (atezolizumab) + Avastin (bevacizumab) in P-III IMbrave150 Study in Chinese Patients with Hepatocellular Carcinoma,Pharma,2020-07-02
Merck &amp; Co. to Initiate P-II Study of MK-5890 for Non-Small Cell Lung Cancer,Pharma,2020-07-02
Collegium to Acquire US Rights of Assertio's Nucynta Franchise for $375M,Pharma,2020-07-02
Novo Nordisk to Invest ~$117.4M in Expansion of its Production Facilities in Denmark,Pharma,2020-07-02
Curis Amends its Existing Collaboration with Aurigene for the Development and Commercialization of CA-170,Pharma,2020-07-02
­WHO to Accelerate Global Research and Innovation Against Corona Virus,Biotech,2020-07-02
Eli Lilly Reports Results of Solanezumab in P-II/III DIAN-TU Study for Dominantly Inherited Alzheimer's Disease,Biotech,2020-10-02
Regeneron Reports Results of Eylea (aflibercept) in P-III PANORAMA Study for Patients with Diabetic Retinopathy,Pharma,2020-10-02
Zealand Pharma to Acquire Valeritas' Business and Retain its Employees,M&A,2020-10-02
Bayer Plans Two P-III Studies to Evaluate Aflibercept 8mg Formulation,Pharma,2020-10-02
Roche Reports Results of Gantenerumab in P-II/III DIAN-TU-001 Study for Autosomal Dominant Alzheimer's Disease,Pharma,2020-10-02
BioIntelliSense's BioSticker Receives FDA's 510 (k) Clearance for Month-Long Vitals Monitoring,MedTech,2020-11-02
Sapphire Biotech Collaborates with Arizona State University to Develop Metastatic Cancer Inhibitor,Pharma,2020-11-02
Kite's KTE-X19 Receives the US FDA's Priority Review for Relapsed or Refractory Mantle Cell Lymphoma,Regulatory,2020-11-02
Bayer and Nuvisan Collaborate to Establish a New Research Entity in Berlin,Pharma,2020-11-02
Eagle's Pemfexy (pemetrexed for injection) Receives Final FDA's Approval to Treat Nonsquamous Non-Small Cell Lung Cancer,Regulatory,2020-11-02
Novartis' Capmatinib (INC280) Receives FDA's Priority Review for METex14 Mutated Advanced Non-Small Cell Lung Cancer,Regulatory,2020-11-02
Janssen Reports Submission of sBLA to the US FDA for Darzalex (daratumumab) based Combination Regimen for Relapsed/Refractory Multiple Myeloma,Pharma,2020-11-02
Caption Health's Caption Guidance Receives FDA's Marketing Authorization as the First AI-Guided Image Acquisition System,MedTech,2020-11-02
Janssen Collaborates with BARDA to Facilitate the Development of Corona Virus Vaccine,Biotech|COVID-19,2020-12-02
Pfizer Terminates its License Agreement with GlycoMimetics Signed in 2011,Pharma,2020-12-02
"Novo Nordisk Launches Esperoct [antihemophilic factor (recombinant), glycopegylated-exei] to Treat Hemophilia A in the US",Pharma,2020-12-02
Eli Lilly's Taltz (ixekizumab) Receives Health Canada's Approval for Active Ankylosing Spondylitis,Regulatory,2020-12-02
Cognoa Collaborates with Autism Learning Partners for Screening App to Accelerate Early Diagnosis of Autism,DigiHealth,2020-12-02
Astellas and Pfizer Report Results of Xtandi (enzalutamide) in P-III PROSPER Study for Non-Metastatic Castration-Resistant Prostate Cancer,Clinical Trials|Pharma,2020-12-02
Merck &amp; Co. Reports Results of Keytruda (pembrolizumab) + CT in P-III KEYNOTE-355 Study as 1L Treatment for Metastatic Triple-Negative Breast Cancer,Biotech|Clinical Trials,2020-12-02
Dr. Reddy's to Acquire Wockhardt's Select Business Divisions for ~$259M in India,M&A,13/2/2020
Deciphera Reports the US FDA's Acceptance of NDA and Priority Review for Ripretinib to Treat Patients with Advanced Gastrointestinal Stromal Tumors,Regulatory,13/2/2020
Vizient Submits Response to the US FDA for Draft Guidance on Biosimilars Development,Biosimilars,28/1/2020
Alvotech Signs an Exclusive Commercialization Agreement with JAMP Pharma for Biosimilars in Canada,Biosimilars,14/1/2020
Medtronic Recalls its MiniMed 600 Series Insulin Pumps Due to Incorrect Insulin Dosing,MedTech,13/2/2020
BenevolentAI Collaborates with UC San Diego to Develop Non-Invasive Therapies for Cerebral Cavernous Malformations,DigiHealth,13/2/2020
Medtronic to Acquire Digital Surgery to Bolster its Robotic-Assisted Surgery Platform and AI Capabilities,DigiHealth|M&A,13/2/2020
Amgen Receives Health Canada's Marketing Authorization Transfer of Otezla for Moderate to Severe Plaque Psoriasis and Psoriatic Arthritis,Regulatory,13/2/2020
BMS Receives FDA's Priority Review Acceptance of Lisocabtagene Maraleucel's BLA for Patients with Relapsed or Refractory Large B-Cell Lymphoma,Pharma,13/2/2020
Thermo Fisher Collaborates with NanoPin to Facilitate Infectious Diseases Diagnosis,MedTech,14/2/2020
Roche's Tecentriq (atezolizumab) + CT Receive NMPA's Approval as 1L Treatment for Extensive-Stage Small Cell Lung Cancer,Regulatory,14/2/2020
Orthofix's STIM onTrack 2.1 Mobile App Receives the US FDA's Approval for Bone Growth Stimulators,DigiHealth,14/2/2020
Codagenix Collaborates with Serum Institute of India to Co-Develop a Live-Attenuated Vaccine Against Coronavirus (COVID-19),Biotech|COVID-19,14/2/2020
Soligenix's RiVax Receives the US FDA's Fast Track Designation for the Prevention of Ricin Poisoning,Regulatory,14/2/2020
Epizyme Reports the US FDA Acceptance of NDA for Tazverik (tazemetostat) to Treat Follicular Lymphoma,Regulatory,14/2/2020
Teva Collaborates with Global HOPE and Direct Relief for Providing Access to Medications in Africa,Pharma,17/2/2020
"Merck &amp; Co's Ervebo (Ebola Zaire Vaccine, Live) Receives Approval in Four African Countries",Biotech,17/2/2020
PharmaMar and Jazz Receive the US FDA's Priority Review Acceptance of Lurbinectedin's NDA for Patients with Relapsed Small Cell Lung Cancer,Regulatory,17/2/2020
"Celltrion Reports Results of Remsima SC (biosimilar, infliximab) in a Clinical Study for Active Crohn's Disease and Ulcerative Colitis #ECCO2020",Biosimilars|Clinical Trials,17/2/2020
Novartis' Beovu (brolucizumab) Receives EC's Approval for Wet Age-Related Macular Degeneration,Regulatory,17/2/2020
Zydus Cadila Launches a Research Program to Develop Vaccine Against Coronavirus,Biotech|COVID-19,17/2/2020
Chugai and Sanofi to Terminate their Licensing Agreement for Tofogliflozin Hydrate in Japan,Pharma,18/2/2020
GSK's Voltaren Arthritis Pain Receives the US FDA's Approval as an OTC Medication,Regulatory,18/2/2020
Noxopharm Collaborates with GenesisCare to Bring Combination Regimen of Veyonda (idronoxil) and Lu-PSMA in Australia,Pharma,18/2/2020
MVC Collaborates with the US NIH to Develop Vaccine Against Corona Virus,Biotech,18/2/2020
­WAT Medical Reports Results of HeadaTerm TENS Therapy in a Clinical Study to Treat Acute Migraine,Clinical Trials|MedTech,18/2/2020
"Pfizer's Vyndaqel (tafamidis, 61mg) Receives EC's Approval as the First Therapy to Treat Transthyretin Amyloid Cardiomyopathy in the EU",Regulatory,18/2/2020
Chugai's RG6042 Receives MHLW's Orphan Drug Designation for Huntington's Disease in Japan,Regulatory,18/2/2020
Sanofi Collaborates with BARDA to Facilitate the Development of Coronavirus Vaccine,Biotech|COVID-19,19/2/2020
Roche Reports the US FDA Acceptance of sBLA and Granted Priority Review for Tecentriq (atezolizumab) as 1L Monotherapy for Advanced Non-Small Cell Lung Cancer,Biotech,19/2/2020
Hyperfine Research Receives the US FDA's 510(k) Clearance for its World's First Bedside MRI system,MedTech,19/2/2020
Abbott's Gallant ICD and CRT-D Device Receives CE Mark in the EU,MedTech,19/2/2020
Janssen Expands its Collaboration with BARDA to Expedite the Discovery of COVID-19 Therapies,Biotech|COVID-19,19/2/2020
Sarepta Receives the US FDA's Approval for VYONDYS 53 (golodirsen) Injection to Treat Duchenne Muscular Dystrophy (DMD) in Patients with Amenable to Skipping Exon 53,Biotech,2019-12-12
Abbott Collaborates with Insulet to Integrate Glucose Sensing Technology with Automated Insulin Delivery System for Seamless Diabetes Care,MedTech,19/2/2020
Astellas and Seattle Genetics' PADCEV (enfortumab vedotin-ejfv) Receives the US FDA's Approval for Locally Advanced or Metastatic Urothelial Cancer in Adults,Biotech,18/12/2019
WuXi Vaccines Signs Twenty Years Manufacturing Agreement with Global Vaccine Leaders for $3B,Biotech,19/2/2020
Merck KGaA to Divest its Allergopharma to Dermapharm,Pharma,20/2/2020
Astellas and Seattle Genetics' Padcev (enfortumab vedotin-ejfv) + Keytruda Receive FDA's Breakthrough Therapy Designation as 1L Treatment for Advanced Bladder Cancer,Biotech,20/2/2020
Intra-Cellular's CAPLYTA (lumateperone) Receives the US FDA's Approval for the Treatment of Schizophrenia in Adults,Biotech|Regulatory,23/1/2020
Blueprint Medicines' Ayvakit (avapritinib) Receives FDA's Approval to Treat Patients with Unresectable or Metastatic PDGFRA Exon 18 Mutant Gastrointestinal Stromal Tumor,Biotech|Regulatory,2020-09-01
Vifor Pharma and Fresenius Kabi Collaborate to Establish Joint Venture in China,Pharma,20/2/2020
Eisai's Dayvigo (lemborexant) Receives the US FDA's Approval to Treat Insomnia in Adults,Biotech|Regulatory,23/12/2019
Abbott to Recall Coronary Dilatation Catheters Due to Failure of Balloon Deflation,MedTech,20/2/2020
Genentech Signs an Agreement with Nimble to Discover and Develop Novel Peptide-Based Therapies,Biotech,20/2/2020
Roche Introduces RocheDiabetes InsulinStart to Facilitate the Access to Insulin Therapy for T2D Patients,DigiHealth,20/2/2020
GSK Signs an Agreement with Immatics to Develop Adoptive Cell Therapies for Multiple Cancer Indications,Biotech,21/2/2020
BioMarin Receives the US FDA's Priority Review Acceptance of Valoctocogene Roxaparvovec's BLA for Patients with Hemophilia A,Regulatory,21/2/2020
VBL Therapeutics to Initiate P-II Study Evaluating VB-111 (ofranergene obadenovec) + Nivolumab in Patients with Metastatic Colorectal Cancer,Pharma,21/2/2020
Teva Reports Results of Austedo (deutetrabenazine) in Two Clinical Studies for Tourette Syndrome,Clinical Trials|Pharma,21/2/2020
Chugai's Rozlytrek Receives MHLW's Approval for ROS1 Fusion-Positive Non-Small Cell Lung Cancer,Regulatory,21/2/2020
Esperion's NEXLETOL (bempedoic acid) Tablet Receives the US FDA's Approval for Lowering Cholesterol Level,Biotech,24/2/2020
Novartis Reports Acceptance of Ofatumumab's (OMB157) sBLA from the US FDA and EMA to Treat Relapsing Forms of Multiple Sclerosis (RMS),Pharma,24/2/2020
Eli Lilly's Trulicity (dulaglutide) Receives the US FDA's Approval to Reduce MACE in T2D Adults,Regulatory,24/2/2020
Lundbeck's Vyepti (eptinezumab-jjmr) Receives the US FDA's Approval to Prevent Migraine in Adults,Biotech|Regulatory,24/2/2020
Asuragen's AmplideX Fragile X Dx and Carrier Screen Kit Receives the US FDA's Approval for Detecting Fragile X Syndrome (FXS),MedTech|Regulatory,24/2/2020
Paratek Signs an Exclusive License Agreement with Almirall for SEYSARA (sarecycline),Pharma,24/2/2020
GSK Signs a Research Collaboration with Clover for the Evaluation of Coronavirus (COVID-19) Vaccine,Biotech,24/2/2020
Sanofi to Establish New Company to Provide Active Pharmaceutical Ingredients in the EU,Pharma,25/2/2020
Roche Reports Acceptance of BLA for Fixed-Dose SC Combination of Perjeta and Herceptin to Treat HER2-Positive Breast Cancer,Regulatory,25/2/2020
AstraZeneca to Divest Global Rights of Movantik (naloxegol) to RedHill Biopharma,Pharma,25/2/2020
STADA Acquires GSK's Consumer Healthcare Portfolio to Expand its OTC Business,M&A,25/2/2020
Takeda's Alunbrig (brigatinib) Receives the US FDA's Priority Review to Treat ALK + Metastatic Non-Small Cell Lung Cancer,Regulatory,25/2/2020
FMCNA's Novalung ECMO System Receives the US FDA's Approval for Acute Respiratory and Cardiopulmonary Failure,MedTech,25/2/2020
Genentech Collaborates with Bicycle Therapeutics to Develop and Commercialize Bicycle-Based Immuno-Oncology Therapies,Biotech,25/2/2020
Novartis Collaborates with DNDi to Develop LXE408 for Visceral Leishmaniasis,Pharma,26/2/2020
WuXi Biologics and Vir Biotechnology Collaborate for the Global Development of Antibodies Against COVID-19,Biotech,26/2/2020
Takeda Exercises its Exclusive Option to Acquire PvP Biologics for ~$330M,M&A,26/2/2020
Johnson &amp; Johnson in Collaboration with Apple Launch Heartline Study App in the US,DigiHealth,26/2/2020
The US FDA Upgrades the Purple Book to Assist the Transparency in Biosimilars,Biosimilars,26/2/2020
Eisai Signs a License Agreement with FUJI YAKUHIN for Dotinurad to Treat Hyperuricemia and Gout in China,Pharma,26/2/2020
Gilead Reports the Initiation of Two P-III Studies of Remdesivir to Treat COVID-19,Biotech,27/2/2020
Gemini Therapeutics Signs a Research Agreement with SERI to Identify New Therapies for Age-related Macular Degeneration,Pharma,27/2/2020
Hikma Signs an Exclusive License Agreement with Glenmark to Commercialize Ryaltris (olopatadine hydrochloride and mometasone furoate nasal spray) in the US,Pharma,27/2/2020
Esperion Receives the US FDA's Approval for Nexlizet (Non-Statin LDL-Cholesterol Lowering Therapy),Regulatory,27/2/2020
GSK Reports the Acceptance of EMA's MAA for Zejula (niraparib) as 1L Maintenance Treatment for Platinum-Responsive Advanced Ovarian Cancer,Pharma,27/2/2020
Co-Diagnostics Receives CE Mark for its Logix Smart Coronavirus PCR Test,COVID-19|MedTech,27/2/2020
"Celltrion's Remsima SC (biosimilar, infliximab) Receives KFDA's Approval for Rheumatoid Arthritis",Biosimilars,28/2/2020
Biogen Signs an Exclusive Worldwide License Agreement with Sangamo to Develop Gene Therapies for Multiple Neurological Diseases,Pharma,28/2/2020
Boehringer Ingelheim Collaborates with Trutino Biosciences to Develop New Therapies Utilizing On-Demand-Cytokine Platform,Biotech,28/2/2020
Fujifilm's CAD EYE Receives CE Mark to Support the Detection of Colonic Polyp Utilizing AI in the EU,MedTech,28/2/2020
Gates Foundation Forms an Alliance with Global Pharma Companies to Develop PAN-TB Drug Regimen for Tuberculosis,Pharma,28/2/2020
Takeda's Vedolizumab SC Receives CHMP's Positive Opinion as a Maintenance Therapy for Moderately to Severely Active UC or CD,Biotech,28/2/2020
Companion Medical's InPen Diabetes Management System Receives the US FDA's Approval for Fixed Dosing and Meal Estimation,MedTech,28/2/2020
Merck KGaA's ERBITUX (cetuximab) Receives NMPA's Approval as a 1L treatment for Recurrent/ Metastatic Squamous Cell Carcinoma of the Head and Neck,Regulatory,2020-02-03
Boehringer Ingelheim's Nintedanib Receives CHMP's Positive Opinion to Treat Systemic Sclerosis-Associated Interstitial Lung Disease,Regulatory,2020-02-03
Medexus Acquires Aptevo BioTherapeutics for its Hematology Asset IXINITY,M&A,2020-02-03
Gilead to Acquire Forty Seven for $4.9B,M&A,2020-02-03
Takeda to Divest a Portfolio of Select OTC and Non-Core Assets to Hypera Pharma in Latin America for $825M,Pharma,2020-02-03
Pfizer and Eli Lilly Report the US FDA Acceptance of BLA for Tanezumab to Treat Chronic Pain Due to Moderate-to-Severe Osteoarthritis,Biotech,2020-02-03
uniQure Signs an Exclusive Research and License Agreement with Gen-X to Develop Novel Synthetic Promoters,Biotech,2020-03-03
Sanofi's Sarclisa (isatuximab-irfc) Receives the US FDA's Approval for Relapsed Refractory Multiple Myeloma,Regulatory,2020-03-03
Thermo Fisher Scientific to Acquire QIAGEN for ~$11.5B,M&A,2020-03-03
Insulet to Halt Study of Omnipod Horizon Due to Software Anomaly,MedTech,2020-03-03
Genentech's Esbriet (pirfenidone) Receives FDA's Breakthrough Therapy Designation for Unclassifiable Interstitial Lung Disease,Regulatory,2020-03-03
Lucid Diagnostics Collaborates with the University of Pennsylvania to Evaluate EsoCheck in Patients with Eosinophilic Esophagitis,MedTech,2020-03-03
Novartis' Mayzent Receives Health Canada's Approval for Secondary Progressive Multiple Sclerosis with Active Disease,Regulatory,2020-03-03
BMS Collaborates with Voluntis to Co-Develop Digital Therapies to Treat Cancer Indications,DigiHealth,2020-04-03
Roche's Elecsys GALAD scores Receive the US FDA's Breakthrough Device Designation for Earlier Diagnosis of Hepatocellular Carcinoma,MedTech,2020-04-03
Takeda to Initiate the Development of Plasma-Derived Therapy to Treat Corona Virus (COVID-19),Biotech,2020-04-03
Alnylam's Givlaari (givosiran) Receives EC's Approval for Acute Hepatic Porphyria in Adults and Adolescents,Regulatory,2020-04-03
Iktos and SRI Collaborate to Accelerate Discovery and Development of Novel Anti-Viral Therapies,Biotech|COVID-19,2020-04-03
Janssen Reports Submission of Ponesimod's MAA to EMA for the Treatment of Relapsing Multiple Sclerosis,Pharma,2020-04-03
Vir and Alnylam Expand their 2017 License Agreement to Target COVID-19,Biotech|COVID-19,2020-05-03
Allergan and Editas Report First Patient Dosing in P-I/II BRILLIANCE Study with AGN-151587 (EDIT-101) to Treat LCA10,Pharma,2020-05-03
The US FDA and FTC Sign Agreement to Support the Development of Biosimilars,Biosimilars,2020-03-02
The US FDA Released Draft Guidelines for Proposed Biosimilar or Proposed Interchangeable Biosimilars,Biosimilars,2020-07-02
Alopexx Signs an Exclusive License Agreement with Shenogen Pharma to Develop and Commercialize DI-LEU16-IL2 for B-Cell Lymphomas in China/Asia,Pharma,2020-05-03
Roche's Actemra (tocilizumab) Receives Approval to Combat Coronavirus Complications in China,Biotech,2020-05-03
Insud's mAbxience Inaugurates New Biosimilar Plant Facility in Argentina,Biosimilars,24/2/2020
Zuellig Pharma Acquires Alliance Pharma (Cambodge) to Bolster its Presence in Indochina,M&A,2020-05-03
The US FDA Informs About Cybersecurity Vulnerabilities in Medical Devices with Bluetooth Low Energy,MedTech,2020-05-03
Heat Biologics Signs a Research Collaboration with University of Miami to Develop Vaccine Against COVID-19,Biotech|COVID-19,2020-06-03
Baysient to Release iDose Software Technology Platform 1.0 to Reduce the Biosimilar Cost in Market,Biosimilars,28/2/2020
Novartis Enters into a Four-Year Collaboration with Orionis Biosciences to Tackle Intractable Disease Targets,Pharma,2020-06-03
Zydus' Saroglitazar Receives DCGI's Approval as the World's First Therapy for Non-Cirrhotic NASH in India,Regulatory,2020-06-03
Allergan's Durysta (bimatoprost implant) Receives the US FDA's Approval as the First Intracameral Biodegradable Sustained-Release Implant for Patients with OAG and OHT,MedTech|Regulatory,2020-06-03
AstraZeneca Reports Results of Imfinzi and Tremelimumab in P-III DANUBE Study for Unresectable Stage IV Bladder Cancer,Biotech|Clinical Trials,2020-06-03
Mount Sinai Signs a Multi-Year Collaboration with Harbour BioMed to Develop Novel Biotherapies for Multiple Cancer Indications and COVID-19,Biotech|COVID-19,2020-06-03
Tetra Therapeutics and Shionogi Expand their Existing 2018 Collaboration to Develop and Commercialize BPN14770,Pharma,2020-09-03
Novartis' Isturisa (osilodrostat) Receives the US FDA's Approval for Cushing's Disease,Regulatory,2020-09-03
AbbVie's Maviret (glecaprevir/pibrentasvir) Receives EC's Marketing Authorization as Eight-Week Regimen for Treatment-Naïve Chronic HCV Patients with Genotype 3 and Compensated Cirrhosis,Regulatory,2020-09-03
Zydus Signs a License Agreement with XOMA to Advance IL-2- Based Immuno-Oncology Therapy,Pharma,2020-09-03
BMS Reports Results of Triple Regimen in P-III ELOQUENT-1 Study for Patients with Newly Diagnosed Untreated Multiple Myeloma,Biotech|Clinical Trials,2020-09-03
Biocon and Mylan Report the US FDA Acceptance of BLA for Proposed Biosimilar of Avastin (bevacizumab),Biosimilars,2020-09-03
AbbVie Collaborates with Global Health Authorities to Investigate its Kaletra/Aluvia (lopinavir/ritonavir) Against COVID-19,COVID-19|Pharma,2020-10-03
"Celltrion Reports Submission of MAA to EMA for CT-P17 (biosimilar, adalimumab)",Biosimilars,2020-10-03
ViiV Healthcare Renews its 2015 Collaboration with UNC-Chapel Hill to Discover a Cure for HIV,Pharma,2020-10-03
Boehringer Ingelheim's Ofev (nintedanib) as the First Treatment for Chronic Fibrosing ILDs with Progressive Phenotype,Regulatory,2020-10-03
Novo Nordisk's Fiasp (insulin aspart injection) Receives Health Canada's Approval for Children with Diabetes,MedTech,2020-10-03
­Bora Pharmaceuticals to Acquire GSK's Facility in Canada,M&A,2020-10-03
CEPI Expands its Investment in the Development of Vaccine Against COVID-19,Biotech|COVID-19,2020-11-03
Roche's CINtec PLUS Cytology Receives the US FDA's Approval as the First Biomarker-Based Triage Test to Improve the Prevention of Cervical Cancer,MedTech,2020-11-03
Bridge Biotherapeutics Signs an AI-Based Research Agreement with Atomwise to Expand its Pellino Inhibitor Portfolio,Pharma,2020-11-03
Janssen's JNJ-6372 Receives the US FDA's Breakthrough Therapy Designation for Non-Small Cell Lung Cancer,Regulatory,2020-11-03
Takeda Reports Results of Ninlaro (ixazomib) in P-III TOURMALINE-MM2 Study for Transplant Ineligible Patients with Multiple Myeloma,Clinical Trials|Pharma,2020-11-03
BMS' Opdivo (nivolumab) + Yervoy (ipilimumab) Receive the US FDA's Approval for Patients with Hepatocellular Carcinoma Prior Treated with Sorafenib,Regulatory,2020-11-03
Vir Biotechnology Collaborates with NIH Vaccine Research Center to Advance the Development of mAbs Against Coronavirus,Biotech|COVID-19,2020-12-03
"Henlius Reports the NMPA's Acceptance of IND for HLX14 (biosimilar, denosumab)",Biosimilars,2020-12-03
Teva's Ajovy (fremanezumab) Receives NICE Positive Recommendation for Prevention of Migraine in Adults,Regulatory,2020-12-03
AstraZeneca's Calquence (acalabrutinib) Receives the US FDA's Breakthrough Therapy Designation to Treat Chronic Lymphocytic Leukaemia (CLL) in Adults,Pharma|Regulatory,14/8/2019
Novavax and Serum Institute of India Collaborate to Develop and Commercialize Vaccines for Malaria,Biotech,2020-12-03
AstraZeneca's Selumetinib Receives the US FDA's Breakthrough Therapy Designation for Neurofibromatosis Type 1,Pharma|Regulatory,2019-01-04
F2G's Olorofim Receives the US FDA's Breakthrough Therapy Designation to Treat Invasive Mold Infections in Patients with Limited or No Treatment Options,Pharma|Regulatory,2019-11-11
AbbVie's Dual Regimen Receives EC's Approval for Patients with Previously Untreated Chronic Lymphocytic Leukemia,Regulatory,2020-12-03
Thermo Fisher Scientific Collaborates with Janssen to Co-Develop CDx for Multiple Cancer Indications,MedTech,2020-12-03
Bayer's Aliqopa (copanlisib) Receives the US FDA's Breakthrough Therapy Designation to Treat Marginal Zone Lymphoma in Adults,Pharma|Regulatory,29/5/2019
Merck and Eisai's Dual Regimen Receives the US FDA's Breakthrough Therapy Designation as 1L Treatment for Advanced Unresectable Hepatocellular Carcinoma,Pharma|Regulatory,23/7/2019
Novartis's Capmatinib (INC280) Receives the US FDA's Breakthrough Therapy Designation for MET-Mutated Advanced Non-Small Cell Lung Cancer,Pharma|Regulatory,2019-06-09
Chugai's Nemolizumab Receives the US FDA's Breakthrough Therapy Designation to Treat Pruritus Associated with Prurigo Nodularis,Pharma|Regulatory,2019-09-12
Agios' Tibsovo (ivosidenib) Receives the US FDA's Breakthrough Therapy Designation for Patients with Relapsed or Refractory Myelodysplastic Syndrome with an IDH1 Mutation,Regulatory,16/12/2019
AbCellera and Eli Lilly Collaborate to Co-develop Antibody Therapies Targeting COVID-19,Biotech|COVID-19,13/3/2020
Roche's cobas SARS-CoV-2 Test Receives the US FDA's Emergency Use Authorization to Identify Corona Virus,COVID-19|MedTech,13/3/2020
Usona Institute's Psilocybin Receives the US FDA Breakthrough Therapy Designation for Major Depressive Disorder,Regulatory,22/11/2019
AstraZeneca and MSD Report Results of Cediranib + Lynparza in P-III GY004 Study for Patients with Platinum-Sensitive Relapsed Ovarian Cancer,Clinical Trials|Pharma,13/3/2020
Boehringer Ingelheim and Eli Lilly's Jardiance (empagliflozin) Receives the US FDA's Fast Track Designation for Chronic Kidney Disease,Regulatory,13/3/2020
EMD Serono and Pfizer to Terminate P-III JAVELIN Head and Neck 100 Study Evaluating Bavencio + CRT for Squamous Cell Carcinoma of the Head and Neck,Pharma,13/3/2020
I-Mab to Initiate the Development of TJM2 for Treating Cytokine Release Syndrome Associated with COVID-19,COVID-19|Pharma,13/3/2020
Johnson &amp; Johnson Collaborates with the Beth Israel Deaconess Medical Center to Accelerate the Development of Vaccine Against COVID-19,Biotech|COVID-19,16/3/2020
Fosun Pharma Signs an Agreement with BioNTech to Develop and Commercialize BNT162 for COVID-19,Biotech|COVID-19,16/3/2020
Eli Lilly and Incyte's Olumiant (baricitinib) Receives the US FDA's Breakthrough Therapy Designation for Alopecia Areata,Regulatory,16/3/2020
Biogen Collaborates with Vir Biotechnology to Develop Antibodies Against COVID-19,Biotech|COVID-19,16/3/2020
Sanofi and Regeneron to Initiate the Clinical Program Evaluating Kevzara (sarilumab) in Patients with Severe COVID-19,COVID-19|Pharma,16/3/2020
"Teva and Celltrion Launch Herzuma (biosimilar, trastuzumab) in the US",Biosimilars,17/3/2020
Pfizer and BioNTech Collaborate to Co-Develop BNT162 Against COVID-19,Biotech|COVID-19,17/3/2020
Novo Nordisk Halts Clinical Studies Evaluating Concizumab (anti-TFPI mAb) for Hemophilia A and B With or Without Inhibitors,Pharma,17/3/2020
AcelRx to Acquire Tetraphase Pharmaceuticals to Expand its Product Portfolio,M&A,17/3/2020
AstraZeneca Reports Results of Imfinzi + Tremelimumab in P-III CASPIAN Study as 1L Treatment for Extensive-Stage Small Cell Lung Cancer,Clinical Trials|Pharma,17/3/2020
Alphabet's Verily Launched its COVID-19 Screening Site in Collaboration with California's Government,COVID-19|DigiHealth,17/3/2020
GSK's Nucala Receives Health Canada's Approval for Severe Eosinophilic Asthma in Children and Adolescents,Regulatory,17/3/2020
NIH Initiates its P-I Trial for COVID-19 at KPWHRI in Seattle,COVID-19|Pharma,17/3/2020
Moleculin Collaborates with UTMB to Evaluate WP1122 for Multiple Viruses Including Coronavirus,COVID-19|Pharma,18/3/2020
Merck &amp; Co. Reports Results of Gefapixant (MK-7264) in Two P-III Studies for Refractory or Unexplained Chronic Cough,Clinical Trials|Pharma,18/3/2020
NuProbe Collaborates with QIAGEN to Develop Diagnostics Tests for Cancer Indications,MedTech,18/3/2020
Regeneron to Initiate COVID-19 Antibody Program in Early Summer,Biotech|COVID-19,18/3/2020
IDEAYA and Pfizer Collaborate to Evaluate IDE196 + Binimetinib in Solid Tumors Harboring GNAQ or GNA11 Hotspot Mutations,Pharma,18/3/2020
Samsung Biologics Collaborates with APRINOIA Therapeutics to Expand its Presence in Greater China,Pharma,18/3/2020
Juno Therapeutics Signs License and Clinical Supply Agreement with Oxford Biomedica for LentiVector Platform,Pharma,19/3/2020
Roche to Initiate P-III COVACTA Study of Actemra/RoActemra in Hospitalized Patients with Severe Covid-19 Pneumonia in Collaboration with BARDA,COVID-19|Pharma,19/3/2020
Novartis' Zolgensma (onasemnogene abeparvovec) Receives MHLW's Approval for Spinal Muscular Atrophy,Regulatory,19/3/2020
Eli Lilly and ISDH Collaborate to Accelerate the Testing for COVID-19,COVID-19|Pharma,19/3/2020
AstraZeneca's Lynparza (olaparib) Receives MHLW's Orphan Drug Designation for BRCA-Mutated Metastatic Pancreatic Cancer,Regulatory,19/3/2020
FDA Divulges Guidance for Conducting Clinical Studies During COVID-19 Pandemic,COVID-19|Regulatory,19/3/2020
Janssen Reports Submission of Ponesimod's NDA to the US FDA for the Treatment of Relapsing Multiple Sclerosis,Regulatory,19/3/2020
CEPI Collaborates with University of Hong Kong to Develop Vaccine for COVID-19,Biotech|COVID-19,20/3/2020
Gilead's Epclusa (Sofosbuvir/Velpatasvir) Receives the US FDA's Approval for Children with Chronic Hepatitis C Infection,Regulatory,20/3/2020
Abbott Launches its Molecular Test to Detect COVID-19 and Receives the US FDA's Emergency Use Authorization,COVID-19|MedTech,20/3/2020
FDA Recommends Avoiding the Use of NSAIDs for COVID-19 Symptoms,COVID-19|Regulatory,20/3/2020
BGI Reports the Availability of RT-PCR SARS-CoV-2 Test for Clinical Use in the US,COVID-19|MedTech,20/3/2020
Insights+ Exclusive: COVID-19 Healthcare News Updates,Uncategorized,28/2/2020
Merck Collaborates with Dragonfly to Develop and Commercialize Novel Therapies Utilizing TriNKET Platform,Pharma,20/3/2020
Takeda's Entyvio (vedolizumab) Receives NMPA's Approval to Treat Moderate to Severe Active Ulcerative Colitis and Crohn's Disease,Regulatory,23/3/2020
Bayer Signs a Research and License Agreement with Curadev to Develop Novel STING Antagonists Across Multiple Indications,Pharma,23/3/2020
Microsoft and Adaptive Biotechnologies Expand Their Collaboration for Mapping the Immune Response to COVID-19,COVID-19|DigiHealth,23/3/2020
Sorrento Develops STI-4398 (COVIDTRAP Protein) to Prevent and Treat COVID-19,COVID-19|Pharma,23/3/2020
Celltrion to Launch Rapid Self-Testing Kit and Accelerates the Development of Treatment Against COVID-19,COVID-19|MedTech,23/3/2020
Takeda Collaborates with Codexis to Advance Novel Gene Therapies for Rare Genetic Disorders,Biotech,23/3/2020
Amgen and its Foundation Grant $12.5M to Support COVID-19 Relief Efforts Globally,COVID-19,24/3/2020
Roche Highlights its Response to COVID-19 Pandemic,COVID-19|Pharma,24/3/2020
Sorrento and SmartPharm To Develop Novel Gene-Encoded Antibody Vaccine for COVID-19,Biotech|COVID-19,24/3/2020
Genentech Receives the US FDA's Approval for P-III Clinical Study Evaluating Actemra to Treat Hospitalized Patients with Severe COVID-19 Pneumonia,COVID-19|Pharma,24/3/2020
QIAGEN Releases QIAstat-Dx Test Kit as the First Syndromic Test to Detect COVID-19 Under New FDA Policy,COVID-19|MedTech,24/3/2020
Astellas Collaborates with CytomX Therapeutics to Develop Probody T-Cell Engaging Bispecific Therapies for Cancer Indications,Pharma,24/3/2020
Sorrento Signs an Exclusive License Agreement with Mabpharm for ACE-MAB to Treat COVID-19,COVID-19|Pharma,25/3/2020
Elevar Therapeutics Acquires Worldwide Development and Commercialization Rights for Oasmia's Apealea,Pharma,25/3/2020
"Alvotech Signs an Exclusive License Agreement with DKSH for AVT02 (biosimilar, adalimumab) in Asia",Biosimilars,25/3/2020
Horizon's Procysbi (Cysteamine Bitartrate) Receives the US FDA's Approval for Delayed Release Oral Tablets,Pharma,18/2/2020
"Samsung Bioepis Receives the US FDA's Approval for Multi-Dose Vial of Ontruzant (biosimilar, trastuzumab)",Biosimilars|Regulatory,25/3/2020
Merck KGaA's Tepmetko (tepotinib) Receives the Japanese MHLW's Approval for Advanced NSCLC with METex14 Skipping Alterations,Regulatory,25/3/2020
AstraZeneca Collaborates with Silence Therapeutics to Develop siRNA Therapeutics Targeting Multiple Diseases,Biotech,25/3/2020
Agile Therapeutics Receives the US FDA's Approval for Twirla (levonorgestrel and ethinyl estradiol) Transdermal System,Regulatory,14/2/2020
Biohaven's Nurtec Receives the US FDA's Approval for Treatment of Migraine in Adults,Regulatory,27/2/2020
Sorrento to Initiate the Novel Decoy Cellular Vaccine Program for COVID-19,Biotech|COVID-19,26/3/2020
Baudax Bio's Anjeso Receives the US FDA's Approval to Manage Moderate to Severe Pain,Regulatory,20/2/2020
Esperion's Nexlizet (bempedoic acid and ezetimibe) Tablet Receives the US FDA's Approval as LDL-Cholesterol Lowering Medicine,Regulatory,26/2/2020
GSK's Advil Dual Action in Combination with Acetaminophen Receives the US FDA's Approval for Pain Relief,Regulatory,28/2/2020
Vir Biotechnology Signs a License Agreement with Xencor to Utilize Xtend Fc Technology in Antibodies Targeting COVID-19,Biotech|COVID-19,26/3/2020
Acacia's Barhemsys (amisulpride) Receives the US FDA's Approval for the Prevention of Postoperative Nausea and Vomiting,Regulatory,27/2/2020
AstraZeneca's Lokelma (sodium zirconium cyclosilicate) Receives MHLW's Approval for the Treatment of Hyperkalemia in Japan,Regulatory,26/3/2020
Gates Foundation Collaborates with the Consortium of Life Sciences Companies to Address Challenges Against the Pandemic COVID-19,COVID-19|Pharma,26/3/2020
PRA Health Sciences Launches COVID-19 Monitoring App to Track Symptoms,COVID-19|DigiHealth,26/3/2020
Boehringer Ingelheim Signs a Second Research Collaboration with Saniona to Develop Therapies Targeting Schizophrenia,Pharma,27/3/2020
BMS' Zeposia (ozanimod) Receives the US FDA's Approval as New Oral Treatment for Relapsing Forms of Multiple Sclerosis,Regulatory,27/3/2020
Sanofi's Sarclisa (isatuximab) Receives CHMP's Positive Opinion for Relapsed and Refractory Multiple Myeloma,Regulatory,27/3/2020
Quidel's Lyra SARS-CoV-2 Assay Receives the US FDA's Expanded Emergency Use Authorization for Molecular Detection of COVID-19,COVID-19|MedTech,27/3/2020
Medopad Provides its Remote Patient Monitoring Platform to Support Global COVID-19 Pandemic,COVID-19|DigiHealth,27/3/2020
Mylan Delays its Merger with Upjohn Due to COVID-19 Pandemic,COVID-19|Pharma,27/3/2020
Sanofi Collaborates with Translate Bio to Develop Novel mRNA Vaccine Against COVID-19,Biotech|COVID-19,30/3/2020
Sanofi and Regeneron Expand Clinical Program of Kevzara (sarilumab) for the Treatment of COVID-19 Outside the US,Biotech|COVID-19,30/3/2020
"Mylan and Lupin Receive CHMP's Positive Opinion for Nepexton (biosimilar, etanercept)",Biosimilars,30/3/2020
AstraZeneca's Imfinzi (durvalumab) Receives the US FDA's Approval for Extensive-Stage Small Cell Lung Cancer,Regulatory,30/3/2020
Eli Lilly's Taltz (ixekizumab) Receives the US FDA's Approval for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis,Regulatory,30/3/2020
BMS's Zeposia (ozanimod) Receives the CHMP's Positive Opinion to Treat Adults with Relapsing-Remitting Multiple Sclerosis with Active Disease,Regulatory,30/3/2020
Johnson &amp; Johnson and BARDA to Fund ~$1B in Research and Development of Novel COVID-19 Vaccines,Biotech|COVID-19,31/3/2020
Abbott Receives FDA's Emergency Use Authorization for its Point-Of-Care Test to Detect Novel COVID-19 in Five Minutes,COVID-19|MedTech,31/3/2020
Bayer's Nubeqa (darolutamide) Receives the EC's Approval for Men with Non-Metastatic Castration-Resistant Prostate Cancer,Regulatory,31/3/2020
The US FDA Authorizes the Emergency Use of Antimalarial Drugs to Combat COVID-19,COVID-19|Regulatory,31/3/2020
AstraZeneca's Lokelma Receives CHMP's Recommendation for Approval for Patients with Hyperkalemia on Stable Hemodialysis,Regulatory,31/3/2020
Lilly Signs a Worldwide License and Research Agreement with Sitryx to Develop New Immunometabolic Therapies,Pharma,31/3/2020
Sorrento and the University of Texas Medical Branch Collaborate for the Preclinical Testing of COVID-19 Therapeutic Candidates,Biotech|COVID-19,2020-01-04
Amgen Provides Update on its Clinical Activities and Medicine Supply Amid COVID-19 Pandemic,COVID-19|Pharma,2020-01-04
VIVUS Expedites the Launch of Telemedicine and Remote Monitoring Modules for Effective Patient Care During COVID-19,COVID-19|DigiHealth,2020-01-04
Amgen Repurchases Astellas' Stakes in Amgen Astellas JV to Strengthen its Footprints in Japan,Biotech,2020-01-04
Daiichi Sankyo Signs a Non-Exclusive License Agreement with Ultragenyx for Gene Therapy Manufacturing Technology,Biotech,2020-01-04
QIAGEN's QIAstat-Dx Test Kit Receives the US FDA's EUA as the First Syndromic Test to Detect COVID-19,COVID-19|DigiHealth,2020-01-04
BD and BioMedomics Launch Rapid Serology Test to Detect Exposure to COVID-19 in 15 Minutes,COVID-19|MedTech,2020-01-04
Three Global Pharmaceutical Companies Launch Worker Volunteer Programs to Combat COVID-19,COVID-19|Pharma,2020-02-04
Y-mAbs Reports the Submission of Naxitamab's BLA to the US FDA for Relapsed/Refractory High-Risk Neuroblastoma,Regulatory,2020-02-04
FDA Launches Emergency Program to Expedite the Development of COVID-19 Treatments,COVID-19|Regulatory,2020-02-04
Gilead Initiates Two P-III Studies Evaluating Remdesivir (GS-5734) for COVID-19 in the UK,COVID-19|Pharma,2020-02-04
Merck &amp; Co. Reports Results of Keytruda (pembrolizumab) in P-III KEYNOTE-177 Study for Advanced Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Colorectal Cancer,Pharma,2020-02-04
Vir and Alnylam Expand Their Existing Collaboration to Develop RNAi Therapeutics Targeting Host Factors for COVID-19,COVID-19|Pharma,2020-02-04
"Pfizer's Ruxience (biosimilar, rituximab) Receives EC's Approval for Cancer Indications and Autoimmune Diseases",Biosimilars,2020-03-04
Celularity's New Cell Therapy Receives the US FDA's IND Approval for COVID-19,COVID-19|Pharma,2020-03-04
Amgen and Adaptive Biotechnologies Collaborate to Develop Therapies Targeting COVID-19,Biotech|COVID-19,2020-03-04
Novartis and Incyte Intend to Initiate the P-III RUXCOVID Study of Jakavi (ruxolitinib) as a Treatment for Patients with COVID-19 Associated Cytokine Storm,COVID-19|Pharma,2020-03-04
Celltrion Enters the Next Phase of Development for its Antiviral Therapy to Combat COVID-19 Pandemic,COVID-19,2020-03-04
Sorrento Initiates the Next Phase of its Collaboration with Celularity,COVID-19|Pharma,2020-03-04
GSK Collaborates with Innovax to Evaluate a Vaccine Against COVID-19 Pandemic,Biotech|COVID-19,2020-06-04
EMA's CHMP Recommends Compassionate Use of Gilead's Remdesivir for COVID-19,COVID-19|Regulatory,2020-06-04
Janssen Signs a Worldwide Collaboration with Fate Therapeutics for Novel iPSC-Derived Cell-Based Cancer Immunotherapies,Biotech,2020-06-04
Gilead Sciences and Second Genome Signs a Four-Year Collaboration to Identify Biomarkers and Therapies Targeting Inflammatory Bowel Disease,Biotech,2020-06-04
Takeda Signs a Multi-Year Research Collaboration with Evotec to Expedite Research Program Across its Core Therapeutic Areas,Pharma,2020-06-04
Sanofi and Regeneron Finalizes the Restructuring of Their Collaboration on Praluent (alirocumab),Biotech,2020-07-04
Alnylam and Dicerna Collaborate to Develop and Commercialize RNAi Therapeutics for Alpha-1 Antitrypsin Deficiency-Associated Liver Disease,Biotech,2020-07-04
GSK Collaborates with Vir to Develop Treatment for COVID-19,COVID-19|Pharma,2020-07-04
Takeda's Alunbrig (brigatinib) Receives EC's Approval as a 1L Treatment for ALK+ Advanced Non-Small Cell Lung Cancer,Regulatory,2020-07-04
CytoDyn Collaborates with UK's Department of Health to Provide Emergency Access to Leronlimab (PRO 140) for Patients with COVID-19,COVID-19|Pharma,2020-07-04
Merck Receives the US FDA's Priority Review for Keytruda's (pembrolizumab) sBLA Based on Biomarker Regardless of Tumor Type,Regulatory,2020-07-04
The US FDA Delays its Decision on Roche's Risdiplam for the Treatment of Spinal Muscular Atrophy,Regulatory,2020-08-04
Oxford Biomedica Joins Consortium to Develop ChAdOx1 nCov-19 for COVID-19,COVID-19|Pharma,2020-08-04
BMS Expands its Existing Patient Support Programs to Aid Uninsured Patients in the US Amid COVID-19,COVID-19|Pharma,2020-08-04
Bayer Launches Eylea (aflibercept) Pre-Filled Syringe in Europe,Biotech,2020-08-04
Zai Lab Signs a Development and Commercialization Agreement with Regeneron for REGN1979 in Oncology,Biotech,2020-08-04
The US FDA will Approve a New Pathway for Biosimilars,Biosimilars,23/3/2020
Biocad with its Partner ICM Received the Registration Certificate for two of its Biosimilar in EU,Biosimilars,30/3/2020
Roche Signs a License Agreement with Arrakis Therapeutics for the Discovery of RNA-Targeted Small Molecule Therapies,Pharma,2020-08-04
AstraZeneca Focuses on the Discovery of Monoclonal Antibodies Neutralizing SARS-CoV-2 Virus,Biotech|COVID-19,2020-09-04
Revance and Mylan Provide Updates on Development BOTOX (onabotulinumtoxinA) Biosimilar,Biosimilars,30/3/2020
Chugai Initiates P-III Clinical Study of Actemra for COVID-19 Pneumonia in Japan,COVID-19|Pharma,2020-09-04
Novavax Accelerates the Initiation of Clinical Study for NVX-CoV2373 to Mid-May 2020,COVID-19|Pharma,2020-09-04
The US FDA to Waive Interchangeability Standard for Insulin Biosimilars,Biosimilars,2020-09-04
EMD Serono and Pfizer's Bavencio (avelumab) Receive the US FDA's Breakthrough Therapy Designation as 1L Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma,Regulatory,2020-09-04
Global Pharmaceuticals and the University of Cambridge Collaborate to Launch a Laboratory for COVID-19 Testing,COVID-19|MedTech,2020-09-04
Pfizer and BioNTech Provide Updates on its Collaboration for Global COVID-19 Vaccine,COVID-19|Pharma,2020-09-04
Astellas Reports NMPA's Acceptance of NDA for XOSPATA (gilteritinib) to Treat R/R AML with a FLT3 Mutation in Adults,Pharma,2020-10-04
BMS Signs a Clinical Trial Collaboration with NeoImmune to Evaluate Opdivo (nivolumab) in Combination with NT-I7 (Hyleukin-7),Pharma,2020-10-04
Cipla Receives FDA's ANDA Approval for its HFA Inhalation Aerosol to Treat Acute Episodes of Bronchospasm or to Prevent Asthmatic Symptoms,Regulatory,2020-10-04
Abbott's TriClip Transcatheter Tricuspid Valve Repair System Receives the CE Mark for Minimally Invasive Tricuspid Valve Repair,MedTech|Regulatory,2020-10-04
Samsung Biologics Signs an Agreement with Vir Biotechnology to Develop Abs for COVID-19,COVID-19|Pharma,2020-10-04
Amgen Signs a Partnership with Adaptive Biotechnologies to Develop Abs for COVID-19,Biotech|COVID-19,2020-10-04
Revance and Mylan Provide Updates on Development BOTOX (onabotulinumtoxinA) Biosimilar,Biosimilars,30/3/2020
Apple and Google Collaborate on Contact Tracing Technology to Combat COVID-19,COVID-19|DigiHealth,13/4/2020
Eli Lilly Signs a Clinical Trial Collaboration with NIH to Evaluate Baricitinib Against COVID-19,COVID-19|Pharma,13/4/2020
Terumo BCT and Marker Therapeutics Receive the US FDA's Emergency Use Authorization for their Purification Device to Treat COVID-19,COVID-19|MedTech,13/4/2020
AstraZeneca and MSD's Koselugo (selumetinib) Receives the US FDA's Approval as the First Therapy for Pediatric Patients with Neurofibromatosis Type 1 Plexiform Neurofibromas,Pharma|Regulatory,13/4/2020
"Bausch Health to Initiate Clinical Study Evaluating Virazole (Ribavirin for Inhalation Solution, USP) in Patients with COVID-19 in Canada",COVID-19|Pharma,13/4/2020
Blackstone and Alnylam Enter into a Collaboration to Accelerate the Advancement of RNAi Therapeutics,Biotech,14/4/2020
"Biocon and Mylan Launch Fulphila (biosimilar, Pegfilgrastim) in Australia",Biosimilars,14/4/2020
Celltrion Anticipates the Initiation of its First-in-Human Clinical Studies Targeting COVID-19 in July,COVID-19,14/4/2020
BD Receives Second FDA's Emergency Use Authorization for its New Molecular Diagnostic Test to Detect COVID-19,COVID-19|MedTech|Regulatory,14/4/2020
Sanofi and GSK Collaborate to Develop Adjuvanted COVID-19 Vaccine,Biotech|COVID-19,14/4/2020
B. Braun Receives the US FDA's EUA for the Use of Infusion Pumps with Nebulizers to Treat COVID-19,COVID-19|MedTech,14/4/2020
Alnylam's Vutrisiran Receives the US FDA's Fast Track Designation to Treat Polyneuropathy of hATTR Amyloidosis,Regulatory,14/4/2020
AstraZeneca Initiates CALAVI Study Evaluating Calquence (acalabrutinib) Against COVID-19,COVID-19|Pharma,15/4/2020
Boehringer Ingelheim Collaborates with Insilico on AI-Based Drug Discovery,Biotech,15/4/2020
Sosei Heptares to Utilize its Structure-Based Drug Design Expertise in New COVID-19 R&amp;D Program,COVID-19|Pharma,15/4/2020
"Merck Launches Ontruzant (biosimilar, trastuzumab) in the US",Biosimilars,15/4/2020
Ortho Clinical Diagnostics' Total Antibody Test Receives the US FDA's Emergency Use Authorization for COVID-19,COVID-19|MedTech,15/4/2020
Abbott Launches its Third Test to Detect COVID-19,COVID-19|MedTech,15/4/2020
GE Healthcare and Microsoft Exploit Remote Patient Data Monitoring Technology to Support Clinicians for the Treatment of COVID-19,COVID-19|DigiHealth,16/4/2020
Vanda Signs a Collaboration with UW Medicine to Initiate CALYPSO Program for Evaluating the Role of Genetic Variation in COVID-19,COVID-19|Pharma,16/4/2020
QIAGEN Launches Therascreen BRAF Test as CDx to a BraftovI Regimen for Metastatic Colorectal Cancer,MedTech,16/4/2020
Novavax Signs a Clinical Trial Agreement with Nucleus Network to Initiate the Clinical Study Evaluating NVX-CoV2373 Against COVID-19,COVID-19|Pharma,16/4/2020
Dynavax Signs an Agreement with Sinovac to Develop a Vaccine for COVID-19,COVID-19|Pharma,16/4/2020
Regeneron Reports the US FDA's Acceptance of Priority Review for REGN-EB3's BLA to Treat Ebola,Biotech|Regulatory,16/4/2020
Sanofi and Luminostics Collaborate to Develop Smartphone-Based Self-Testing Solution for COVID-19,COVID-19|DigiHealth,17/4/2020
Roche Develops Elecsys Anti-SARS-CoV-2 Serology Test to Detect Ab Against COVID-19,COVID-19|MedTech,17/4/2020
BARDA Grants ~ $483M to Moderna for Accelerating the Development of mRNA-1273 Against COVID-19,COVID-19|Pharma,17/4/2020
Chi-Med's Surufatinib Receives the US FDA's Fast Track Designations for Pancreatic and Non-Pancreatic Neuroendocrine Tumors,Pharma|Regulatory,17/4/2020
1Health.io Launches Self-Collection Kits to Detect COVID-19,COVID-19|MedTech,17/4/2020
Sinovac Initiates the P-I Clinical Study for Vaccine Candidate Against COVID-19,Pharma|Regulatory,17/4/2020
Novartis Signs an Agreement with the US FDA to Evaluate Hydroxychloroquine in Patients with COVID-19,COVID-19|Pharma,20/4/2020
Roche Reports the FDA and EMA's Acceptance of sBLA for Ocrevus Shorter 2-Hour Infusion Time,Biotech|Regulatory,20/4/2020
Incyte Initiates P-III RUXCOVID Study Evaluating Jakafi (ruxolitinib) to Treat Patients with COVID-19 Associated Cytokine Storm,COVID-19|Pharma,20/4/2020
Fosun Pharma Receives the US FDA's EUA for its COVID-19 RT-PCR Detection Kit,COVID-19|MedTech,20/4/2020
Otsuka Signs a Development and Commercialization Agreement with Esperion for Nexletol (bempedoic acid) and Nexlizet (bempedoic acid and ezetimibe) in Japan,Pharma,20/7/2020
Alexion to Initiate P-III Study of Ultomiris (ravulizumab-cwvz) in Hospitalized Patients with Severe COVID-19,Biotech|COVID-19,20/4/2020
"RedHill Biopharma Collaborates with NIAID to Investigate RHB-107 (upamostat, WX-671) Against COVID-19",COVID-19|Pharma,21/4/2020
Cue Biopharma Signs Clinical Trial Collaboration with Merck to Evaluate CUE-101 + Keytruda (pembrolizumab) as 1L Treatment for HPV+ Recurrent/Metastatic Head and Neck Cancer,Pharma,21/4/2020
Roche's cobas HPV Test Receives the US FDA's Approval for cobas 6800/8800 System to Identify Women at Risk for Cervical Cancer,MedTech,21/4/2020
Noxopharm Anticipates the US FDA's Approval for Evaluating Veyonda in a Clinical Study for COVID-19,COVID-19|Pharma,21/4/2020
Sangamo Signs an Exclusive License Agreement with Mogrify for iPSC and ESC-Derived Regulatory T-Cells,Biotech,21/4/2020
Novartis Reports Results of Mayzent (siponimod) in P-III EXPAND Study for Secondary Progressive Multiple Sclerosis,Clinical Trials|Pharma,21/4/2020
Bayer Collaborates with the Population Health Research Institute to Identify Treatment for COVID-19,COVID-19|Pharma,22/4/2020
Gilead and Kite Sign a Three Years Agreement with oNKo-innate to Discover Cancer Immunotherapies,Biotech,22/4/2020
Novartis' Kymriah (tisagenlecleucel) Receives the US FDA's Regenerative Medicine Advanced Therapy Designation for Follicular Lymphoma,Regulatory,22/4/2020
Hope Biosciences Reports its Third US FDA's Approval for Clinical Trial in COVID-19,COVID-19|Pharma,22/4/2020
Pfizer and BioNTech to Commence Clinical Study for COVID-19 in Germany,COVID-19|Pharma,22/4/2020
Sobi's Affiliate Florio GmbH Launches a Digital Platform to Improve the Lives of Patients with Hemophilia,DigiHealth,22/4/2020
Valneva and Dynavax Collaborate to Advance the Development of Vaccine Against COVID-19,COVID-19|Pharma,23/4/2020
The European Commission Approves the Merger of Mylan and Upjohn with Conditions,Pharma,23/4/2020
AstraZeneca and Saint Luke's Mid America Heart Institute to Initiate P-III DARE-19 Evaluating Farxiga Against COVID-19,COVID-19|Pharma,23/4/2020
LabCorp Receives the US FDA's Emergency Use Authorization for its COVID-19 At-Home Test Kit,COVID-19|MedTech,23/4/2020
Mobidiag Receives Emergency Use Authorization for its Automated COVID-19 Test in Finland,COVID-19|MedTech,23/4/2020
Theravance Reports First Patient Dosing in P-I Study with TD-0903 to Treat Patients with Acute Lung Injury Associated with COVID-19,COVID-19|Pharma,23/4/2020
Janssen Collaborates with Emergent BioSolutions to Accelerate the Manufacturing of its Vaccine Against COVID-19,Biotech|COVID-19,24/4/2020
Merck &amp; Co. Reports the Resubmission of sBLA to the US FDA for Keytruda (pembrolizumab) Six-Week Dosing Schedule,Regulatory,24/4/2020
AstraZeneca and MSD Report Results of Lynparza in P-III PROfound Study for BRCA1/2 or ATM-Mutated Metastatic Castration-Resistant Prostate Cancer,Clinical Trials|Pharma,24/4/2020
Takeda to Divest Select OTC and Non-Core Assets in Europe to Orifarm for $670M,Pharma,24/4/2020
Sanofi Receives the US FDA's Approval for its MenQuadfi Meningococcal (MenACWY) Conjugate Vaccine,Biotech,24/4/2020
Santhera Signs a Clinical Trial Agreement with Cold Spring Harbor Laboratory to Evaluate Lonodelestat (POL6014) Against Acute Respiratory Distress Syndrome Associated with COVID-19,COVID-19|Pharma,27/4/2020
Janssen Reports Submission of Two sBLA to the US FDA for SIMPONI ARIA (golimumab) to Treat Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis,Biotech|Regulatory,27/4/2020
Chugai Reports Results of P-III SAkuraStar Study of Satralizumab for Neuromyelitis Optica Spectrum Disorder,Clinical Trials|Pharma,27/4/2020
Regeneron and Sanofi Provide Update of P-II/III Adaptive-Designed Trial of Kevzara in Hospitalized Patients with COVID-19 in the US,COVID-19|Pharma,27/4/2020
Capital Health Launches Antibody Testing Initiative for COVID-19,COVID-19|MedTech,27/4/2020
Merck Collaborates with ISB to Evaluate the Mechanism of COVID-19 and to Identify Potential Prognostic Biomarkers,COVID-19,28/4/2020
Roche and PTC Therapeutics Report Results of Risdiplam in FIREFISH Part 2 Study for Infants with Type 1 Spinal Muscular Atrophy,Clinical Trials|Pharma,28/4/2020
CEPI Collaborates with Clover to Support the Development of Vaccine Against COVID-19 in Australia ,COVID-19|Pharma,28/4/2020
Takeda's Mobocertinib (TAK-788) Receives the US FDA's Breakthrough Therapy Designation for NSCLC Patients with EGFR Exon 20 Insertion Mutations,Regulatory,28/4/2020
Abbott's Freestyle Libre System Receives Health Canada Authorization Under Interim Order for Hospitalized Patients During COVID-19,COVID-19|DigiHealth,28/4/2020
Moderna to Initiate P-II Study of mRNA-1273 Against Novel COVID-19,,28/4/2020
"Biocon and Mylan Launch Fulphila (biosimilar, pegfilgrastim) in Canada",Biosimilars,28/4/2020
Sarepta Signs a Research Agreement with the US Department of Defense to Identify Antisense Oligonucleotides Against COVID-19,COVID-19|Pharma,29/4/2020
Novartis' Cosentyx (secukinumab) Receives EC's Approval for Axial Spondyloarthritis Spectrum Marking its Fourth Indication in EU,Regulatory,29/4/2020
BioNTech and Pfizer Complete Dosing of BNT162 in First Cohort of P-I/II Study in Germany,Biotech|COVID-19,29/4/2020
Astellas Signs a Three-Year Research Alliance with Harvard University Across Multiple Therapeutic Areas,Biotech,29/4/2020
Novartis Plans to Commence P-III Clinical Study Evaluating Canakinumab for Patients with COVID-19 Pneumonia,COVID-19|Pharma,29/4/2020
Merck's Keytruda (pembrolizumab) Receives the US FDA's Approval for Additional Recommended Dose of 400 mg Every Six Weeks for All Approved Indications,Regulatory,29/4/2020
Johnson &amp; Johnson Signs a Manufacturing Agreement with the Catalent to Bolster the Capacity of COVID-19 Vaccine in the US,COVID-19|Pharma,30/4/2020
Gilead Reports Results of Remdesivir in P-III SIMPLE Studies for Patients with Severe COVID-19,Biotech|Clinical Trials|COVID-19,30/4/2020
AstraZeneca Signs a Worldwide Development and Distribution Agreement with Oxford University for Vaccine Against COVID-19,Biotech|COVID-19,30/4/2020
GSK's Zejula (niraparib) Receives the US FDA's Approval as 1L Monotherapy Maintenance Treatment for Women with Advanced Ovarian Cancer Regardless of Biomarker Status,Biotech|Pharma,30/4/2020
Curium's Pulmotech MAA Receives the US FDA's Approval for Lung Imaging,Regulatory,24/3/2020
Bergenbio's Bemcentinib Selected to be Fast-Tracked Under UK's ACCORD Program Targeting COVID-19,COVID-19|Pharma,30/4/2020
Rockwell's Triferic AVNU Receives the US FDA's Approval to Replace Iron and Maintain Hemoglobin Hemodialysis Patients,Regulatory,27/3/2020
MSD Signs a Two-Year Research Agreement with Almac to Discover DUB Therapeutic Targets for Neurodegenerative Diseases,Pharma,30/4/2020
Pfizer Signs a Development and Commercialization Agreement with Valneva for Lyme Disease Vaccine,Biotech,2020-01-05
Moderna Signs a Ten-Year Worldwide Agreement with Lonza to Manufacture mRNA-1273 Against COVID-19,Biotech|COVID-19,2020-01-05
"Novartis' Enerzair Breezhaler (QVM149, IND/GLY/MF) Receives CHMP's Recommendation for Approval as a Treatment for Uncontrolled Asthma",Pharma|Regulatory,2020-01-05
WuXi Biologics and Aravive Collaborate to Develop Novel High-Affinity Bispecific Antibodies for Cancer and Fibrosis,Biotech,2020-01-05
Gilead's Remdesivir Receives the US FDA's Emergency Use Authorization for the Treatment of COVID-19,COVID-19|Regulatory,2020-04-05
"Revance and Mylan to Extend Biosimilar to BOTOX Program Decision Beyond April 30, 2020",Biosimilars,2020-04-05
MHLW Expedites the Reviews of Gilead's Remdesivir to Treat Patients with COVID-19 in Japan,Regulatory,2020-04-05
Roche Receives FDA's Emergency Use Authorization for its Elecsys to Detect COVID-19,COVID-19|MedTech,2020-04-05
"Teva and Celltrion Launch Truxima (biosimilar, rituximab) to Treat Wegener's Granulomatosis and Microscopic Polyangiitis in the US",Biosimilars,2020-05-05
Lilly and Junshi Collaborate to Co-Develop Antibody Therapies for the Treatment of COVID-19,Biotech|COVID-19,2020-05-05
Vir and Alnylam Anticipate the Initiation of Clinical Study Assessing VIR-2703 By the Year End,Biotech|COVID-19,2020-05-05
Alexion to Acquire Portola for ~$1.41B,M&A,2020-05-05
Bio-Rad Receives the US FDA's Emergency Use Authorization for its Droplet Digital PCR Test Kit to Detect COVID-19,COVID-19|MedTech,2020-05-05
Pfizer and BioNTech Report First Patient Dosing with BNT162 in P-I/II Study for COVID-19 in the US,Biotech|COVID-19,2020-06-05
NeoGenomics Collaborates with Bayer to Provide NTRK Testing for Patients with Colorectal and Thyroid Cancer,Biotech,2020-06-05
Regeneron Anticipates the Initiation of Clinical Study for its COVID-19 Antibody Cocktail in June,Biotech|COVID-19,2020-06-05
Bavarian Nordic Collaborates with AdaptVac to Advance COVID-19 Vaccine Program,Biotech|COVID-19,2020-06-05
Sanofi and Regeneron Report Results of Libtayo (cemiplimab) in a P-II Study as 2L Treatment for Advanced Basal Cell Carcinoma,Biotech|Clinical Trials,2020-06-05
iBio Supports AzarGen's Development of a Biosimilar to Rituximab,Biosimilars,26/3/2020
PTC Therapeutics to Acquire Censa Pharmaceuticals to Bolster its Rare Disease Portfolio,M&A,2020-07-05
"Novartis and Incyte's Tabrecta (capmatinib, INC280) Receives the US FDA's Approval for Metastatic Non-Small Cell Lung Cancer with METex14",Regulatory,2020-07-05
"Bausch + Lomb Signs an Exclusive License Agreement with STADA and Xbrane for Xlucane (biosimilar, ranibizumab) in the US and Canada",Biosimilars,2020-07-05
Amgen Reports Results of Otezla (apremilast) in P-III ADVANCE Study for Mild-To-Moderate Plaque Psoriasis,Clinical Trials|Pharma,2020-07-05
Laurent Receives Health Canada's Approval to Initiate P-II RESOLUTION Study Evaluating LAU-7b for COVID-19,Biotech|COVID-19,2020-07-05
Gedeon Richter Signs an Asset Purchase Agreement with Mycenax for Biosimilar Tocilizumab to Treat Rheumatoid Arthritis,Biosimilars,29/4/2020
Henlius HLX02 (Trastuzumab for Injection) Receives EU GMP Certificates,Biosimilars,23/4/2020
"Henlius Receives NMPA's IND Approval for its HLX13 (biosimilar, ipilimumab)",Biosimilars,2020-08-04
"Xbrane Biopharma Reports Update on the Ongoing P-III Xplore Study of Xlucane (biosimilar, ranibizumab)",Biosimilars,2020-02-04
Gilead's Veklury (remdesivir) Receives MHLW's Approval for Patients with Severe COVID-19 in Japan,COVID-19|Regulatory,2020-08-05
Sanofi's Insulin Aspart Biosimilar Receives CHMP's Positive Recommendation for Approval in the EU,Biosimilars,30/4/2020
Moderna Anticipates the Initiation of P-III Study of mRNA-1273 for COVID-19 by Early Summer,Biotech|COVID-19,2020-08-05
CoVIg-19 Plasma Alliance to Initiate Clinical Study Evaluating Hyperimmune Therapy for COVID-19 by Summer 2020,COVID-19|Pharma,2020-08-05
GSK to Evaluate Otilimab for Treating Pulmonary Disease Associated with COVID-19,Biotech|COVID-19,2020-08-05
"Celltrion Launches Remsima SC (biosimilar, infliximab) for the Treatment of Autoimmune Diseases in the Netherlands",Biosimilars,2020-08-05
Fitbit Launches Heart Study to Validate its Wearable Technology for Identifying Atrial Fibrillation,DigiHealth,2020-08-05
AstraZeneca Terminates Their License Agreement with Allergan for Brazikumab Signed in 2016,Pharma,2020-11-05
Sorrento Collaborates with Mount Sinai Health System to Develop COVI-SHIELD Antibody Cocktail Targeting COVID-19,Biotech|COVID-19,2020-11-05
Regeneron's RGC Signs a Research Collaboration with Colorado Center to Advance the Drug Discovery for Personalized Medicine,Biotech,2020-11-05
Eli Lilly's Retevmo (selpercatinib) Receives the US FDA's Approval as the First Therapy to Treat Advanced RET-Driven Lung and Thyroid Cancers,Pharma,2020-11-05
Sanofi Reports Results of Sarclisa (isatuximab) in P-III IKEMA trial in Patients with Relapsed Multiple Myeloma,Biotech|Clinical Trials|Pharma,2020-12-05
Neurocrine Biosciences Exercises its Option with Idorsia for ACT-709478,Biotech,2020-12-05
PharmaMar Signs an Exclusive License Agreement with MegaPharm for Lurbinectedin,Biotech,2020-12-05
Novartis Signs an Agreement with Dyno to Develop Novel AVV Therapies Utilizing AI Technology for Ocular Diseases,Biotech,2020-12-05
Abbott Receives FDA's Emergency Use Authorization for its Fourth Ab Blood Test to Detect COVID-19,COVID-19|MedTech,2020-12-05
GRYT Health and BMS Sign an Agreement to Launch Virtual Platform COVID Advocacy Exchange,COVID-19|Pharma,2020-12-05
Gilead Collaborates with Generics Makers to Supply Remdesivir in 127 Countries,COVID-19|Pharma,13/5/2020
Moderna's mRNA-1273 Receives the US FDA's Fast Track Designation to Treat COVID-19,COVID-19|Regulatory,13/5/2020
Alvotech Reports Results of AVT02 (a proposed biosimilar to adalimumab) in Two Clinical Studies for Autoimmune Diseases,Biosimilars|Clinical Trials,13/5/2020
Skyhawk Therapeutics Expands its Agreement with Merck to Develop Novel Small Molecules Modulating RNA Splicing,Biotech,13/5/2020
LifeScan Collaborates with Noom to Launch Digital Diabetes and Weight Loss Management Program,DigiHealth,13/5/2020
"BMS and bluebird bio to Resubmit the BLA for Idecabtagene Vicleucel (ide-cel, bb2121) to Treat Patients with Multiple Myeloma",Biotech,14/5/2020
Sanofi's Sutimlimab Receives the US FDA's Priority Review to Treat Hemolysis Patients with Cold Agglutinin Disease,Regulatory,14/5/2020
Novocure and ZaiLab's Optune Receive NMPA's Approval for the Treatment of Newly Diagnosed and Recurrent Glioblastoma,MedTech|Regulatory,14/5/2020
Roche to Present Results of Tiragolumab in P-II CITYSCAPE Study for Non-Small Cell Lung Cancer at ASCO20,Clinical Trials|Pharma,14/5/2020
Innovent and Eli Lilly Report Results of TYVYT (sintilimab) in P-II ORIENT-2 Study as 2L Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma,Biotech|Clinical Trials,14/5/2020
Boehringer Ingelheim Acquires Northern Biologics' Preclinical Cancer Antibody Pipeline to Bolster its Immuno-oncology Portfolio,M&A,15/5/2020
Seattle's TUKYSA (tucatinib) Receives the US FDA's Approval for Advanced Unresectable or Metastatic HER2-Positive Breast Cancer,Biotech|Regulatory,17/4/2020
Immunomedics' Trodelvy Receives the US FDA's Accelerated Approval for 2L Patients with Metastatic Triple-Negative Breast Cancer (TNBC),Regulatory,22/4/2020
UroGen's Jelmyto Receives the US FDA's Expedited Approval as a Novel Non-Surgical Treatment for Patients with Low-Grade Upper Tract Urothelial Cancer,Regulatory,15/4/2020
"Incyte's Pemazyre (pemigatinib) Receives the US FDA's Approval as the Novel Treatment for Adults with Previously Treated, Unresectable LA or Metastatic Cholangiocarcinoma",Regulatory,17/4/2020
Sanofi's COVID-19 Vaccine to be Available Globally,COVID-19|Pharma,15/5/2020
Roche Launches v-TAC Blood Gas Digital Solution for Improving Patient Care,DigiHealth,15/5/2020
Recursion Signs a Worldwide License Agreement with Takeda to Develop TAK-733 for Hereditary Cancer Syndrome,Pharma,15/5/2020
"Samsung Bioepis Reports Results of Ontruzant (biosimilar, trastuzumab) in P-III Follow-up Study (SB3-G31-BC-E) for Early or Locally Advanced HER2-Positive Breast Cancer",Biosimilars|Clinical Trials,15/5/2020
Janssen to Present Updated Results of JNJ-4528 in P-Ib/II CARTITUDE-1 Study for Multiple Myeloma at ASCO 2020,Biotech|Clinical Trials,15/5/2020
Daiichi Sankyo and AstraZeneca's Enhertu (fam-trastuzumab deruxtecan-nxki) Receive the US FDA's Breakthrough Therapy Designation for HER2 Mutant Metastatic Non-Small Cell Lung Cancer,Biotech|Regulatory,18/5/2020
AstraZeneca's Bevespi Aerosphere (glycopyrronium/formoterol fumarate) Receives NMPA's Approval for Patients with COPD,Biotech|Regulatory,18/5/2020
EMA to Grant Initial Authorization to Gilead's Remdesivir for COVID-19 is Imminent,COVID-19|Regulatory,18/5/2020
Moderna Reports Positive Interim P-I Data of mRNA-1273 Against COVID-19,Biotech|COVID-19,18/5/2020
Roche's Tecentriq Receives the US FDA's Approval as 1L Monotherapy for Patients with Metastatic Non-Small Cell Lung Cancer,Biotech|Regulatory,19/5/2020
Teva's Austedo (deutetrabenazine) Receives the NMPA's Approval to Treat Chorea Associated with Huntington's Disease and Tardive Dyskinesia in Adults,Pharma,19/5/2020
Samsung Bioepis Reports Results of SB11 (proposed biosimilar ranibizumab) in P-III Study for Neovascular Age-Related Macular Degeneration,Biosimilars|Clinical Trials,19/5/2020
Roche Signs an Exclusive Worldwide Option and License Agreement with Vividion Focusing on Novel E3 Ligases,Pharma,19/5/2020
Innovent Biologics and MD Anderson Collaborate to Co-develop TYVYT (sintilimab) in Rare Cancer Indications in the US,Biotech,19/5/2020
AveXis Receives EC's Conditional Approval and Activates “Day One” Access Program for Zolgensma (onasemnogene abeparvovec) to Treat Spinal Muscular Atrophy,Regulatory,20/5/2020
Biocon Receives EMA's GMP Certification for Multiple Biosimilars Manufacturing Facilities in Bengaluru,Biosimilars,20/5/2020
Roche Launches Elecsys Anti-SARS-CoV-2 Antibody Blood Test in the US,COVID-19|MedTech,20/5/2020
Eiger BioPharmaceuticals Reports the US FDA's Acceptance of NDA for Zokinvy (lonafarnib) to Treat Progeria and Progeroid Laminopathies,Regulatory,20/5/2020
Aldeyra Therapeutics to Advance ADX-1612 to Clinical Testing and Provides Update on ADX-629 for COVID-19,COVID-19|Pharma,20/5/2020
Astellas and FibroGen Report EMA's Acceptance of MAA for Roxadustat to Treat Patients with Chronic Kidney Disease,Pharma|Regulatory,21/5/2020
Apple and Google Launch COVID-19 Exposure Notification System to Support Health Agencies,COVID-19|DigiHealth,21/5/2020
AstraZeneca Receives First Supply Agreement for University of Oxford's ChAdOx1 nCoV-19 Vaccine Against COVID-19,Biotech|COVID-19,21/5/2020
Synlogic Terminates its Agreement with AbbVie for Synthetic Biotic Medicines to Treat Inflammatory Bowel Disease,Pharma,21/5/2020
Gilead and Galapagos Report Results of Filgotinib in P-IIb/III SELECTION Study for Moderately to Severely Active Ulcerative Colitis,Biotech|Clinical Trials,21/5/2020
Roche Acquires Stratos Genomics to Advance the Development of Nanopore Sequencer,M&A|MedTech,22/5/2020
GSK Collaborates with Samsung Biologics for Large Scale Biopharmaceutical Manufacturing,Biotech,22/5/2020
Daiichi Sankyo and AstraZeneca's Enhertu (fam-trastuzumab deruxtecan-nxki) Receive the US FDA's Orphan Drug Designation for Gastric Cancer,Biotech|Regulatory,22/5/2020
Top 20 Medical Device Companies Based on 2019 Revenue,Biotech,22/5/2020
Bayer Reports Submission of MAA to the MHLW for Larotrectinib to Treat Solid Tumors with NTRK Gene Fusion,Biotech,22/5/2020
Gilead Plans to Submit MAA to CDSCO for its Remdesivir to Treat COVID-19 in India,Biotech|COVID-19,22/5/2020
"BMS Reports EMA's Validation of MAA for Idecabtagene Vicleucel (Ide-cel, bb2121) and CC-486",Biotech,22/5/2020
"Fresenius Kabi Reports EMA's Acceptance of MAA for its MSB11455 (biosimilar, pegfilgrastim)",Biosimilars|Regulatory,25/5/2020
AbCellera Signs an Exclusive Multi-Year Agreement with Eli Lilly to Develop Abs for up to Nine Targets,Pharma,25/5/2020
BARDA to Fund $1B to AstraZeneca for Research and Development of Novel COVID-19 Vaccines,Pharma,25/5/2020
"Evofem Biosciences' Phexxi (lactic acid, citric acid, and potassium bitartrate) Vaginal Gel Receives the US FDA's Approval for the Prevention of Pregnancy",Pharma,25/5/2020
Sanofi and Regeneron Report Positive Results of Dupixent (dupilumab) in P-IIIa Dupixent Eosinophilic Esophagitis Study for EoE,Clinical Trials|Pharma,25/5/2020
Novavax Initiates P-I/II Study of NVX-CoV2373 Vaccine Against COVID-19,COVID-19|Pharma,26/5/2020
AstraZeneca Signs an Agreement with ArcherDX for Utilizing Personalized Cancer Assays to Detect MRD in Patients with Early-Stage Non-Small Cell Lung Cancer,Biotech,26/5/2020
Chi-Med and BeiGene Collaborate to Evaluate the Combinations of Surufatinib and Fruquintinib with Tislelizumab for Solid Tumors,Biotech,26/5/2020
NeoGenomics Collaborates with Inivata to Commercialize InVisionFirst-Lung Liquid Biopsy Test in the US,MedTech,26/5/2020
Merck Reports Three Major Initiatives Focusing on Developing Vaccine Against COVID-19,Biotech|COVID-19|M&A,26/5/2020
Algernon Reports Submission of IND to the US FDA for Ifenprodil to Treat COVID-19,Biotech|COVID-19|Regulatory,26/5/2020
Boehringer Ingelheim and Lilly Collaborate with DCRI for Evaluating Jardiance (empagliflozin) in a Pragmatic EMPACT-MI Study,Pharma,26/5/2020
Shionogi to Acquire Tetra Therapeutics for ~$500M,M&A,27/5/2020
Glenmark to Initiate P-III Clinical Study Evaluating the Combination Therapy for Hospitalized Patients with COVID-19 in India,Biotech|COVID-19,27/5/2020
Roche Reports Results of Port Delivery System with Ranibizumab in P-III Archway Study for Neovascular Age-Related Macular Degeneration,Clinical Trials|Pharma,27/5/2020
Sanofi's Dupixent (dupilumab) Receives the US FDA's Approval as First Biologic for Children Aged 6-11 Years with Moderate-to-Severe Atopic Dermatitis,Regulatory,27/5/2020
BMS Signs an Exclusive Worldwide Agreement with Repare Therapeutics to Identify Multiple Precision Oncology Therapies,Pharma,27/5/2020
Eli Lilly and Junshi to Initiate Clinical Trials of COVID-19 Antibody in Q2'2020,Biotech|COVID-19,27/5/2020
Gilead Signs a Ten Years Agreement with Arcus to Co-Develop and Co-Commercialize Next-Generation Cancer Immunotherapies,Pharma,28/5/2020
Roche Initiates P-III REMDACTA Study Evaluating Actemra (tocilizumab) + Remdesivir for Hospitalized Patients with Severe COVID-19 Pneumonia,COVID-19|Pharma,28/5/2020
Roche's Ocrevus (ocrelizumab) Shorter 2-Hour Infusion Time Receives EMA's Approval for Relapsing or Primary Progressive Multiple Sclerosis,Biotech,28/5/2020
AcelRx Amends its Agreement to Acquire Tetraphase Pharmaceuticals,M&A,28/5/2020
"Fresenius Kabi Reports the US FDA's Acceptance of BLA for its MSB11455 (biosimilar, pegfilgrastim)",Biosimilars,28/5/2020
Atriva to Initiate P-II Clinical Study Evaluating ATR-002 for Treatment of Patients with COVID-19,COVID-19,28/5/2020
AstraZeneca Signs an Agreement with Serum Institute to Supply 1B Doses of Oxford University's COVID-19 Vaccine,Biotech,2020-05-06
"Fresenius Kabi Signs an Agreement with Medec to Commercialize IDACIO (adalimumab, biosimilar) in Germany",Biosimilars,29/5/2020
Eli Lilly's Tauvid (flortaucipir F 18) Receives the US FDA's Approval as the First Drug to Image Tau Pathology in Patients Being Evaluated for Alzheimer's Disease,Regulatory,29/5/2020
Roche Reports Updated Data of Alecensa in P-III ALEX Study for Patients with ALK-Positive Non-Small Cell Lung Cancer,Biotech,29/5/2020
"JHL Biotech Reports Dosing of its First Patient with JHL1266 (biosimilar, denosumab) in P-I Study in Australia",Biosimilars|Regulatory,18/5/2020
European Commission Waives the Takeda's Commitment to Obtain Clearance on Shire's Acquisition,Pharma,29/5/2020
"Celltrion Launches its Third Biosimilar Truxima (biosimilar, rituximab) in Brazil",Biosimilars,27/5/2020
Genmab Reports Results of Daratumumab Based Combination Therapy in P-III ANDROMEDA Study for Light-chain Amyloidosis,Biotech|Clinical Trials,29/5/2020
Amgen Reports Clinical Data of AMG 510 in CodeBreaK 100 Study for Multiple Solid Tumors #ASCO20,Biotech,2020-01-06
Celltrion and MSD Report Results of First-Line Triplet Regimen P-I/II PANTHERA trial in Patients with HER2-Positive Advanced Gastric Cancer,Biosimilars|Clinical Trials,27/5/2020
AbbVie Signs a Worldwide License Agreement with Jacobio to Advance SHP2 Inhibitors,Biotech,2020-01-06
Merck KGaA and Pfizer's Bavencio (avelumab) Demonstrates the Potential in Gestational Trophoblastic Tumors #ASCO20,Biotech,2020-01-06
Seattle Genetics Report Updated Results of Tukysa (tucatinib) in HER2CLIMB Study for Patients with HER2-Positive Breast Cancer with Stable or Active Brain Metastases #ASCO20,Pharma,2020-01-06
Mycenax Signs an Agreement with Gedeon Richter for LusiNEX,Biosimilars,28/5/2020
"Daewon Pharmaceutical Launches its Terrosa (biosimilar, teriparatide) to Treat Osteoporosis",Biosimilars,26/5/2020
Merck's Reports Results of Keytruda (pembrolizumab) in P-III KEYNOTE-177 for Patients with MSI-H Colorectal Cancer #ASCO20,Biotech|Clinical Trials,2020-01-06
Takeda to Present Results of Iclusig (ponatinib) in P-II OPTIC Study for Chronic Myeloid Leukemia in the Chronic Phase at ASCO and EHA #ASCO20,Clinical Trials|Pharma,2020-01-06
AstraZeneca Reports Results of Tagrisso (osimertinib) in P-III ADAURA study for EGFR-Mutated Lung Cancer #ASCO20,Biotech|Clinical Trials,2020-01-06
AstraZeneca and Daiichi Sankyo Provide Updates of Enhertu (fam-trastuzumab deruxtecan-nxki) in HER2-Positive Metastatic Colorectal Cancer and HER2-Mutant Non-Small Cell Lung Cancer #ASCO20,Biotech,2020-01-06
Eli Lilly Initiates the World's First Clinical Study to Evaluate the Potential of COVID-19 Antibody Treatment in Humans,Biotech|COVID-19,2020-02-06
"Mylan and Lupin Receive EC's MAA for Nepexto (biosimilar, etanercept)",Biosimilars,2020-04-06
Inovio to Initiate P-I/II Study of INO-4800 Against COVID-19 in South Korea,Biotech|COVID-19,2020-04-06
AstraZeneca Signs Exclusive Worldwide License Agreement with Accent for RMP-Targeting Therapies,Pharma,2020-04-06
Roche's Elecsys IL-6 Test Receives the US FDA's EUA to Identify Patients at High Risk of Severe Inflammatory Response with COVID-19,COVID-19|MedTech,2020-04-06
Formycon To Update on its Biosimilar Programs,Biosimilars,15/5/2020
Celltrion Anticipates the Launch of Insulin Pen Biosimilar by 2025,Biosimilars,2020-03-06
Lilly Reveals New Data for Olumiant (baricitinib) to Treat Rheumatoid Arthritis and Systemic Lupus Erythematosus #EULAR,Biotech,2020-03-06
Eli Lilly to Present Data of Taltz (ixekizumab) for Patients with Psoriatic Arthritis at EULAR 2020 #EULAR,Biotech,2020-03-06
Personalis Collaborates with Sarepta Therapeutics on Immune Response to Precision Genetic Therapeutics,Biotech,2020-03-06
The US FDA Extends Review of sBLA of Ofatumumab (OMB157) for Patients with Relapsing Multiple Sclerosis,Biotech|Regulatory,2020-03-06
Intravacc and EpiVax Collaborate to Develop an Emerging Vaccine for COVID-19,Biotech|COVID-19,2020-03-06
Y-mAbs Reports the US FDA's Acceptance of Priority Review for Danyelza's (naxitamab) BLA to Treat Neuroblastoma,Pharma|Regulatory,2020-03-06
Regeneron and Intellia Expand Their 2016 Collaboration to Develop CRISPR/CAS9 Based Therapies,Biotech,2020-02-06
Sanofi's Sarclisa (isatuximab) Receives EC's Approval for adults with Relapsed and Refractory Multiple Myeloma,Biotech,2020-02-06
Roche's Tecentriq + Avastin Receives the US FDA's Approval for Unresectable or Metastatic Hepatocellular Carcinoma,Regulatory,2020-02-06
Revance and Mylan to Advance Development Program for a Proposed Biosimilar to BOTOX,Biosimilars,2020-02-06
"Henlius and Accord Receive CHMP's Positive Opinion for its HLX02 (biosimilar, trastuzumab)",Biosimilars,2020-02-06
Melinta Therapeutics to Acquire Tetraphase Pharmaceuticals,M&A,2020-05-06
Novartis Reports Results of Enerzair Breezhaler (QVM149) in P-IIIb ARGON Study to Treat Uncontrolled Asthma,Biotech|Clinical Trials,2020-05-06
AstraZeneca in Talks with Gilead for a Megamerger,M&A,2020-08-06
AbbVie Enters into a Collaboration to Develop Monoclonal Antibody Therapy for Preventing COVID-19,Biotech|COVID-19,2020-08-06
Oxford Biomedica Signs a Five-Year Agreement with the Vaccines Manufacturing and Innovation Centre (VMIC) for (VMIC),COVID-19|Pharma,2020-08-06
AstraZeneca Reports Results of Calquence (acalabrutinib) in CALAVI Study for Hospitalized COVID-19 Patients,Biotech|Clinical Trials|COVID-19,2020-08-06
Eli Lilly to Initiate P-I Study of its Second Antibody Treatment Against COVID-19,Biotech|COVID-19,2020-08-06
Alphamab Oncology Signs an Agreement with Sanofi for KN026,Biotech,2020-09-06
Roche Signs an Agreement with Innovent to Develop Therapies for Hematological and Solid Cancers,Pharma,2020-09-06
Astellas Reports Results of Roxadustat in P-III DOLOMITES Study to Treat Anemia in Non-Dialysis Dependent Adult Patients with Chronic Kidney Disease,Clinical Trials|Pharma,2020-09-06
Mallinckrodt Reports Completion of BLA Submission to the US FDA for StrataGraft to Treat Deep Partial-Thickness Thermal Burns in Adults,Biotech|Regulatory,2020-09-06
Eli Lilly Reports Dosing of its First Patient with Tirzepatide in P-III SURPASS-CVOT Study for Cardiovascular Outcomes,Pharma,2020-09-06
Eli Lilly Signs Five-Years License Agreement with Evox Therapeutics for its DeliverEX Platform,Pharma,2020-09-06
Denali and Sanofi Provide Update on its RIPK1 Program,Pharma,2020-10-06
"Sandoz Receives Health Canada's Approval to Launch Ziextenzo (biosimilar, pegfilgrastim) and Riximyo (biosimilar, rituximab) in Canada",Biosimilars,2020-10-06
AstraZeneca Plans to Advance the Combination of Neutralizing Antibody for COVID-19 into Clinical in Next Two Months,Biotech|COVID-19,2020-10-06
AbbVie Collaborates with Genmab to Develop and Commercialize Therapies for Cancer Worth Over $3B,Biotech,2020-10-06
BMS Signs a Clinical Trial Collaboration with UbiVac to Evaluate the Triplet Therapy for Advanced Triple Negative Breast Cancer,Pharma,2020-10-06
Takeda Signs an Exclusive License and Research Agreement with Debiopharm to Develop Novel Microbiome Therapeutics for the Gastrointestinal Disorders,Biotech,2020-10-06
Dexcom's Glucose Monitoring Wearable System Receives CE Mark in the Europe,DigiHealth,2020-10-06
Johnson &Johnson to Initiate P-I/IIa Clinical Study of its COVID-19 Vaccine in July,Biotech|COVID-19,2020-11-06
RedHill Biopharma Reports the Submission of CTA for P-II/III Study Evaluating Opaganib Against COVID-19 in Russia,Biotech|COVID-19,2020-11-06
Cipla to Acquire 21.85% Stake in GoApptiv for ~$1.2M,M&A,2020-11-06
BMS' Opdivo (nivolumab) Receives the US FDA's Approval for Advanced Esophageal Squamous Cell Carcinoma,Regulatory,2020-11-06
Sorrento Submits EUA to the US FDA for its COVI-TRACK Test to Detect COVID-19,COVID-19|MedTech,2020-11-06
"Pfizer Receives the US FDA's Approval for its Nyvepria (biosimilar, pegfilgrastim)",Biosimilars,2020-11-06
"Celltrion to Evaluate Remsima (biosimilar, infliximab) Against COVID-19 in the UK",Biosimilars,2020-11-06
Novo Nordisk to Acquire AstraZeneca's Spin-off Corvidia for ~$2.1B,M&A,2020-12-06
"Mylan and Biocon Receive the US FDA's Approval for Semglee (biosimilar, insulin glargine)",Biosimilars,2020-12-06
Moderna to Initiate P-III Study of its mRNA-1273 Against COVID-19 in July 2020,Biotech|COVID-19,2020-12-06
Lannett to Submit Biosimilar Application to the US FDA for its Insulin Glargine by the End of 2022,Biosimilars,2020-12-06
Regeneron Initiates its First Clinical Study of Antibody Cocktail for the Treatment and Prevention of COVID-19,Biotech|COVID-19,2020-12-06
Takeda to Divest OTC and Select Non-core Assets to Celltrion for ~ $278M,Biotech,2020-12-06
Medtronic Receives CE Mark for MiniMed 780G Insulin Pump to Treat Type 1 Diabetes,MedTech,2020-12-06
AstraZeneca To Supply 400M Doses of Vaccines to IVA by the End of 2020,Biotech|COVID-19,15/6/2020
Gilead Signs a License Agreement with Zydus and Dr. Reddy's for Remdesivir to Treat COVID-19,Biotech|COVID-19,15/6/2020
Eli Lilly Initiates P-III Study Evaluating Baricitinib in Hospitalized Patients with COVID-19,Biotech|COVID-19,15/6/2020
Merck's Gardasil 9 Receives the US FDA's Approval to Prevent HPV-Related Head and Neck Cancers,Regulatory,15/6/2020
Foundation Medicine Acquires Lexent to Expand its Liquid Biopsy Platforms,M&A,15/6/2020
AstraZeneca Signs an Agreement with Catalent to Manufacture AZD1222 for COVID-19,COVID-19|Pharma,16/6/2020
Akili's EndeavorRx Receives the US FDA's Approval as the First Game-Based Digital Therapeutic to Improve Attention Function in Children with ADHD,DigiHealth,16/6/2020
Celltrion Anticipates the Launch of its POCT Kit for COVID-19 in July 2020,MedTech,16/6/2020
Bayer and MassBio to Launch Joint Mentoring Program to Foster Startups in Asia,Pharma,16/6/2020
"Celltrion Report Results of Truxima (biosimilar, rituximab) Based Regimen in P-II Study for R/R Aggressive B-cell Lymphoma #EHA25",Biosimilars|Clinical Trials,16/6/2020
Sun Pharma Signs a License Agreement with Hikma for Ilumya (tildrakizumab) in MENA Regions,Biotech,16/6/2020
Takeda and Neurocrine Collaborate for Seven Neuro Programs Worth Up to $2B,Pharma,17/6/2020
Merck and Pfizer Report Results of Steglatro (ertugliflozin) in P-III VERTIS CV Study for Type 2 Diabetes and Atherosclerotic Cardiovascular Disease,Clinical Trials|Pharma,17/6/2020
GSK Signs a Synthetic Lethality Cancer Agreement with Ideaya for ~$170M,Biotech,17/6/2020
Novartis' Cosentyx (secukinumab) Receives the US FDA's Approval for Active Non-Radiographic Axial Spondyloarthritis,Biotech,17/6/2020
Sanofi Report Results of Avalglucosidase alfa in P-III COMET Study for Late Onset Pompe Disease,Biotech|Clinical Trials,17/6/2020
Deciphera Pharmaceuticals' Qinlock (ripretinib) Receives the US FDA's Approval to Treat 4L Gastrointestinal Stromal Tumor,Regulatory,15/5/2020
Zionexa And Petnet Solutions' Cerianna (Fluoroestradiol F 18) Receive the US FDA's Approval for Advancing Treatments in Metastatic Breast Cancer Patients,Regulatory,28/5/2020
Amivas's Artesunate Receives the US FDA's Approval for Treatment of Severe Malaria,Regulatory,27/5/2020
Tolmar's Fensolvi Received the US FDA's Approval to Treat Pediatric Patients Two Years of Age and Older withntral Prec Ceocious Puberty (CPP),Regulatory,2020-04-05
AstraZeneca Signs an Agreement with Cobra Biologics for Vaccines Against COVID-19,Biotech|COVID-19,17/6/2020
Gilead to Initiate P-II/III Study Evaluating Remdesivir in Pediatric Patients Hospitalized With COVID-19,COVID-19|Pharma,18/6/2020
Roche Reports Results of Tecentriq + CT in P-III IMpassion031 Study for Patients with Early Triple-Negative Breast Cancer,Biotech|Clinical Trials,18/6/2020
Samsung Launches a Blood Pressure Monitoring App in South Korea,DigiHealth,18/6/2020
AstraZeneca Collaborates with Gendius to Provide Diabetes Management Support for Patients in the GCC,DigiHealth,18/6/2020
Genmab and Janssen's Darzalex Faspro (daratumumab and hyaluronidase-fihj) Receive the US FDA's Approval to Treat Multiple Myeloma in Adults,Regulatory,2020-01-05
Merck's Keytruda (pembrolizumab) Receives the US FDA's Approval as Monotherapy for Patients with Unresectable or Metastatic Tumor Mutational Burden-High Solid Tumors,Pharma,18/6/2020
Dr. Reddy's Elyxyb (celecoxib oral solution) Receives the US FDA's Approval for Acute Treatment of Migraine with or Without Aura in Adults,Regulatory,2020-06-05
Sunovion Pharmaceutical's Kynmobi (apomorphine hydrochloride) Receives the US FDA's Approval to Treat Parkinson's Disease Off Episodes,Regulatory,21/5/2020
PRA Collaborates with Microsoft to Foster COVID-19 Monitoring,COVID-19|DigiHealth,18/6/2020
Astellas' VESIcare LS (solifenacin succinate) Receives the US FDA's Approval to Treat Neurogenic Detrusor Overactivity (Ndo) In Pediatric Patients Aged 2 Years and Older,Regulatory|Uncategorized,27/5/2020
AbbVie and Neurocrine's Oriahnn Receive the US FDA's Approval as the First Oral Therapy for the Management of Heavy Menstrual Bleeding Due to Uterine Fibroids in Pre-menopausal Women,Regulatory,29/5/2020
AbbVie Signs an Exclusive Worldwide Option and License Agreement with Alpine to Develop and Commercialize ALPN-101,Pharma,19/6/2020
Roche and Cipla Expand Their 2018 Agreement to Improve Access of Oncology Therapies in India,Biotech,19/6/2020
RedHill Expands its P-II/III Study Evaluating Yeliva (opaganib) Against COVID-19 in Italy and UK,Biotech|COVID-19,19/6/2020
"Innovent Receives the NMPA's Approval for Byvasda (biosimilar, bevacizumab) to Treat Non-Small Cell Lung Cancer and Metastatic Colorectal Cancer in China",Biosimilars,19/6/2020
Pfizer and Sangamo's Giroctocogene Fitelparvovec (SB-525) Demonstrate Positive Effect in P-I/II Alta Study for Hemophilia A,Pharma,19/6/2020
Ultragenyx and Kyowa Kirin's Crysvita (burosumab) Receive the US FDA's Approval for the Treatment of Tumor-Induced Osteomalacia,Pharma,19/6/2020
Glenmark Launches FabiFlu (favipiravir) as the First Oral Medication to Treat Mild to Moderate COVID-19 in India,COVID-19|Pharma,22/6/2020
Merck KGaA and Pfizer Report EMA's Validation for Bavencio (avelumab) as a 1L Treatment for Locally Advanced or Metastatic Urothelial Carcinoma,Biotech,22/6/2020
Novartis Halts Clinical Trial Evaluating Hydroxychloroquine Against COVID-19 Due to Slow Enrollment,COVID-19|Pharma,22/6/2020
Cipla Launches Cipremi (remdesivir lyophilized powder for injection 100 mg) to Treat Patients with Severe COVID-19,COVID-19|Pharma,22/6/2020
Merck's Keytruda Receives the NMPA's Approval as a 2L Treatment for Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma,Regulatory,22/6/2020
Gilead to Initiate P-I Study Evaluating Inhaled Version of Remedesivir Against COVID-19 in August 2020,COVID-19,23/6/2020
Sanofi Expands its 2018 Collaboration with Translate Bio to Develop mRNA Vaccines Against Infectious Diseases,Biotech|COVID-19,23/6/2020
AbbVie Reports the US FDA's Acceptance of BOTOX's sBLA for Pediatric Patients with Neurogenic Detrusor Overactivity,Biotech,23/6/2020
ATAI Launches IntroSpect Digital Therapeutics to Foster Mental Health Care,MedTech,23/6/2020
BioInvent Reports the Enrollment of First Patient in P-I/IIa Study of BI-1206 + Keytruda for Solid Tumors,Biotech,23/6/2020
Schrodinger Expands its Drug Discovery Efforts Against COVID-19 Deploying Parallel Computing on Google Cloud,COVID-19|MedTech,23/6/2020
Sanofi Anticipates the Approval of its COVID-19 Vaccine by First Half of 2021,Biotech|COVID-19,24/6/2020
Gilead Holds an Exclusive Option to Acquire Pionyr Immunotherapeutics for ~$1.75B,M&A,24/6/2020
Sarepta Signs a Two-Year Research and Option Agreement with Codiak for Up to Five Neuromuscular Targets,Pharma,24/6/2020
AstraZeneca Signs an Agreement with Symbiosis for Sterile Manufacturing of its AZD1222 Against COVID-19,Biotech|COVID-19,24/6/2020
The US FDA Launches Project Patient Voice to Share Patient-Reported Outcomes from Cancer Trials,DigiHealth,24/6/2020
FibroGen Report Enrollment of First Patient in P-II Study Evaluating Pamrevlumab in Patients Hospitalized with Acute COVID-19,Biotech|COVID-19,24/6/2020
CSL Behring to Acquire uniQure' Hemophilia B Candidate (AMT-061) for ~$2B,M&A|Pharma,25/6/2020
Merck Collaborates with Yumanity to Accelerate the Development of Two Therapies Targeting Neurodegenerative Diseases,Pharma,25/6/2020
AstraZeneca Reports Results of Breztri Aerosphere in P-III ETHOS Study to Treat COPD,Clinical Trials|Pharma,25/6/2020
Merck's Keytruda (pembrolizumab) Receives the US FDA's Approval for Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma,Regulatory,25/6/2020
Fulcrum Initiates P-III LOSVID Study Evaluating Losmapimod for Patients Hospitalized with COVID-19,COVID-19|Pharma,25/6/2020
Theravance Reports First Patient Dosing in a P-II Study of TD-0903 for Hospitalized Patients with Acute Lung Injury Associated with COVID-19,COVID-19|Pharma,25/6/2020
AbbVie Signs an Exclusive Research and Option to License Agreement with Sosei Heptares Targeting Inflammatory and Autoimmune Diseases,Pharma,26/6/2020
Zogenix's Fintepla (fenfluramine) Receives the US FDA's Approval for the Treatment of Seizures Associated with Dravet Syndrome,Pharma|Regulatory,26/6/2020
EMA Anticipates the EC's Conditional Marketing Authorization for Gilead's Remdesivir in Coming Week,COVID-19|Pharma,26/6/2020
Roche Launches uPath PD-L1 (SP263) Automated Digital Pathology Algorithm to Speed Up NSCLC Diagnosis,MedTech,26/6/2020
Sandoz Launches the Biosimilars Generation Campaign in Canada,Biosimilars,26/6/2020
Medtronic Receives the US FDA's Approval for its Percept PC Neurostimulator with BrainSense Technology,MedTech|Regulatory,26/6/2020
EMA's CHMP Recommends the Approval of Two Biosimilar Referencing Lilly's Forsteo (teriparatide) for the Treatment of Osteoporosis,Biosimilars,26/6/2020
Daiichi Sankyo in Talks with AstraZeneca for the Supply of AZD1222 to Combat COVID-19 in Japan,Biotech|COVID-19,29/6/2020
MHLW Approves Novartis' Five New Therapies Expanding its Footprints in Japan,Pharma|Regulatory,29/6/2020
Alexion's Ultomiris (ravulizumab) Receives EC's Approval for Atypical Hemolytic Uremic Syndrome,Biotech|Regulatory,29/6/2020
Roche's Enspryng (satralizumab) Receives MHLW's Approval for Neuromyelitis Optica Spectrum Disorder in Japan,Biotech|Regulatory,29/6/2020
"Samsung Bioepis' Aybintio (biosimilar, bevacizumab) Receives CHMP's Positive Opinion to Treat Multiple Cancer Indications",Biosimilars|Regulatory,29/6/2020
Gilead Unveils the Price of Remdesivir as $390 per Vial in Developed Countries,COVID-19|Pharma,30/6/2020
Abbott Integrates its CGM Technology with Tandem's Insulin Delivery System for Improving Diabetes Management,MedTech,30/6/2020
Bharat Biotech to Initiate Clinical Trials Evaluating Covaxin (India's First COVID-19 Vaccine) in July 2020,Biotech|COVID-19,30/6/2020
AstraZeneca and MSD's Selumetinib Receive MHLW's Orphan Drug Designation for Neurofibromatosis Type 1 in Japan,Pharma|Regulatory,30/6/2020
Roche's Phesgo (fixed-dose combination of Perjeta and Herceptin) Receives the US FDA's Approval for Early and Metastatic HER2-Positive Breast Cancer,Biotech|Regulatory,30/6/2020
"Celltrion's Remsima SC (biosimilar, infliximab) Receives CHMP's Positive Opinion for an Additional Five Indications Including Inflammatory Bowel Disease and Ankylosing Spondylitis",Biosimilars|Regulatory,30/6/2020
Takeda Collaborates with Carmine for Non-Viral Gene Therapies Worth Up to $900M,Biotech,2020-01-07
G1 Therapeutics and Boehringer Ingelheim Collaborate to Co-Promote Trilaciclib for Small Cell Lung Cancer in the US and Puerto Rico,Pharma,2020-01-07
Samsung Bioepis Reports the Initiation of P-III Study for SB15 Proposed Biosimilar to Eylea (aflibercept),Biosimilars,2020-01-07
Merck KGaA and Pfizer's Bavencio (avelumab) Receive the US FDA's Approval as a 1L Treatment for Locally Advanced or Metastatic Urothelial Carcinoma,Biotech|Regulatory,2020-01-07
Boston Scientific Receives the US FDA's 510(k) Clearance for its LUX-Dx Insertable Cardiac Monitor System,DigiHealth,2020-01-07
QurAlis Signs a License Agreement with Eli Lilly for its ALS Therapeutic Candidates,Pharma,2020-01-07
Pfizer and BioNTech Report Results of BNT162b1 mRNA-Based Vaccine in P-I/II Study Against COVID-19,Biotech|Clinical Trials|COVID-19,2020-02-07
Dr. Reddy's and GRA Collaborate with Fujifilm for Avigan (favipiravir) to Treat COVID-19 Outside Japan,COVID-19|Pharma,2020-02-07
Sorrento Selects T-VIVA-19 as a Targeted Protein Vaccine Candidate Against COVID-19,Biotech|COVID-19,2020-02-07
Janssen Receives EC's Approval for its Ebola Vaccine Dual Regimen,Biotech,2020-02-07
"Henlius Reports Positive Results of HLX04 (biosimilar, bevacizumab) in P-III Trial for Metastatic Colorectal Cancer",Biosimilars|Clinical Trials|Regulatory,16/6/2020
Yuhan Collaborates with GI Innovation for its Allergy Treatment Worth up to $1.2B,Pharma,2020-02-07
"Kyowa Kirin's FKB327 (biosimilar, adalimumab) Receives the MMA Approval in Japan",Biosimilars|Regulatory,29/6/2020
Biogen Signs a License Agreement with Massachusetts Eye and Ear to Develop Treatment for Inherited Retinal Disorder,Pharma,2020-02-07
Helsinn and MEI Terminate its P-III Study of Pracinostat for Patients with AML,Biotech,2020-03-07
Sarepta Signs an Exclusive Worldwide License with Hansa to Develop Imlifidase for Duchenne Muscular Dystrophy and Limb-Girdle Muscular Dystrophy,Biotech,2020-03-07
Sanofi and Regeneron's Kevzara (sarilumab) Fails in P-III Trial for Patients with COVID-19 in the US,Biotech|COVID-19,2020-03-07
Zydus to Initiate Clinical Trials Evaluating ZyCoV-D Vaccine Against COVID-19 in July 2020,Biotech|COVID-19,2020-03-07
ViiV Healthcare's Rukobia (fostemsavir) Receives the US FDA's Approval for HIV in Patients with Limited Treatment Options,Regulatory,2020-03-07
Medivir's MIV-818 Receives EC's Orphan Medicinal Product Designation to Treat Hepatocellular Carcinoma,Regulatory,2020-03-07
CytoDyn Signs an Agreement with American Regent for Leronlimab to Treat COVID-19 Patients in the US,Pharma,2020-06-07
MSD Signs a Clinical Trial Collaboration with Ascentage Pharma for Solid Tumors,Pharma,2020-06-07
Mylan's Remdesivir Lyophilized Powder for Injection Receives the DCGI Accelerated Approval for Restricted Emergency Use in COVID-19 Patients in India,COVID-19|Pharma,2020-06-07
Regeneron with its Partner NIAID Report the Initiation of P-III Trial to Evaluate REGN-COV2 for Treatment and Prevention of COVID-19,COVID-19|Pharma,2020-06-07
EspeRare's ER-004 Receives the US FDA's Breakthrough Therapy Designation for Prenatal Treatment of XLHED,Pharma,2020-06-07
Emergent Signs a Five-Year Manufacturing Services Agreement with Janssen for Ad26.COV2-S to Treat COVID-19,COVID-19|Pharma,2020-07-07
Becton Dickinson Receives the US FDA's EUA for its Third Point-Of-Care SARS-CoV-2 Diagnostic Test to Detect COVID-19,MedTech|Regulatory,2020-07-07
BMS Signs an Exclusive Option to License Agreement with Dragonfly Therapeutics to Develop Novel Therapies for Multiple Sclerosis and Neuro-inflammation Targets,Pharma,2020-07-07
Abbott's Gallant ICD and CRT-D Devices Receives the US FDA's Approval for Heart Rhythm Disorder with Bluetooth Connectivity,MedTech,2020-07-07
Novartis' Enerzair Breezhaler Receives the EC's Approval as a Maintenance Treatment of Asthma in Adult Patients Uncontrolled with LABA/ICS,DigiHealth|Pharma,2020-07-07
Daiichi Reports EMA's Validation of MAA and Accelerated Assessment for Trastuzumab Deruxtecan to Treat HER2 Positive Metastatic Breast Cancer,Pharma,2020-07-07
Regeneron Signs an Agreement with BARDA and the US Department of Defense for REGN-COV2 Worth $450M,Biotech|COVID-19,2020-08-07
GSK and Medicago to Initiate P-I Trial of Plant-Based COVID-19 Vaccine in July 2020,Biotech|COVID-19,2020-08-07
Angion Commences P-II Study of ANG-3777 in Patients with Acute Lung Injury Associated with COVID-19 Pneumonia in Brazil,COVID-19|Pharma,2020-08-07
Zai Lab Signs an Exclusive License Agreement with Turning Point Therapeutics for Repotrectinib in Greater China,Pharma,2020-08-07
AstraZeneca and MSD's Lynparza (olaparib) Receives EC's Approval for BRCA-Mutated Metastatic Pancreatic Cancer,Biotech,2020-08-07
Merck Collaborates with Foghorn to Develop Oncology Therapies Against Transcription Factor Target,Biotech,2020-08-07
Biogen and Eisai Complete the Submission of BLA to the US FDA for Aducanumab to Treat Alzheimer's Disease,Biotech,2020-09-07
Roche and Reverie Labs Collaborate to Advance Kinase Drug Discovery Programs,Pharma,2020-09-07
AstraZeneca's Brilinta (ticagrelor) Receives the US FDA's Priority Review for Reducing Stroke in Patients with Acute Ischemic Stroke or Transient Ischemic Attack,Pharma,2020-09-07
The European Commission Signs an Agreement with Roche and Merck to Supply their COVID-19 Therapies in EU,Biotech|COVID-19,2020-09-07
"Mylan and Fujifilm Kyowa Kirin Receive the US FDA's Approval for its Hulio (biosimilar, adalimumab)",Biosimilars,2020-09-07
Cipla Launches Cipremi at $53.34 per Vial in India,Biotech|COVID-19,2020-10-07
Sanofi Signs an Agreement with Kymera to Advance Novel Protein Degrader Therapies Worth Up to $2.1B,Pharma,2020-10-07
Bayer Reports Results of Finerenone P-III FIDELIO-DKD Renal Outcomes Study in Patients with Chronic Kidney Disease and Type 2 Diabetes,Clinical Trials|Pharma,2020-10-07
AstraZeneca Collaborates with ProteinQure to Design Novel Peptide Therapeutics,Biotech|COVID-19,2020-10-07
Philips Collaborates with BioIntelliSense to Enhance Remote Patient Monitoring,MedTech,2020-10-07
LEO Reports the US FDA's Acceptance of BLA for Tralokinumab to Treat Adults with Moderate to Severe Atopic Dermatitis,Biotech,2020-10-07
Biocon's ALZUMAb (itolizumab) Receives the DCGI's Approval for Emergency Use to Treat Patients with Moderate to Severe COVID-19,Pharma,13/7/2020
Roche Reports Results of Tecentriq in P-III IMagyn050 Study for Women with 1L Newly Diagnosed Advanced Stage Ovarian Cancer,Clinical Trials|Pharma,13/7/2020
Samsung Biologics Expands its Development Partnership with STCube for STM418,Pharma,13/7/2020
Pfizer with its Partner BioNTech Receives the US FDA's Fast Track Designation for Two mRNA Based Therapies to Treat COVID-19,Regulatory,13/7/2020
Gilead's Veklury (remdesivir) Receives the TGA's Approval to Treat Adults and Adolescents with Severe COVID-19 Symptoms,COVID-19|Regulatory,13/7/2020
Paige Secures Funding from Goldman Sachs to Continue Innovation in Digital Pathology,MedTech,14/7/2020
Roche Signs a ~$1B Agreement with Blueprint Medicines for its Precision Therapy to Treat Patients with RET-Altered Cancer Indications,Biotech,14/7/2020
Roche's Mosunetuzumab Receives the US FDA's Breakthrough Therapy Designation to Treat Relapsed or Refractory Follicular Lymphoma,Pharma,14/7/2020
Roche Expands its Collaboration with Immunomedics to Evaluate Tecentriq Based Combination Therapy in Urothelial and Non-Small Cell Lung Cancers,Biotech,14/7/2020
Merck Signs an Exclusive Agreement with Dewpoint Therapeutics to Develop Curative Treatment for HIV,Biotech,14/7/2020
Sanofi and MD Anderson Sign a Five-Year Pact to Expedite Oncology Research and Development,Pharma,14/7/2020
"Moderna to Commence Late-stage COVID-19 Vaccine Trial on 27 July, 2020",Biotech|COVID-19,15/7/2020
Samsung Biologics Signs Multi-Product Development and Manufacturing Agreement with ImmuneOncia,Biotech,15/7/2020
3M Collaborates with MIT to Develop Paper-Based Diagnostic Test for COVID-19,COVID-19|MedTech,15/7/2020
GSK's Belantamab Mafodotin Receives the US FDA Advisory Committee's Recommendation to Treat Relapsed/Refractory Multiple Myeloma,Biotech,15/7/2020
AstraZeneca and the University of Oxford to Share Positive News on its COVID-19 Vaccine Imminently,COVID-19,15/7/2020
Medtronic to Acquire Medicrea for Boosting its Spine Offerings,M&A,16/7/2020
Novartis Launches Zero Profit Portfolio for Symptomatic Treatment of COVID-19,COVID-19|Pharma,16/7/2020
AstraZeneca Report Results of Brilinta (ticagrelor) in P-III THALES Study for Patients with Acute Ischemic Stroke or Transient Ischemic Attack,Clinical Trials|Pharma,16/7/2020
Zydus Initiates Adaptive P-I/II Clinical Study Evaluating its ZyCoV-D Against COVID-19 in India,Biotech|COVID-19,16/7/2020
NCCN Collaborates with Pfizer to Explore Adoption of Biosimilars in Oncology,Biosimilars,16/7/2020
MSD Collaborates with Novocure to Evaluate Tumor Treating Fields Together with Keytruda (pembrolizumab) in Non-Small Cell Lung Cancer,Pharma,16/7/2020
Merck and Bayer Receive the US FDA's Priority Review for Vericiguat to Reduce the Risk of CV Death in Patients with Symptomatic Chronic Heart Failure with HFrEF,Regulatory,16/7/2020
Kronos Bio to Acquire Gilead's SYK Inhibitor Portfolio,M&A,17/7/2020
Merck KGaA Takes an Early Option in its Existing Immuno-Oncology Collaboration with F-star,Pharma,17/7/2020
Kiniksa's Rilonacept Receives the US FDA's Orphan Drug Designation to Treat Pericarditis,Regulatory,17/7/2020
Thermo Fisher Scientific Amends its Agreement to Acquire QIAGEN,M&A|MedTech,17/7/2020
Eli Lilly Reports Results of Mirikizumab in P-III OASIS-2 Study to Treat Moderate to Severe Plaque Psoriasis,Biotech|Clinical Trials,17/7/2020
Oncorus Initiates P-I Study of ONCR-177 in Patients with Advanced/ Refractory Cutaneous Subcutaneous or Metastatic Nodal Solid Tumors,Biotech,17/7/2020
Celltrion Initiates P-I Study of its COVID-19 Antibody Treatment in South Korea,Biotech|COVID-19,20/7/2020
GSK to Acquire 10% stake in CureVac for $163M,Biotech,20/7/2020
Roche Signs RWD Collaboration with PicnicHealth to Create Personalized Treatment for Patients with Multiple Sclerosis,MedTech,20/7/2020
Quest Diagnostic Receives the US FDA's First EUA for Sample Pooling in COVID-19,COVID-19|MedTech,20/7/2020
Royalty Pharma Acquires PTC's Royalty Interest in Risdiplam for $650M,Pharma,20/7/2020
AstraZeneca and Oxford University's AZD1222 Delivers Dual Immune Response in its P-II/III COV001 Study Against COVID-19,Biotech|COVID-19,21/7/2020
Pfizer and BioNTech Elicits Strong T-cell Response in P-I/II Study Against COVID-19,Biotech|COVID-19,21/7/2020
Mylan Launches Remdesivir Under the Brand Name Desrem for COVID-19 in India,COVID-19|Pharma,21/7/2020
Roche Collaborates with Jnana Therapeutics to Discover Novel Therapies to Treat Immune-Mediated and Neurological Diseases,Biotech,21/7/2020
The UK Government to Launch AbC-19 Lateral Flow Free Finger-Prick Test for COVID-19,COVID-19|MedTech,21/7/2020
Paige Receives the US FDA's 510(k) Clearance for its FullFocus Viewer to Use in Digital Pathology,MedTech|Regulatory,21/7/2020
Biocon Collaborates with Voluntis on Digital Therapeutics for Insulins,DigiHealth,22/7/2020
Gilead to Acquire Tizona's Stakes for $300M,M&A,22/7/2020
Boston Scientific Receives the US FDA's Approval for Next-Generation WATCHMAN FLX Left Atrial Appendage Closure Device,MedTech|Regulatory,22/7/2020
Evotec Collaborates with Quantro Therapeutics to Discover and Develop Novel Therapies for Cancer and Other Diseases,Biotech,22/7/2020
AbbVie Reports Results of Rinvoq (upadacitinib) as Monotherapy in a P-III Measure Up 2 Study for Atopic Dermatitis,Clinical Trials|Pharma,22/7/2020
Viela Bio's Uplizna (inebilizumab-cdon) Receives the US FDA's Approval to Treat Neuromyelitis Optica Spectrum Disorder (NMOSD),Biotech,2020-11-06
Pharma Mar's Zepzelca (lurbinectedin) Receives the US FDA's Accelerated Approval for Adult Patients with Metastatic Small Cell Lung Cancer (SCLC),Biotech,15/6/2020
Ultragenyx's Dojolvi (UX007/triheptanoin) Receives the US FDA's Approval to Treat Long-Chain Fatty Acid Oxidation Disorders,Biotech|Regulatory,15/6/2020
ViiV Healthcare's Tivicay PD (dolutegravir) Receives the US FDA's Approval for Children Living with HIV,Biotech,2020-12-06
Daiichi Sankyo Signs a Research Agreement Gustave Roussy for DS-1062 and Patritumab Deruxtecan to Treat Lung and Breast Cancer,Biotech,23/7/2020
Glenmark Report Results of FabiFlu (favipiravir) in P-III Clinical Study for Patients with Mild to Moderate COVID-19,COVID-19|Clinical Trials|Pharma,23/7/2020
Genentech Reports Results of Port Delivery System with Ranibizumab in P-III Archway Study for Neovascular Age-Related Macular Degeneration,Biotech|Clinical Trials,23/7/2020
Ovid Therapeutics and University of Connecticut Collaborate to Accelerate the Development of OV101 (gaboxadol) for Angelman Syndrome,Pharma,23/7/2020
BioMarin Reports the Submission of MAA to EMA for Vosoritide to Treat Children with Achondroplasia,Pharma,24/7/2020
Zydus to Initiate Clinical Study of Desidustat in Patients with Chemotherapy-Induced Anemia (CIA),COVID-19|Pharma,24/7/2020
Synaffix Expands its Existing Collaboration with ADC Therapeutics to Explore Two Additional Programs,Biotech,24/7/2020
PharmaShots Celebrates Successful Accomplishment of Two Years,Insights+,25/7/2020
Pfizer and BioNTech Initiate P-II/III Global Study of its Lead mRNA Vaccine Candidate Against COVID-19,Biotech|COVID-19,28/7/2020
Eli Lilly Amends its 2013 Agreement with Chi-Med to Commercialize Elunate (fruquintinib) in China,Pharma,28/7/2020
Eli Lilly's P-tau217 Blood Test Demonstrate High Accuracy in Diagnosis of Alzheimer's Disease,MedTech,29/7/2020
Roche's Actemra/RoActemra (tocilizumab) Fails to Meet the Primary Endpoint in P-III COVACTA Study for Patients with COVID-19 Associated Pneumonia,Biotech|COVID-19,29/7/2020
AbbVie Report Results of Rinvoq (upadacitinib) in a P-III AD Up Study for Patients with Atopic Dermatitis,Clinical Trials|Pharma,29/7/2020
Baxter and Ayogo Expand their Partnership to Advance Digital Health Solution for Home Dialysis,DigiHealth,29/7/2020
BARDA Signs a Multi-Year Agreement with Regeneron for its REGN-EB3 for National Preparedness,Biotech|COVID-19,30/7/2020
UCB Canada's Brivlera (brivaracetam) Receives Health Canada Approval to Treat Partial-Onset Seizures in Pediatric Epilepsy Patients,Biotech|Regulatory,30/7/2020
"Henlius and Accord's Zercepac (trastuzumab, biosimilar) Receive the EMA Approval for HER2-Positive Breast Cancer and Gastric Cancer",Biosimilars|Regulatory,30/7/2020
AstraZeneca's Tagrisso (osimertinib) Receives the US FDA's BT Designation for the Adjuvant Treatment of Patients with Stage IB-IIIA EGFR-Mutated Lung Cancer,Pharma|Regulatory,30/7/2020
Eli Lilly Reports Results of Jardiance (empagliflozin) in P-III EMPEROR Trial for Heart Failure Patients with Reduced Ejection Fraction with and without Diabetes,Clinical Trials|Pharma,30/7/2020
Sangamo Signs a Worldwide License Agreement with Novartis to Develop Genomic Therapies for Three Neurodevelopmental Targets,Pharma,30/7/2020
Johnson & Johnson Initiates P-I/IIa Study of its Ad26.COV2.S Against COVID-19 in the US and Belgium,Biotech|COVID-19,31/7/2020
Oxford Biomedica Signs Three Year Clinical Supply Agreement with Axovant to Manufacture and Supply AXO-Lenti-PD for Parkinson's Disease,Biotech|COVID-19,31/7/2020
MorphoSys' Monjuvi (tafasitamab-cxix) + Lenalidomide Receives the US FDA's Approval as 2L Treatment for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma,Biotech,2020-03-08
Immunic Reports Results of IMU-838 in P-II EMPhASIS Study in Patients with Relapsing-Remitting Multiple Sclerosis,Biotech|Clinical Trials,2020-03-08
Regeneron Collaborates with BioNTech to Advance the Combination of FixVac and Libtayo (cemiplimab) in Melanoma,Pharma,2020-03-08
Roche's Rozlytrek Receives EC's Conditional Marketing Authorization for NTRK Fusion-Positive Solid Tumors and ROS1-Positive Advanced NSCLC,Pharma,2020-03-08
RedHill Replaces its Co-Commercialization Agreement with Daiichi Sankyo for Movantik (naloxegol),Pharma,2020-04-08
Novartis Reports Results of Kymriah (tisagenlecleucel) in P-II ELARA Study for Follicular Lymphoma,Clinical Trials|Pharma,2020-04-08
AstraZeneca Signs a License Agreement with Redx Pharma for RXC006 to Treat Idiopathic Pulmonary Fibrosis,Pharma,2020-05-08
LEO Pharma Receives the US FDA's Fast Track Designation for Delgocitinib Cream to Treat Moderate-to-Severe Chronic Hand Eczema,Pharma|Regulatory,2020-05-08
AbbVie Terminates Tau and ASN Agreement with Voyager Signed in 2018 and 2019,Biotech,2020-05-08
Roche's cobas Epstein-Barr Virus Test Receives the US FDA's Authorization for Transplant Patients,MedTech,2020-05-08
BioNTech and Fosun Pharma Initiate Clinical Trial of BNT162b1 Against COVID-19 in China,Biotech|COVID-19,2020-05-08
"Celltrion's Remsima SC (infliximab, CT-P13) Receives the EC's MAA for Additional Five Indications",Biosimilars,27/7/2020
"Bio-Thera Signs a License Agreement with Pharmapark for BAT2506 (golimumab, biosimilar)",Biosimilars,17/7/2020
Lundbeck Halts P-II Study of Lu AF11167 in Patients with Negative Symptoms of Schizophrenia,Pharma,2020-06-08
UCB's Cimzia (certolizumab pegol) Receives the EMA's Approval for a Reduced Maintenance Dose in Patients with Axial Spondyloarthritis Spectrum,Pharma,2020-06-08
Moderna Prices its COVID-19 Vaccine at $32-$37 per Dose for Smaller Volume Agreements,Biotech|COVID-19,2020-06-08
Evotec Signs an Agreement with Sanofi for Novel Drug Development,Pharma,2018-05-10
Emergent BioSolutions Announces Completion of Acquisition of PaxVax for ~$270M,M&A,2018-05-10
Mitsubishi Tanabe Pharma (MTP-CA) Receives Health Canada Approval of Radicava for Amyotrophic Lateral Sclerosis (ALS),Regulatory,2018-05-10
Konan Medical Receives FDA 510(k) Approval for its objectiveFIELD Device,MedTech,2018-11-10
Palette Life Sciences Signs a Worldwide Commercialization and Development Agreement with Nestle Skin Health,Pharma,17/10/2018
J&amp;J to Acquire Ci:z Holdings for Expansion of its Dermatology Portfolio,M&A,24/10/2018
Novartis Receives EU Approval for Cosentyx's (secukinumab) Label Update in Patients with Psoriatic Arthritis (PsA),Biotech,26/10/2018
AstraZeneca Divests US Rights of Synagis &amp; MEDI8897 to Sobi for Prevention of Serious Lower Respiratory Tract infection (LRTI),Biotech,13/11/2018
GSK's Trelegy Ellipta (Fluticasone Furoate/Umeclidinium/Vilanterol ‘FF/UMEC/VI') Receives Expanded Level Approval from EU for COPD,Biotech,13/11/2018
"Dragonfly and Celgene Extended their Collaboration from 2017, for the Treatment of Solid and Hematological Cancers",Biotech,15/11/2018
Arena Pharmaceutical Licenses Exclusive Worldwide Rights of Ralinepag (APD811) to United Therapeutics for $1.2B,Biotech,16/11/2018
Vela Diagnostics' ViroKey SARS-CoV-2 RT-PCR Test Receives the US FDA's Emergency Use Authorization,COVID-19|MedTech,2020-07-08
Eli Lilly's Lyumjev (insulin lispro-aabc injection) Receives the US FDA's Approval for Type 1 and Type 2 Diabetes,Biotech,15/6/2020
Evoke's Gimoti (metoclopramide) Receives the US FDA's Approval to Relief Symptoms in Adults with Acute and Recurrent Diabetic Gastroparesis,Biotech,19/6/2020
Chugai and Biofourmis Collaborate to Develop Solutions for Digitally Measuring Endometriosis Pain,DigiHealth,23/7/2020
Abbott's IOS-Compatible App Receives the US FDA's Approval for Patients with Neurological Disorder,DigiHealth|Regulatory,24/7/2020
AstraZeneca's Breztri Aerosphere Receives the US FDA's Approval for the Maintenance Treatment of COPD,Pharma|Regulatory,24/7/2020
Gilead and Galapagos' Jyseleca (filgotinib) Receive the CHMP's Positive Opinion for Moderate to Severe Rheumatoid Arthritis,Pharma|Regulatory,24/7/2020
Sorrento to Acquire SmartPharm and Develop Pipeline of Gene-Encoded Therapeutic Antibodies Targeting COVID-19 and Cancer,COVID-19|M&A,27/7/2020
AstraZeneca Signs an Agreement with Daiichi Sankyo to Develop and Commercialize DS-1062 Worth Up to $6B,Biotech,27/7/2020
"Centus Biotherapeutics' Equidacent (bevacizumab, biosimilar) Receives CHMP's Positive Opinion for the Treatment of Multiple Cancer Indications",Biosimilars,27/7/2020
Kite's Tecartus (brexucabtagene autoleucel) Receives the US FDA's Approval as the First Cell-Based Gene Therapy for Relapsed or Refractory MCL,Biotech|Regulatory,27/7/2020
"Cadila to Launch its Bevaro (bevasizumab, biosimilar) in India",Biosimilars,22/7/2020
Three Pharma Companies Launch Favipiravir to Treat COVID-19 in India,COVID-19|Pharma,27/7/2020
AstraZeneca Signs an Agreement with Emergent BioSolutions to Expand Manufacturing of AZD1222 for COVID-19,Biotech|COVID-19,28/7/2020
AstraZeneca Report Results of Farxiga in P-III DAPA-CKD Study for Patients with Chronic Kidney Disease,Clinical Trials|Pharma,28/7/2020
Zebra Medical Receives the US FDA's Approval for its HealthMammo Mammography Tool,MedTech,28/7/2020
Roche and UCB Collaborate to Develop UCB0107 for Alzheimer's Disease,Biotech,29/7/2020
Sanofi and GSK Sign an Agreement with the UK Government to Supply ~60M Doses of COVID-19 Vaccine,Biotech|COVID-19,29/7/2020
Merck's MK-6482 Receives the US FDA's Breakthrough Therapy Designation to Treat Patients With Von Hippel-Lindau Disease-Associated Renal Cell Carcinoma,Pharma|Regulatory,29/7/2020
"Cadila to Launch its Ritucad (rituximab, biosimilar) in India",Biosimilars,29/7/2020
Roche's Tecentriq + Cotellic and Zelboraf Receives the US FDA's Approval for Patients with Advanced Melanoma,Biotech|Regulatory,31/7/2020
Takeda's Pevonedistat Receives the US FDA's Breakthrough Therapy Designation to Treat Patients with Higher-Risk Myelodysplastic Syndrome,Pharma,31/7/2020
Roche Receives the US FDA's Approval for VENTANA HER2 Dual ISH Test as CDx to Identify Breast Cancer,MedTech,31/7/2020
Sanofi and GSK Receive $2.1B from the US Government to Supply 100M Doses of COVID-19 Vaccine,Biotech|COVID-19,2020-03-08
Eli Lilly in Collaboration with NIAID Initiate P-III Study of LY-CoV555 to Prevent COVID-19,Biotech|COVID-19,2020-04-08
Siemens Healthineers to Acquire Varian for $16.4B,M&A|MedTech,2020-04-08
Merck and Hanmi Collaborate to Develop Efinopegdutide for NASH,Pharma,2020-04-08
"Janssen's Darzalex (daratumumab, SC) Receives Health Canada Approval for the Treatment of Patients with Multiple Myeloma",Biotech|Regulatory,2020-04-08
Lupin and SunPharma Launch Generic Favipiravir to Treat Mild to Moderate COVID-19 in India,COVID-19|Pharma,2020-05-08
Teva and Alvotech Collaborate to Commercialize Five Biosimilar Candidates in the US,Biosimilars,2020-05-08
Johnson &amp; Johnson Signs an Agreement with the US Government to Supply 100M Doses of COVID-19 Vaccine Worth ~$1B,Biotech|COVID-19,2020-06-08
AstraZeneca Collaborates with Eko to Advance the Digital Health Tools for the Diagnosis of CV Diseases,DigiHealth|MedTech,2020-06-08
Novartis Reports Results of Ofatumumab (OMB157) in P-III ASCLEPIOS Trials for Relapsing Multiple Sclerosis,Biotech|Clinical Trials,2020-06-08
Biogen Signs an Agreement with Denali on LRRK2 Program for Parkinson's Disease Worth ~$2.125B,Pharma,2020-07-08
Roche's Tecentriq (atezolizumab) + Paclitaxel Fail to Meet the Primary Endpoint in P-III IMpassion131 Study for Patients with Metastatic Triple-Negative Breast Cancer,Biotech,2020-07-08
AstraZeneca Collaborates with Daiichi Sankyo to Evaluate the Combination of Patritumab Deruxtecan (U3-1402) + Tagrisso for EGFR-Mutated Non-Small Cell Lung Cancer,Biotech,2020-07-08
Bausch Health to Spin off its Eye Health Business,Pharma,2020-07-08
Elanco Receives EC's Approval for its Pending Acquisition of Bayer Animal Health,Animal Health,2020-08-06
Merck Animal Health to Acquire Rights to Sentinel Brand of Combination Parasiticides for Companion Animals in the US for $400M,Animal Health,13/5/2020
Elanco Receives the US FTC's Approval for Acquisition of Bayer Animal Health,Animal Health,15/7/2020
Merck Animal Health Receives the US FDA's Approval for Bravecto (fluralaner) Monthly Chews to Protect Dogs and Puppies Against Fleas and Ticks,Animal Health,2020-09-07
Boehringer Ingelheim Receives Approval for its Classical Swine Fever Live Vaccine in China,Animal Health,2020-10-06
?Elanco To Acquire Bayer's Animal Health Business for $7.6B,Animal Health|M&A,20/8/2019
Cadila Pharma Launches NuPTH Biosimilar to Forteo for the Treatment of Osteoporosis in India,Biosimilars,2020-07-08
Roche's Evrysdi (risdiplam) Receives the US FDA's Approval for SMA in Adults and Children,Pharma|Regulatory,2020-10-08
Boehringer Ingelheim Acquires GST to Boost its Stem Cell Capabilities in Animal Health,Animal Health,2020-10-08
The US FDA Approves Guardant360 CDx as the First Liquid Biopsy NGS Assay to Identify EGFR Mutations in Non-Small Cell Lung Cancer,MedTech,2020-10-08
Roche Report Mixed Results of Etrolizumab in P-III Studies for Patients with Moderately to Severely Active Ulcerative Colitis,Clinical Trials|Pharma,2020-10-08
"Samsung Bioepis Launches Ontruzant (trastuzumab, biosimilar) for Early and Metastatic HER2-Overexpressing Breast Cancer in Brazil",Biosimilars,2020-11-08
Gilead Reports NDA Submission to the US FDA for Veklury (Remdesivir) to Treat COVID-19,Pharma|Regulatory,2020-11-08
Olympus to Acquire Arc Medical Design for Expanding its Product Portfolio,M&A|MedTech,2020-11-08
Bayer to Acquire KaNDy Therapeutics for Augmenting its Women's Healthcare Portfolio,M&A,2020-11-08
Ligand to Acquire Pfenex for $516M,M&A,2020-11-08
Medtronic to Acquire Companion Medical for Adding Smart Insulin Pen to its Diabetes Unit,M&A|MedTech,2020-12-08
BMS' Opdivo (nivolumab) + Yervoy (ipilimumab) + CT Receive Health Canada Approval for Metastatic Non-Small Cell Lung Cancer,Regulatory,2020-12-08
Sarepta Therapeutics Collaborates with University of Florida to Accelerate the Development of Therapies for Rare Genetic Diseases,Biotech,2020-12-08
Innovent and Eli Lilly Report sNDA Acceptance of Tyvyt (sintilimab) Combination Regimen as 1L Therapy in Squamous Non-Small Cell Lung Cancer in China,Biotech,2020-12-08
Roche Collaborates with Celleron Therapeutics for Emactuzumab to Treat Patients with Tenosynovial Giant Cell Tumor,Biotech,2020-12-08
Regeneron Reports the US FDA's Acceptance of Evinacumab's BLA for Priority Review as a Treatment for Patients with HoFH,Regulatory,13/8/2020
Roche Reports the US FDA's Acceptance of sBLA for Xolair (omalizumab) Prefilled Syringe for Self-Administration Across All Indications,Biotech|Regulatory,13/8/2020
Alphabet's Verily Establishes CLIA-Certified Lab Focusing on COVID-19 Testing,COVID-19|MedTech,13/8/2020
Zydus Launches Cheapest Version of Remdesivir at $37.41 per Vial in India,COVID-19|Pharma,13/8/2020
Novo Nordisk Resumes P-III Study of Concizumab for Patients with Hemophilia A and B,Biotech|Clinical Trials,13/8/2020
Strata Oncology Collaborates with Mirati Therapeutics to Broaden Enrollment in Clinical Trial of MRTX849 for Patients with Advanced Solid Tumors,Clinical Trials|Pharma,13/8/2020
AstraZeneca to Initiate Production of its COVID-19 Vaccine Early in 2021,Biotech|COVID-19,14/8/2020
EC Concludes Exploratory Talks with J&amp;J to Supply 200M Doses of COVID-19 Vaccine,Biotech|COVID-19,14/8/2020
SK bioscience Collaborate with Novavax to Supply Antigen for COVID-19 Vaccine,Biotech|COVID-19,14/8/2020
Novavax Collaborates with UK Government to Supply 60M Doses of NVX-CoV2373 to Combat COVID-19,Biotech|COVID-19,14/8/2020
Solasia Signs a License Agreement with Isofol to Develop and Commercialize Arfolitixorin for mCRC in Japan,Pharma,14/8/2020
Sanofi to Acquire Principia Biopharma for ~$3.68B,M&A|Pharma,17/8/2020
Roche's Enspryng (satralizumab-mwge) Receives the US FDA's Approval for Neuromyelitis Optica Spectrum Disorder,Biotech|Regulatory,17/8/2020
BMS Signs an Exclusive Worldwide License Agreement with Dragonfly Therapeutics for DF6002,Pharma,17/8/2020
Abeona Signs a License and Inventory Purchase Agreements with Taysha for ABO-202 to Treat CLN1 Disease (Infantile Batten disease),Biotech,17/8/2020
Henlius' HLX02 Receives the NMPA's Approval as the First Trastuzumab Biosimilar in China,Biosimilars,17/8/2020
Gilead Expands its Oncology Collaboration with Tango for ~$6.3B,Pharma,18/8/2020
AstraZeneca Collaborates with mAbxience to Produce COVID-19 Vaccine in Latin America,Biotech|COVID-19,18/8/2020
PTC Reports the EMA's Acceptance of MAA for Evrysdi (risdiplam) to Treat SMA,Pharma|Regulatory,18/8/2020
AstraZeneca's Imfinzi (durvalumab) Receives the US FDA's Priority Review for Less Frequent Fixed-Dose Use in NSCLC and Bladder Cancer,Pharma|Regulatory,18/8/2020
G1 Therapeutics Reports the US FDA Acceptance and Priority Review of NDA for Trilaciclib to Treat SCLC,Pharma|Regulatory,18/8/2020
Lilly and Innovent Report the Global Expansion of their Alliance for Tyvyt (sintilimab),Pharma,18/8/2020
Regeneron Collaborates with Roche to Improve the Global Supply of REGN-COV2 Against COVID-19,Biotech|COVID-19,19/8/2020
Novo Nordisk Collaborates with Evotec to Develop Therapies Targeting Chronic Kidney Disease,Pharma,19/8/2020
Sanofi's Dupixent (dupilumab) Receives the Health Canada Approval for Severe Chronic Rhinosinusitis with Nasal Polyposis,Pharma|Regulatory,19/8/2020
Johnson & Johnson to Acquire Momenta Pharmaceuticals for $6.5B,M&A,19/8/2020
The US FDA Rejects Gilead's Filgotinib Due to Toxicity Issues,Pharma|Regulatory,19/8/2020
Roche's Tecentriq + Bevacizumab Receive Health Canada's Approval as 1L Treatment for Unresectable or Metastatic Hepatocellular Carcinoma,Pharma|Regulatory,19/8/2020
Fitbit Reports Results of its COVID-19 Study for Early Detection of Diseases,COVID-19|MedTech,20/8/2020
Qiagen Launches QIAseq SARS-CoV-2 Primer Panel for Tracking COVID-19 Mutations and Strains,COVID-19|MedTech,20/8/2020
Sorrento Files IND for STI-1499 (COVI-GUARD) in Patients Hospitalized with COVID-19,COVID-19|Regulatory,20/8/2020
Precision BioSciences Receives the US FDA's Fast Track Designation for PBCAR0191 to Treat Advanced B-cell Precursor Acute Lymphoblastic Leukemia,Pharma|Regulatory,20/8/2020
BioSymetrics Signs an Agreement with Janssen and Sema4 to Utilize AI for the Prediction of COVID-19,COVID-19|DigiHealth,20/8/2020
Evotec and Centogene Expand their Collaboration to Target Gaucher Disease,Biotech,20/8/2020
Novartis' Kesimpta (ofatumumab) Receives the US FDA's Approval as the First Self-Administered Therapy for Relapsing Multiple Sclerosis,Biotech|Regulatory,21/8/2020
"Jazz Pharmaceuticals' Xywav (calcium, magnesium, potassium, and sodium oxybates) Receives the US FDA's Approval for Cataplexy or Excessive Daytime Sleepiness Associated with Narcolepsy",Regulatory,22/7/2020
MC2 Therapeutics Wynzora Cream Receives the US FDA's Approval to Treat Plaque Psoriasis in Adults,Regulatory,22/7/2020
Osmotica's Upneeq Receives the US FDA's Approval to Treat Blepharoptosis (Droopy Eyelid) in Adults,Regulatory,2020-09-07
Pfizer and BioNTech Plan for Regulatory Review of its COVID-19 Vaccine in October 2020,Biotech|Clinical Trials|COVID-19,21/8/2020
AstraZeneca's Imfinzi (durvalumab) Receives MHLW's Approval for Extensive-Stage Small Cell Lung Cancer,Biotech|Regulatory,21/8/2020
Acacia Pharma's Byfavo (remimazolam) Receives the US FDA's Approval for the Induction and Maintenance of Procedural Sedation,Regulatory,2020-02-07
The US FDA Approves Kyprolis (carfilzomib) + Darzalex (daratumumab) + Dexamethasone in Two Dosing Regimens for R/R Multiple Myeloma,Regulatory,21/8/2020
Junshi and Impact to Establish Joint Venture for Senaparib (IMP4297) in China,Pharma,21/8/2020
BioMarin Reports NDA Submission to the US FDA for Vosoritide to Treat Children with Achondroplasia,Pharma,21/8/2020
AstraZeneca Collaborates with RenalytixAI to Develop Precision Medicine for Chronic Diseases,Pharma,24/8/2020
Vertex's Kaftrio + Ivacaftor Receive the EC's Approval to Treat Cystic Fibrosis in People Aged 12 Years and Older,Regulatory,24/8/2020
Chugai's Kadcyla (trastuzumab emtansine) Receives MHLW's Approval for Adjuvant Therapy of HER2-Positive Early Breast Cancer,Biotech|Regulatory,24/8/2020
Takeda to Divest its Consumer Health Unit to Blackstone for $2.3B in Japan,Pharma,24/8/2020
ReiThera Reports First Patient Dosing with its COVID-19 Vaccine Candidate in Italy,Biotech|Clinical Trials,24/8/2020
BMS to Acquire Forbius for its AVID200 to Expand its Footprints in Oncology and Fibrosis,M&A,24/8/2020
Bayer and One Drop Collaborate to Develop Digital Therapies Across Multiple Therapeutic Areas,DigiHealth,24/8/2020
Novartis' Triple Regimen Fails to Meet the Primary Endpoint in P-III COMBI-i Study for Advanced Melanoma,Biotech|Clinical Trials,25/8/2020
Bionano Genomics Acquires Lineagen to Facilitate the Clinical Adoption of Saphyr for Digital Cytogenetics,M&A|MedTech,25/8/2020
Merck's Keytruda (pembrolizumab) Receives Two New PMDA's Approvals in Japan,Biotech|Regulatory,25/8/2020
AstraZeneca Initiates P-I Study of AZD7442 Against COVID-19,Biotech|Clinical Trials|COVID-19,25/8/2020
"BeiGene Signs a License and Supply Agreement with Bio-Thera for BAT1706 (biosimilar, bevacizumab) in China",Biosimilars,25/8/2020
AbbVie Exercises its Option to License Morphosys' avß6 Integrin Inhibitor Program for Fibrotic Disease,Pharma,25/8/2020
AbbVie and Harvard University Collaborate to Develop Novel Therapies Against Emergent Viral Diseases,Pharma,25/8/2020
ACADIA Acquires CerSci Therapeutics for $52.5M,M&A,26/8/2020
Takeda and Ovid Report Results of Soticlestat (TAK-935/OV935) in P-II ELEKTRA Study for Dravet Syndrome or Lennox-Gastaut Syndrome,Clinical Trials,26/8/2020
Novartis Reports Results of Asciminib (ABL001) in P-III ASCEMBL Study for Chronic Myeloid Leukemia,Clinical Trials,26/8/2020
Qiagen to Launch Digital Test for Detecting SARS-CoV-2 Antibodies in the US,COVID-19|MedTech,26/8/2020
Philips and B. Braun's Onvision Needle Tip Tracking Technology Receive the US FDA's 510 (k) Clearance for Regional Anesthesia,MedTech|Regulatory,26/8/2020
Takeda Collaborates with Engitix to Target Fibrotic Liver Diseases,Pharma,26/8/2020
"Lupin and Mylan Launch Nepexto (biosimilar, etanercept) in Germany",Biosimilars,27/8/2020
GSK's Blenrep (belantamab mafodotin) Receives EC's Approval for R/R Multiple Myeloma,Regulatory,27/8/2020
Celltrion Initiates P-I Study of CT-P59 Against COVID-19 in Korea,Clinical Trials,27/8/2020
FDC Launches Two Variants of Favipiravir for COVID-19 in India,COVID-19|Pharma,27/8/2020
Abbott's BinaxNOW COVID-19 Ag Card Receives the US FDA's EUA to Detect SARS-CoV-2 Infection,COVID-19|MedTech,27/8/2020
BeiGene Signs an Exclusive License Agreement with Singlomics for Neutralizing COVID-19 Antibodies,Biotech|COVID-19,27/8/2020
Otsuka Inqovi (decitabine and cedazuridine) Received the US FDA's Approval to MDS and CMML,Regulatory,20/7/2020
Amazon Enters into Fitness Space with the Launch of Halo Band and App,DigiHealth,28/8/2020
BioNTech and Fosun Pharma to Supply ~10M Doses of COVID-19 Vaccine to Hong Kong and Macao,Biotech,28/8/2020
Philips to Acquire Intact Vascular for $360M,M&A|MedTech,28/8/2020
Galecto's GB0139 Receives the US FDA's and EMA's Orphan Drug Designations for Idiopathic Pulmonary Fibrosis,Pharma|Regulatory,28/8/2020
Bayer Reports the NDA Submission to NMPA for Vericiguat to Treat Chronic Heart Failure in China,Pharma|Regulatory,28/8/2020
Taysha Gene Therapies' TSHA-101 Receives the US FDA's Orphan Drug Designation and Rare Pediatric Disease Designation for GM2 Gangliosidosis,Biotech|Regulatory,28/8/2020
Novartis Reports Results of LNP023 in P-II Study for Paroxysmal Nocturnal Hemoglobinuria,Clinical Trials|Pharma,31/8/2020
World's First App-Based Nicotine Addiction Treatment Receives the MHLW's Approval in Japan,DigiHealth|Regulatory,31/8/2020
AstraZeneca Reports Results of Farxiga (dapagliflozin) in P-III DAPA-CKD Trial for Patients With and Without Type-2 Diabetes,Clinical Trials|Pharma,31/8/2020
"Cadila Launches Cadalimab (biosimilar, adalimumab) in India",Biosimilars,31/8/2020
Mylan and Biocon Launch Semglee (insulin glargine injection) as Vials and Pre-Filled Pen in the US,Biosimilars,31/8/2020
Ionis to Acquire Remaining Stake in Akcea Therapeutics for $18.5/share,M&A,31/8/2020
Johnson & Johnson Collaborates with the Government of Canada to Supply its Ad26.COV2.S for COVID-19,Biotech|COVID-19,2020-01-09
AstraZeneca Expands the Development of AZD1222 into P-III Study in the US Across All Adult Age Groups,Biotech|Clinical Trials|COVID-19,2020-01-09
GSK and VIR Biotechnology Initiate P-II/III COMET-ICE Study of VIR-7831 Against COVID-19,Biotech|Clinical Trials|COVID-19,2020-01-09
AstraZeneca Expands Supply Agreement with Oxford Biomedica for AZD1222 to Combat COVID-19,Biotech|COVID-19,2020-01-09
Roche's Enspryng (satralizumab) Receives Health Canada Approval for Neuromyelitis Optica Spectrum Disorder,Biotech|Regulatory,2020-01-09
Roche's cobas HIV-1/HIV-2 Qualitative Test Receives the US FDA's Approval to Detect HIV Infection,MedTech,2020-01-09
Gilead Signs an Exclusive License Agreement with Jounce for Cancer Immunotherapies,Biotech,2020-02-09
AstraZeneca's Imfinzi (durvalumab) Receives EC's Approval as 1L Treatment for Extensive-Stage Small Cell Lung Cancer,Biotech|Regulatory,2020-02-09
Nestlé to Acquire Aimmune Therapeutics for $2.6B,M&A|Pharma,2020-02-09
Medtronic's MiniMed 770G Insulin Pump System with Smartphone Connectivity Receives the US FDA's Approval for Patients with Type 1 Diabetes,MedTech|Regulatory,2020-02-09
BMS' Onureg (azacitidine) Receives the US FDA's Approval as Continued Treatment for Acute Myeloid Leukemia,Pharma|Regulatory,2020-02-09
"Celltrion Plans to Initiate P-I Trial for its CT-P41 (biosimilar, denosumab) in September 2020",Biosimilars|Regulatory,14/8/2020
Idorsia Transfers its Agreement with ReveraGen to Santhera for Vamorolone,Pharma,2020-02-09
"Formycon with its Partner BIOEQ Plans to Initiate P-III MAGELLAN-AMD Trial for its FYB203 (biosimilar, aflibercept)",Biosimilars|Regulatory,24/8/2020
"Samsung Bioepis' Aybintio (SB8, biosimilar, bevacizumab) Receives the EC's Approval for Launch in EU",Biosimilars|Regulatory,21/8/2020
"Cadila to Launch its Cadalimab (biosimilar, adalimumab) in India",Biosimilars|Regulatory,28/8/2020
"Sandoz Canada Negotiated with Pan-Canadian Pharmaceutical Alliance (pCPA) to Launch Ziextenzo (biosimilar, pegfilgrastim) and Riximyo (biosimilar, rituximab) in Canada",Biosimilars|Regulatory,19/8/2020
Boehringer Ingelheim Collaborates with BiomX to Discover Microbiome-Based Biomarkers for Inflammatory Bowel Disease,MedTech,2020-03-09
Sanofi And GSK Initiate P-I/II Study of COVID-19 Protein-Based Vaccine,Biotech|COVID-19,2020-03-09
Merck Signs a Second Oncology Collaboration with Highlight Therapeutics,Biotech,2020-03-09
Janssen Halts the Development of Pimodivir for Influenza,Clinical Trials,2020-03-09
Baxter's Theranova Dialyzers Receives the US FDA's De Novo Authorization to Deliver HDx Therapy,MedTech|Regulatory,2020-03-09
Bicycle Reports First Patient Dosing in P-IIa Study of BT1718 for MT1-MMP-Positive Squamous NSCLC,Clinical Trials|Pharma,2020-03-09
Bio-Thera Initiates P-I Study of BAT2206 Proposed Biosimilar to Stelara (ustekinumab),Biosimilars,2020-04-09
Eli Lilly's Trulicity (dulaglutide) Receives the US FDA's Approval for Additional Doses to Treat Type 2 Diabetes,Pharma|Regulatory,2020-04-09
Roche Receives the US FDA's EUA for cobas SARS-CoV-2 and Influenza A/B Test,MedTech,2020-04-09
"Innovent's Sulinno (biosimilar, adalimumab) Receives NMPA's Approval for Autoimmune Diseases",Biosimilars|Regulatory,2020-04-09
Abbott Initiates LIFE-BTK Trial to Evaluate the Esprit BTK Drug-Eluting Resorbable Scaffold,Clinical Trials|MedTech,2020-04-09
Kite and HiFiBiO Therapeutics Collaborate to Develop Antibodies Targeting Acute Myeloid Leukemia,Biotech,2020-04-09
AbbVie to License I-Mab's Lemzoparlimab (TJC4) for ~$2B,Biotech,2020-04-09
Chi-Med Initiates P-III FRESCO-2 Study of Fruquintinib in Metastatic Colorectal Cancer,Clinical Trials|Pharma,2020-07-09
Kite Reports sBLA Submission to the US FDA for Yescarta (axicabtagene ciloleucel) in Relapsed or Refractory Indolent Non-Hodgkin Lymphomas,Biotech|Regulatory,2020-07-09
Genentech' Gavreto (pralsetinib) Receives the US FDA's Approval Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer,Regulatory,2020-07-09
AstraZeneca to Present Results of Breztri Aerosphere in P-III ETHOS Study at ERS International Congress 2020,Biotech|Clinical Trials,2020-07-09
Grifols to Acquire Remaining Stake of Alkahest for ~$146M,M&A,2020-07-09
Project ALS' Prosetin Receives the US FDA's Orphan Drug Designation for Amyotrophic Lateral Sclerosis,Regulatory,2020-07-09
Boehringer Ingelheim and Pharmaxis Halt the Development of BI 1467335 for Diabetic Retinopathy,Clinical Trials,2020-08-09
Mylan to Acquire Aspen's Thrombosis Business in the EU for ~ $758M,M&A,2020-08-09
Sanofi Reports Results of Dupixent (dupilumab) in P-III LIBERTY ASTHMA TRAVERSE OLE Study for Asthma,Biotech|Clinical Trials,2020-08-09
Roche's cobas BKV Test Receives the US FDA's 510 (k) Clearance to Improve Treatment for Transplant Patients,MedTech|Regulatory,2020-08-09
Silence Therapeutics Highlights its R&amp;D Pipeline and Initiates Dose Escalation Studies for SLN360,Clinical Trials,2020-08-09
Janssen's Imbruvica (ibrutinib) + Rituximab Receives the EC's Marketing Authorization for Previously Untreated Patients with Chronic Lymphocytic Leukemia,Regulatory,2020-08-09
Roche Expands its MS Portfolio with the Initiation of P-III Clinical Program of Fenebrutinib and Ocrevus (ocrelizumab),Clinical Trials,2020-09-09
Takeda Divests its Select Non-Core Assets in the EU and Canada to Cheplapharm for $562M,Pharma,2020-09-09
Theranica's Nerivio Wearable Device Receives CE Mark for Acute Treatment of Migraine in Europe,MedTech|Regulatory,2020-09-09
Merck Reports Results of Gefapixant (45mg) in Two P-III Studies for the Treatment of Refractory or Unexplained Chronic Cough,Clinical Trials,2020-09-09
Regenxbio Reports First Patients Dosing in its P-II AAVIATE Study of RGX-314 for Wet AMD,Clinical Trials,2020-09-09
Sanofi to Present New Data of its Neurology Portfolio at MSVirtual2020,Clinical Trials|Pharma,2020-09-09
Bayer Collaborates with Recursion to Fortify Digital Drug Discovery for Fibrotic Diseases,DigiHealth,2020-10-09
AstraZeneca Reports Results of Fasenra (benralizumab) in P-III OSTRO Study for Chronic Rhinosinusitis with Nasal Polyps,Clinical Trials,2020-10-09
Pfizer and BioNTech to Supply 200M Doses of it COVID-19 Vaccine in the EU,Biotech|COVID-19,2020-10-09
Genentech to Present New Data of Enspryng (satralizumab-mwge) for Neuromyelitis Optica Spectrum Disorder at MSVirtual2020,Biotech|Clinical Trials,2020-10-09
Jazz Collaborates with Redx Pharma to Develop Two Targeted Cancer Therapies,Biotech,2020-10-09
Takeda Reports Results of Ninlaro (ixazomib) in a P-III Clinical Study for Newly Diagnosed Multiple Myeloma,Clinical Trials,2020-10-09
"Henlius Reports NMPA's Acceptance of NDA for HLX04 (biosimilar, bevacizumab)",Biosimilars,2020-11-09
Roche to Present New Data of Ocrevus (ocrelizumab) for Relapsing-Remitting Multiple Sclerosis at MSVirtual2020,Clinical Trials,2020-11-09
GSK and Innoviva's Trelegy Ellipta (FF/UMEC/VI) Receive the US FDA's Approval for Asthma and COPD,Regulatory,2020-11-09
Chugai and Takeda Collaborate to Evaluate the Combination Therapy for Multiple Tumor Types in Japan,Biotech|Clinical Trials,2020-11-09
Janssen Reports sBLA Submission to the US FDA for Darzalex Faspro (daratumumab and hyaluronidase-fihj) to Treat Patients with Light Chain (AL) Amyloidosis,Biotech,2020-11-09
Janssen's Tremfya (guselkumab) Receives the US FDA's Approval as the First Selective IL-23 Inhibitor for Active Psoriatic Arthritis,Biotech|Regulatory,2020-11-09
Gilead to Acquire Immunomedics for ~$21B,M&A,14/9/2020
AstraZeneca Resumes COVID-19 Vaccine Trials in the UK,Clinical Trials,14/9/2020
Sanofi's Dupixent Receives the US FDA's Breakthrough Therapy Designation for Eosinophilic Esophagitis,Biotech|Regulatory,14/9/2020
Novartis Reports Results of Beovu (brolucizumab) in P-III KITE Study for Diabetic Macular Edema,Clinical Trials,14/9/2020
Boehringer Ingelheim and Click Collaborate on Digital Therapy for Behaviour Modification in Schizophrenia,DigiHealth,14/9/2020
Merck Signs Up to $4.5B Oncology Deal with Seattle Genetics,Pharma,14/9/2020
Fitbit to Launch ECG App in the US and EU in October 2020,DigiHealth,15/9/2020
Eli Lilly and Incyte's Olumiant + Gilead's Veklury Reduce Time to Recovery in Hospitalized Patients with COVID-19,Clinical Trials,15/9/2020
Janssen Collaborates with SpringWorks to Evaluate Nirogacestat + Teclistamab for Relapsed or Refractory Multiple Myeloma,Clinical Trials|Pharma,15/9/2020
Novartis' Beovu (brolucizumab) Receives EMA's Approval for its Safety Label Update to Treat Wet Age-Related Macular Degeneration,Regulatory,15/9/2020
The US FDA Rejects Mallinckrodt's Terlipressin Due to Doubts in its Risk-Benefit Profile,Regulatory,15/9/2020
Boehringer Ingelheim Reports Results of BI 425809 in P-II Study for Patients with Schizophrenia,Clinical Trials,15/9/2020
"Merck's Brenzys (etanercept, biosimilar) Receives Health Canada Approval for Multiple Indications",Biosimilars|Regulatory,16/9/2020
BMS Exercises its Option to Globally License Obsidian's CD40L Cell Therapy,Biotech,16/9/2020
Gilead's Magrolimab Receives the US FDA's Breakthrough Therapy Designation for Myelodysplastic Syndrome,Regulatory,16/9/2020
Takeda to Divest TachoSil to Corza Health for ~$416M,Biotech,16/9/2020
Roche's CINtec PLUS Cytology Test Receives the US FDA's Approval to Aid Clinicians in Preventing Cervical Cancer,MedTech,16/9/2020
Eli Lilly Reports POC Data of LY-CoV555 in P-II BLAZE-1 Study for COVID-19 in Outpatient Setting,Clinical Trials|COVID-19,16/9/2020
Baxter Signs an Exclusive Distribution Agreement With bioMérieux for Acute Kidney Injury Diagnostic Test in the US and EU,MedTech,17/9/2020
Novartis Reports Results of Dual regimen in P-III COMBI-AD Study for Patients with Stage III Melanoma,Clinical Trials,17/9/2020
"Samsung Bioepis to Present P-III Exploratory Analyses Results of Aybintio (bevacizumab, biosimilar) at ESMO 2020",Biosimilars|Clinical Trials,17/9/2020
Sorrento to Initiate P-I Study of STI-1499 in COVID-19 Positive Patients,Clinical Trials|COVID-19,17/9/2020
Junshi and Wigen Collaborate to Develop and Commercialize Four Therapies Targeting Cancer Indications,Pharma,17/9/2020
Roche to Present its Oncology Portfolio at the ESMO Virtual Congress 2020,Pharma,17/9/2020
NS Phrama's Viltepso (viltolarsen) Receives the US FDA's Approval for Patients with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping Therapy,Regulatory,2020-12-08
Bayer's Lampit (nifurtimox) Receives the US FDA's Approval for Treatment of Chagas Disease in Children,Regulatory,2020-07-08
Trevena's Olinvyk (oliceridine) Receives the US FDA's Approval for the Treatment of Central Nervous System,Regulatory,2020-10-08
Novo Nordisk's Sogroya (somapacitan-beco) Receives the US FDA Approval for Adult Growth Hormone Deficiency,Uncategorized,28/8/2020
Cassiopea's Winlevi (Clascoterone Cream) Receives the US FDA's Approval for the Treatment of Acne Vulgaris,Regulatory,27/8/2020
Recordati Rare Diseases' Cystadrops (Cysteamine Ophthalmic Solution) Receives the US FDA's Approval for the Treatment of Ocular Manifestations of Cystinosis,Regulatory,25/8/2020
Innocoll's Xaracoll (bupivacaine HCl) Receives the US FDA's Approval for the Acute Postsurgical Pain Relief in Adults Following Open Inguinal Hernia Repair,Regulatory,31/8/2020
GSK's Blenrep (belantamab mafodotin-blmf) Receives the US FDA's Approval as a Monotherapy Treatment for Multiple Myeloma,Regulatory,2020-06-08
AstraZeneca Acquires Dogma Therapeutics' Oral PCSK9 Inhibitor Program,M&A,18/9/2020
Eli Lilly Collaborates with Amgen to Boost the Global Supply of its COVID-19 Therapies,Biotech|COVID-19,18/9/2020
Roche Launches Elecsys Anti-SARS-CoV-2 S Test for COVID-19 Antibodies,COVID-19|MedTech,18/9/2020
AstraZeneca and MSD Report Five Year Data of Lynparza in P-III SOLO-1 Study for 1L Maintenance Treatment in Patients with BRCA-Mutated Ovarian Cancer,Clinical Trials,18/9/2020
Roche Reports Results of Actemra in P-III EMPACTA Study in Patients with COVID-19 Associated Pneumonia,Clinical Trials|COVID-19,18/9/2020
AstraZeneca Reports Updated Results of Imfinzi in P-III Studies for NSCLC and ES-SCLC,Clinical Trials,18/9/2020
AstraZeneca Reports the Results of Tagrisso (osimertinib) in P-III ADAURA Study for the Adjuvant Treatment of Patients Early-Stage EGFR-Mutated Lung Cancer,Clinical Trials|Pharma,21/9/2020
Takeda Collaborates with Foundation Medicine for Lung Cancer CDx,MedTech,21/9/2020
Roche Acquires Inflazome for ~$450M,M&A,21/9/2020
AstraZeneca and MSD's Lynparza (Olaparib) Receives the CHMP's Positive Opinion as 1L Maintenance Treatment for HRD-Positive Advanced Ovarian Cancer,Regulatory,21/9/2020
Bausch Health Acquires Option to Purchase Allegro's Ophthalmology Assets,Pharma,21/9/2020
Roche Presents New P-III Data of Tecentriq in Triple-Negative Breast Cancer at ESMO Virtual Congress 2020,Clinical Trials,21/9/2020
Lilly's Olumiant (baricitinib) Receives CHMP's Positive Opinion for Moderate to Severe Atopic Dermatitis,Regulatory,21/9/2020
Novartis' Kisqali (ribociclib) Receives Highest Score on the ESMO Magnitude of Clinical Benefit Scale,Clinical Trials,22/9/2020
Genentech Collaborates with Scenic Biotech to Develop Novel Therapies Targeting Genetic Modifiers,Biotech,22/9/2020
Alexion's Ultomiris (ravulizumab) Receives the CHMP's Positive Opinion for its New Advanced Formulation,Regulatory,22/9/2020
Illumina to Acquire GRAIL for ~$8B,M&A,22/9/2020
BMS' Inrebic (fedratinib) Receives Health Canada's Approval for Patients with Myelofibrosis,Regulatory,22/9/2020
UCB Reports the FDA's and EMA's Acceptance of BLA and MAA for Bimekizumab to Treat Moderate to Severe Plaque Psoriasis,Regulatory,23/9/2020
Novartis to Initiate Pivotal Confirmatory Study of AVXS-101 Intrathecal Formulation in Older Patients with SMA,Clinical Trials,23/9/2020
BMS and bluebird bio Report the US FDA's Acceptance of Idecabtagene Vicleucel's BLA for Priority Review to Treat Multiple Myeloma,Regulatory,23/9/2020
Micreos Initiates P-I/IIa Study Evaluating XZ.700 as the World's First Endolysin Therapy for Atopic Dermatitis,Biotech|Clinical Trials,23/9/2020
Sanofi's Supemtek Receives CHMP's Positive Opinion for Approval to Prevent Influenza,Biotech|Regulatory,23/9/2020
Pfizer Reports the US FDA's Acceptance of Xalkori's (crizotinib) sNDA for Pediatric Patients with R/R Systemic ALCL,Regulatory,23/9/2020
J&J Initiates Global P-III Clinical Study of its COVID-19 Vaccine,Biotech|COVID-19,24/9/2020
Novartis and Siemens Collaborate to Develop Blood Tests for Multiple Sclerosis,MedTech,24/9/2020
Genentech and AC Immune's Semorinemab Flounders in P-II TAURIEL Study for Early Alzheimer's Disease,Clinical Trials,24/9/2020
Pear Therapeutics Reports the Availability of its Prescription Digital Therapeutics to Wellpath Community Care Centers,DigiHealth,24/9/2020
Verona Initiates P-III ENHANCE Studies Evaluating Nebulized Ensifentrine for the Maintenance Treatment of COPD,Clinical Trials,24/9/2020
IDEAYA and Pfizer Expand CTC and Supply Agreement for Solid Tumors Harboring GNAQ or GNA11 Mutations,Pharma,24/9/2020
"Accord Launches Zercepac (biosimilar, trastuzumab) in the UK",Biosimilars,25/9/2020
Novavax Initiates P-III Study of its COVID-19 Vaccine in the UK,Clinical Trials|COVID-19,25/9/2020
Roche's Polivy (polatuzumab vedotin) Receives Health Canada's Approval For R/R Diffuse Large B Cell Lymphoma,Regulatory,25/9/2020
Medtronic Evaluates Insertable Cardiac Monitor to Identify Patients at High Risk of Worsening Heart Failure,MedTech,25/9/2020
BMS Reports Results of Opdivo (nivolumab) in P-III CheckMate -274 Study for Patients with High-Risk Muscle-Invasive Urothelial Carcinoma,Clinical Trials,25/9/2020
Philips Launches QuickClear Mechanical Thrombectomy System for Blood Clot Removal,MedTech,25/9/2020
Roche Reports Two-Year Data for Evrysdi (risdiplam) in Infants with Type 1 SMA,Clinical Trials,28/9/2020
Gilead's Jyseleca (filgotinib) Receives the MHLW's Approval for Rheumatoid Arthritis in Japan,Regulatory,28/9/2020
Chugai's Tecentriq (atezolizumab) and Avastin (bevacizumab) Receive MHLW's Approval as 1L Treatment for Unresectable Hepatocellular Carcinoma,Regulatory,28/9/2020
GSK's Nucala (mepolizumab) Receives the US FDA's Approval as the First Treatment for Hypereosinophilic Syndrome,Regulatory,28/9/2020
Innovent Report Results of Dual Regimen in P-III ORIENT-32 Study as 1L Therapy for Advanced HCC,Biosimilars|Clinical Trials,28/9/2020
Pfizer Initiates Clinical Study of Eighth Candidate Emerges Under the Collaboration with Sosei Heptares,Clinical Trials,28/9/2020
Sarepta Reports Two-Year Follow Up Results of SRP-9001 for Duchenne Muscular Dystrophy,Biotech|Clinical Trials,29/9/2020
AbbVie's Elezanumab (ABT-555) Receives the US FDA's Orphan Drug and Fast Track Designation for Spinal Cord Injury,Regulatory,29/9/2020
Pfizer's Xeljanz (tofacitinib) Receives the US FDA's Approval for Active Polyarticular Course Juvenile Idiopathic Arthritis,Regulatory,29/9/2020
CSL Behring's Haegarda (C1 Esterase Inhibitor) Receives the US FDA's Approval for Pediatric Patients with Hereditary Angioedema,Regulatory,29/9/2020
Boston Scientific Launches ACURATE neo2 Aortic Valve System in Europe,MedTech,29/9/2020
Inovio Reports FDA's Partial Clinical Hold on P-II/III Trial of INO-4800 Against COVID-19,Biotech|Clinical Trials|COVID-19,29/9/2020
Regeneron's REGN-COV2 Demonstrate Reduction in Viral Load and Improve Symptoms in Non-Hospitalized Patients with COVID-19,Clinical Trials|COVID-19,30/9/2020
BMS's Reblozyl (luspatercept) Receives Health Canada Approval for Beta Thalassemia,Regulatory,30/9/2020
Abbott's FreeStyle Libre 3 System Receives CE Mark in Europe,MedTech,30/9/2020
Galapagos Reports First Patients Dosing with GLPG3970 (Toledo Compound) for Psoriasis,Clinical Trials,30/9/2020
Junshi Reports Results of Dual Regimen in P-III Jupiter-02 Study as 1L Therapy for Nasopharyngeal Carcinoma,Clinical Trials,30/9/2020
Medtronic to Acquire Avenu Medical,M&A|MedTech,30/9/2020
Sanofi Launches Tetraxim (DTaP-IPV) for Preschoolers in India,Biotech,2020-01-10
"Henlius Signs an Exclusive License Agreement with Accord for HLX02 (biosimilar, trastuzumab) in the US and Canada",Biosimilars,2020-01-10
"Janssen Reports the NDA Submission to the US FDA for Uptravi (selexipag, IV) to Treat Pulmonary Arterial Hypertension",Regulatory,2020-01-10
Lotus Signs an Exclusive Commercialization Agreement with CKD for Biosimilar Darbepoetin Alfa,Biosimilars,18/9/2020
Alnylam Reports Results of Lumasiran in P-III ILLUMINATE-B Study for Primary Hyperoxaluria Type 1 in Children Under the Age of Six,Clinical Trials,2020-01-10
Moderna's mRNA-1273 COVID-19 Vaccine Demonstrate Immune Responses in Older Adults,Biotech|Clinical Trials|COVID-19,2020-01-10
Sobi & Selecta Report Results of SEL-212 in P-II COMPARE Study for Chronic Refractory Gout,Clinical Trials,2020-01-10
Alvotech and DKSH Extend their Collaboration to Commercialize Six Biosimilars in Asia,Biosimilars,22/9/2020
"Henlius Reports First Patient Dosing with HLX11 (biosimilar, pertuzumab) for HER2-Positive Metastatic Breast Cancer and Early Breast Cancer",Biosimilars,20/9/2020
"Henlius Presents P-III Data of HLX04 (biosimilar, bevacizumab) at CSCO 2020",Biosimilars,20/9/2020
"Henlius Present P-III Data of HLX02 (biosimilar, trastuzumab) at ESMO",Biosimilars,17/9/2020
Neuclone Discloses Two Biosimilars Referencing Opdivo (nivolumab) and Keytruda (pembrolizumab),Biosimilars,2020-01-09
AstraZeneca Resumes Clinical Study of its COVID-19 Vaccine in Japan,Clinical Trials|COVID-19,2020-05-10
Amgen Report Five Year Data of Aimovig (erenumab-aooe) in Open-Label Treatment Period of P-II Study for Episodic Migraine,Clinical Trials,2020-05-10
Novartis Reports Results of Zolgensma in P-III STR1VE-EU Study for SMA Type 1,Clinical Trials,2020-05-10
AstraZeneca's Farxiga Receives the US FDA's Breakthrough Therapy Designation for Chronic Kidney Disease,Regulatory,2020-05-10
STADA Expands its Specialty Footprint with the Acquisition of Lobsor Pharmaceuticals,M&A,2020-05-10
BMS to Acquire MyoKardia for ~$13.1B,M&A,2020-05-10
GSK and AstraZeneca Plan to Deploy NVIDIA's Supercomputer for Drug Development,DigiHealth,2020-06-10
Novartis Reports Results of Beovu (brolucizumab) in Two New Post-Hoc Analyses of P-III HAWK and HARRIER Studies for Wet AMD,Clinical Trials,2020-06-10
Pfizer Signs an Agreement with SpringWorks to Evaluate Nirogacestat + PF-06863135 for R/R Multiple Myeloma,Pharma,2020-06-10
Amgen Report Results of Sotorasib in P-II CodeBreaK 100 Study for Advanced Non-Small Cell Lung Cancer,Clinical Trials,2020-06-10
GSK's Zejula (niraparib) Receives Health Canada Approval for 1L Treatment of Women with Advanced Ovarian Cancer,Regulatory,2020-06-10
Santhera Halts P-III SIDEROS Study Evaluating Puldysa in Patients with DMD,Clinical Trials,2020-06-10
Qiagen to Launch Viral RNA Epidemiology Test for COVID-19 and Other RNA Viruses,COVID-19|MedTech,2020-06-10
PhaseBio Reports First Patients Dosing in its P-III REVERSE-IT Study of Bentracimab in Canada,Clinical Trials,2020-07-10
Merck Signs an Out-Licensing Agreement with Novartis for M6495 (Anti-ADAMTS5 Nanobody) for Osteoarthritis,Biotech,2020-07-10
"BioNTech and Pfizer Initiates Rolling Submission to EMA for SARS-CoV-2 Vaccine Candidate, BNT162b2",Regulatory,2020-07-10
"Samsung Bioepis and Biogen Announce EMA Filing Acceptance of SB11 (biosimilar, ranibizumab)",Biosimilars,2020-07-10
GSK Signs an Agreement with Vir Biotechnology to Develop Solutions for Coronaviruses,Regulatory,2020-07-10
Exact Sciences and Pfizer Announce Extension and Amendment of their Cologuard Promotion Agreement,Regulatory,2020-07-10
Eli Lilly Seeks the US FDA's EUA for its COVID-19 Antibody Treatment,COVID-19|Regulatory,2020-08-10
Polarean Reports the NDA Submission of Hyperpolarised 129Xenon Gas Drug-Device Diagnostic to the US FDA for Lung Imaging,MedTech|Regulatory,2020-08-10
BMS Report Results of Opdivo (nivolumab) + CT in P-III CheckMate-816 Trial for Resectable Non-Small Cell Lung Cancer,Clinical Trials,2020-08-10
Eli Lilly Collaborates with Dexcom for Diabetes Management,MedTech,2020-08-10
BMS' Zeposia (ozanimod) Receives Health Canada Approval for Relapsing Remitting Multiple Sclerosis,Regulatory,2020-08-10
BioMarin Receives the US FDA's Approval Allowing Maximum Dose of 60mg with Palynziq (pegvaliase-pqpz) for PKU,Regulatory,2020-08-10
Lilly and Incyte's Olumiant (baricitinib) Reports Additional Data Demonstrating Reduction in COVID-19 Recovery Time,Clinical Trials,2020-09-10
Neurocrine Presents New Data Analyses of Ongentys (opicapone) for Parkinson Disease at ANA 2020 Virtual Meeting,Clinical Trials,28/9/2020
Genentech Collaborates with Imbio to Develop Imaging Diagnostics for Lung Diseases,MedTech,2020-09-10
J&amp;J to Supply EU with up to 400M Doses of its COVID-19 Vaccine,Biotech|COVID-19,2020-09-10
Amgen Report Mixed Results of Omecamtiv Mecarbil in P-lll GALACTIC-HF Study for Heart Failure,Regulatory,2020-09-10
Regeneron Seeks the US FDA's EUA for REGN-COV2 Antibody Combination to Treat COVID-19,COVID-19|Regulatory,2020-09-10
Takeda Signs ~$1B Pact with Arrowhead for ARO-AAT Targeting Alpha-1 Antitrypsin-Associated Liver Disease,Pharma,2020-09-10
Pfizer's Ibrance (palbociclib) Fails to Meet its Primary Endpoint in P-lll PENELOPE-B Study for Early Breast Cancer,Clinical Trials,2020-12-10
AstraZeneca Advances its AZD7442 in Two P-III Clinical Studies for COVID-19,Clinical Trials|COVID-19,2020-12-10
True Digital Surgery and Aesculap Launch Aesculap Aeos Robotic Digital Microscope in US,DigiHealth,16/9/2020
"Innovent and Lilly's Halpryza (biosimilar, rituximab) Receive NMPA's Approval in China",Biosimilars|Regulatory,2020-12-10
Novartis's Iptacopan (LNP023) Receives EMA's Prime Designation for C3 Glomerulopathy,Regulatory,2020-12-10
Janssen Reports Results of Tremfya (guselkumab) in Interim Analysis of P-II GALAXI 1 Study for Moderately to Severely Active Crohn's Disease,Clinical Trials,2020-12-10
Janssen Reports Five-Year Data of Stelara (ustekinumab) in P-lll LTE Study for Severe Crohn's Disease,Clinical Trials,2020-12-10
Takeda Reports Results of Entyvio (vedolizumab) in Interim Analysis from VISIBLE OLE Study for Moderately to Severely Active Ulcerative Colitis,Clinical Trials,13/10/2020
Lilly Reports Results of Mirikizumab in P-ll SERENITY Study for Crohn's Disease,Clinical Trials,13/10/2020
Abbott's AdviseDx SARS-CoV-2 IgM Test Receives the US FDA's EUA for COVID-19,MedTech,13/10/2020
Gilead and Galapagos Report Results of Filgotinib in P-llb/lll SELECTION Study for Ulcerative Colitis,Clinical Trials,13/10/2020
Sanofi Reports Results of Dupixent (dupilumab) in P-III LIBERTY ASTHMA VOYAGE Study in Children with Asthma,Clinical Trials,13/10/2020
Roche to Launch Elecsys SARS-CoV-2 Antigen Test for Suspected COVID-19 Patients,MedTech,13/10/2020
J&amp;J Pauses Dosing in COVID-19 Vaccine Studies Due to Unexplained Illness,Clinical Trials,14/10/2020
Linnaeus Reports First Patients Dosing with LNS8801 + Keytruda (pembrolizumab) in P-I/II Study for Advanced Cancer,Clinical Trials,14/10/2020
Celltrion Launch P-III Post-Exposure Prophylaxis Clinical Trial of CT-P59 for COVID-19,Clinical Trials,14/10/2020
Moderna Initiates Rolling Submission to Health Canada for mRNA-1273 Against COVID-19,Regulatory,14/10/2020
Prestige's PBP1510 Receives EMA's Positive Opinion on Orphan Designation for Pancreatic Cancer,Regulatory,14/10/2020
Boehringer Ingelheim Presents Results of Gilotrif (afatinib) for NSCLC at IASLC NACLC 2020,Clinical Trials,14/10/2020
Roche Signs a License Agreement with Dyno to Develop AVV Gene Therapy for ~$1.8B,Biotech,15/10/2020
"Regeneron's Inmazeb (atoltivimab, maftivimab, and odesivimab) Receives the US FDA's Approval as the First Treatment for Ebola",Biotech|Regulatory,15/10/2020
Takeda Collaborates with Accenture and AWS to Transform into a Cloud-Based Company,DigiHealth,15/10/2020
Bayer Report Results of Aliqopa (copanlisib) + Rituximab in P-III CHRONOS-3 Study for Relapsed Indolent Non-Hodgkin's Lymphoma,Clinical Trials,15/10/2020
RadioMedix and Curium Detectnet (copper Cu 64 dotatate injection) Receives US FDA's Approval for Positive Neuroendocrine Tumors (NETs),Regulatory,2020-03-09
Athena Bioscience's Qdolo (tramadol hydrochloride) Receives US FDA's NDA Approval for Oral Solution,Regulatory,2020-01-09
Sorrento to Initiate P-II Study of STI-5656 (abivertinib maleate) for COVID-19 in Brazil,Clinical Trials|Regulatory,15/10/2020
Eton Pharmaceutical's Alkindi Sprinkle (hydrocortisone) Receives US FDA's Approval as Replacement Therapy in Pediatric Patients,Regulatory,29/9/2020
Eli Lilly Pauses Enrollment in ACTIV-3 Clinical Trial Due to Safety Concerns,Clinical Trials|COVID-19,15/10/2020
Eli Lily to Acquire Disarm Therapeutics for ~$1.36B,M&A,16/10/2020
Merck's Keytruda (pembrolizumab) Receives the US FDA's Approval for Relapsed or Refractory Classical Hodgkin Lymphoma,Regulatory,16/10/2020
Chugai Reports NDA Submission of Risdiplam to the MHLW as the First Oral Drug for SMA in Japan,Regulatory,16/10/2020
Sanofi and Translate Bio to Advance MRT5500 into Clinical Study Against COVID-19,Clinical Trials,16/10/2020
Galapagos &amp; Servier's GLPG1972/S201086 Fails to Meet its Primary Endpoint in P-II ROCCELLA Study for Knee Osteoarthritis,Clinical Trials,16/10/2020
Novartis's Luxturna (voretigene neparvovec) Receives Health Canada Approval as the First Gene Replacement Therapy for Inherited Retinal Disease,Regulatory,16/10/2020
Novartis' Leqvio (inclisiran) Receives CHMP's Positive Opinion for Approval to Treat Hypercholesterolemia,Regulatory,19/10/2020
AbbVie and Roche's Venclexta (venetoclax) Receive the US FDA's Approval for Acute Myeloid Leukemia,Regulatory,19/10/2020
"Henlius Signs a License Agreement with Essex to Co-develop HLX04 (biosimilar, bevacizumab) for Ophthalmic Diseases",Biosimilars,19/10/2020
AstraZeneca's Trixeo Aerosphere Receives CHMP's Recommendation for Approval to Treat COPD,Regulatory,19/10/2020
Janssen's Tremfya (guselkumab) Receives CHMP's Positive Opinion for Approval to Treat Active Psoriatic Arthritis (PsA),Regulatory,19/10/2020
Sanofi's Sarclisa (isatuximab) Receives NICE Recommendation for Patients with Multiple Myeloma,Regulatory,19/10/2020
Roche Collaborates with Genesis Therapeutics for AI-Driven Drug Discovery,MedTech,20/10/2020
ImmunoGen Signs an Agreement with Huadong to Develop &amp; Commercialize Mirvetuximab Soravtansine in Greater China,Pharma,20/10/2020
AbbVie Submits Regulatory Applications to the US FDA and EMA for Rinvoq (upadacitinib) to Treat Atopic Dermatitis,Regulatory,20/10/2020
Endo to Acquire BioSpecifics for ~ $540M,M&A,20/10/2020
AstraZeneca's Tagrisso (osimertinib) Receives the US FDA's Priority Review for the Adjuvant Treatment of Patients with Early-Stage EGFR-Mutated Lung Cancer,Regulatory,20/10/2020
Bayer and 111 Collaborate to Explore the Vast Blue Ocean of Online Healthcare in China,DigiHealth,20/10/2020
Samsung Biologics Collaborates with Dinona to Develop DNP-019 for COVID-19,COVID-19|Pharma,21/10/2020
Lilly's Taltz (ixekizumab) Receives Health Canada Approval for Non-Radiographic Axial Spondyloarthritis,Regulatory,21/10/2020
Roche and Prothena to Advance Prasinezumab in P-IIb Study for Patients with Early Parkinson's Disease,Clinical Trials,21/10/2020
"NeuClone Reports Positive Results of NeuLara (biosimilar, ustekinumab) in P-l Study for Autoimmune Diseases",Biosimilars,21/10/2020
StageBio Acquires TPL Path Labs to Expand its Footprints Globally,M&A|MedTech,21/10/2020
"Jazz Reports Results of Xywav (calcium, magnesium, potassium, and sodium oxybates) in P-III Study for Cataplexy or EDS in Patients with Narcolepsy",Clinical Trials,21/10/2020
AWS and Onica Collaborate with Teva to Support its Digihaler Portfolio,DigiHealth,22/10/2020
Novo Nordisk Signs a License Agreement with Chugai for Antibody Engineering Technologies,Biotech,22/10/2020
Novartis's Branaplam (LMI070) Receives the US FDA's Orphan Drug Designation for Huntington's Disease,Regulatory,22/10/2020
ViiV Healthcare Present Results of Long-Acting Cabotegravir and Rilpivirine at IDWeeK 2020,Clinical Trials,22/10/2020
Roche Collaborates with Atea Pharmaceuticals to Develop AT-527 for COVID-19,COVID-19|Pharma,22/10/2020
GSK Presents Results of Maternal &amp; Older Adults RSV Vaccines at IDWeek 2020,Biotech,22/10/2020
Dicerna Presents New Interim Data of PHYOX 3 OLE Study Evaluating Nedosiran for Primary Hyperoxaluria at ASN Week 2020,Clinical Trials,23/10/2020
Gilead's Veklury (remdesivir) Receives the US FDA's Approval as the First Treatment for COVID-19,Regulatory,23/10/2020
UCB's Vimpat (lacosamide) Receives CHMP's Positive Opinion for Primary Generalized Tonic-Clonic Seizures,Regulatory,23/10/2020
Daiichi Sankyo Initiates P-I Study of DS-1055 for Relapsed/Refractory Advanced or Metastatic Solid Tumors,Clinical Trials,23/10/2020
Sanifit Presents Results of SNF472 for the Treatment of Vascular Calcification at ASN Kidney Week 2020,Clinical Trials,23/10/2020
Akebia Presents Results of Vadadustat in P-lll INNO2VATE Program for Anemia Due to CKD at ASN Kidney Week,Clinical Trials,23/10/2020
AstraZeneca Resumes P-III Study of AZD1222 Against COVID-19 in the US,Clinical Trials,26/10/2020
Eisai and Cogstate Expand their Agreement to Develop and Commercialize Digital Cognitive Assessment Technologies,DigiHealth,26/10/2020
Boehringer Ingelheim and Eli Lilly Report Results of Jardiance in Adults with HFrEF Regardless of Chronic Kidney Disease Status,Clinical Trials,26/10/2020
AstraZeneca Presents Results of Farxiga (dapagliflozin) in P-lll DAPA-CKD Study for Chronic Kidney Disease at ASN Kidney Week 2020,Clinical Trials,26/10/2020
Foundation Medicine's FoundationOne CDx Receives the US FDA's Approval as a CDx for Vitrakvi (larotrectinib),MedTech|Regulatory,26/10/2020
Bayer Acquires Asklepios for ~$4B,M&A,26/10/2020
Jazz Pharmaceuticals Acquires SpringWorks' FAAH Inhibitor Program for Post-Traumatic Stress Disorder,Pharma,27/10/2020
"Samsung Bioepis Reports Results of Renflexis (biosimilar, infliximab) from Two Studies in IBD Patients",Biosimilars|Clinical Trials,27/10/2020
Sanofi and Regeneron Report Results of Dupixent (dupilumab) in Part A of P-lll Study for Eosinophilic Esophagitis (EoE),Clinical Trials,27/10/2020
Novartis Presents Results of Iptacopan (LNP023) in P-ll Study for C3 Glomerulopathy at ASN Annual Meeting 2020,Clinical Trials,27/10/2020
CStone Signs an Out-Licensing Agreement with EQRx for Sugemalimab and CS1003,Pharma,27/10/2020
Exact Sciences to Acquire Thrive Earlier Detection for ~$2.15B,M&A|MedTech,28/10/2020
Sanofi Presents Results of Olipudase Alfa in Two Clinical Studies at ASHG 2020,Clinical Trials,28/10/2020
Novartis Signs an Option and License Agreement with Molecular Partners to Develop Two DARPin Therapies for COVID-19,COVID-19,28/10/2020
Thermo Fisher Expands its Direct-to-Patient Service Offerings,Pharma,28/10/2020
AstraZeneca's Forxiga (dapagliflozin) Receive NMPA's Approval for Label Update to Include Data of P-III DECLARE-TIMI 58 Study,Regulatory,28/10/2020
Dermavant Presents Results of Tapinarof in Pivotal P-III PSOARING Program at the 29th EADV Virtual Congress,Clinical Trials,28/10/2020
BMS Signs a Five-Year Agreement with Insitro to Develop Therapies for ALS and Frontotemporal Dementia,Biotech,29/10/2020
Lilly Reports Results of Bamlanivimab (LY-CoV555) in P-II BLAZE-1 Study in New England Journal of Medicine,Clinical Trials|COVID-19,29/10/2020
Novartis Acquires Vedere Bio for $280M,M&A,29/10/2020
CStone Signs a License Agreement with LegoChem for LCB71 to Treat Multiple Cancer Indications,Biotech,29/10/2020
Boehringer Ingelheim Initiates P-II Study of BI 764198 for Patients with Severe Respiratory Illness from COVID-19,Clinical Trials|COVID-19,29/10/2020
Roche's Tecentriq in Combination with Avastin Receives China NMPA's Approval for the Treatment of Unresectable Hepatocellular Carcinoma,Regulatory,30/10/2020
AstraZenca Reports Results of Fasenra (benralizumab) in P-lllb PONENTE Trial for Asthma,Clinical Trials,30/10/2020
Sanofi Entered into an Agreement with Merck to Conduct a P-II Study of THOR-707 in Sequenced Administration with MSD's KEYTRUDA (pembrolizumab) in Patients with Various Cancers,Clinical Trials|Regulatory,30/10/2020
AbbVie Reports Results of SKYRIZI (risankizumab) in P-III LIMMitless Study in Patients with Moderate to Severe Plaque Psoriasis,Clinical Trials,30/10/2020
GSK's Zejula (niraparib) Receives EC's Approval as a Treatment in Advanced Ovarian Cancer,Clinical Trials|Regulatory,30/10/2020
AstraZenca Expands Supply Agreement with Cheplapharm for Atacand (candesartan cilexetil) and Atacand Plus (candesartan cilexetil + hydrochlorothiazide) to Cheplapharm,Regulatory,30/10/2020
UCB Reports Results of Bimekizumab in P-III BE SURE Study for Moderate-to-Severe Psoriasis,Clinical Trials,2020-02-11
Regeneron Pauses Dosing of Garetosmab (REGN2477) in P-II LUMINA-1 Study for Fibrodysplasia Ossificans Progressiva,Clinical Trials,2020-02-11
Medtronic Expands ENT Portfolio with the Acquisition of Ai Biomed and the Approval of NIM Vital Nerve Monitoring System,M&A|Regulatory,2020-02-11
Sun Pharma Reports Five Year Results of Ilumya (tildrakizumab-asmn) in P-III Studies for Moderate-to-Severe Plaque Psoriasis,Clinical Trials,2020-02-11
Novartis Reports Results of Aimovig (erenumab) in P-lV Study for Episodic and Chronic Migraine,Clinical Trials,2020-02-11
Sanofi to Acquire Kiadis for ~$358M,M&A,2020-02-11
Janssen Reports sNDA Submission of Paliperidone Palmitate 6-Month (PP6M) to the US FDA for Schizophrenia,Regulatory,2020-03-11
Tetra Therapeutics Reports Positive Results of BPN14770 in P-II Study for Fragile X Syndrome,Clinical Trials,2020-03-11
AstraZeneca and Fusion Collaborate to Develop and Commercialize Radiopharmaceuticals and Combination Therapies for Cancer,Pharma,2020-03-11
"Celltrion Presents Results of CT-P17 (biosimilar, adalimumab) in P-III Study for RA at ACR 2020",Biosimilars,2020-03-11
Roche's Tecentriq (atezolizumab) + Avastin (bevacizumab) Receive the EC's Approval for Unresectable Hepatocellular Carcinoma,Regulatory,2020-03-11
Novartis Reports Results of Kisqali (ribociclib) in P-III MONALEESA-7 Study in Women with HR+/HER2- Advanced Breast Cancer,Clinical Trials,2020-03-11
BMS' Deucravacitinib (BMS-986165) Demonstrate Superiority Over Amgen' Otezla (apremilast) in P-III POETYK PSO-1 Study for Plaque Psoriasis,Clinical Trials,2020-04-11
SomaLogic Collaborates with the US FDA to Advance Biosimilar Development,Biosimilars,29/10/2020
CEPI to Invest ~$328M in Clover's COVID-19 Vaccine Candidate,Regulatory,2020-04-11
Boston Scientific's Ranger DCB Receives the US FDA's Approval for Peripheral Artery Disease in the SFA and PPA,MedTech,2020-04-11
Biomarin Reports the US FDA's Acceptance of Vosoritide's NDA to Treat Children with Achondroplasia,Regulatory,2020-04-11
Jounce Stops Enrollment in P-II EMERGE Study Evaluating Vopratelimab for Lung Cancer,Clinical Trials,2020-04-11
Abbott to Launch its Cardiac Mapping Platform in Europe and Australia,MedTech,2020-04-11
Medicure Signs Agreement with Reliance Life Sciences for Marketing Rights of a Cardiovascular Biosimilar,Biosimilars,2020-05-10
"Henlius Present Results of HLX03 (biosimilar, adalimumab) in P-lll Study for Plaque Psoriasis at EADV 2020",Biosimilars,29/10/2020
BioInvent Presents New Clinical and Preclinical Data of BI-1206 at ASH Annual Meeting,Clinical Trials,2020-05-11
Innovent and Lilly Report Results of Tyvyt (sintilimab) in Seven Clinical Studies to be Presented at the ESMO ASIA Congress 2020,Clinical Trials,2020-05-11
Novartis Reports Results of Cosentyx (secukinumab) in P-IIIb ULTIMATE Study for Psoriatic Arthritis,Clinical Trials,2020-05-11
Novavax Collaborates with Commonwealth of Australia to Supply 40M doses of NVX-CoV2373 for COVID-19,Biotech|COVID-19,2020-05-11
Coloplast Acquires Nine Continents Medical,M&A|MedTech,2020-05-11
Merck to Acquire VelosBio for $2.75B,M&A,2020-05-11
AstraZeneca's Forxiga (dapagliflozin) Receives EC's Approval for Heart Failure,Regulatory,2020-06-11
Merck KGaA Collaborates with Iktos to Deploy AI in New Drug Design,DigiHealth,2020-06-11
AstraZeneca and MSD's Lynparza (olaparib) Receive EU's Approval as 1L Maintenance Treatment for HRD-Positive Advanced Ovarian Cancer,Regulatory,2020-06-11
"Formycon Reports BLA Resubmission Strategy for FYB201 (biosimilar, ranibizumab)",Biosimilars,2020-06-11
Novo Nordisk to Acquire Emisphere Technologies for $1.8B,M&A,2020-06-11
AstraZeneca's Brilinta (ticagrelor) Receives the US FDA's Approval to Reduce the Risk of Stroke in Patients with an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack,Regulatory,2020-06-11
Merck and Transcenta Collaborate to Implement Continuous Manufacturing for Protein Therapeutics,Pharma,2020-09-11
The US FDA's Advisory Panel Slams Biogen's Aducanumab for Alzheimer's Disease,Regulatory,2020-09-11
Eisai Reports Results of Lenvima (lenvatinib) + Everolimus in P-II 218 Study for Advanced Renal Cell Carcinoma,Clinical Trials,2020-09-11
Alvotech and Cipla Collaborate to Ensure Access to Biosimilars in South Africa,Biosimilars,2020-09-11
Celltrion Reports Results of CT-P59 in P-I Study for COVID-19,Clinical Trials|COVID-19,2020-09-11
Novartis' Ilaris (canakinumab) Fails to Meet its Primary Endpoints in P-lll Study for COVID-19 Pneumonia and CRS,Clinical Trials|COVID-19,2020-09-11
AstraZeneca's Calquence (acalabrutinib) Receives EU's Approval for Chronic Lymphocytic Leukaemia,Clinical Trials,2020-10-11
Pfizer and BioNTech's BNT162b2 Demonstrates 90% Efficacy in Preventing COVID-19,Clinical Trials|COVID-19,2020-10-11
Lilly's Bamlanivimab (LY-CoV555) Receives the US FDA's EUA for the Treatment of Recently Diagnosed COVID-19,Clinical Trials|COVID-19,2020-10-11
Bayer Reports Regulatory Submission of Finerenone (BAY 94-8862) to the US and EU for CKD and T2D,Regulatory,2020-10-11
AstraZeneca and Amgen Report Results of Tezepelumab in P-III NAVIGATOR for Asthma,Clinical Trials,2020-10-11
Novavax Receives the US FDA's Fast Track Designation for NVX-CoV2373 to Treat COVID-19,Clinical Trials|COVID-19,2020-10-11
"Henlius Reports First Patients Dosing in P-I Study of HLX14 (denosumab, biosimilar)",Biosimilars|Clinical Trials,2020-11-11
NightWare Receives the US FDA's Approval for the First Medical Device to Stop NightMAres Related to PTSD,DigiHealth|Regulatory,2020-11-11
Abbott Launches IonicRF Generator for Patients with Chronic Pain in the US,MedTech,2020-11-11
Samsung Bioepis Initiates P-I Study of SB16 Proposed Biosimilar to Prolia (denosumab),Biosimilars|Clinical Trials,2020-11-11
"Prestige Signs an Exclusive Agreement with Teva to Commercialize Tuznue (biosimilar, trastuzumab) in Israel",Biosimilars,2020-11-11
CureVac Publishes Results of CVnCoV in Interim P-l Study for COVID-19,Clinical Trials|COVID-19,2020-11-11
J&J Resumes all Clinical Trial of its COVID-19 Vaccine in the EU,Clinical Trials|COVID-19,2020-12-11
Moderna Report Results of mRNA-4157 + Keytruda in Interim P-l Study for HNSCC and MSS-CRC,Clinical Trials,2020-12-11
Pfizer Reports Results of Abrocitinib in Fifth P-lll JADE REGIMEN Across Different Dosing Regimens,Clinical Trials,2020-12-11
Pfizer and BioNTech to Supply EU with up to 200M Doses of BNT162B2 Against COVID-19,Clinical Trials,2020-12-11
Qiagen Collaborate with TScan to Develop T Cell-Based COVID-19 Test,MedTech,2020-12-11
AstraZenca's Calquence (acalabrutinib) Fails to Meet its Primary Endpoint in P-II Studies for COVID-19,Clinical Trials,2020-12-11
Medtronic Launches InPen Integrated with CGM Data for People with Diabetes on MDI,MedTech,13/11/2020
UCB Acquires Handl Therapeutics to Augment its Gene Therapy Portfolio,M&A,13/11/2020
Health2Sync Divulges Benefits of Integrating Fitbit Wearable Devices into Diabetes Care in Taiwan,DigiHealth,13/11/2020
GSK and Medicago Initiate P-II/III Study of its Plant-Derived COVID-19 Vaccine,Clinical Trials|COVID-19,13/11/2020
Qiagen Launches Portable Digital SARS-CoV-2 Antigen Test in the US,MedTech,13/11/2020
BD Acquires the Medical Business Assets of CUBEX,M&A,13/11/2020
Microsoft Collaborates with Twist and Illumina to Advance Data Storage in DNA,MedTech,16/11/2020
J&amp;J and US Government Amends their Agreement for the Next Phase of COVID-19 Vaccine Development,Biotech,16/11/2020
Eisai's Fycompa (perampanel) Receives EC's Approval for Expanded Indication in Pediatric Patients with POS and PGTCS,Regulatory,16/11/2020
Roche's Xofluza (baloxavir marboxil) Receives CHMP's Recommendation for Approval to Treat Influenza,Regulatory,16/11/2020
Eli Lilly Signs a License Agreement with Seed Therapeutics for Protein Degradation-Based Therapies,Pharma,16/11/2020
"Henlius Report the NMPA's Acceptance of HLX15 (biosimilar, Daratumumab) to Treat Multiple Myeloma",Biosimilars,16/11/2020
Bharat Biotech Initiates P-III Study for Covaxin Against COVID-19,Clinical Trials|COVID-19,17/11/2020
Moderna's mRNA-1273 Demonstrates 94.5% Efficacy in Preventing Symptomatic COVID-19,Clinical Trials|COVID-19,17/11/2020
Zymeworks and ALX Oncology Collaborate to Evaluate Zanidatamab + ALX148 for Advanced HER2-Expressing Breast Cancer,Pharma,17/11/2020
Roche Signs a License Agreement with Lead Pharma to Develop Oral Therapies for Immune-Mediated Diseases,Pharma,17/11/2020
Johnson &amp; Johnson Initiates Second Global P-III Study of its COVID-19 Vaccine,Clinical Trials|COVID-19,17/11/2020
QBiotics' Stelfonta (tigilanol tiglate) Receives the US FDA's Approval as the First Treatment for Non-Metastatic MCT in Dogs,Animal Health|Regulatory,17/11/2020
Bayer's Finerenone Demonstrates Positive Outcomes in Patients with Chronic Kidney Disease and Type 2 Diabetes,Clinical Trials,18/11/2020
ViiV Healthcare's Cabotegravir Receives US FDA's Breakthrough Therapy Designation for HIV Prevention,Regulatory,18/11/2020
Sanofi's Avalglucosidase alfa Receives US FDA's Priority Review as Enzyme Replacement Therapy for Pompe Disease,Regulatory,18/11/2020
"Pfizer Launches US Pilot Programme for Delivery and Distribution of COVID-19 Vaccine, BNT162b2",COVID-19,18/11/2020
BioMarin Pharmaceutical Signs an Agreement with Deep Genomics on Advancing Programs Identified Using Artificial Intelligence,Regulatory,18/11/2020
"Samsung Bioepis and Biogen Announces FDA Filing Acceptance of Lucentis' Biosimilar, SB11 for Retinal Vascular Disorders",Regulatory,18/11/2020
Sanofi's Supemtek (quadrivalent recombinant influenza vaccine) Receives the EC's Approval to Prevent Influenza,Biotech|Regulatory,19/11/2020
Pfizer and BioNTech's BNT162b2 Demonstrates 95% Efficacy in Preventing COVID-19,Clinical Trials|COVID-19,19/11/2020
Pear Therapeutics Launches Somryst Insomnia App Via an End-to-End Virtual Care Experience,DigiHealth,19/11/2020
ViiV's PROgress Study Demonstrates Inclusion of PROs into Clinical Practice Can Improve HIV Care,Clinical Trials,19/11/2020
Bayer to Fund Five New Startup Companies as Part of G4A Digital Health Partnerships Program,DigiHealth,19/11/2020
Lucira's All-In-One Test Kit Receives the US FDA's EUA as the First COVID-19 Test for Self-Testing at Home,MedTech,19/11/2020
Nevakar's Ephedrine Sulfate Injection Receives the US FDA's Approval as Ready-To-Use Vials,Regulatory,22/10/2020
Kala Pharmaceuticals' Eysuvis (loteprednol etabonate ophthalmic suspension) Receives US FDA's Approval for Dry Eye Disease,Regulatory,27/10/2020
Chiesi's Bronchitol (mannitol) Inhalation Powder Receives the US FDA's Approval for Cystic Fibrosis,Regulatory,19/11/2020
Alvotech Reports the US FDA and EMA's Acceptance of AVT02 Proposed Biosimilar to Humira (adalimumab),Biosimilars,20/11/2020
Novartis Signs a License Agreement with Mesoblast to Develop and Commercialize Remestemcel-L for ARDS,Biotech,20/11/2020
Eli Lilly and Incyte Receive FDA's EUA for Baricitinib + Remdesivir to Treat Hospitalized Patients with COVID-19,COVID-19|Regulatory,20/11/2020
Lilly Signs Agreement with Ypsomed to Advance an Automated Insulin Delivery System for People with Diabetes,Regulatory,20/11/2020
Pfizer And LianBio Collaborate to Expand the Development of Novel Therapeutics in Greater China,Pharma,20/11/2020
AstraZenca's Imfinzi (durvalumab) Receives the US FDA's Approval for Less-Frequent Fixed-Dose Use,Regulatory,20/11/2020
Regeneron's Casirivimab and Imdevimab Receive the US FDA's EUA as the First Combination Therapy for COVID-19,Clinical Trials|COVID-19,23/11/2020
Lilly's Bamlanivimab (LY-CoV555) Receives Health Canada's Interim Authorization as a Treatment for COVID-19,COVID-19|Regulatory,23/11/2020
"Innovent Reports Results of Tyvyt + Byvasda (biosimilar, bevacizumab) in P-lll ORIENT-32 Study as 1L Treatment for HCC",Biosimilars|Clinical Trials,23/11/2020
Eiger's Zokinvy (lonafarnib) Receives the US FDA's Approval for Treatment of Progeria and Processing-Deficient PL,Regulatory,23/11/2020
Eli Lilly Signs an Exclusive Agreement with Precision BioSciences on Genome Editing Research,Biotech,23/11/2020
AstraZeneca's AZD1222 Meets its Primary Endpoint in Preventing COVID-19,Clinical Trials|COVID-19,23/11/2020
Merck to Acquire OncoImmune for $425M,M&A,24/11/2020
Schrödinger Signs a $2.7B Agreement with BMS to Develop and Commercialize Therapies in Multiple Disease Areas,Pharma,24/11/2020
Baxter's Homechoice Claria APD System Receives the US FDA's 510 (k) Clearance for Kidney Failure,MedTech,24/11/2020
Roche's Xofluza (baloxavir marboxil) Receives the US FDA's Approval for Post-Exposure Prevention of Influenza,Regulatory,24/11/2020
Targovax Reports Results of ONCOS-102 in P-l/ll Study as 1L and 2L Treatment for Malignant Pleural Mesothelioma,Clinical Trials,24/11/2020
Selvita to Acquire Fidelta from Galapagos for ~$37M,M&A,24/11/2020
BMS' Opdivo (nivolumab) Receives EC's Approval as 2L Treatment for Unresectable Advanced and Metastatic Esophageal Squamous Cell Carcinoma,Regulatory,25/11/2020
Alnylam's Oxlumo (lumasiran) Receives the US FDA's Approval for Treatment of Primary Hyperoxaluria Type 1 in Pediatric and Adult Patients,Regulatory,25/11/2020
Alvotech and Alvotech & CCHT Sign an Exclusive Commercialization Agreement with Yangtze River for Eight Biosimilars in China,Biosimilars,25/11/2020
Russia's Sputnik V Demonstrates 91.4% Efficacy Against COVID-19,Biotech|COVID-19,25/11/2020
Evotec Collaborates with Rappta Therapeutics to Focus on Oncology Target,Pharma,25/11/2020
Bausch Health Initiates Second P-III Study for NOV03 (perfluorohexyloctane) to Treat DED Associated With MGD,Clinical Trials,25/11/2020
Janssen's Tremfya (guselkumab) Receives EC's Approval as a First in Class Treatment for Active Psoriatic Arthritis,Regulatory,26/11/2020
Bio-Thera Reports MAA Submission to EMA for BAT1706 a Proposed Biosimilar to Avastin,Biosimilars,26/11/2020
Urovant's Vibegron Fails to Meet its Primary Endpoint in P-IIa Study for IBS Pain,Clinical Trials,26/11/2020
BioNTech and Fosun Pharma Initiate P-ll Study of BNT162b2 Against COVID-19 in China,Clinical Trials,26/11/2020
CorticoMetrics's THINQ Receives the US FDA's 510(k) Clearance for MRI Brain Volumetric Reporting,MedTech,26/11/2020
Y-mAbs' Danyelza (naxitamab-gqgk) Receives the US FDA's Approval for Neuroblastoma,Regulatory,26/11/2020
Merck KGaA Reports EMA's Validation of MAA for Tepotinib to Treat Advanced NSCLC with METex14 Skipping Alterations,Regulatory,27/11/2020
Egle Identifies First Novel Regulatory T-cell Targets Under its Collaboration with Takeda,Biotech,27/11/2020
Merck Collaborates with Siemens for the Digitalization of Production,Pharma,27/11/2020
CoSara Receives CDSCO's Approval for its Saragene COVID-19 2-Gene Multiplex Test,MedTech,27/11/2020
PostEra Collaborates with NeuroLucent to Identify Therapies for Alzheimer's Disease,Pharma,27/11/2020
BASE10 Collaborates with DNA Link to Support Authorization of COVID-19 IgG Antibody Test at the Point of Care,MedTech,27/11/2020
Glenmark to Divest Select Anti-Allergy Brands to Dr. Reddy's in Russia and Other CIS Countries,M&A,30/11/2020
Moderna Amends its Agreement with UK Government for an Additional 2M Doses of COVID-19 Vaccine,Biotech|COVID-19,30/11/2020
Shionogi Receives MHLW's Approval for Xofluza's sNDA to Treat Post-Exposure Prophylaxis of Influenza Virus Infection,Regulatory,30/11/2020
Shionogi and Nagasaki University Collaborate with the Kitasato Institute for Antimalarial Drugs,Pharma,30/11/2020
AbbVie and Eisai's Humira (adalimumab) Receives MHLW's Approval for Pyoderma Gangrenosum,Regulatory,30/11/2020
AstraZeneca's Forxiga (dapagliflozin) Receives MHLW's Approval for Chronic Heart Failure,Regulatory,30/11/2020
Moderna to Seek the FDA and EMA's EUA for mRNA-1273 and Shows 100% Efficacy in P-III COVE-Study,COVID-19|Regulatory,2020-01-12
Sanofi's Dupixent (dupilumab) Receives EC's Approval for Children with Severe Atopic Dermatitis,Regulatory,2020-01-12
Member of COVID R&amp;D Alliance Report the First Patient Enrollment in COMMUNITY Study,Clinical Trials|COVID-19,2020-01-12
Kaia Health Allied with Chiesi Group to Commercialize COPD App in Europe,DigiHealth,2020-01-12
AstraZeneca Initiates P-IIb Study of ION449 (AZD8233) to Lower LDL-cholesterol,Clinical Trials,2020-01-12
Eisai Sign a Research Agreement with Wren Therapeutics to Discover Potential Treatment for Synucleinopathies,Pharma,2020-01-12
Genentech and Novartis's Xolair (omalizumab) Receives the FDA's Approval for Adults with Nasal Polyps,Regulatory,2020-02-12
BioNTech and Pfizer Report CMA Submission of BNT162b2 to EMA for COVID-19,COVID-19|Regulatory,2020-02-12
Boston Scientific to Divest BTG's Specialty Pharma Business for ~$800M,M&A,2020-02-12
Regeneron Collaborates with Penn to Explore Intranasal Delivery of COVID-19 Ab Cocktail via Gene Therapy Platform,Biotech|COVID-19,2020-02-12
AstraZeneca to Divest European Rights of Crestor (rosuvastatin) to Grünenthal for ~$350M,M&A,2020-02-12
"The US FDA Approves Pfizer's Oncology Supportive Care Biosimilar Nyvepria (biosimilar, pegfilgrastim)",Biosimilars,20/11/2020
Roche's Gavreto (pralsetinib) Receives the US FDA's Approval for Advanced or Metastatic RET-Mutant and RET Fusion-Positive Thyroid Cancers,Regulatory,2020-02-12
The US FDA Draft New Guidelines for Biosimilarity and Interchangeability,Biosimilars,19/11/2020
Samsung Biologics and AstraZeneca to Dissolve Rituximab Alliance,Biosimilars,20/11/2020
Genentech Files Complaint Against Centus Over Proposed Bevacizumab Biosimilar,Biosimilars,19/11/2020
"Formycon and Bioeq Report First Patients Dosing in P-III Study of FYB202 (biosimilar, ustekinumab)",Biosimilars,2020-09-11
"Xbrane Reports Patient Enrollment Completion in P-lll XPLORE Study of Xlucane (biosimilar, ranibizumab)",Biosimilars,2020-11-11
Pfizer &amp; BioNTech Receives MHRA's EUA for BNT162b2 Against COVID-19,COVID-19|Regulatory,2020-03-12
Samsung Bioepis Presents Results of SB11 Proposed Biosimilar to Lucentis in P-III Study at the AAO 2020 Virtual,Biosimilars,2020-11-11
Roche's Elecsys Anti-SARS-CoV-2 S Receives the US FDA's EUA to Detect Ab Against SARS-CoV-2 Spike Protein,COVID-19|MedTech,2020-03-12
Samsung Bioepis and Biogen Report the FDA's Acceptance of BLA for SB11 Proposed Biosimilar to Lucentis,Biosimilars,18/11/2020
"Henlius Presents Results of HLX04 (biosimilar, bevacizumab) in P-III Study at ESMO Asia 2020",Biosimilars,20/11/2020
AbbVie Collaborates with Frontier Medicines to Develop Novel Therapies and E3 Degraders Against Difficult-to-Drug Targets,Pharma,2020-03-12
"Innovent's Sulinno (biosimilar, adalimumab) Receive NMPA's Approval for Polyarticular Juvenile Idiopathic Arthritis",Biosimilars,23/11/2020
AstraZeneca to Unveil its Robust Pipeline of Breast Cancer at SABCS,Clinical Trials|Pharma,2020-03-12
Janssen Acquires Rights to Hemera's HMR59 for Late-Stage Age-Related Macular Degeneration,M&A,2020-03-12
Merck KGaA Collaborates with Artios Pharma for DNA Damage Cancer Therapies,Biotech,2020-03-12
Janssen Reports BLA Submission of Amivantamab to the US FDA for Metastatic NSCLC with EGFR Exon 20 Insertion Mutations,Biotech,2020-04-12
Richter Acquires Janssen's Evra Transdermal Contraceptive Patch Assets for $263.5M,M&A,2020-04-12
Jazz Pharma and PharmaMar's Zepzelca Fail to Meet its Primary Endpoint in P-III ATLANTIS Study for SCLC,Clinical Trials,2020-04-12
reMYND Commences P-l Study of RES19-T for Alzheimer's Disease,Clinical Trials,2020-04-12
Abbott's FreeStyle Libre 2 Receives Health Canada's Approval for Adults and Children with Diabetes,MedTech|Regulatory,2020-04-12
Exactech Acquires Muvr and it's Digital Health Tech for Orthopedic Practices,DigiHealth|M&A|MedTech,2020-04-12
Janssen Reports Long-Term Benefits of Imbruvica (ibrutinib) as 1L Treatment for High-Risk Chronic Lymphocytic Leukemia,Clinical Trials,2020-07-12
Kite Reports Results of Yescarta in P-II ZUMA-5 Study for Adult Patients with R/R Indolent Non-Hodgkin lymphoma,Clinical Trials,2020-07-12
Roche Reports Long-Term Benefits of Venclexta/Venclyxto Based Combination for R/R Chronic Lymphocytic Leukemia,Clinical Trials,2020-07-12
AstraZeneca Reports Long-Term Efficacy and Tolerability of Calquence (acalabrutinib) in P-ll ACE-LY-004 Study for MCL,Clinical Trials,2020-07-12
Roche Presents Results of Hemlibra Reinforcing the Long-Term Benefits for Hemophilia A at ASH 2020,Clinical Trials,2020-07-12
Roche Reports of Polivy + Bendamustine and MabThera / Rituxan in P-lb/ll GO29365 Study for R/R Diffuse Large B-Cell Lymphoma,Clinical Trials,2020-07-12
AbbVie Reports Results of Imbruvica (ibrutinib) in Two P-III Studies as 1L Treatment for Chronic Lymphocytic Leukemia,Clinical Trials,2020-08-12
Nektar Therapeutics Presents Preclinical Data of NKTR-255 in P-Ib/II Study at ASH 2020,Clinical Trials,2020-08-12
Bayer Signs an Exclusive Worldwide License Agreement with Atara for Mesothelin-Targeted CAR T-cell Therapies to Treat Solid Tumors,Pharma,2020-08-12
Qiagen Launches QuantiFERON SARS-CoV-2 RUO Solution for COVID-19,MedTech,2020-08-12
Astellas Collaborates with KaliVir to Develop and Commercialize VET2-L2,Biotech,2020-08-12
RetinAI Collaborates with Novartis to Provide AI Solutions in Ophthalmology,DigiHealth,2020-08-12
Novartis' Asciminib (ABL001) Demonstrate Superiority Over Pfizer's Bosulif in Chronic Myeloid Leukemia Trial,Clinical Trials,2020-09-12
AstraZeneca Reports Results of AZD1222 in Interim Analysis of P-lll Program for COVID-19,Clinical Trials|COVID-19,2020-09-12
Medtronic Launches Carpediem as the First Pediatric and Neonatal Acute Dialysis Machine in the US,MedTech,2020-09-12
Amgen's Sotorasib Receives the US FDA's Breakthrough Therapy Designation for Advanced or Metastatic NSCLC with KRAS G12C Mutation,Regulatory,2020-09-12
Roche Highlights its Bispecific Antibody Portfolio Across a Range of Blood Cancers at ASH 2020,Clinical Trials,2020-09-12
Elsevier Acquires Shadow Health,DigiHealth|M&A,2020-09-12
Boehringer Ingelheim to Acquires Labor Dr. Merk &amp; Kollegen for Boosting its Next Generation Cancer Immunology Program,M&A,2020-10-12
Lilly Reports Results of Tirzepatide in P-lll SURPASS-1 Monotherapy Trial for Type-2 Diabetes,Clinical Trials,2020-10-12
Roche Collaborate with Moderna to include SARS-CoV-2 Ab Test in COVID-19 Vaccine Trials,COVID-19|MedTech,2020-10-12
Novartis Reports Results of Kisqali in P-III MONALEESA-7 Trial to Treat HR+/HER2- Metastatic Breast Cancer,Clinical Trials,2020-10-12
Google Launches Health Research App Focusing on Respiratory Illnesses,DigiHealth,2020-10-12
Pfizer and BioNTech ‘s BNT162b2 Receive Health Canada Authorization to Combat COVID-19,COVID-19|Regulatory,2020-10-12
Boehringer Ingelheim to Acquires NBE-Therapeutics ~ $1.5B,M&A,2020-11-12
Gilead to Acquire MYR for ~$1.4B,M&A,2020-11-12
Biogen Reports NDA Submission of Aducanumab (BIIB037) to the MHLW for Alzheimer's Disease,Regulatory,2020-11-12
Roche Presents Results of Tecentriq (atezolizumab) in P-III IMvigor010 Study for MIUC at ESMO 2020,Clinical Trials,2020-11-12
Roche Launches Elecsys SARS-CoV-2 Antigen Test to Support High-Volume COVID-19 Testing,COVID-19|MedTech,2020-11-12
Chugai In-Licenses Roche's Antibody Cocktail for COVID-19 in Japan,Biotech|COVID-19,2020-11-12
AstraZeneca to Acquire Alexion for $39B,M&A,14/12/2020
Pfizer and BioNTech's BNT162b2 Receives the US FDA's EUA to Prevent COVID-19,COVID-19|Regulatory,14/12/2020
Alvotech and Fuji Pharma Extends Agreement for the Commercialization of Four Biosimilars in Japan,Biosimilars,14/12/2020
AstraZeneca's Trixeo Aerosphere Receives EU's Approval for the Maintenance Treatment of COPD,Regulatory,14/12/2020
Novartis' Ruxolitinib Fails to Meet its Primary Endpoint in P-lll RUXCOVID Study for COVID-19,Clinical Trials|COVID-19,14/12/2020
Daiichi Sankyo and AZ's Trastuzumab Deruxtecan Receives CHMP's Recommendation for Approval to Treat HER2 Positive Metastatic Breast Cancer,Regulatory,14/12/2020
Genentech's Ocrevus Shorter 2-Hour Infusion Receives the US FDA's Approval for Relapsing & Primary Progressive Multiple Sclerosis,Biotech|Regulatory,15/12/2020
Genentech Signs a Worldwide License Agreement with Relay Therapeutics to Develop and Commercialize RLY-1971,Pharma,15/12/2020
Samsung Bioepis Initiates P-Ill Study of SB16 Proposed Biosimilar to Prolia (denosumab),Biosimilars,15/12/2020
Roche Launches Cobas PIK3CA Mutation Test for Patients with Advanced or Metastatic Breast Cancer,MedTech,15/12/2020
CureVac Commences P-llb/lll Trial of CVnCoV for COVID-19,Clinical Trials,15/12/2020
EMA's CHMP Recommends Four-Week Dosing Option for AstraZeneca's Imfinzi to Treat Unresectable NSCLC,Regulatory,15/12/2020
Lilly to Acquire Prevail Therapeutics for ~$1.04B,M&A,15/12/2020
Sedor's Sesquient Receives the US FDA's Approval for Status Epilepticus,Regulatory,2020-09-11
Rhythm's Imcivree (setmelanotide) Receives the US FDA's Approval for Chronic Weight Management in Patients with Obesity,Regulatory,27/11/2020
Gilead Amends Agreement with Galapagos for Development and Commercialization of Jyseleca (filgotinib),Pharma,16/12/2020
Athenex's Klisyri (tirbanibulin) Receives the US FDA's Approval for Actinic Keratosis on the Face or Scalp,Regulatory,16/12/2020
Takeda Reports the US FDA's Acceptance of NDA for TAK-721 (budesonide oral suspension) to Treat Eosinophilic Esophagitis,Regulatory,16/12/2020
Bone Health's OsteoBoost Vibration Belt Receives the US FDA's Breakthrough Device Designation for Osteoporosis,MedTech|Regulatory,16/12/2020
Ellume's COVID-19 Home Test Receives the US FDA's EUA as First Over-the-Counter Diagnostic Test,COVID-19|MedTech|Regulatory,16/12/2020
Abbott's COVID-19 IgG Quantitative Antibody Blood Test Receives CE Mark,COVID-19|MedTech,16/12/2020
Novartis's Entresto Receives the US FDA's Advisory Committee Recommendation to Treat Patients with HFpEF,Regulatory,17/12/2020
Novo Nordisk to Initiate a P-lll Study of Semaglutide to Treat Alzheimer Disease,Clinical Trials,17/12/2020
Novartis's Zolgensma Receives Health Canada Approval as the One-Time Gene Therapy for Pediatric Patients with SMA,Regulatory,17/12/2020
Amgen Reports NDA Submission of Sotorasib to the US FDA for Advanced/Metastatic NSCLC With KRAS G12C Mutation,Regulatory,17/12/2020
Eli Lilly Signs an Exclusive Agreement with Precision BioSciences on Genome Editing Research,Biotech,20/11/2020
Kite's Tecartus (KTE-X19) Receives EC's Conditional Marketing Authorization for R/R Mantle Cell Lymphoma,Regulatory,17/12/2020
Novartis to Acquire Cadent Therapeutics for ~$770M,M&A,17/12/2020
Moderna's mRNA-1273 Receives the US FDA's Advisory Committee Vote Supporting EUA Against COVID-19,COVID-19|Regulatory,18/12/2020
GSK Signs an Exclusive License Agreement with Surface Oncology to Develop and Commercialize SRF813,Pharma,18/12/2020
GSK's Benlysta (belimumab) Receives the US FDA's Approval as the First Therapy for Active Lupus Nephritis (LN),Regulatory,18/12/2020
"Sandoz to Launch Hyrimoz (biosimilar, adalimumab) in Canada",Biosimilars,18/12/2020
"Amgen's Riabni (biosimilar, rituximab) Receives the US FDA's Approval for Multiple Diseases",Biosimilars,18/12/2020
NOWDiagnostics Receives CE Mark for its ADEXUSDx COVID-19 Antibody Fingerstick Test,COVID-19|MedTech,18/12/2020
GSK Signs a License Agreement with Sosei Heptares Targeting Immune Disorders of the Digestive System,Pharma,21/12/2020
Merck Signs a ~$1B Pact with Janux to Develop Cancer Therapies Using T Cell Engager Technology,Biotech,21/12/2020
Philips to Acquire BioTelemetry for ~$2.8B,M&A|MedTech,21/12/2020
ViiV Healthcare's First Long-Acting Injectable Receive EC's Approval for the Treatment of HIV,Regulatory,21/12/2020
Ultragenyx Signs a License Agreement with Mereo for Setrusumab in Osteogenesis Imperfecta,Pharma,21/12/2020
Moderna's mRNA-1273 Receives the US FDA's EUA Against COVID-19,COVID-19|Regulatory,21/12/2020
AstraZeneca's Tagrisso (osimertinib) Receives the US FDA's Approval for the Adjuvant Treatment of Patients with Early-Stage EGFR-Mutated Lung Cancer,Regulatory,22/12/2020
Roche Reports Results of Faricimab in Two Global P-III Studies for Diabetic Macular Edema,Clinical Trials,22/12/2020
Servier to Acquire Agios' Oncology Business for ~$2B,M&A,22/12/2020
"Biogen's Plegridy (peginterferon beta-1a, IM) Receives EC's Approval for Relapsing-Remitting MS",Regulatory,22/12/2020
Pfizer and BioNTech's Comirnaty (BNT162b2) Receives EC's Conditional Marketing Authorization for COVID-19,Regulatory,22/12/2020
AstraZeneca's Tezepelumab Fails to Meet its Primary Endpoint in P-III SOURCE Study for Asthma,Clinical Trials,22/12/2020
Janssen's Darzalex (daratumumab) Receives Health Canada Approval for the Treatment of Multiple Myeloma,Regulatory,23/12/2020
Voyager Therapeutics Provides Update on NBIB-1817 (VY-AADC) Program to Treat Parkinson Disease,Clinical Trials,23/12/2020
Janssen Initiates Rolling Submission of BLA to US FDA of Autoleucel (cilta-cel) to Treat Multiple Myeloma,Regulatory,23/12/2020
Ocular Therapeutix Reports sNDA Submission of Dextenza (dexamethasone ophthalmic insert) to the US FDA for Ocular Itching,Clinical Trials,23/12/2020
AMO Pharma Initiates P-II REACH-CDM study of AMO-02 (tideglusib) to treat Congenital Myotonic Dystrophy,Clinical Trials,23/12/2020
Roche's Phesgo (Perjeta + Herceptin) Receives EC's Approval for the Treatment of HER2-Positive Breast Cancer,Regulatory,23/12/2020
Innovent's Sulinno (Adalimumab biosimilar) Receives China's NMPA Approval for Pediatric Plaque Psoriasis and Non-infectious Uveitis,Biosimilars,28/12/2020
Innovent's Byvasda (Bevacizumab Biosimilar) Receive NMPA's Approval for Adult Recurrent Glioblastoma,Regulatory,28/12/2020
Aurobindo Pharma Sign Agreement with COVAXX to Develop and Commercialize COVID-19 Vaccine UB-612 for India and UNICEF,Pharma,28/12/2020
Amyrt's AP103 Receives the US FDA's Orphan Drug designation for Dystrophic Epidermolysis Bullosa (DEB),Regulatory,28/12/2020
Casi and Juventas Cell Therapy's CNCT19 (CD19 CAR-T) Receives China NMPA's BT Designation for Relapsed/refractory B-Cell Acute Lymphoblastic Leukemia (B-ALL),Regulatory,28/12/2020
Algernon's Last Patient Out in NP-120 (Ifenprodil) P-IIb/III Study for COVID-19,Clinical Trials,28/12/2020
Janssen Report MAA Submission of Amivantamab to EMA for Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations,Biotech,29/12/2020
Zai Lab Signs an Exclusive License Agreement with Cullinan Oncology for the Development and Commercialization of CLN-081 in Greater China,Biotech,29/12/2020
Myovant Signs Agreement with Pfizer to Develop and Commercialize Relugolix in Oncology and Women's Health,Pharma,29/12/2020
Biocon has Launched Tacrolimus Capsules in the US,MedTech,29/12/2020
Pfizer Report the US FDA's Acceptance and Priority Review of sNDA for Lorbrena (lorlatinib) to treat (ALK)-Positive (NSCLC),Biotech,29/12/2020
Alligator Bioscience Submits CTA for the P-II OPTIMIZE-1 Study of Mitazalimab,Clinical Trials,29/12/2020
Chi-Med Initiates Rolling Submission of NDA to the US FDA of Surufatinib to Treat Advanced Neuroendocrine Tumors,Regulatory,30/12/2020
"Novo Nordisk Reports Submission of Label Extension Application to the EMA for Semaglutide (once weekly, 2.0 mg) for T2D",Regulatory,30/12/2020
Skyhawk Collaborates with Vertex to Discover and Develop Novel Small Molecules Modulating RNA Splicing for Serious Diseases,Pharma,30/12/2020
AstraZeneca's AZD1222 Receives MHRA's Emergency Supply Authorization in the UK,COVID-19|Regulatory,30/12/2020
Regeneron's Antibody Cocktail Demonstrate Promising Results in Hospitalized Patients on Low-Flow Oxygen,Clinical Trials|COVID-19,30/12/2020
Zydus Cadila Seeks Approval to Commence P-III Clinical Study of ZyCoV-D,COVID-19|Regulatory,30/12/2020
Sinopharm's COVID-19 Vaccine Demonstrates 79% Efficacy in P-III Study,Clinical Trials|COVID-19,31/12/2020
Vertex Reports Health Canada's Acceptance of Trikafta's NDA for Priority Review to Treat Cystic Fibrosis,Regulatory,31/12/2020
The US FDA Grants EUA for Quanterix's Simoa Semi-Quantitative SARS-CoV-2 IgG Antibody Test,COVID-19|MedTech,31/12/2020
Sorrento Reports Submission of MAA to COFEPRIS for COVI-STIX Rapid Detection Test,MedTech|Regulatory,31/12/2020
Health Canada Accelerates the Review for AstraZeneca's COVID-19 Vaccine,COVID-19|Regulatory,31/12/2020
Incyte Collaborates with Cellenkos for CK0804 to Treat Myelofibrosis,Pharma,31/12/2020
RedHill Reports Results of Yeliva (opaganib) in P-II Study for COVID-19,Clinical Trials|COVID-19,2021-04-01
AstraZeneca's COVISHIELD Receives EUA in India for COVID-19,COVID-19|Regulatory,2021-04-01
Antengene Reports NDA Submission for ATG-010 (selinexor) to Treat RRMM and RR DLBCL in South Korea,Regulatory,2021-04-01
Tiziana Completes Clinical Trial of Nasally Administered Foralumab for COVID-19 in Brazil,Clinical Trials|COVID-19,2021-04-01
Oura Ring Monitors Body Temperature and Identify Early COVID-19 Symptoms,MedTech,2021-04-01
Provention Bio Reports Submission of BLA and Priority Review to the US FDA for Teplizumab to Prevent T1D,Regulatory,2021-04-01
Hologic to Acquire Somatex for ~$64 M,M&A,2021-05-01
Pfizer and OPKO Reports the US FDA's Acceptance of BLA for Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency,Regulatory,2021-05-01
Genentech's Tiragolumab + Tecentriq Receive the US FDA's Breakthrough Therapy Designation for PD-L1-High Non-Small Cell Lung Cancer,Regulatory,2021-05-01
aTyr Reports Results of ATYR1923 in P-ll Study for COVID-19 Patients with Severe Respiratory Complications,Clinical Trials|COVID-19,2021-05-01
Y-Biologics Signs a License Agreement with 3D Medicines for YBL-013 in the Territory of Greater China,Pharma,2021-05-01
Biogen Signs a License Agreement with ViGeneron for Ophthalmic Gene Therapy Development,Biotech,2021-05-01
Stryker Acquires OrthoSensor and its Knee Surgery Sensor Technology,M&A|MedTech,2021-06-01
Evotec Receives Milestones in its Neurodegeneration Collaboration with BMS,Pharma,2021-06-01
Regenxbio Reports the Initiation of First Pivotal Program for RGX-314 to Treat Wet AMD,Clinical Trials,2021-06-01
AbbVie Reports Results of Skyrizi (Risankizumab) in P-III Studies for Active Psoriatic Arthritis,Biotech|Clinical Trials,2021-06-01
AstraZeneca's Farxiga (dapagliflozin) Receives the US FDA's Priority Review for Chronic Kidney Disease,Regulatory,2021-06-01
Nirmidas Receives the US FDA's EUA for its COVID-19 Rapid Antibody Fingerstick Test,COVID-19|MedTech,2021-06-01
Pfizer Collaborates with Dewpoint to Develop Therapies for Rare Form of Muscular Dystrophy,Pharma,2021-07-01
Genentech Signs ~$1B Pact with Ribometrix to Develop RNA-Targeted Small Molecule Therapies,Biotech,2021-07-01
Astellas Reports the US FDA's Acceptance of Priority Review for its NDO Therapy,Regulatory,2021-07-01
"Merck KGaA Acquires AmpTec to Strengthen its mRNA Capabilities for Vaccines, Treatments and Diagnostics",M&A,2021-07-01
Pfizer Signs a License and Supply Agreement with ImaginAb for CD8 ImmunoPET Technology,Biotech,2021-07-01
Hologic to Acquire Biotheranostics for ~$230M,M&A|MedTech,2021-07-01
Bayer Collaborates with CureVac for CVnCoV Against COVID-19,Biotech|COVID-19,2021-08-01
Alnylam Reports Results of Vutrisiran in P-III HELIOS-A Study for Patients with hATTR Amyloidosis with Polyneuropathy,Clinical Trials,2021-08-01
Pfizer Reports the First Patients Dosing of PF-06939926 in P-III CIFFREO Study for DMD,Clinical Trials,2021-08-01
PerkinElmer to Acquire Oxford Immunotec for ~$591M,M&A,2021-08-01
Sarepta Reports Mixed Results of SRP-9001 (rAAVrh74.MHCK7.micro-dystrophin) in Part 1 of Study 102 for DMD,Clinical Trials,2021-08-01
Almirall and Tyris Collaborate to Develop Next Generation Gene Therapies,Biotech,2021-08-01
AbbVie Reports Results of Skyrizi (risankizumab) in P-III Induction Studies for Crohn's Disease,Clinical Trials,2021-11-01
Roche's Xofluza Receives the EC's Approval for the Treatment of Influenza,Regulatory,2021-11-01
BioMarin Reports Results of Valoctocogene Roxaparvovec in P-III GENEr8-1 Study for Hemophilia A,Clinical Trials,2021-11-01
Sanofi to Acquire Kymab for ~$1.45B,M&A,2021-11-01
Chi-Med and Inmagene Collaborate to Develop Therapies for Immunological Diseases,Pharma,2021-11-01
BMS Collaborates with ArsenalBio to Advance Next-Generation T cell Therapies for Solid Tumors,Pharma,2021-11-01
Biogen and Apple Collaborate to Launch Virtual Study on Cognitive Decline,Clinical Trials|DigiHealth,2021-12-01
Novartis In-Licenses BieGene's Tislelizumab to Expand its Oncology Portfolio,Biotech,2021-12-01
Bluebird bio to Spin Off its Oncology Business into Independent Company,Pharma,2021-12-01
AstraZeneca Collaborates with Adaptive on Mapping Immune Response in Cancer,Biotech,2021-12-01
Roche Reports Updated OS Data of Tecentriq + Avastin in P-III IMbrave150 Study for Unresectable HCC,Clinical Trials,2021-12-01
GSK and VIR Biotechnology to Evaluate VIR-7832 in the Early Treatment of COVID-19,Clinical Trials,2021-12-01
Gilead Collaborates with VIR to Evaluate Combination Therapy for Chronic Hepatitis B Virus,Pharma,13/1/2021
"Lundback's Vyepti (eptinezumab, IV) Receives Health Canada's Approval for Preventive Treatment of Migraine",Regulatory,13/1/2021
Bayer Reports the US FDA's Acceptance of NDA and Grants Priority Review for Finerenone (BAY 94-8862) to Treat CKD and T2D,Regulatory,13/1/2021
UCB Launches Nile AI as a Digital Health Company to Transform the Course of Epilepsy,DigiHealth,13/1/2021
Teladoc Health and Dexcom Offers CGM-Powered Insight for T2D,DigiHealth,13/1/2021
The US Government to Purchase Additional Doses of Regeneron's Casirivimab and Imdevimab to Combat COVID-19,COVID-19,13/1/2021
Kamada to Commercialize Three Biosimilar Products in Israel,Biosimilars,14/1/2021
Amgen Collaborates with Evoq to Develop Novel Therapies for Autoimmune Disorders,Pharma,14/1/2021
"ViiV Healthcare's Tivicay (dolutegravir, dispersible tablets) Receives the EMA's Approval for Children with HIV",Regulatory,14/1/2021
Celltrion Report Results of CT-P59 in P-II/III Study for COVID-19,Clinical Trials|COVID-19,14/1/2021
Sanofi Signs a License Agreement with Biond for BND-22,Biotech,14/1/2021
BeiGene's Tislelizumab (BGB-A317) + CT Receive NMPA's Approval as 1L Therapy for Advanced Squamous NSCLC,Regulatory,14/1/2021
Takeda and KSQ Collaborate to Develop and Commercialize Novel Immuno-Oncology Therapies,Biotech,15/1/2021
Pfizer's Xalkori (crizotinib) Receives the US FDA's Approval for ALK-Positive Anaplastic Large Cell Lymphoma In Children And Young Adults,Regulatory,15/1/2021
Abbott to Launch NeuroSphere myPath App to Record Pain Relief in Chronic Pain Patients,DigiHealth,15/1/2021
"Henlius' HLX15 (biosimilar, daratumumab) Receives IND Approval for Multiple Myeloma in China",Biosimilars,15/1/2021
Philips Collaborates with Merck KGaA to Advance Personalized Fertility Treatment,DigiHealth,15/1/2021
Novartis' Ligelizumab (QGE031) Receives the US FDA's Breakthrough Designation for Patients with Chronic Spontaneous Urticaria,Regulatory,15/1/2021
GSK Presents Results of Dostarlimab in P-I GARNET Study for dMMR Solid Cancers at ASCO GI,Clinical Trials,18/1/2021
Daiichi Sankyo and AstraZeneca's Enhertu Receive the US FDA's Approval for Previously Treated HER2-Positive Advanced Gastric Cancer,Regulatory,18/1/2021
AstraZeneca's Imfinzi (durvalumab) New Dosing Option Receives Approval for NSCLC in the EU &amp; UK,Regulatory,18/1/2021
Genmab's Darzalex Faspro (daratumumab and hyaluronidase-fihj) Receives the US FDA's Approval for Patients with Newly Diagnosed Light-chain (AL) Amyloidosis,Regulatory,18/1/2021
Cardiff Oncology Report Results of Onvansertib in P- Ib/II Study for KRAS-Mutated Metastatic Colorectal Cancer,Clinical Trials,18/1/2021
Nanobiotix Presents Results of NBTXR3 (PEP503) in P-Ib/II Study for Rectal Cancer at ASCO-GI 2021,Clinical Trials,18/1/2021
Boehringer Ingelheim Collaborates with Cure Genetics to Develop Next-Generation Liver-Targeted Gene Therapy,Biotech,19/1/2021
Tessa's CD30 CAR-T Therapy Receives EMA's PRIME Designation for Relapsed or Refractory Classical Hodgkin Lymphoma,Regulatory,19/1/2021
Janssen Signs a Research Agreement with TenNor to Develop Treatments for Nontuberculous Mycobacteria Diseases,Biotech,19/1/2021
Grifols to Evaluate New Immunoglobulin Therapy Against COVID-19 in Spain,Clinical Trials,19/1/2021
"Innovent Out Licenses Byvasda's (biosimilar, bevacizumab) Development and Commercialization Rights to PT Etana in Indonesia",Biosimilars,19/1/2021
Philips to Acquire Capsule Technologies for ~$635M,DigiHealth|M&A,19/1/2021
Biocryst's Orladeyo (berotralstat) Receives the US FDA's Approval to Prevent Attacks of Hereditary Angioedema (HAE),Regulatory,15/12/2020
Myovant's Orgovyx (relugolix) Receives the US FDA's Approval as the First Oral GnRH Receptor Antagonist for Advanced Prostate Cancer,Regulatory,15/12/2020
Lilly and Merus Collaborate to Discover Novel T-Cell Re-Directing Bispecific Antibodies,Biotech,20/1/2021
Thermo Fisher to Acquire Mesa Biotech for $450M,M&A|MedTech,20/1/2021
Omeros Reports the US FDA's Acceptance and Priority Review of BLA for Narsoplimab (OMS721) to Treat HSCT-TMA,Regulatory,20/1/2021
Daiichi Sankyo and AstraZeneca's Enhertu (trastuzumab deruxtecan) Receives EU's Approval for the HER2 Positive Metastatic Breast Cancer,Regulatory,20/1/2021
Sorrento Presents Preliminary Results of STI-2020 Against COVID-19,Clinical Trials,20/1/2021
Biohaven's Troriluzole Fails to Meet its Co-Primary Endpoints in P-II/III Study for Alzheimer's Disease,Clinical Trials,20/1/2021
MacroGenics' Margenza (margetuximab-cmkb) Receives the US FDA's Patients with Pretreated Metastatic HER2-Positive Breast Cancer,Regulatory,15/12/2020
Ridgeback's Ebanga (mAb114) Receives the US FDA's Approval for the Treatment of Ebola,Regulatory,22/12/2020
Urovant's Gemtesa (vibegron) Receives the US FDA's Approval for Overactive Bladder,Regulatory,23/12/2020
Merck KGaA and GSK's Bintrafusp Alfa Fails to Meet its Co-Primary Endpoints in Lung Cancer Study,Clinical Trials,21/1/2021
Vanda's Hetlioz (tasimelteon) Receives the US FDA's Approval for Nighttime Sleep Disturbances in Smith-Magenis Syndrome,Regulatory,2020-01-12
Bayer and Merck's Verquvo (vericiguat) Receives the US FDA's Approval to Treat Chronic Heart Failure,Regulatory,21/1/2021
Haemonetics to Acquire Cardiva Medical for ~$510M,M&A|MedTech,21/1/2021
Qiagen's PCR Tests Demonstrate Effectiveness in Detecting Mutations in SARS-CoV-2 Virus,MedTech,21/1/2021
Roche Reports the US FDA's Acceptance of sNDA and Granted Priority Review for Esbriet (pirfenidone) to Treat UILD,Regulatory,21/1/2021
Novo Nordisk Report Submission of label Expansion Application to US FDA's for Ozempic (semaglutide) for T2D,Regulatory,21/1/2021
The US FDA Approves Gallium 68 PSMA-11 as the First PSMA-Targeted PET Imaging Drug for Men with Prostate Cancer,Regulatory,2020-01-12
Boston Scientific to Acquire Preventice for ~$1.2B,M&A|MedTech,22/1/2021
Servier and MiNA Therapeutics Collaborate to Develop saRNA Therapies for Neurological Diseases,Biotech,22/1/2021
Eli Lilly Reports Results of Bamlanivimab (LY-CoV555) in P-III BLAZE-2 Study for Preventing COVID-19 at Nursing Homes,Clinical Trials,22/1/2021
ViiV's Cabenuva (cabotegravir and rilpivirine) Receives the US FDA's Approval as the First and Only Complete Long-Acting Regimen for HIV treatment,Regulatory,22/1/2021
MTPA and Aquestive Sign a License and Supply Agreement for Exservan (riluzole) to Treat ALS in the US,Biotech,22/1/2021
Takeda's Alunbrig (brigatinib) Receives MHLW's Approval as a 1L and 2L Treatment for ALK+ Advanced or Recurrent NSCLC,Regulatory,22/1/2021
Exelixis Cabometyx (cabozantinib) + Opdivo (nivolumab) Receives US FDA's Approval as a 1L Treatment for Patients with Advanced Renal Cell Carcinoma,Regulatory,25/1/2021
P&G Signs a License Agreement with Rhinostics to Launch its Novel Nasal Swab into the Market for Rapid COVID-19 Testing and Address Supply Shortages,Regulatory,25/1/2021
Aurinia Lupkynis (voclosporin) Receives US FDA's Approval to Treat Adult Patients with Active Lupus Nephritis,Regulatory,25/1/2021
Pfizer and BioNTech Signs an Agreement with Covax for Advance Purchase of Vaccine to Help Combat COVID-19,COVID-19|Regulatory,25/1/2021
Incyte Reports Acceptance and Priority Review of BLA for Retifanlimab to Treat Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC),Regulatory,25/1/2021
Ervaxx and Cardiff University Collaborate to Develop Novel T-cell and T-cell Receptor-based Immunotherapeutics Targeting Dark Antigens,Biotech,25/1/2021
Merck's Keytruda (pembrolizumab) Receives EC's Approval as 1L Treatment for Metastatic Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Colorectal Cancer,Regulatory,27/1/2021
Eli Lilly and AbCellera Report Results of Bamlanivimab (LY-CoV555) and Etesevimab (LY-CoV16) in P-II/III BLAZE-1 Study for Preventing COVID-19,Clinical Trials|COVID-19,27/1/2021
Shionogi Concludes a License Agreement with BioAge for BGE-175 to Control the Aggravation of COVID-19,Clinical Trials|COVID-19,27/1/2021
Regeneron Reports Results of REGEN-COV Antibody Cocktail Used as Passive Vaccine to Prevent COVID-19,Clinical Trials|COVID-19,27/1/2021
AbbVie's Rinvoq (upadacitinib) Receives the EC's Approval for Psoriatic Arthritis and Ankylosing Spondylitis,Regulatory,27/1/2021
Abbott's Panbio Rapid Antigen Test Receives CE Mark for Mass COVID-19 Screening,COVID-19|MedTech,27/1/2021
Eli Lilly Collaborates with GSK and VIR to Evaluate Bamlanivimab (LY-CoV555) with VIR-7831 (GSK4182136) for COVID-19,Clinical Trials|COVID-19,28/1/2021
"Innovent's Byvasda (biosimilar, bevacizumab) Receives NMPA's Approval for the Treatment of Adult Recurrent Glioblastoma",Biosimilars,21/12/2020
AMCP Partnership Forum Develops Strategies to Support the Use and Development of Biosimilar in the US,Biosimilars,21/12/2020
AstraZeneca Selects AI-Generated CKD Target Under its Collaboration with BenevolentAI,Biotech,28/1/2021
Pfizer's Xeljanz (tofacitinib) Fails to Meet its Co-Primary Endpoint in ORAL Surveillance Safety Study,Clinical Trials,28/1/2021
Regeneron's REGEN-COV Antibody Cocktail Confirms its Effectiveness Against UK and South Africa SARS-CoV-2 Variants,Clinical Trials|COVID-19,28/1/2021
ImaginAb Signs a Multi-Year Non-Exclusive License Agreement with Neuvogen for CD8 ImmunoPET Technology,Pharma,28/1/2021
BioInvent Report Results of BI-1206 + Rituximab in P- I/IIa Study for Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma,Clinical Trials,28/1/2021
"Bio-Thera Collaborates with Biomm to Commercialize BAT1706 (biosimilar, bevacizumab) in Brazil",Biosimilars,17/12/2020
"Celltrion Receives the CHMP's Positive Opinion for CT-P17 (biosimilar, adalimumab)",Biosimilars,2020-11-12
"Henlius Receives the NMPA's Approval for HLX03 (biosimilar, adalimumab) to Treat Autoimmune Disease",Biosimilars,2020-07-12
Merck Signs an Exclusive Worldwide License Agreement with Artiva to Develop CAR-NK Cell Therapies,Biotech,29/1/2021
Amgen Report Results of Sotorasib in P-II Study for KRAS G12C-Mutated Advanced NSCLC,Clinical Trials,29/1/2021
Bio-Thera Solutions Reports the US FDA's Acceptance of BLA for BAT1706 (Proposed Biosimilar to Avastin),Biosimilars,29/1/2021
Lilly Signs a License Agreement with Asahi Kasei Pharma for AK1780 to Treat Chronic Pain,Pharma,29/1/2021
Janssen Reports Results of Amivantamab in P-I CHRYSALIS Study for Metastatic or Unresectable NSCLC and EGFR Exon 20 Insertion Mutations,Clinical Trials,29/1/2021
Roche Collaborate with Cambridge Quantum Computing to Develop Quantum Algorithm for Drug Discovery and Development,MedTech,29/1/2021
Merck's Report Results of Keytruda (pembrolizumab) in Combination With Ipilimumab vs Keytruda Monotherapy in P-III KEYNOTE-598 for Metastatic Non-Small Cell Lung Cancer Patients,Clinical Trials,2021-01-02
Novo Nordisk Receives the CHMP's Positive Opinion for Sogroya (somapacitan),Regulatory,2021-01-02
Amgen's Sotorasib Receives NMPA's Breakthrough Therapy Designation in China for the Treatment of Advanced NSCLC With KRAS G12C Mutation,Regulatory,2021-01-02
Johnson & Johnson Report Results from P-III ENSEMBLE Trial for COVID-19 Vaccine,COVID-19,2021-01-02
Gan &amp; Lee Receives the US FDA's Fast Track Designation for GLR2007 for the Treatment of Patients with Glioblastoma,Regulatory,2021-01-02
Incyte Receive Positive CHMP's Opinion for Pemigatinib,Regulatory,2021-01-02
Horizon Therapeutics to Acquire Viela Bio for ~ $3.05B,M&A,2021-02-02
Gilead Signs an Option and License Agreement with Gritstone for HIV Vaccine,Biotech,2021-02-02
Janssen Reports CHMP's Acceptance for Accelerated Assessment of Cilta-cel's MAA to Treat Patients with Heavily Pretreated Multiple Myeloma,Regulatory,2021-02-02
Medtronic Receives the US FDA's Approval for DiamondTemp Ablation System to Treat Atrial Fibrillation,MedTech,2021-02-02
Clover and Dynavax Plan to Initiate P-II/III Trial for Adjuvanted COVID-19 Vaccine Candidate,Clinical Trials|COVID-19,2021-02-02
"Celltrion Receives Health Canada's Approval for Remsima SC (biosimilar, infliximab) for Rheumatoid Arthritis",Biosimilars,2021-02-02
BMS' Deucravacitinib Demonstrate Superiority Over Otezla (apremilast) in P-III POETYK PSO-2 Study for Plaque Psoriasis,Clinical Trials,2021-03-02
Genentech Signs an Exclusive License Agreement with X-Chem to Discover Oncology Targets,Pharma,2021-03-02
Innovent's Tyvyt (sintilimab) + Pemetrexed and Platinum CT Receives NMPA's Approval as 1L Therapy with Non-squamous Non-Small Cell Lung Cancer,Regulatory,2021-03-02
GSK Collaborate with CureVac to Develop Next Generation mRNA COVID-19 Vaccines,Biotech|COVID-19,2021-03-02
Russia's Sputnik V Demonstrates 92% Efficacy Against COVID-19,Clinical Trials|COVID-19,2021-03-02
Covaxx Initiates P-II Trial of UB-612 Against COVID-19 in Taiwan,Clinical Trials|COVID-19,2021-03-02
Jazz to Acquire GW Pharmaceuticals for $7.2B,M&A,2021-04-02
EMA's CHMP Recommends the Approval of Two Bevacizumab Biosimilars,Biosimilars,28/1/2021
"Innovent Reports sNDA Acceptance of Tyvyt (sintilimab) + Byvasda (biosimilar, bevacizumab) as 1L Therapy for Hepatocellular Carcinoma",Biosimilars,13/1/2021
Merck KGaA's Tepmetko (tepotinib) Receives the US FDA's Approval for Patients with Metastatic NSCLC with METex14 Skipping Alterations,Regulatory,2021-04-02
Pfizer Signs a License and Research Agreement with Imcyse to Develop Imotopes for Rheumatoid Arthritis,Pharma,2021-04-02
"Henlius to Initiate P-III Study of HLX04-O (biosimilar, bevacizumab) in Australia",Biosimilars,29/1/2021
Thermo Fisher Collaborates with JW Therapeutics for CAR-T Therapies in China,Biotech,2021-04-02
Daiichi Sankyo Initiates P-II Study of Patritumab Deruxtecan in Patients with EGFR-Mutated NSCLC,Clinical Trials,2021-04-02
Astellas' Xospata (gilteritinib) Receives NMPA's Conditional Approval for R/R AML with a FLT3 Mutation,Regulatory,2021-04-02
AstraZeneca's Forxiga (dapagliflozin) Receives NMPA's Approval for Chronic Heart Failure,Regulatory,2021-05-02
Biocon Biologics Signs an Agreement with CHAI to Expand Access to its Oncology Biosimilars in 30 Countries,Biosimilars,2021-05-02
23andMe Going Public Via Virgin Group SPAC Merger,M&A,2021-05-02
Johnson &amp; Johnson Reports EUA Submission to US FDA's for its Single Shot COVID-19 Vaccine Candidate,Regulatory,2021-05-02
Enzene Receives Marketing Authorization for Teriparatide (biosimilar) in India,Biosimilars,2021-05-02
Reistone Report Results for SHR0302 in P-II Study to Treat Ulcerative Colitis,Clinical Trials,2021-05-02
BMS' Breyanzi (lisocabtagene maraleucel) Receives the US FDA's Approval for Adults With R/R Large-B-Cell Lymphoma,Regulatory,2021-08-02
Daiichi Sankyo Signs an Outsourcing Agreement with AstraZeneca for COVID-19 Vaccine in Japan,COVID-19,2021-08-02
Roche's Elecsys GDF-15 Assay Receives the US FDA's Breakthrough Device Designation as a CDX in Cancer Treatment,MedTech,2021-08-02
CureVac Collaborate with UK Government to Develop Vaccines Against SARS-CoV-2 variants,Biotech|COVID-19,2021-08-02
AstraZeneca's Imfinzi Fails to Meet its Primary Endpoints in P-III KESTREL Study,Clinical Trials,2021-08-02
Celltrion's Regdanvimab (CT-P59) Receives Korean MFDS Conditional Marketing Authorization for COVID-19,Clinical Trials|COVID-19,2021-08-02
ViiV Healthcare's Rukobia (fostemsavir) Receives Marketing Authorization for the Treatment of Adults with Multidrug-Resistant HIV,Regulatory,2021-09-02
Hologic Collaborate with Google Cloud to Advance Screening in Cervical Cancer,MedTech,2021-09-02
Signifier's eXciteOSA Receives US FDA's Approval for the Treatment of Mild Obstructive Sleep Apnea and Snoring,MedTech,2021-09-02
BMS' Inrebic (fedratinib) Receives EC's Approval for Patients with Newly Diagnosed and Previously Treated Myelofibrosis,Regulatory,2021-09-02
Medidata Launches Sensor Cloud to Connect Device and Wearables in Clinical Trials,MedTech,2021-09-02
BMS Report Results of Opdivo (nivolumab) + Cabometyx (cabozantinib) in P-III CheckMate -9ER Trial for 1L Treatment of Advanced Renal Cell Carcinoma,Clinical Trials,2021-09-02
Lee's Pharma Socazolimab Receives NMPA's Breakthrough Therapy Designation for Treatment of Recurrent or Metastatic Cervical Cancer,Regulatory,2021-10-02
Regeneron and Sanofi's Libtayo (cemiplimab-rwlc) Receives US FDA's Approval for Patients with Advanced Basal Cell Carcinoma,Regulatory,2021-10-02
Eli Lilly and AbCellera's Bamlanivimab (LY-CoV555) and Etesevimab (LY-CoV016) Receive the US FDA's EUA for COVID-19,Regulatory,2021-10-02
Lannett Expand its Partnership with HEC to Include Biosimilar Fast-Acting Insulin,Biosimilars,2021-10-02
Vico's VO659 Receives EC's Orphan Drug Designation for Spinocerebellar Ataxia,Regulatory,2021-10-02
Lonza to Divest Specialty Ingredients Business to Bain Capital and Cinven for $4.7B,M&A,2021-10-02
Kaia Health Offers a Complete Musculoskeletal Care Solution with Kaia Gateway and Premium Partners,MedTech,2021-11-02
Galapagos and Gilead Discontinue the P-III Trials of Ziritaxestat (GLPG1690) for Idiopathic Pulmonary Fibrosis,Clinical Trials,2021-11-02
AbbVie Signs a License Agreement with Caribou Biosciences for CAR-T Cell Therapies,Biotech,2021-11-02
Sanofi Collaborates with i2O Therapeutics to Evaluate Oral i2O Therapeutics,Biotech,2021-11-02
AstraZeneca Signs Letter of Intent with IDT Biologika to Boost COVID-19 Vaccine Manufacturing Capability in the EU,COVID-19,2021-11-02
Evotec Collaborates with Related Sciences for Drug Discovery and Development,Pharma,2021-11-02
BMS Collaborates with Molecular Templates to Develop Engineered Toxin Body Therapies for Cancer,Biotech,2021-12-02
Novartis to Acquire GSK's Cephalosporin Antibiotics Business,M&A,2021-12-02
Regeneron's Evkeeza (evinacumab-dgnb) Receives the US FDA's Approval for Patients with Homozygous Familial Hypercholesterolemia,Regulatory,2021-12-02
Roche Reports Results of Faricimab in Four P-III Studies for Diabetic Macular Edema and Age-Related Macular Degeneration,Clinical Trials,2021-12-02
Takeda Collaborates with Ensoma to Accelerate Next-Generation In Vivo Gene Therapies,Biotech,2021-12-02
Visby's POC COVID-19 Test Receives the US FDA's EUA for Use in CLIA Waived Settings,MedTech,2021-12-02
G1 Therapeutics' Cosela (trilaciclib) Receives US FDA's Approval as the First Myeloprotection Therapy for Extensive-Stage Small Cell Lung Cancer,Regulatory,15/2/2021
Takeda Report Results of TAK-620 (maribavir) in P-III SOLCTICE Trial for the Treatment of Post-Transplant Patients with Cytomegalovirus Infection,Clinical Trials,15/2/2021
Pfizer's Panzyga Receives the US FDA's Approval of sBLA for Chronic Inflammatory Demyelinating Polyneuropathy,Regulatory,15/2/2021
Merck Report Result of Keytruda (pembrolizumab) + Lenvima (lenvatinib) as 1L Treatment for Advanced Renal Cell Carcinoma,Regulatory,15/2/2021
"Biocon Biologics and Viatris Receive EC's Approval for Kixelle (biosimilar, insulin aspart) for Diabetes Mellitus",Biosimilars,15/2/2021
Roche's Receives the US FDA's Clearance for Urine Sample Type for BK Virus Quantitative Test,MedTech,15/2/2021
Exelixis Report Results of Cabometyx (cabozantinib) in P-II PAPMET Study for Patients with Metastatic Papillary Renal Cell Carcinoma,Clinical Trials,16/2/2021
"Celltrion Receives EC's Approval for Yuflyma (biosimilar, adalimumab) for the Treatment of Multiple Chronic Inflammatory Diseases",Biosimilars,16/2/2021
Targovax Receives US FDA's Fast Track Designation for ONCOS-102 for Malignant Pleural Mesothelioma,Regulatory,16/2/2021
AstraZeneca and Serum Institute of India's COVID-19 Vaccine Receive WHO's EUA to Prevent COVID-19,Regulatory,16/2/2021
Aker BioMarine Collaborate with Université de Sherbrooke Department of Medicine for Alzheimer's Disease,Biotech,16/2/2021
Onward Signs a Worldwide Exclusive License and Co-Development Agreement with Biomunex for Immuno-Oncology,Pharma,16/2/2021
Guardant Health Launches Guardant Reveal Liquid Biopsy Test for Early-Stage Colorectal Cancer,Biotech,17/2/2021
BMS and Acceleron's Reblozyl (Luspatercept) Receives Health Canada Approval for Adult Patients With Myelodysplastic Syndromes,Regulatory,17/2/2021
Novartis Report Results of Kesimpta (ofatumumab) Sensoready Autoinjector Pen for Multiple Sclerosis,Biotech,17/2/2021
GSK Initiates P-III study for RSV Candidate Vaccine Programme for Older Adults,Clinical Trials,17/2/2021
Novartis's Entresto Receives US FDA's Approval for Chronic Heart Failure,Regulatory,17/2/2021
Boehringer Ingelheim Animal Health Establishes Pawru for its PetPro Portfolio,Animal Health,17/2/2021
"Coherus Reports the US FDA's Acceptance of BLA for CHS-1420 (biosimilar, adalimumab)",Biosimilars,18/2/2021
Lilly Reports Results of Tirzepatide in P-lll SURPASS-3 and 5 Trials for Type-2 Diabetes,Clinical Trials,18/2/2021
Novartis Collaborates with Bill &amp; Melinda Gates Foundation to Discover and Develop Gene Therapy for Sickle Cell Disease,Biotech,18/2/2021
GSK Expand its 2020 Collaboration with Vir to Advance New Therapies for Influenza and Other Respiratory Viruses,Biotech,18/2/2021
Myovant and Pfizer Publish the Results of Relugolix Combination Regimen in P-III LIBERTY Studies in NEJM,Clinical Trials,18/2/2021
BeiGene Reports the US FDA's Acceptance of sNDA for Brukinsa (zanubrutinib) in Waldenström's Macroglobulinemia,Regulatory,18/2/2021
"ViiV's Vocabria (cabotegravir, tablet formulation) Receives the US FDA's Approval for the Treatment of HIV-1 infection",Regulatory,22/1/2021
Lilly Collaborates with Rigel to Develop RIPK1 Inhibitors for Immunological and Neurodegenerative Diseases,Pharma,19/2/2021
"Fresenius Kabi Launches Idacio (biosimilar, adalimumab) for Multiple Chronic Inflammatory Conditions in Canada",Biosimilars,19/2/2021
Dermavant Report Results of Tapinarof Cream in P-III PSOARING 3 Study with Durable and Remittive Benefits for Plaque Psoriasis,Clinical Trials,19/2/2021
The US FDA Approves Patient Specific Talus Spacer to Treat AVN of Ankle Joint as a Humanitarian Use Device,MedTech|Regulatory,19/2/2021
Astellas and Seagen Reports Submission of Two BLA to the US FDA for Padcev (enfortumab vedotin) in Locally Advanced or Metastatic Urothelial Cancer,Regulatory,19/2/2021
RedHill Signs a Manufacturing Agreement with Cosmo for Movantik and RHB-204,COVID-19|Pharma,19/2/2021
Roche Concludes the License Agreement with Chugai for AT-527 to Treat COVID-19 in Japan,Biotech|COVID-19,22/2/2021
Immunocore's Tebentafusp Receives the US FDA's Breakthrough Therapy Designation for Unresectable or Metastatic Uveal Melanoma,Regulatory,22/2/2021
Astellas Reports Results of Fezolinetant in Two P-III Studies for the Nonhormonal Treatment of VMS in Postmenopausal Women,Clinical Trials,22/2/2021
Incyte Reports the US FDA's Acceptance of NDA for Priority Review of Ruxolitinib Cream to Treat Atopic Dermatitis,Regulatory,22/2/2021
AstraZeneca to Withdraw Imfinzi Indication in Advanced Bladder Cancer in the US,Regulatory,22/2/2021
Sanofi and GSK Initiate P-II Study of their Adjuvanted Recombinant Protein-Based COVID-19 Vaccine,Clinical Trials|COVID-19,22/2/2021
Regeneron and Sanofi's Libtayo (cemiplimab-rwlc) Receive the US FDA's Approval as 1L Treatment for Advanced NSCLC,Regulatory,23/2/2021
AbbVie Report Results of Rinvoq (upadacitinib) in Second P-III Induction Study for Ulcerative Colitis,Clinical Trials,23/2/2021
Incyte Reports the US FDA's Acceptance of sNDA for Priority Review of Jakafi (ruxolitinib) to Treat Chronic Graft Versus Host Disease,Regulatory,23/2/2021
BMS Expands its Collaboration with Compugen to Evaluate the Combination of COM701 + Opdivo,Clinical Trials,23/2/2021
Amgen Reports sNDA Submission of Otezla (apremilast) to The US FDA's for Adults with Mild to Moderate Plaque Psoriasis,Regulatory,23/2/2021
MatriSys Report Results of MSB-0221 in P-I study for the Topical Treatment of Atopic Dermatitis,Clinical Trials,23/2/2021
Graviton Signs an Exclusive Worldwide License Agreement with Beijing Tide for TDI01,Pharma,24/2/2021
Sanofi's Dupixent (dupilumab) Receives Health Canada Approval as the First Biologic to Treat Atopic Dermatitis in Children,Regulatory,24/2/2021
Merck KGaA Signs an Exclusive Worldwide License Agreement with Day One for Pimasertib and MSC2015103B,Pharma,24/2/2021
Pfizer Reports the US FDA's Acceptance and Priority Review of BLA for Ticovac (Tick-Borne Encephalitis Vaccine),Regulatory,24/2/2021
Takeda Reports First Patients Dosing in P-I/II Study of Novavax's COVID-19 Vaccine Candidate in Japan,Clinical Trials,24/2/2021
Bio-Techne Collaborates with Luminary to Utilize TcBuster in the Development of CAR-T cell Therapies,Biotech,24/2/2021
UCB Collaborates with Microsoft to Accelerate Drug Discovery and Development,Biotech,25/2/2021
Sanofi Collaborates with Sirion to Develop Gene Therapy Treatment with Improved AAV Capsids,Biotech,25/2/2021
Roche Report Results of Evrysdi (risdiplam) in FIREFISH Study for Infants with Type 1 SMA,Clinical Trials,25/2/2021
AbbVie's Humira (adalimumab) Receives the US FDA's Approval to Treat Pediatric Patients with Ulcerative Colitis,Regulatory,25/2/2021
Qiagen Expand its Collaboration with Inovio to Develop Liquid Biopsy Based CDx for VGX-3100 to Treat Advanced Cervical Dysplasia,MedTech,25/2/2021
Intra-Cellular Reports the Expansion of Pipeline with the Addition of ITI-1284,Pharma,25/2/2021
Merck to Acquire Pandion for ~$1.85B,M&A,26/2/2021
Otsuka and Click Initiate Digital Study in Adults with Major Depressive Disorder,MedTech,26/2/2021
GSK Report Results of Otilimab in P-II OSCAR Study to Treat Hospitalized Patients with COVID-19,Clinical Trials,26/2/2021
Lilly to Integrate its Digital Insulin Pen with Welldoc's BlueStar App,MedTech,26/2/2021
Daiichi Sankyo Collaborates with LYSA-LYSARC-CALYM for Valemetostat in Patients with R/R B-Cell Lymphoma,Pharma,26/2/2021
Regeneron Reports IDMC Clearance of Efficacy for REGEN-COV (Casirivimab + Imdevimab) in P-III COVID-19 Outpatient Outcomes Trial,Regulatory,26/2/2021
BridgeBio and Origin's Nulibry (fosdenopterin) Receives the US FDA's Approval as the First Therapy to Reduce the Risk of Mortality in Patients with MoCD Type A,Regulatory,2021-01-03
Roivant to Acquire Silicon Therapeutics for ~$450M,M&A,2021-01-03
AstraZeneca and Amgen Report Results of Tezepelumab in P-III NAVIGATOR Trial for Severe Asthma,Clinical Trials,2021-01-03
Johnson &amp; Johnson Receives the US FDA's EUA for COVID-19 Vaccine,Regulatory,2021-01-03
Regeneron's Ab Cocktail (casirivimab + imdevimab) Receives the CHMP's Positive Opinion to Treat COVID-19,COVID-19|Regulatory,2021-01-03
BMS' Opdivo (nivolumab) + Cabometyx (cabozantinib) Receive CHMP's Positive Opinion as 1L Treatment for Advanced Renal Cell Carcinoma,Regulatory,2021-01-03
Merck KGaA Sign an Exclusive Worldwide License Agreement with Debiopharm for Xevinapant,Pharma,2021-02-03
Merck Reports the US FDA's Acceptance of NDA for Review of Gefapixant to Treat Refractory or Unexplained Chronic Cough,Regulatory,2021-02-03
Samsung Bioepis Initiates P-I Study of SB17 Proposed Biosimilar to Stelara (ustekinumab),Biosimilars|Clinical Trials,2021-02-03
Hologic to Acquire Diagenode for ~$159M,M&A|MedTech,2021-02-03
YL Biologics Reports the NDA Submission of YLB217 (biosimilar product of long-acting erythropoiesis stimulating agent Nesp),Biosimilars,2021-02-02
AstraZeneca Collaborates with Junshi to Commercialize Toripalimab in China,Pharma,2021-02-03
Veru to Advance VERU-111 in P-III Study for COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome,Clinical Trials,2021-02-03
Fujifilm Kyowa Kirin and Mylan EPD Launch Adalimumab Biosimilar in Japan,Biosimilars,15/2/2021
"Sandoz Launches Hyrimoz (biosimilar, adalimumab) in Canada",Biosimilars,16/2/2021
AbbVie Signs a Purchase Right Agreement to Acquire Mitokinin,M&A,2021-03-03
"Viatris Launches Hulio (biosimilar, adalimumab) in Canada",Biosimilars,18/2/2021
"Biocon Biologics and Viatris Receive CHMP's Positive Opinion for Abevmy (biosimilar, bevacizumab)",Biosimilars,2021-03-03
"Tanvex Reports Results of TX05 (biosimilar, trastuzumab) in P-III Study for HER2-Positive Early Breast Cancer",Biosimilars,20/2/2021
"Celltrion Initiates P-III Study of CT-P42 (biosimilar, aflibercept)",Biosimilars,2021-08-02
G1 Therapeutics and Boehringer Ingelheim Launch Cosela (trilaciclib) in the US,Pharma,2021-03-03
Fusion to Acquire Ipsen's IPN-1087 to Expand its Pipeline of Radiopharmaceuticals,M&A,2021-03-03
BeiGene's Brukinsa (zanubrutinib) Receives Health Canada's Approval for Waldenström's Macroglobulinemia,Regulatory,2021-03-03
Amgen Reports Results of Blincyto (blinatumomab) in P-III Study for Relapsed Acute Lymphoblastic Leukemia in Pediatric Patients,Clinical Trials,2021-03-03
Boston Scientific Signs an Agreement with BPEA to Acquire Lumenis' Surgical Business,M&A|MedTech,2021-04-03
Takeda Signs an Exclusive License Agreement with Ovid for Soticlestat to Treat Dravet Syndrome and Lennox-Gastaut Syndrome,Pharma,2021-04-03
Pfizer's Lorbrena (lorlatinib) Receives FDA's Approval for Expanding its Indication to Treat ALK-Positive Metastatic Lung Cancer,Regulatory,2021-04-03
Regeneron and Sanofi Report the US FDA's Acceptance of sBLA for Review of Dupixent to Treat Moderate-to-Severe Asthma in Children,Regulatory,2021-04-03
Roche Collaborates with Tempest to Evaluate TPST-1120 in a Combination Study as 1L Treatment for Hepatocellular Carcinoma,Clinical Trials,2021-04-03
Vir and GSK Provide Update on ACTIV-3 Trial of VIR-7831 in Hospitalized Adults with COVID-19,Clinical Trials,2021-04-03
Amgen to Acquire Five Prime for ~$1.9B,M&A,2021-05-03
Lilly Reports Results of Tirzepatide in P-lll SURPASS-2 Trial for Type-2 Diabetes,Clinical Trials,2021-05-03
Agilent to Acquire Resolution Bioscience for $695M,M&A|MedTech,2021-05-03
Roche's Actemra/RoActemra (tocilizumab) Receives the US FDA's Approval as the First Biologic for Systemic Sclerosis-Associated Interstitial Lung Disease,Regulatory,2021-05-03
Takeda Reports NDA Submission to Import and Distribute Moderna's mRNA-1273 in Japan,COVID-19|Regulatory,2021-05-03
Eli Lilly and Incyte Report Results of Olumiant (baricitinib) in P-III BRAVE-AA2 Study for Severe Alopecia Areata,Clinical Trials,2021-05-03
ViiV Healthcare Present Results of Long- Acting Cabotegravir and Rilpivirine in P-IIIb ATLAS-2M Study for HIV at CROI 2021,Clinical Trials,2021-08-03
Lee's Pharma to Initiate P-III Trial of Socazolimab as 1L Treatment of Extensive-stage Small-Cell Lung Cancer,Clinical Trials,2021-08-03
Roche to Withdraw Tecentriq Indication in Metastatic Bladder Cancer in the US,Regulatory,2021-08-03
Gilead Presents Four-Year Data of Biktarvy for HIV-1 in Treatment-Naïve Adults at CROI 2021,Clinical Trials,2021-08-03
Kite's Yescarta Receives the US FDA's Approval for R/R Follicular Lymphoma,Regulatory,2021-08-03
Atea Presents Results of AT-527 in P-I Study for COVID 19 at CROI,Clinical Trials,2021-08-03
"Alteogen Reports Completion of P-I Study of ALT-L9 (biosimilar, aflibercept) in Korea",Biosimilars,2021-09-03
Lilly Collaborates with Biolojic to Discover and Develop Antibody Therapies for Diabetes,Biotech,2021-09-03
TrinamiX Signs a Joint Development Agreement with VIAVI Solutions to Bring Near-Infrared Spectroscopy into Smartphones,MedTech,2021-09-03
Abbott Launches NeuroSphere Virtual Clinic for Remote Neurostim Programming in the US,MedTech,2021-09-03
Axsome's AXS-05 Receives US FDA's Breakthrough Therapy Designation for the Treatment of Alzheimer's Disease Agitation,Regulatory,26/6/2020
Roche's Ventana ALK (D5F3) CDx Assay Receives the US FDA's Approval for the Treatment of ALK-Positive NSCLC,Regulatory,2021-09-03
Junshi's Toripalimab Receives the US FDA's Breakthrough Therapy Designation for the Treatment of Nasopharyngeal Carcinoma,Regulatory,2020-10-09
Novartis' Iptacopan (LNP023) Receives the US FDA's Breakthrough Therapy Designation for PNH and Rare Pediatric Disease Designation for C3G,Regulatory,16/12/2020
Exelixis Signs an Exclusive License Agreement with WuXi Biologics to Expand its Growing Oncology Biologics Pipeline,Biotech,2021-09-03
RemeGen's Disitamab Vedotin (RC48) Receives the US FDA's Breakthrough Therapy Designation for Urothelial Cancer,Regulatory,25/9/2020
Zymeworks' Zanidatamab Receives the US FDA's Breakthrough Therapy Designation for the Treatment of Biliary Tract Cancer,Regulatory,30/11/2020
IO Biotech's IO102 + IO103 Receive the US FDA's Breakthrough Therapy Designation for Unresectable/ Metastatic Melanoma,Regulatory,15/12/2020
PolyPid's D-PLEX100 Receives the US FDA's Breakthrough Therapy Designation for the Prevention of Surgical Site Infections in Colorectal Surgery,Regulatory,24/11/2020
ImmunoGen's IMGN632 Receives the US FDA's Breakthrough Therapy Designation for Relapsed or Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm,Regulatory,2020-05-10
Takeda to Acquire Maverick for ~$525M,M&A,2021-10-03
Novartis' Canakinumab Fails to Meet its Primary Endpoint in P-III CANOPY-2 Study,Clinical Trials,2021-10-03
ViiV Healthcare Presents Results of GSK3640254 (GSK'254) in P-IIa study for the Treatment of HIV at CROI,Clinical Trials,2021-10-03
Avelas' AVB-620 (pegloprastide) Receives the US FDA's Breakthrough Therapy Designation for Use During Breast Cancer Surgery,Regulatory,14/12/2020
F2G Receives the US FDA's Breakthrough Therapy Designation for Olorofim,Regulatory,22/10/2020
Telix Receives the US FDA's Breakthrough Therapy Designation for TLX250-CDx (89Zr-girentuximab),Regulatory,2020-01-07
Sorrento Collaborates with Mount Sinai to Develop Ab Combination for Neutralizing SARS-CoV-2 and other Emerging Variants of COVID-19,Biotech|COVID-19,2021-10-03
Resverlogix Receives the US FDA Breakthrough Therapy Designation for Apabetalone,Regulatory,2020-03-02
Concert's CTP-543 Receives the US FDA's Breakthrough Therapy Designation to Treat Alopecia Areata,Regulatory,2020-08-07
SMA Foundation Collaborates with PTC to Discover and Develop Regenerative Medicine,Biotech,2021-10-03
Insmed's Brensocatib Receives the US FDA's Breakthrough Therapy Designation to Treat Non-Cystic Fibrosis Bronchiectasis,Regulatory,2020-08-06
Gilead Present Results of Lenacapavir in P-II/III CAPELLA Trial for the Treatment of HIV at CROI,Clinical Trials,2021-10-03
MyoKardia's Mavacamten Receives the US FDA's Breakthrough Therapy Designation for Symptomatic Patients with Obstructive Hypertrophic Cardiomyopathy,Regulatory,23/7/2020
Debiopharm's Debio 1143 Receives the US FDA's Breakthrough Therapy Designation for Front-Line Treatment of Head and Neck Cancer,Regulatory,27/2/2020
Kiniksa's Vixarelimab Receives the US FDA's Breakthrough Therapy Designation to Treat Pruritus Associated with Prurigo Nodularis,Regulatory,16/11/2020
Turning Point's Repotrectinib Receives the US FDA's Breakthrough Therapy Designation for the Treatment of ROS1-Positive Metastatic Non-Small Cell Lung Cancer,Regulatory,2020-08-12
Inventiva's Lanifibranor Receives the US FDA's Breakthrough Designation for the Treatment of NASH,Regulatory,2020-12-10
Elli Lilly Reports Results of Bamlanivimab (LY-CoV555) and Etesevimab (LY-CoV016) in P-III BLAZE-1 Study for the Prevention of COVID-19,Clinical Trials,2021-11-03
Grifols Acquires Remaining 56% of GigaGen for ~$80M,M&A,2021-11-03
Empatica's Aura System Receives European CE Mark for Detecting Early Symptoms of COVID-19 Using Wearables,MedTech,2021-11-03
Cyprium's CUTX-101 Receives the US FDA's Breakthrough Therapy Designation for the Treatment of Menkes Disease,Regulatory,15/12/2020
Roche's Actemra/RoActemra (tocilizumab) + Veklury Fail to Meet its Primary Endpoints in P-III REMDACTA Study for Patients with Severe COVID-19 Pneumonia,Clinical Trials,2021-11-03
Aprea's APR-246 Receives the US FDA's Breakthrough Therapy Designation for Myelodysplastic Syndromes with a TP53 Mutation,Regulatory,30/1/2020
ContraFect's Exebacase Receives the US FDA's Breakthrough Therapy Designation for MRSA Bacteremia including Right-Sided Endocarditis,Regulatory,24/2/2020
BeyondSpring's Plinabulin Receives the US FDA's and NMPA's Breakthrough Therapy Designations for Chemotherapy-Induced Neutropenia Indication,Regulatory,2020-08-09
Lannett Receives the US FDA's Feedback for Development of Biosimilar Insulin Glargine,Biosimilars,2021-11-03
Vertex's VX-880 Receives the US FDA's Fast Track Designation for T1D,Regulatory,2021-11-03
Acceleron's Sotatercept Receives the US FDA's Breakthrough Therapy Designation for Pulmonary Arterial Hypertension,Regulatory,2020-08-04
Vir and GSK Report Results of VIR-7831 in P-III COMET-ICE Trial for COVID-19,Clinical Trials,2021-12-03
Astellas Reports NDA Submission of Enfortumab Vedotin to the MHLW for Locally Advanced or Metastatic Urothelial Cancer in Japan,Regulatory,2021-12-03
Abbott Launches Pandemic Defense Coalition to Detect Future Threats,COVID-19|MedTech,2021-12-03
Sanofi and Translate Bio Initiate P-I/II Study of MRT5500 Against COVID-19,Clinical Trials,2021-12-03
Takeda Reports NDA Submission of Lanadelumab to the MHLW as a Preventive Treatment for Hereditary Angioedema Attack in Japan,Regulatory,2021-12-03
PhaseBio Signs a Supply Agreement with BioVectra to Support the Development and Commercialization of Bentracimab,Biotech,2021-12-03
Eli Lilly Report Result of Donanemab in P-II TRAILBLAZER-ALZ Study for Alzheimer's Disease,Clinical Trials,15/3/2021
Regeneron and Sanofi Report Results of Libtayo (cemiplimab) in P-III Trial for Cervical Cancer,Clinical Trials,15/3/2021
Roche to Acquire GenMark Diagnostics for $1.8B,M&A,15/3/2021
BMS Collaborates with Aveo to Evaluate Opdivo (nivolumab) + Fotivda (tivozanib) in P-III Study for Relapsed Renal Cell Carcinoma,Clinical Trials|Pharma,15/3/2021
Cardinal Health to Divest its Cordis Business to Hellman &amp; Friedman for $1B,M&A|MedTech,15/3/2021
BioXcel's BXCL501 Receives the US FDA's Breakthrough Therapy Designation for Acute Treatment of Agitation Associated with Dementia,Regulatory,15/3/2021
Takeda Signs a License Agreement with Genevant to Develop Novel Nucleic Acid Therapeutics for Liver Fibrosis,Biotech,16/3/2021
Gilead Collaborates with Merck to Jointly Develop and Commercialize Lenacapavir + Islatravir for HIV,Pharma,16/3/2021
Novartis and Molecular Partners Report Inclusion of Ensovibep (MP0420) in NIH-Sponsored ACTIV-3 Trial for the Treatment of COVID 19,Clinical Trials,16/3/2021
Roche Launches Cobas SARS-CoV-2 Variant Test to Detect Emerging Coronavirus Mutations,MedTech,16/3/2021
Genentech Reports Two-Year Data of Evrysdi (risdiplam) for People with Type 2 or Type 3 SMA,Clinical Trials,16/3/2021
Merck Reports the US FDA's Acceptance of NDA for Priority Review of Belzutifan (MK-6482) to Treat Patients with Von Hippel-Lindau Disease Associated RCC,Regulatory,16/3/2021
TG Therapeutics' Ukoniq (umbralisib) Receives the US FDA's Approval for R/R Marginal Zone Lymphoma and Follicular Lymphoma,Regulatory,2021-05-02
Oncopeptides' Pepaxto (melphalan flufenamide) Receives the US FDA's Approval for Triple Class Refractory Multiple Myeloma,Regulatory,2021-01-03
GSK and Medicago Initiate P-III Trial for Adjuvanted COVID-19 Vaccine Candidate,Clinical Trials,17/3/2021
Lilly Reports Results of Mirikizumab in P-III LUCENT-1 Induction Study for Ulcerative Colitis,Clinical Trials,17/3/2021
Sanofi Out Licenses Two Sickle Cell Disease Programs to GBT for $353M,Pharma,17/3/2021
FibroGen Initiates P-III LELANTOS-2 Study of Pamrevlumab for Duchenne Muscular Dystrophy,Clinical Trials,17/3/2021
Johnson &amp; Johnson Report Long-Term Data of Tremfya (guselkumab) in P-III DISCOVER-2 Study for Active Psoriatic Arthritis,Clinical Trials,17/3/2021
NCCN Collaborates with Pfizer for New Biosimilars Research Projects in Oncology,Biosimilars,17/3/2021
Merck Collaborates with Amathus Therapeutics to Develop Treatments for Neurodegenerative Diseases,Pharma,18/3/2021
WuXi Biologics to Acquire Pfizer's Biologics Manufacturing Facilities in China,Biosimilars|M&A,18/3/2021
Merck Signs a Five-Year Agreement with M2GEN to Advance Cancer Therapies,Biotech,18/3/2021
FSD Pharma Signs a License Agreement with Innovet to Develop Veterinary Drugs for Gastro-Intestinal Diseases in Dogs and Cats,Animal Health,18/3/2021
Merck's Keytruda (pembrolizumab) Receives the EC's Approval in Adults &amp; Pediatric patients with R/R cHL,Regulatory,18/3/2021
Durect's Posimir (bupivacaine solution) Receives the US FDA's Approval for the Treatment of Post-Surgical Pain,Regulatory,2021-02-02
Sarepta's Amondys 45 (casimersen) Receives the US FDA's Approval for DMD in Patients Amenable to Skipping Exon 4,Regulatory,25/2/2021
GSK Initiates P-III Study of GSK3511294 (GSK'294) for the Treatment of Severe Asthma,Clinical Trials,18/3/2021
B. Braun's Acetaminophen Injection Receives the US FDA Approval in Multiple Doses,Regulatory,25/2/2021
Gilead Expands its Collaboration with Novo Nordisk to Evaluate Triple Combination Regimen for Compensated Cirrhosis (F4) due to NASH,Clinical Trials,19/3/2021
Boston Signs Out-License and Option Agreement with GSK to Advance Two Programs for Oncology and CNS Disorders,Pharma,19/3/2021
Pfizer Signs a WW License Agreement with Pyxis to Develop and Commercialize Two ADC Candidates,Biotech,19/3/2021
Sarepta Therapeutics Report Results of SRP-9003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2E,Clinical Trials,19/3/2021
Kiniksa's Arcalyst (rilonacept) Receives the US FDA's Approval for the Treatment of Pericarditis,Regulatory,19/3/2021
Takeda Collaborates with Anima to Discover and Develop mRNA Translation Modulators for Neurological Diseases,Biotech,19/3/2021
BMS Reports the US FDA's Acceptance of NDA for Mavacamten to Treat Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM),Regulatory,22/3/2021
Merck Presents Results of Keytruda (pembrolizumab) + Lenvima (lenvatinib) in P-III KEYNOTE-775/Study 309 trial for the Treatment of Advanced Endometrial Cancer at SGO,Clinical Trials,22/3/2021
Janssen's Ponvory (ponesimod) Receives the US FDA's Approval for the Treatment of Relapsing Multiple Sclerosis,Regulatory,22/3/2021
BridgeBio Presents Results of Encaleret in P-IIb Study for the Treatment of ADH1 at ENDO 2021,Clinical Trials,22/3/2021
BioMarin Report Results of Vosoritide in P-III OLE Study for the Treatment of Children with Achondroplasia at ENDO 2021,Clinical Trials,22/3/2021
AstraZeneca's AZD1222 Meets its Primary Endpoint in Preventing COVID-19,COVID-19,22/3/2021
Takeda Collaborates with Evotec on RNA Targeting Drug Development,Biotech,23/3/2021
Roche Reports Results of Tecentriq in P-III IMpower010 Study for Patients with Early Lung Cancer,Clinical Trials,23/3/2021
Roche Pauses Dosing of Tominersen in P-III GENERATION HD1 for Manifest Huntington's Disease,Clinical Trials,23/3/2021
Insulet Presents Results of Omnipod 5 Automated Insulin Delivery System for T1D at ENDO 2021,MedTech,23/3/2021
Novo Nordisk Receives the US FDA's Refusal to File Letter for Semaglutide to Treat T2D,Regulatory,23/3/2021
Regeneron Reports Results of REGEN-COV Antibody Cocktail in P-III Trial to Prevent COVID-19,Clinical Trials|COVID-19,23/3/2021
Roche Launches New Configurations for Cobas Pro to Increase Testing Efficiency,MedTech,24/3/2021
Zealand's Zegalogue (dasiglucagon) Receives the US FDA's Approval for the Treatment of Severe Hypoglycemia,Regulatory,24/3/2021
Incyte's Pemazyre (pemigatinib) Receives MHLW's Approval for Unresectable Biliary Tract Cancer with a FGFR2 Fusion Gene,Regulatory,24/3/2021
Fresenius Medical Care Collaborates with DaVita to Expand the Use of NxStage Home Hemodialysis Machines,MedTech,24/3/2021
Novo Nordisk Presents Results of Semaglutide in P-IIIa STEP 4 Trial to Treat Obesity at ENDO 2021,Clinical Trials,24/3/2021
Bayer's Vitrakvi Receives MHLW's Approval for the Treatment of NTRK Fusion-Positive Advanced or Recurrent Solid Tumors,Regulatory,24/3/2021
AstraZeneca Reports Results of AZD1222 in Primary Analysis of P-III Trial for the Prevention of COVID-19,Clinical Trials|COVID-19,25/3/2021
Chugai's Polivy Receives MHLW's Approval for Relapsed or Refractory Diffuse Large B-cell Lymphoma,Regulatory,25/3/2021
J&amp;J Visions' Acuvue Theravision with Ketotifen Receives MHLW's Approval for Vision Correction and Allergic Eye Itch,Regulatory,25/3/2021
"EirGenix Report Results of EG12014 (biosimilar, trastuzumab) in P-III Trial for HER2-Positive Breast Cancer",Biosimilars,25/3/2021
ProQR Reports Results of QR-421 in P-I/II Stellar Trial for Usher Syndrome,Clinical Trials,25/3/2021
Pfizer and Myovant Report Results of Relugolix Combination Therapy in P-III LIBERTY Withdrawal Study in Women with Uterine Fibroids,Clinical Trials,25/3/2021
BMS Report Results of Relatlimab + Opdivo (nivolumab) in P-II/III RELATIVITY-047 Study in Patients with Previously Untreated Metastatic or Unresectable Melanoma,Clinical Trials,26/3/2021
Takeda Reports EMA's Acceptance of TAK-003 for the Prevention of Dengue,Regulatory,26/3/2021
Astellas and Seagen Report EMA's Acceptance of MAA for Enfortumab Vedotin to Treat Locally Advanced or Metastatic Urothelial Cancer,Regulatory,26/3/2021
Immunai Acquire Dropprint Genomics to Expand its Target Discovery Capabilities,M&A|MedTech,26/3/2021
Tetra Bio-Pharma Initiates Additional Studies of ARDS-003 in Neuroinflammation and Antiviral Diseases,Clinical Trials,26/3/2021
Pfizer and BioNTech Initiate COVID-19 Vaccine Trial in Children Under 12,Clinical Trials|COVID-19,26/3/2021
BMS and bluebird bio's Abecma (idecabtagene vicleucel) Receive the US FDA's Approval as the First Anti-BCMA CAR T Cell Therapy for R/R Multiple Myeloma,Regulatory,29/3/2021
GSK's Benlysta (belimumab) Receives CHMP's Opinion Recommending its Approval for Active Lupus Nephritis,Regulatory,29/3/2021
Helius Medical's PoNS Receives the US FDA's Approval to Improve Gait in Multiple Sclerosis Patients,MedTech|Regulatory,29/3/2021
GSK and VIR Report EUA Submission to the US FDA for VIR-7831 to Treat COVID-19,Biotech|COVID-19|Regulatory,29/3/2021
Qiagen's NeuMoDx Multiplex Test Receives the US FDA's EUA and Expands its COVID-19 Portfolio,COVID-19|MedTech,29/3/2021
Roche's Tecentriq Receives CHMP's Positive Opinion for 1L Treatment for Metastatic Non-Small Cell Lung Cancer,Regulatory,29/3/2021
"Samsung Bioepis Expand its Footprints with the Launch of Hadlima (biosimilar, adalimumab) in Australia and Canada",Biosimilars,30/3/2021
Roche and PTC's Evrysdi (risdiplam) Receive the EC's Approval as First and Only at Home Treatment For Spinal Muscular Atrophy,Regulatory,30/3/2021
Medtronic's Harmony Transcatheter Pulmonary Valve Receives the US FDA's Approval for Patients with Congenital Heart Disease,MedTech|Regulatory,30/3/2021
Eli Lilly along with VIR and GSK Report Results of Bamlanivimab + VIR-7831 in P-II BLAZE-4 Study for Low-Risk Adults with COVID,Clinical Trials|COVID-19,30/3/2021
Cipla Expands its Partnership with Alvotech to Commercialize Biosimilars in Australia and New Zealand,Biosimilars,2021-02-03
Cerecor Signs a Worldwide License Agreement with Kyowa Kirin for CERC-00,Pharma,30/3/2021
Novartis' Kesimpta (ofatumumab) Receives the EC's Approval for Adult Patients with Relapsing Multiple Sclerosis,Regulatory,30/3/2021
Novartis In-Licenses Fibroblast Activation Protein (FAP) to Expand its Oncology Radioligand Pipeline,Pharma,31/3/2021
Merck to Acquire Alydia Health for ~$240M on Behalf of its Planned Spinoff of Organon,M&A,31/3/2021
AbbVie Reports the US FDA's Acceptance of NDA for Atogepant as a Preventive Treatment for Migraine,Regulatory,31/3/2021
Ipsen's Cabometyx + Opdivo Receive EC's Approval as a 1L Treatment for Patients with Advanced Renal Cell Carcinoma,Regulatory,31/3/2021
Amgen to Acquire Rodeo Therapeutics for ~$721M,M&A,31/3/2021
Waters Launches Peptide Multi-Attribute Method for BioAccord System to Develop and Commercialize Biosimilars,Biosimilars,18/3/2021
Roche Launches Elecsys Epstein-Barr Virus (EBV) Immunoassay Panel to Identify EBV Infection Staging,MedTech,31/3/2021
"Samsung Bioepis and Yuhan Collaborate for the Commercialization of Adalloce (biosimilar, adalimumab) in Korea",Biosimilars,15/3/2021
mAbxience Collaborates with ABEC to Expand Biosimilar and CDMO Manufacturing Capacity,Biosimilars,23/3/2021
"Henlius Reports First Patient Dosing in P-II/III Study of HLX10 + HLX04 (biosimilar, bevacizumab) for 1L mCRC",Biosimilars,2021-11-03
"Henlius' HLX04-O (biosimilar, bevacizumab) Receives the US FDA's IND Approval for wAMD",Biosimilars,19/3/2021
"Formycon and Bioeq Confirms BLA Submission Strategy and Timeline for FYB201 (biosimilar, ranibizumab)",Biosimilars,2021-01-03
BridgeBio Collaborates with Helsinn to Co- Develop and Commercialize Infigratinib in Oncology,Pharma,2021-01-04
BioXcel Report Results of BXCL501 in P-Ib/II RELEASE Study for the Treatment of Opioid Withdrawal Symptoms,Clinical Trials,2021-01-04
Amryt Reports NDA Submission for Oleogel-S10 (filsuvez) to Treat Cutaneous Manifestations of Junctional and Dystrophic Epidermolysis Bullosa,Regulatory,2021-01-04
ADQ to Acquire Amoun Pharmaceutical from Bausch Health for ~$740M,M&A,2021-01-04
Sanofi's Sarclisa (isatuximab-irfc) + Carfilzomib and Dexamethasone Receives the US FDA's Approval for the Treatment of R/R Multiple Myeloma,Regulatory,2021-01-04
"Alnylam Report Results of Lumasiran in P-III ILLUMINATE-A Study for Primary Hyperoxaluria Type 1, Published in NEJM",Clinical Trials,2021-01-04
BeyondSpring Submits NDA to the US FDA and China NMPA for Plinabulin to Prevent CT-Induced Neutropenia,Regulatory,2021-02-04
Kite Reports Submission of sBLA to the US FDA for Tecartus in Adult Patients with R/R Acute Lymphoblastic Leukemia,Regulatory,2021-02-04
Janssen and SpringWorks Reports Dosing of First Patient in P-Ib trial for Nirogacestat + Teclistamab to Treat Relapsed or Refractory Multiple Myeloma,Clinical Trials,2021-02-04
Revance Presents Results of DaxibotulinumtoxinA for Injection in P-III ASPEN-1 Trial for the Treatment of Cervical Dystonia at AAN2021,Clinical Trials,2021-02-04
"Acceleron Presents Results of Sotatercept in P-II PULSAR Trial for the Treatment of Pulmonary Arterial Hypertension, Published in NEJM",Clinical Trials,2021-02-04
Pfizer and BioNTech Report Results of BNT162b2 to Prevent COVID-19,COVID-19,2021-02-04
Merck KGaA Exercises Third Option in its Immuno-Oncology Collaboration with F- star,Biotech,2021-05-04
Gilead Expands its Collaboration with AbCellera to Develop Antibodies Against Multiple Indications,Biotech,2021-05-04
Taiho Oncology's Futibatinib (TAS-120) Receives the US FDA's Breakthrough Therapy Designation for Advanced Cholangiocarcinoma,Regulatory,2021-05-04
Lilly's Taltz (ixekizumab) Receives Health Canada's Approval for Pediatric Patients with Moderate to Severe Plaque Psoriasis,Regulatory,2021-05-04
"mAbxience's MB02 (biosimilar, bevacizumab) Receives EC's Approval for the Treatment of Cancer",Biosimilars,2021-05-04
uniQure Reports Completion of Enrollment in First Cohort of P- I/II Trial for AMT-130 to Treat Huntington's Disease,Clinical Trials,2021-05-04
Sorrento to Acquire ACEA Therapeutics for ~$488M,M&A,2021-06-04
Welldoc Expands their Partnership with Dexcom to Offer Type 2 Diabetes Management Solution,DigiHealth,2021-06-04
Ultragenyx Collaborates with n-Lorem Foundation to Advance Personalized Medicines Treatment for Patients with Ultra-Rare Diseases,Biotech,2021-06-04
Exelixis Reports the US FDA's Acceptance of IND for XB002 in Patients with Advanced Solid Tumors,Regulatory,2021-06-04
Horizon Presents Results of Uplizna (inebilizumab-cdon) in N-MOmentum Trial for NMOSD at AAN 2021,Clinical Trials,2021-06-04
Passage Bio's PBKR03 Receives EC's Orphan Drug Designation for Krabbe Disease,Regulatory,2021-06-04
The US FDA Extends Review Period of Olumiant's sNDA to Treat Moderate to Severe Atopic Dermatitis,Regulatory,2021-07-04
Pear Sign a Multiple Agreements to Expands its Prescription Digital Therapeutic Platform,DigiHealth,2021-07-04
Progenity Signs an Agreement with Ionis Pharmaceuticals to Evaluate Oral Biotherapeutics Delivery System with Antisense Oligonucleotides,Biotech,2021-07-04
AstraZeneca Collaborates with MGH to Accelerate Digital Health Solutions,DigiHealth,2021-07-04
J&amp;J Vision Collaborates with Menicon to Offer Contact Lenses for Managing the Progression of Myopia in Children,MedTech,2021-07-04
Novartis Collaborates with Artios Pharma to Discover Next Generation DDR Cancer Therapies,Biotech,2021-07-04
BMS and PsiOxus Therapeutics Expand their 2016 Immuno-Oncology Collaboration,Biotech,2021-08-04
"Biogen's Tysabri (natalizumab, SC) Receives EC's Marketing Authorization to Treat Relapsing-Remitting Multiple Sclerosis",Regulatory,2021-08-04
AbbVie Submits Regulatory Applications to the US FDA and EMA for Skyrizi (risankizumab) to Treat Psoriatic Arthritis,Regulatory,2021-08-04
Merck KGaA Selects PRA's Remote Patient Monitoring Platform for Human Growth Hormone Treatment System,DigiHealth,2021-08-04
Daiichi Sankyo Reports First patient Dosing in P- I/II Trial of DS-1594 to Treat Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia,Clinical Trials,2021-08-04
Lilly and Incyte Report Results of Baricitinib in P-III COV-BARRIER Study for Hospitalized Patients with COVID-19,Clinical Trials,2021-08-04
Top 20 BioPharma Companies based on 2020 Total Revenue,,30/12/1899
"Biogen Signs a License and Commercialization Agreement with Bio-Thera for BAT1806 (biosimilar, tocilizumab) to Treat Moderate to Severe Rheumatoid Arthritis",Biosimilars,2021-09-04
Hologic to Acquire Mobidiag for ~ $795M,M&A|MedTech,2021-09-04
Merck Report Results of Keytruda (pembrolizumab) in P-III KEYNOTE-564 Trial as Adjuvant Treatment for Renal Cell Carcinoma,Clinical Trials,2021-09-04
BMS Reports Results of Opdivo (nivolumab) + CT or Yervoy (ipilimumab) in P-III CheckMate -648 Trial for Unresectable Advanced or Metastatic ESCC,Regulatory,2021-09-04
PlantForm Signs Research and Development Agreement with Bio-Manguinhos/Fiocruz to Develop Biosimilar Pembrolizumab,Biosimilars,2021-09-04
Evotec and Exscientia Initiate Human Clinical Trials of their Novel Immuno-Oncology Drug,Pharma,2021-09-04
Sanofi to Acquire Tidal Therapeutics for ~$470M,M&A,2021-12-04
Roche Report Results of Ab Cocktail (Casirivimab + Imdevimab) in P-III REGN-COV 2069 Trial for Symptomatic COVID 19 Infection,Clinical Trials|COVID-19,2021-12-04
AstraZeneca's Farxiga (dapagliflozin) Fails to Meet its Primary Endpoint in P-III DARE-19 Trial for COVID 19,Clinical Trials|COVID-19,2021-12-04
Daiichi Sankyo Initiates P-II Trial of Pexidartinib for Tenosynovial Giant Cell Tumor in Japan,Clinical Trials,2021-12-04
Bayer Reports Results of Aliqopa (copanlisib) + Rituximab in P-III CHRONOS-3 Study for Relapsed Indolent Non-Hodgkin's Lymphoma,Clinical Trials,2021-12-04
BMS Presents Results of Opdivo (nivolumab) + CT in P-III CheckMate-816 Trial for Resectable NSCLC at AACR2021,Clinical Trials,2021-12-04
Microsoft to Acquire Nuance for ~$19.7B,DigiHealth|M&A,13/4/2021
Novartis's Xolair (omalizumab) Prefilled Syringe for Self-Injection Receives the US FDA's Approval Across All Indications,Regulatory,13/4/2021
Sage and Biogen Report Results of SAGE-324 in P-II KINETIC Study for Essential Tremor,Clinical Trials,13/4/2021
DiaSorin to Acquire Luminex for ~$1.8B,M&A|MedTech,13/4/2021
Sanofi Collaborates with C4XD for an Oral Therapy to Treat Inflammatory Diseases,Pharma,13/4/2021
Avantor to Acquire Ritter and its Affiliates for ~$1.06B,M&A|MedTech,13/4/2021
J&amp;J Pauses Dosing of COVID-19 Vaccine Due to Blood Clotting,Clinical Trials|COVID-19,14/4/2021
Roche and Biocorp Launch Mallya Smart Insulin Pen for Patients with Diabetes in France,MedTech,14/4/2021
AstraZeneca's Tagrisso (osimertinib) Receives the NMPA's Approval for the Adjuvant Treatment of Patients with Early-Stage EGFR-Mutated Lung Cancer,Regulatory,14/4/2021
Spark Therapeutics Signs an Option Agreement with Senti Bio to Develop Precision Gene Therapies,Biotech,14/4/2021
Innovent and Lilly Present Results of Tyvyt (sintilimab) in P-III ORIENT-3 Trial as 2L Treatment for Advanced or Metastatic Squamous NSCLC at AACR 2021,Clinical Trials,14/4/2021
Merck KGaA Expand its Collaboration with NKMax to Evaluate the Combination of SNK01 + Erbitux (cetuximab) for Metastatic NSCLC,Pharma,14/4/2021
Eli Lilly Signs an Exclusive License Agreement with SciNeuro to Develop and Commercialize Alpha-synuclein Targeted Therapies in China,Pharma,15/4/2021
Genentech Presents Results of Two-Year Data for Evrysdi (risdiplam) in Infants with Type 1 SMA at AAN2021,Clinical Trials,15/4/2021
Medtronic Launches World's First Extended Insulin Infusion Set to Reduce Burden for People with Diabetes in Europe,MedTech,15/4/2021
BMS' Opdivo (nivolumab) + Cabometyx (cabozantinib) Receive EC's Approval for 1L Treatment of Advanced Renal Cell Carcinoma,Regulatory,15/4/2021
Melinta's Kimyrsa (oritavancin) Receives the US FDA's Approval for the Treatment of Acute Bacterial Skin and Skin Structure Infections,Regulatory,15/3/2021
The US FDA Approves New Indication and Formulation for Astellas' Myrbetriq,Regulatory,26/3/2021
AVEO Oncology's Fotivda (tivozanib) Receives the US FDA's Approval for the Treatment of R/R Advanced Renal Cell Carcinoma,Regulatory,2021-10-03
Boehringer Ingelheim and MD Anderson Expand their Collaboration to Accelerate Targeted Therapies for Lung Cancer,Pharma,15/4/2021
Corium's Azstarys (serdexmethylphenidate and dexmethylphenidate) Receives the US FDA's Approval for ADHD in Patients Aged 6 Years and Older,Regulatory,2021-03-03
Althera's Roszet (rosuvastatin and ezetimibe) Receives the US FDA's Approval for Treatment of Elevated Low-Density Lipoprotein Cholesterol,Regulatory,31/3/2021
"Prestige Biopharma and Pharmapark Sign an Exclusive License and Supply Agreement to Commercialize HD204 (biosimilar, bevacizumab) in Russia",Biosimilars,16/4/2021
Genentech Presents New Data of Ocrevus (ocrelizumab) for Relapsing and Primary Progressive Multiple Sclerosis at AAN2021,Clinical Trials,16/4/2021
Omada Health Launches the First Virtual Cardiometabolic Clinic for Patients with Diabetes and Hypertension,MedTech,16/4/2021
GSK Discontinues the P-II Trials of Feladilimab for Advanced or Metastatic Head and Neck Squamous Cell Carcinoma,Clinical Trials,16/4/2021
Roche's Evrysdi (risdiplam) Receives Health Canada's Approval for Spinal Muscular Atrophy in Adults and Children,Regulatory,16/4/2021
ThermoFisher to Acquire PPD for ~$17.4B,M&A|MedTech,16/4/2021
"Zogenix Presents Results of Fintepla's (fenfluramine) Study Highlighting the Impact of Treatment on Dravet Syndrome Patients, Caregivers, and Families at AAN 2021",Clinical Trials,19/4/2021
Lilly and Incyte Report Results of Baricitinib in P-III COV-BARRIER Study for Hospitalized Patients with COVID-19,Clinical Trials,19/4/2021
Sanofi's Sarclisa (isatuximab) Receives EC's Approval for Adults with Relapsed and Refractory Multiple Myeloma,Regulatory,19/4/2021
Evotec Signs a License Agreement with Kazia Therapeutics for Clinical Development of EVT801,Pharma,19/4/2021
Janssen Presents Results of Nipocalimab (M281) in P-II Vivacity-MG Study for Adults with Generalized Myasthenia Gravis at AAN2021,Clinical Trials,19/4/2021
Novartis Reports Results of Kesimpta (ofatumumab) in P- III ASCLEPIOS Trials for Newly Diagnosed Patients with RMS,Clinical Trials,19/4/2021
Incyte and MorphoSys Report First Patient Dosing in P-III inMIND Study for Relapsed or Refractory Follicular or Marginal Zone Lymphoma,Clinical Trials,20/4/2021
Astellas and Seagen Report the US FDA's Acceptance of Two sBLA for Padcev (enfortumab vedotin) in Locally Advanced or Metastatic Urothelial Cancer,Regulatory,20/4/2021
Alnylam Presents Results of Vutrisiran in P-III HELIOS-A Study for Patients with hATTR Amyloidosis with Polyneuropathy at AAN 2021,Clinical Trials,20/4/2021
Biogen and Eisai Report Results of Lecanemab (BAN2401) in P-IIb Study 201 for Patients with Early Alzheimer Disease,Clinical Trials,20/4/2021
"Janssen's Darzalex (daratumumab, SC) Combination Regimen Receives Health Canada's Approval for Patients with Newly Diagnosed Light Chain Amyloidosis",Regulatory,20/4/2021
Lilly and Incyte Report Results of Baricitinib in P-III BRAVE-AA1 Study for Severe Alopecia Areata,Clinical Trials,20/4/2021
Vertex Amend its Collaboration with CRISPR Therapeutics for Development and Commercialization of CTX001 in SCD and Beta Thalassemia,Pharma,21/4/2021
Jazz Presents Results of Xywav (Oral Solution) in P-III Withdrawal Study for Adult Patients with Idiopathic Hypersomnia at AAN2021,Clinical Trials,21/4/2021
SparingVision Acquires GAMUT Therapeutics to Expands its Novel Ocular Disease Pipeline,M&A,21/4/2021
Janssen Collaborates with PhysIQ for Wearable Biosensors and Digital Biomarkers Initiatives,MedTech,21/4/2021
GW Pharmaceuticals' Epidyolex (cannabidiol) Receives EC's Approval for the Treatment of Seizures Associated with Tuberous Sclerosis Complex,Regulatory,21/4/2021
LEXEO Therapeutics Receives the US FDA's Fast Track Designation for LX1001 to Treat APOE4 Associated Alzheimer Disease,Regulatory,21/4/2021
Medtronic Receives the US FDA's Approval for Pipeline Flex Embolization Device with Shield Technology,MedTech,22/4/2021
Novo Nordisk to Initiate P-IIIa Study for Oral Semaglutide to Treat Obesity,Clinical Trials,22/4/2021
TG Therapeutics Initiates Patient Enrolment in P-III ULTRA-V Trial for Triple Combination Regimen to Treat R/R Chronic Lymphocytic Leukemia,Clinical Trials,22/4/2021
AgeneBio Reports Completion of Patient Enrollment in P-IIB HOPE4MCI Trial for AGB101 to Treat Amnestic Mild Cognitive Impairment due to Alzheimer Disease,Clinical Trials,22/4/2021
Johnson &amp; Johnson Publishes Results of COVID-19 Single Shot Vaccine in NEJM,COVID-19,22/4/2021
Claritas Collaborates with CMAX to Initiate P-I Study of R-107 for Pulmonary Arterial Hypertension,Pharma,22/4/2021
PharmaShots' Key Highlights of First Quarter 2021,,30/12/1899
Vertex Signs a License Agreement with Obsidian Therapeutics to Discover Regulated Gene Editing Therapies,Biotech,23/4/2021
Roche Receives the US FDA's Approval for First CDx to Identify Endometrial Cancer Patients Eligible for Immunotherapy,MedTech|Regulatory,23/4/2021
GSK's Jemperli (dostarlimab-gxly) Receives the US FDA's Approval for dMMR Endometrial Cancer,Regulatory,23/4/2021
AbbVie's Humira (adalimumab) Receives Health Canada's Approval for Pediatric Patients with Active Ulcerative Colitis,Regulatory,23/4/2021
Gilead Reports NDA Submission of Filgotinib to PMDA for Ulcerative Colitis in Japan,Regulatory,23/4/2021
BMS' Opdivo + Yervoy and Onureg Receive EC's CHMP Positive Opinion for MPM and AML,Regulatory,23/4/2021
BMS Presents Results of Deucravacitinib in Two P- III Trials for Moderate to Severe Plaque Psoriasis at AAD2021,Clinical Trials,26/4/2021
GSK's Jemperli (dostarlimab) Receives the EC's Approval for Recurrent or Advanced dMMR/MSI-H Endometrial Cancer,Regulatory,26/4/2021
Dermavant Presents Results of Tapinarof in Two P-III Trials for the Treatment of Psoriasis at AAD2021,Clinical Trials,26/4/2021
Sanofi and AstraZeneca Report Results of Nirsevimab in P-III MELODY Study for the Protection of Healthy Infants Against Respiratory Syncytial Virus Disease,Clinical Trials,26/4/2021
AstraZeneca and MSD's Selumetinib Receive EU's CHMP Positive Opinion as the First Therapy for Pediatric Patients with Neurofibromatosis Type 1 Plexiform Neurofibromas,Regulatory,26/4/2021
AstraZeneca's Tagrisso (osimertinib) Receives EU's CHMP Positive Opinion for the Adjuvant Treatment of Patients with Early-Stage EGFR-Mutated Lung Cancer,Regulatory,26/4/2021
"Biocon Biologics and Viatris Receive European Commission Approval for Abevmy (biosimilar, bevacizumab)",Biosimilars,27/4/2021
Medtronic Collaborates with Surgical Theater to Provide Augmented Reality Platform to Neurosurgery,MedTech,27/4/2021
I-Mab Reports Results of Olamkicept (TJ301) in P-II Study for Ulcerative Colitis,Clinical Trials,27/4/2021
Pieris Out-licenses PRS-342 to Boston Pharmaceuticals for ~$363M,Biotech,27/4/2021
Daiichi Sankyo Expands its Collaboration with Esperion to Additional Territories,Pharma,27/4/2021
Glenmark's Ryaltris Nasal Spray Receives EC's Approval as 1L Treatment for Allergic Rhinitis,Regulatory,27/4/2021
The US FDA Grants Priority Review to Takeda's Mobocertinib (TAK-788) for EGFR Exon20 Insertion+ Metastatic Non-Small Cell Lung Cancer,Regulatory,28/4/2021
Abbott Launches AI-Powered Coronary Imaging Platform in Europe,MedTech,28/4/2021
Y-mAbs Reports MAA Submission to EMA for Omburtamab to Treat Pediatric Patients with CNS/Leptomeningeal Metastasis from Neuroblastoma,Regulatory,28/4/2021
InveniAI Collaborates with Shionogi on AI-Based Drug Discovery,Biotech,28/4/2021
LogicBio Signs an Option Agreement with Canbridge to Develop Gene Editing Therapies,Biotech,28/4/2021
Voluntis Collaborates with Eisai to Develop Digital Therapeutics for Oncology Patients,DigiHealth,28/4/2021
Pfizer Acquires Amplyx to Expand its Infectious Disease Portfolio,M&A,29/4/2021
Organicell Reports the Expansion of its Trial for Zofin to Treat COVID-19 Patients in India,Clinical Trials|COVID-19,29/4/2021
BioMarin Collaborates with Allen Institute to Develop Gene Therapies for Rare Brain Diseases,Biotech,29/4/2021
BeiGene Reports Results of Brukinsa (zanubrutinib) in P-III Head-to-Head APSEN Trial for R/R Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma,Clinical Trials,29/4/2021
Alcon to Acquire Exclusive US Commercialization Rights to Novartis' Simbrinza,Pharma,29/4/2021
Angion and Vifor Pharma Report Completion of Patient Enrollment in P-II AKI-002-15 Study of ANG-3777 for Cardiac-Surgery Associated Acute Kidney Injury,Clinical Trials,29/4/2021
Alphamab and Pfizer Initiate P-II Trial Evaluating KN046 + Inlyta (axitinib) as a 1L Treatment of Non-Small Cell Lung Cancer,Clinical Trials,30/4/2021
Innovent Reports First Patient Dosing in P-II Trial of IBI302 for Neovascular Age-Related Macular Degeneration,Clinical Trials,30/4/2021
Celltrion Reports Results of Regdanvimab (CT-P59) in Pre-Clinical Study Against the South African Variant (B.1.351),Clinical Trials|COVID-19,30/4/2021
Repertoire Collaborates with Yale University to Identify Novel Antigen and T- Cell Receptor for Multiple Sclerosis,Biotech,30/4/2021
Janssen Reports MAA Submission to EMA for Cilta-cel to Treat Relapsed/ Refractory Multiple Myeloma,Regulatory,30/4/2021
BMS Reports the US FDA's Acceptance of Opdivo's sBLA for Priority Review to Treat Muscle Invasive Urothelial Carcinoma,Regulatory,30/4/2021
AstraZeneca's Farxiga (dapagliflozin) Receives the US FDA's Approval for Chronic Kidney Disease,Regulatory,2021-03-05
Samsung Bioepis Presents Results of SB11 (proposed biosimilar ranibizumab) at ARVO 2021,Biosimilars,2021-03-05
Novartis Presents Results of Beovu (brolucizumab -dbll) in P-III KESTREL and KITE Studies for Diabetic Macular Edema at ARVO2021,Clinical Trials,2021-03-05
British Columbia Adds Humira Adalimumab to Biosimilar Switching Program,Biosimilars,2021-09-04
Valeo Pharma Launches Redesca and Redesca HP (LMHW biosimilar) in Canada,Biosimilars,15/4/2021
Xcenda's FormularyDecisions Launches Resource Hub for Biosimilars,Biosimilars,2021-08-04
Sobi and Hellenic Institute Report Results of Anakinra in P-III SAVE-MORE Study for Hospitalized Patients with COVID-19 Pneumonia,Clinical Trials,2021-03-05
Guardant Health Reports Results of Blood-Only Liquid Biopsy Test Predicting Risk of Colorectal Cancer Recurrence,MedTech,2021-03-05
Eli Lilly and Incyte Present New Data of Olumiant (baricitinib) in P-III BREEZE-AD5 Trial Moderate to Severe Atopic Dermatitis at AAD2021,Clinical Trials,2021-03-05
Province Expands the Use of Biosimilars to Improve the Sustainability of Public Drug Plans,Biosimilars,21/4/2021
"Boehringer Ingelheim Reports Results of Cyltezo (biosimilar, adalimumab) in P-III VOLTAIRE-X Study for Moderate-to-Severe Chronic Plaque Psoriasis",Biosimilars,23/4/2021
New Brunswick Government Introduces Biosimilars Switch Policy to Improve Patient Access to Safe and Effective Medicine,Biosimilars,21/4/2021
Roivant Going Public Via MAAC SPAC Merger for ~$7.3B,M&A,2021-04-05
Labcorp to Acquire Myriad's Vectra Testing Business for $150M,MedTech,2021-04-05
Sandoz Initiates Patient Enrolment of Proposed Biosimilar Aflibercept in P-III MYLIGHT Study for Neovascular Age-Related Macular Degeneration,Biosimilars,2021-04-05
Novavax Reports the Pediatric Expansion for P-III Clinical Trial of NVX-CoV2373 Against COVID-19,Clinical Trials,2021-04-05
BMS Presents Clinical and RWE Data of Mavacamten for Obstructive Hypertrophic Cardiomyopathy at ACC 2021,Clinical Trials,2021-04-05
Vaxart Reports News Data of VXA-CoV2-1 (Oral COVID-19 Vaccine) in P-I Trial Against Other Coronaviruses,Clinical Trials,2021-04-05
Athenex to Acquire Kuur Therapeutics for ~$185M,Biotech,2021-05-05
Roche's Tecentriq Receives EC's Approval as 1L Treatment for Metastatic Non-Small Cell Lung Cancer,Regulatory,2021-05-05
"Amgen Launches Amgevita (biosimilar, adalimumab) for the Treatment of Multiple Chronic Inflammatory Diseases in Canada",Biosimilars,2021-05-05
AbCellera to Initiate Clinical Trial of LY-CoV1404 Against Viral Variants of COVID 19,Clinical Trials,2021-05-05
ProQR Therapeutics Signs an Exclusive Worldwide License Agreement with Yarrow to Develop Therapies for Non-Ophthalmic Target,Pharma,2021-05-05
Exelixis Acquires GamaMabs' Oncology Antibody Program to Expand its Biotherapeutics Portfolio,Biotech,2021-05-05
GSK's Benlysta (belimumab) Receives EC's Approval for the Treatment of Active Lupus Nephritis,Regulatory,2021-06-05
Phenomix Collaborates with Mayo Clinic for AI-Powered Obesity Phenotype Blood Test,MedTech,2021-06-05
Medtronic Launches CareGuidePro App for Managing Spinal Cord Stimulation,DigiHealth,2021-06-05
Sanofi Signs a Three-Year Collaboration with Stanford Medicine to Accelerate Immunology Research,Biotech,2021-06-05
Roche's Ab Cocktail (Casirivimab and Imdevimab) Receives EUA to Treat COVID-19 in India,COVID-19,2021-06-05
Amgen Reports the US FDA's Acceptance of sNDA for Review of Otezla (apremilast) to Treat Mild-To-Moderate Plaque Psoriasis,Regulatory,2021-06-05
Merck and Eisai Receive the US FDA‘s Priority Review for Keytruda (pembrolizumab) + Lenvima (lenvatinib) to Treat Advanced Renal Cell Carcinoma and Endometrial Carcinoma,Regulatory,2021-07-05
AbCellera Signs a Multi-Target Collaboration with Angios to Develop Bispecific Antibodies for the Treatment of Diabetic Retinopathy,Biotech,2021-07-05
BeiGene and Asieris Enter into Clinical Collaboration for APL-1202 + Tislelizumab to Treat Muscle Invasive Bladder Cancer,Pharma,2021-07-05
BMS Signs a Research Collaboration with DarwinHealth to Discover Novel Cancer Target Initiative,MedTech,2021-07-05
Merck and Fusion Pharmaceuticals Enter into a Clinical Collaboration for FPI-1434 + Keytruda (pembrolizumab) to Treat Solid Tumors Expressing IGF-1R,Pharma,2021-07-05
AstraZeneca Reports Results of Imfinzi (durvalumab) and Imfinzi + Tremelimumab in P-III POSEIDON Study as 1L Treatment for Stage IV Non-Small Cell Lung Cancer,Biotech|Clinical Trials,2021-07-05
GSK and Vir Report Initiation of EMA Rolling Review of VIR-7831 (sotrovimab) for the Early Treatment of COVID-19,Regulatory,2021-10-05
BD to Spin Off its Diabetes Care Business into New Public Company,MedTech,2021-10-05
Eli Lilly Signs an International Agreements with Four Diabetes Technology Companies for Connected Insulin Pen Solutions,MedTech,2021-10-05
Walmart Health Signs an Agreement to Acquire MeMD for its Telehealth Services,DigiHealth,2021-10-05
Pfizer and BioNTech Initiate Rolling Submission of BLA for the US FDA's Approval of their COVID-19 Vaccine,COVID-19|Regulatory,2021-10-05
Aurinia Publishes the Results of Lupkynis (voclosporin) in P-III AURORA 1 Study for Patients with Active Lupus Nephritis in The Lancet,Clinical Trials,2021-10-05
Bayer Reports Results of Finerenone in P- III FIGARO-DKD CV Outcomes Study for Chronic Kidney Disease and Type 2 Diabetes,Clinical Trials,2021-11-05
Pfizer and BioNTech Receive the US FDA's EMA for COVID-19 Vaccine in Adolescents,Regulatory,2021-11-05
AstraZeneca and Amgen Submit BLA to US FDA for Tezepelumab to Treat Severe Asthma,Regulatory,2021-11-05
Allergan Aesthetics to Acquire Soliton and its Resonic Device for ~$550M,M&A|MedTech,2021-11-05
Biogen Collaborates with Capsigen to Discover Novel AAV Capsids for Targeted CNS and Neuromuscular Disorders,Biotech,2021-11-05
Lilly Signs a ~$1.25B Research Collaboration with MiNA Therapeutics to Develop saRNA Therapies,Biotech,2021-11-05
Autobahn Acquires Global Rights to Astellas' ASP3652 to Bolster its Brain Targeting Chemistry Platform,Pharma,2021-12-05
Cellectis Collaborates with Sanofi for Alemtuzumab to be Utilized in CART-Cell Trials,Biotech,2021-12-05
Incyte and MorphoSys Report First Patient Dosing in P-III frontMIND Study of Tafasitamab + Lenalidomide as a 1L Treatment for DLBCL,Clinical Trials,2021-12-05
Nanobiotix Collaborates with Lianbio to Develop and Commercialize NBTXR3 in China and other Asian Countries,Pharma,2021-12-05
Medtronic Launches SonarMed Airway Monitoring System to Detect Airway Obstruction During Ventilation in Pediatric Patients,MedTech,2021-12-05
ADC Therapeutics' Zynlonta (loncastuximab tesirine-lpyl) Receives the US FDA's Approval for the Treatment of R/R Diffuse Large B-Cell Lymphoma,Regulatory,23/4/2021
InflaRx Reports Results of Vilobelimab in P- II IXPLORE Study in Patients with Anti-Neutrophil Cytoplasmic Autoantibody Associated Vasculitis,Clinical Trials,2021-12-05
Mayne Pharma' Nextstellis Receives the US FDA's Approval for the Prevention of Pregnancy,Regulatory,16/4/2021
Biogen Exercises its Option to Acquire TMS-007 for Acute Ischemic Stroke,Pharma,13/5/2021
Supernus' Qelbree (SPN-812) Receives the US FDA's Approval for the Treatment of ADHD,Regulatory,2021-02-04
Regeneron and Sanofi Present Positive Results of Libtayo (cemiplimab) from P-III Trial for Cervical Cancer at ESMO2021,Clinical Trials,13/5/2021
Antengene Receives IND Approval for P-III SIENDO Trial of XPOVIO (Selinexor) to Treat Advanced or Recurrent Endometrial Cancer in China,Regulatory,13/5/2021
AstraZeneca and Amgen Present Results of Tezepelumab in P-III NAVIGATOR Study for Severe Asthma at ATS2021,Clinical Trials,13/5/2021
Fulcrum Therapeutics' Losmapimod Receives the US FDA's Fast Track Designation to Treat Facioscapulohumeral Muscular Dystrophy,Regulatory,13/5/2021
Dr Reddy's Acquires an Exclusive License for Pregene's PRG1801 in India,Biotech,13/5/2021
Hikma' Kloxxado (naloxone hydrochloride) Receives the US FDA's Approval for the Treatment of Opioid Overdose,Regulatory,30/4/2021
Biogen and Envisagenics Enter into a Collaboration for the Advancement of RNA Splicing Research to Treat Central Nervous System Diseases,Biotech,14/5/2021
Novo Nordisk Reports Results of Semaglutide from P-IIIa STEP 1 Trial in Patients with Obesity,Clinical Trials,14/5/2021
Heron Therapeutics' ZYNRELEF (HTX-011) Receives the US FDA's Approval for the Management of Postoperative Pain,Regulatory,14/5/2021
Reistone Reports First Patient Dosing in P-III RSJ10333 Trial of SHR0302 for the Treatment of Atopic Dermatitis,Clinical Trials,14/5/2021
Goldfinch Bio Initiates P-I Clinical Trial of GFB-024 for the Treatment of Severe Insulin Resistant Diabetic Nephropathy,Clinical Trials,14/5/2021
AzurRx BioPharma Reports Positive Interim P-II Data of MS1819 + PERT for Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency,Clinical Trials|Pharma,14/5/2021
Biogen's BIIB112 (cotoretigene toliparvovec) Fails to Meet its Primary Endpoint in P-II/III XIRIUS Study for XLRP,Clinical Trials,17/5/2021
BMS Presents Results of Mavacamten in P-III Study for Obstructive Hypertrophic Cardiomyopathy at ACC 2021,Clinical Trials,17/5/2021
Sanofi and GSK Report Results of its COVID-19 Vaccine in a P-II Study Across All Adult Age Groups,Clinical Trials|COVID-19,17/5/2021
PerkinElmer to Acquire Immunodiagnostic Systems Holdings for ~$155M,M&A|MedTech,17/5/2021
Apellis' Empaveli (pegcetacoplan) Receives the US FDA's Approval for Paroxysmal Nocturnal Hemoglobinuria,Regulatory,17/5/2021
Charles River to Acquire Vigene Biosciences for $292.5M,Biotech|M&A,17/5/2021
Abbott Receives CE Mark for Next-Generation Navitor TAVI System to Treat Aortic Stenosis,MedTech|Regulatory,18/5/2021
Regeneron and Sanofi Present Results of Dupixent (dupilumab) in P-III VOYAGE Study for Asthma at ATS 2021,Clinical Trials,18/5/2021
Eli Lilly and Innovent Report the US FDA's Acceptance of Sintilimab + Chemotherapy's BLA for 1L Treatment for Non-Squamous NSCLC,Regulatory,18/5/2021
Roche Receives the US FDA's EUA for cobas SARS-CoV-2 Test to Suspect COVID-19,MedTech|Regulatory,18/5/2021
Medicago and GSK Report Results of Plant-Derived Vaccine in a P-II Study for COVID-19,Clinical Trials|COVID-19,18/5/2021
BlueRock Collaborates with Fujifilm and Opsis to Discover and Develop Cell Therapies for Eye Diseases,Pharma,18/5/2021
BMS Signs an Exclusive Global License with Agenus for its Anti-TIGIT Bispecific Antibody Program,Biotech,19/5/2021
Sarepta's SRP-9001 Demonstrates Robust Expression and Safety Results in ENDEAVOR Study for DMD,Biotech,19/5/2021
Glaukos Expands its Partnership with Santen for Preserflo MicroShunt,MedTech,19/5/2021
Janssen Signs an Option and License Agreement with Mestag to Discover Novel Fibroblast Targets for Inflammatory Disease,Pharma,19/5/2021
BMS Extends its 2019 Collaboration with Exscientia for AI Driven Drug Discovery,Pharma,19/5/2021
BioXcel Reports the US FDA's Acceptance of BXCL501's NDA for the Acute Treatment of Agitation Associated with Schizophrenia and Bipolar Disorders I and II,Regulatory,19/5/2021
Genentech Reports Results of Tecentriq in P-III IMpower010 Study for 1L Treatment of NSCLC,Clinical Trials,20/5/2021
Takeda Presents Results of Mobocertinib in P-I/II Study for Patients with EGFR Exon20 Insertion+ mNSCLC,Clinical Trials,20/5/2021
Janssen Reports Updated Data of Amivantamab + Lazertinib in P-I CHRYSALIS Study for EGFR-Mutated NSCLC,Clinical Trials,20/5/2021
Allogene Reports Results of ALLO-501 and ALLO-501A in P-I Studies for Relapsed/Refractory Non-Hodgkin Lymphoma,Clinical Trials,20/5/2021
Janssen to Present Results of Imbruvica (ibrutinib)-based Combination Regimen as 1L Treatment for Chronic Lymphocytic Leukemia at ASCO,Clinical Trials,20/5/2021
Lilly Reports Results of Tirzepatide in SURPASS-4 Study for Patients with Type 2 Diabetes,Clinical Trials,20/5/2021
Moderna's COVID-19 Vaccine Receives Approval for Emergency Use in Japan,COVID-19|Regulatory,21/5/2021
AstraZeneca's Vaxzevria (AZD1222) Receives Approval for Emergency Use in Japan to Treat COVID-19,COVID-19|Regulatory,21/5/2021
Takeda Reports the US FDA's Acceptance and Priority Review of Maribavir's NDA for Post-Transplant CMV Infection,Regulatory,21/5/2021
Astellas and Seagen Report Updated Results of Padcev in Two Studies for Locally Advanced or Metastatic Urothelial Cancer Not Eligible for Cisplatin Chemotherapy,Clinical Trials,21/5/2021
Aurinia to Present Results of Lupkynis (voclosporin) in AURORA 2 Continuation Study for Lupus Nephritis at EULAR 2021,Clinical Trials,21/5/2021
BeiGene Reports Results of Tislelizumab + CT in P-III RATIONALE 309 Study as 1L Treatment for Recurrent or Metastatic Nasopharyngeal Cancer,Clinical Trials,21/5/2021
BMS Receive the CHMP's Positive Opinion Recommending Approval of Opdivo (nivolumab) + Yervoy (ipilimumab) for dMMR or MSI-H mCRC After Prior Chemotherapy,Regulatory,24/5/2021
Janssen's Rybrevant (amivantamab-vmjw) Receives the US FDA's Approval as the First Targeted Treatment for Patients with NSCLC with EGFR Exon 20 Insertion Mutations,Regulatory,24/5/2021
Regeneron Receives CHMP's Positive Opinion Recommending the Approval of Libtayo (cemiplimab) for NSCLC and BCC,Regulatory,24/5/2021
Takeda Reports Long-Term Safety and Efficacy Results of its Dengue Vaccine Candidate,Clinical Trials,24/5/2021
Lilly Presents Results of Mirikizumab in P-II SERENITY Study for Crohn's Disease at DDW 2021,Clinical Trials,24/5/2021
Pfizer Initiates Study to Evaluate its Pneumococcal Vaccine with Booster dose of its COVID-19 Vaccine,Clinical Trials,24/5/2021
Boehringer Ingelheim to Develop Dicerna's GalXC RNAi Candidate for NASH,Biotech,25/5/2021
"Janssen's Stelara Fails to Show Superiority over AbbVie's Humira in P-IIIb SEAVUE Study for Crohn's Disease, Presented at DDW 2021",Clinical Trials,25/5/2021
AbbVie Presents New Late-Breaking Data Analyses of Skyrizi (risankizumab) for Crohn's Disease at DDW 2021,Clinical Trials,25/5/2021
Bayer Seeks Approval of Larotrectinib for Advanced Solid Tumors in China,Regulatory,25/5/2021
Boehringer Ingelheim's BI 425809 Receives the US FDA's Breakthrough Therapy Designation for Cognitive Impairment Associated with Schizophrenia,Regulatory,25/5/2021
Merck Signs a Clinical Trial Collaboration with Xilio for Anti-CTLA-4 Monoclonal Antibody Program,Clinical Trials,25/5/2021
BMS and Xencor Collaborate to Use Xtend XmAb Technology in SARS-CoV-2 Neutralizing mAb Combination for COVID-19,Biotech,26/5/2021
QIAGEN Collaborates with Mirati to Develop KRASG12C CDx for Non-Small Cell Lung Cancer,MedTech,26/5/2021
"BioFactura Initiates P-I Study of BFI-751 (biosimilar, ustekinumab) in Australia and New Zealand",Biosimilars|Clinical Trials,26/5/2021
AbbVie's Venclyxto Receives the EC's Approval for Patients with Newly Diagnosed Acute Myeloid Leukemia who are Ineligible for Intensive Chemotherapy,Regulatory,26/5/2021
Moderna's mRNA-1273 Meets its Primary Endpoint in P-II/III TeenCOVE Study to Prevent COVID 19 in Adolescents,Clinical Trials|COVID-19,26/5/2021
TG Therapeutics Reports the US FDA's Acceptance of BLA for Ublituximab + Ukoniq (umbralisib) to Treat Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma,Regulatory,26/5/2021
GSK and Vir Receive the US FDA's EUA for Sotrovimab (VIR-7831) to Treat COVID-19 in Adults and Pediatric Patients,Regulatory,27/5/2021
Pfizer and Myovant's Myfembree Receive the US FDA's Approval for Heavy Menstrual Bleeding Associated with Uterine Fibroids,Regulatory,27/5/2021
Sanofi and GSK Initiate P-III Clinical Study of their COVID-19 Vaccine,Clinical Trials|COVID-19,27/5/2021
Novartis and Molecular Partners Initiate P-II/III EMPATHY Study to Evaluate Ensovibep (MP0420) for the Treatment of COVID-19,Clinical Trials|COVID-19,27/5/2021
Senti Bio Collaborates with BlueRock to Develop Gene Circuit Engineered Cell Therapies for Regenerative Medicine,Biotech,27/5/2021
Eli Lilly to Initiate P-I Study of LY3819469 for Cardiometabolic Diseases,Clinical Trials|Regulatory,27/5/2021
ONO and BMS' Opdivo + Yervoy Receive Approval for 1L Treatment for Unresectable Advanced or Recurrent Malignant Pleural Mesothelioma,Regulatory,28/5/2021
BMS' Zeposia (ozanimod) Receives the US FDA's Approval for Ulcerative Colitis,Regulatory,28/5/2021
AstraZeneca's Tagrisso (osimertinib) Receives EU's Approval for the Adjuvant Treatment of Patients with Early-Stage EGFR-Mutated Lung Cancer,Regulatory,28/5/2021
uniQure Provides Positive Recommendation to Advance P- I/II Study of AMT-130 for Huntington Disease,Clinical Trials,28/5/2021
The US FDA's EMDAC Supports Provention Bio's Teplizumab in Delaying Diabetes,Regulatory,28/5/2021
Seelos' SLS-005 (Trehalose) Receives EC's Orphan Drug Designation to Treat Amyotrophic Lateral Sclerosis,Regulatory,28/5/2021
Amgen's Lumakras (sotorasib) Receives the US FDA's Approval as the First KRAS Blocking Cancer Therapy,Regulatory,31/5/2021
Pfizer and BioNTech Receive EC's Conditional Marketing Approval for the COVID-19 Vaccine in Adolescents,Regulatory,31/5/2021
Novartis Reports One Year Results of Beovu (brolucizumabin) in P- III MERLIN Study to Treat Wet Age-Related Macular Degeneration,Clinical Trials,31/5/2021
BridgeBio and Helsinn's Truseltiq (infigratinib) Receive the US FDA's Approval for Cholangiocarcinoma,Regulatory,31/5/2021
Novo Nordisk Resubmits Label Expansion Application to the US FDA for Semaglutide (2.0mg),Regulatory,31/5/2021
Ipsen Reports the US FDA's Acceptance of NDA for Palovarotene to Treat Fibrodysplasia Ossificans Progressiva,Regulatory,31/5/2021
BMS' Abecma (idecabtagene vicleucel) Receives the Health Canada's Approval as the First Anti-BCMA CAR T Cell Therapy for Relapsed and Refractory Multiple Myeloma,Regulatory,2021-01-06
Sanofi Stops the P-II/III STAGED-PKD Study of Venglustat for Autosomal Dominant Polycystic Kidney Disease,Clinical Trials,2021-01-06
AB Science Holds the Clinical Studies of Masitinib Globally,Clinical Trials,2021-01-06
Biohaven's Nurtec ODT (rimegepant) Receives the US FDA's Approval for Treatment of Migraine,Regulatory,2021-01-06
Amgen and Kyowa Kirin Collaborate to Develop and Commercialize KHK4083 for Atopic Dermatitis,Pharma,2021-01-06
Santhera and ReveraGen Report Results of Vamorolone in P-IIb VISION-DMD Study for Duchenne Muscular Dystrophy,Clinical Trials,2021-01-06
Novartis' Cosentyx (secukinumab) Receives the US FDA's Approval for the Treatment of Moderate to Severe Plaque Psoriasis,Regulatory,2021-02-06
Janssen's Teclistamab Receives the US FDA's Breakthrough Therapy Designation for Relapsed or Refractory Multiple Myeloma,Regulatory,2021-02-06
Alnylam Reports Completion of Patient Enrollment in P-III APOLLO-B Study for Patisiran to Treat Transthyretin-Mediated (ATTR) Amyloidosis with Cardiomyopathy,Clinical Trials,2021-02-06
AstraZeneca Presents Results of Anifrolumab in New Post-Hoc Analysis of P-III TULIP Study for Systemic Lupus Erythematosus at EULAR 2021,Clinical Trials,2021-02-06
Novartis Presents Two-Year Data of Cosentyx in P-III JUNIPERA Study for JPsA and ERA at EULAR 2021,Clinical Trials,2021-02-06
AbbVie Presents Results of Long-Term Efficacy and Safety Analyses for Rinvoq (upadacitinib) in P-III SELECT-COMPARE Study for Rheumatoid Arthritis at EULAR 2021,Clinical Trials,2021-02-06
MorphoSys to Acquire Constellation Pharmaceuticals for ~$1.7B,M&A,2021-03-06
Prime Therapeutics Launches MedDrive for Greater Biosimilar Drug Adoption,Biosimilars,26/5/2021
BMS' Opdivo (nivolumab) + Yervoy (ipilimumab) Receive EC's Approval for 1L Treatment for Unresectable Malignant Pleural Mesothelioma,Regulatory,2021-03-06
Xbrane to Initiate New Biosimilar Development Program Annually,Biosimilars,17/5/2021
Novartis Presents Results of Kymriah in P-II ELARA Study for Relapsed or Refractory Follicular Lymphoma at ASCO 2021,Clinical Trials,2021-03-06
Quebec Reports the Intention on Implementing Shift Towards Biosimilars,Biosimilars,19/5/2021
Sandoz Canada Congratulates the Quebec Government on Implementing a Shift Towards Biosimilars,Biosimilars,18/5/2021
"Sandoz Launches Inclunox and Inclunox HP (biosimilar, enoxaparin sodium solution) in Canada",Biosimilars,17/5/2021
"Zydus Cadila Launches Ujvira (biosimilar, trastuzumab emtansine) for Early and Advanced HER2 Positive Breast Cancer",Biosimilars,24/5/2021
"Celltrion Presents One Year Results of Yuflyma (biosimilar, adalimumab) in P-III CT-P17 3.1 Trial for Rheumatoid Arthritis at EULAR 2021",Biosimilars|Clinical Trials,2021-03-06
Meiji Reports Results of P-I Study of DMB-3115 (proposed ustekinumab biosimilar) and Initiate P-III Study for Plaque Psoriasis,Biosimilars,21/5/2021
Lupin Reports the US FDA Acceptance of BLA for Pegfilgrastim Biosimilar,Biosimilars,2021-03-06
"Biogen and Bio-Thera Report Results of BAT1806 (biosimilar, tocilizumab) in P-III Study for Moderate to Severe Rheumatoid Arthritis",Biosimilars|Clinical Trials,2021-03-06
"The US Supreme Court Denies Sandoz's Petition for Erelzi (biosimilar, etanercept)",Biosimilars,17/5/2021
Viatris Expects its First Interchangeable Designation for Insulin Products,Biosimilars,14/5/2021
Alvotech Seeks to End the AbbVie's Wrong Monopoly on Humira and Develops New Biosimilar for Chronic Pain,Biosimilars,2021-11-05
Innovent and Lilly's Tyvyt (sintilimab injection) + Gemcitabine and Platinum CT Receive NMPA's Approval as 1L Therapy for Squamous Non-Small Cell Lung Cancer,Regulatory,2021-04-06
Merck Presents Results of Keytruda (pembrolizumab) in P-III KEYNOTE-564 as Adjuvant Therapy for Renal Cell Carcinoma at ASC0 2021,Clinical Trials,2021-04-06
United Therapeutics Reports the First Patient Enrollment in P-III TETON Study of Tyvaso for Idiopathic Pulmonary Fibrosis,Pharma,2021-04-06
BMS Presents Results of Opdivo (nivolumab) + CT or Yervoy (ipilimumab) in P-III CheckMate -648 Trial for Unresectable Advanced or Metastatic ESCC at ASCO 2021,Clinical Trials,2021-04-06
Dermavant Submits NDA to the US FDA for Tapinarof Cream to Treat Plaque Psoriasis,Regulatory,2021-04-06
Tonix Pharmaceuticals Presents Results of TNX-102 SL in P-III RELIEF study for the Management of Fibromyalgia at ASCP 2021,Clinical Trials,2021-04-06
Novartis Presents Results of Iptacopan in P-II Study for IgA Nephropathy at ERA-EDTA Congress,Clinical Trials,2021-07-06
ProMetic' Ryplazim (plasminogen) Receives the US FDA's Approval as First Treatment for Patients with Plasminogen Deficiency,Regulatory,2021-07-06
"Novo Nordisk's Wegovy (semaglutide, 2.4mg) Receives the US FDA's Approval for Weight Management in Adults with Obesity",Regulatory,2021-07-06
AstraZeneca Reports Results of Calquence (acalabrutinib) in P-III Head-to-Head ELEVATE-RR Trial for Chronic Lymphocytic Leukemia,Clinical Trials,2021-07-06
AstraZeneca Reports Updated Results of Imfinzi (durvalumab) in P-III PACIFIC Trial for Non-Small Cell Lung Cancer,Clinical Trials,2021-07-06
SpringWorks and Seagen Enter into a Clinical Collaboration to Evaluate Nirogacestat + SEA-BCMA for R/R Multiple Myeloma,Clinical Trials,2021-07-06
Biogen and Eisai's Aduhelm (aducanumab-avwa) Receive the US FDA's Accelerated Approval for Alzheimer Disease,Regulatory,2021-08-06
MSD Animal Health Acquires LICA's Assets to Enhance its Dairy Farm Management Solutions,Animal Health,2021-08-06
Janssen Discontinues its 2018 License Agreement with Argenx for Cusatuzumab,Pharma,2021-08-06
Roche's SARS-CoV-2 Antigen Test Receives CE mark For Self Testing of COVID-19 at Home,COVID-19|MedTech|Regulatory,2021-08-06
BeiGene Reports NMPA's Acceptance of sBLA for Tislelizumab to Treat MSI-H or dMMR Solid Tumors,Regulatory,2021-08-06
AbbVie's Rinvoq (upadacitinib) Receives the Health Canada's Approval for the Treatment of Psoriatic Arthritis,Regulatory,2021-08-06
Bayer to Advance its Investigational Cell and Gene Therapy for Parkinson's Disease,Clinical Trials,2021-09-06
Progentec Signs a Research Collaboration with GSK to Evaluate Proteomics and Digital Health Tools for SLE,DigiHealth,2021-09-06
Pfizer's Prevnar 20 (Pneumococcal 20-Valent Conjugate Vaccine) Receives the US FDA's Approval for the Prevention of Invasive Disease and Pneumonia,Regulatory,2021-09-06
Cardiff Oncology Reports First Patient Dosing in P-II Trial for Onvansertib + Irinotecan and 5-FU as a 2L Treatment for Metastatic Pancreatic Ductal Adenocarcinoma,Clinical Trials,2021-09-06
"Bio-Thera Reports the Initiation of P-III Clinical Trial for BAT2506 (biosimilar, golimumab)",Biosimilars|Clinical Trials,2021-09-06
AbbVie Collaborates with Caraway to Develop TMEM175 for Parkinson's Disease and Other Related Disorders,Biotech,2021-09-06
Merck Signs ~$1.2B Supply Agreement with US Government for Molnupiravir to Treat COVID-19,COVID-19|Pharma,2021-10-06
Inovio Expands its Partnership with Advaccine to Initiate P-III Efficacy Trial for INO-4800 to Treat COVID-19,Biotech|COVID-19,2021-10-06
Hummingbird Collaborates with Novogene to Expand Precision Therapy Testing for NRG1-Fusion Driven Cancers in China,Biotech,2021-10-06
Vertex's Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) Receives the US FDA's Approval in Children Aged 6 to 11 with Certain Mutations in Cystic Fibrosis,Regulatory,2021-10-06
BeiGene Signs an Exclusive Worldwide Collaboration with Shoreline to Develop and Commercialize Genetically Modified NK Cell Therapies,Biotech,2021-10-06
Takeda Expands its License Agreement with Codexis to Discover Novel Gene Therapies for Fourth Rare Genetic Disorders,Biotech,2021-10-06
Gilead's Epclusa (Sofosbuvir/Velpatasvir) Receives the US FDA's Approval for Children with Chronic Hepatitis C Infection,Regulatory,2021-11-06
BeyondSpring Presents Results of Plinabulin in P-III PROTECTIVE-1 Study for Prevention of Chemotherapy-Induced Neutropenia at ASCO 2021,Clinical Trials,2021-11-06
Verona Pharma Signs $219M Agreement with Nuance Pharma to Develop and Commercialize Ensifentrine in Greater China,Pharma,2021-11-06
Roche Reports New Interim Data of JEWELFISH &amp; RAINBOWFISH Studies for Evrysdi (risdiplam) to Treat Spinal Muscular Atrophy,Clinical Trials,2021-11-06
AbbVie Reports Results of Four-Year Follow-Up Analysis in P-III CLL14 Trial for Venclyxto/Venclexta to Treat Chronic Lymphocytic Leukemia,Clinical Trials,2021-11-06
Vertex and CRISPR Therapeutics Present New Data of CTX001 from 22 Patients with TDT and SCD at EMA 2021,Biotech|Clinical Trials,2021-11-06
Sanofi Presents Results of Sutimlimab in P-III CADENZA Trial to Treat Hemolysis Patients with Cold Agglutinin Disease at EHA 2021,Clinical Trials,14/6/2021
"Celltrion Presents Real-World Data of Truxima (biosimilar, rituximab) for Diffuse Large B-Cell Lymphoma at EHA 2021",Biosimilars|Clinical Trials,14/6/2021
Janssen Presents Results of Darzalex (daratumumab) in P-III MAIA Study for Transplant Ineligible Patients with Multiple Myeloma at EHA 2021,Clinical Trials,14/6/2021
AbbVie Presents Results of Imbruvica (ibrutinib) + Venclexta/Venclyxto in P-III GLOW Study as 1L Treatment for CLL or SLL at EHA 2021,Clinical Trials,14/6/2021
Kite Presents Results of Yescarta (axicabtagene ciloleucel) in P-II ZUMA-5 Trial for R/R Follicular Lymphoma at EHA 2021,Clinical Trials,14/6/2021
GSK Signs an Agreement with iTeos to Develop and Commercialize EOS-448 for Patients with Cancer,Biotech,14/6/2021
Biogen's BIIB111 Fails to Meet its Primary Endpoint in P-III STAR Study for Choroideremia,Clinical Trials,15/6/2021
Novavax's COVID-19 Vaccine Demonstrates 90.4% Efficacy in P-III PREVENT-19 Study,Clinical Trials|COVID-19,15/6/2021
AstraZeneca's COVID-19 Vaccine Demonstrates 92% Efficacy Against Delta (Indian) Variant,Clinical Trials|COVID-19,15/6/2021
BeiGene's Tislelizumab in Combination with Asieris' APL-1202 Receive the US FDA's IND Approval for MIBC,Regulatory,15/6/2021
AstraZeneca's AZD7442 Fails to Meet its Primary Endpoint in P-III STORM CHASER Study for the Prevention of Symptomatic COVID-19,Clinical Trials|COVID-19,15/6/2021
Sage and Biogen Report Results of Zuranolone in P-III WATERFALL Study for Major Depressive Disorder,Clinical Trials,15/6/2021
Innovent Reports First Patient Dosing in P-II Clinical Trial for the Treatment of Obesity in China,Clinical Trials,16/6/2021
Linnaeus Therapeutics Reports the Expansion of Clinical Collaboration with Merck to Evaluate LNS8801 + Keytruda for the Treatment of Patients with Advanced Cancer,Pharma,16/6/2021
Gilead and Jounce's JTX-1811 Receives US FDA's IND Clearance for Cancer Immunotherapies,Biotech,16/6/2021
Regeneron Reports Results of REGEN-COV (casirivimab and imdevimab) in P-III RECOVERY Trial for COVID-19 Patients,Clinical Trials|COVID-19,16/6/2021
Organicell Reports Results of Expanded Access Trial for Zofin to Treat Mild to Moderate COVID-19,Clinical Trials|COVID-19,16/6/2021
Lundbeck Presents Results of Vyepti (eptinezumab-jjmr) in RELIEF Study for Preventive Treatment of Migraine at JAMA,Biotech|Clinical Trials,16/6/2021
Pfizer Presents Results of Tofacitinib in STOP-COVID Study for Patients Hospitalized with COVID-19 Pneumonia at NEJM,Clinical Trials|COVID-19,17/6/2021
MannKind and United Therapeutics Reports the US FDA's Acceptance of NDA for Priority Review of Tyvaso DPI to Treat PAH and PH-ILD,Regulatory,17/6/2021
CureVac Report Results of CVnCoV in Second Interim Analysis of P-llb/lll HERALD Trial to Treat COVID-19,Clinical Trials|COVID-19,17/6/2021
Blueprint Medicines' Ayvakit (avapritinib) Receives FDA's Approval to Treat Patients with Advanced Systemic Mastocytosis,Regulatory,17/6/2021
Atea Pharma Secures $50M Milestone Payment with Roche in the Development of AT-527 for COVID-19,COVID-19|Pharma,17/6/2021
Biogen's Gosuranemab (BIIB092) Fails to Meet its Primary Endpoint in P-II TANGO Study for Alzheimer Disease,Clinical Trials,17/6/2021
Lantheus' Pylarify (piflufolastat F 18) Injection Receives the US FDA's Approval for the Treatment of Prostate Cancer,Regulatory,27/5/2021
Biogen Reports First Patient Dosing in P-III TOPAZ-1 Study of BIIB059 to Treat Systemic Lupus Erythematosus,Clinical Trials,18/6/2021
Kite Enter into a Partnership with Shoreline Biosciences to Develop Novel Allogeneic Cell Therapies,Biotech,18/6/2021
BeiGene Reports First Patient Dosing in P-III AdvanTIG-302 Trial of Ociperlimab (BGB-A1217) + Tislelizumab (BGB-A317) to Treat Non-Small Cell Lung Cancer,Clinical Trials,18/6/2021
CytoReason Collaborates with Sanofi to Initiate its Project Utilizing AI Technology for Asthma,DigiHealth|Pharma,18/6/2021
BioNTech Reports First Patient Dosing in P-II Clinical Trial of BNT111 to Treat Advanced Melanoma,Biotech|Clinical Trials,18/6/2021
Lineage Signs an Exclusive Option Agreement with Amasa Therapeutics to Supply and Use of Clinical-Grade Hystem,Biotech,18/6/2021
Sanofi's Aubagio (teriflunomide) Receives EC's Approval as First Oral MS Therapy for 1L Treatment with Relapsing-Remitting Multiple Sclerosis in Children and Adolescents,Regulatory,21/6/2021
BMS' Onureg (azacytidine) Receives EC's Approval for as Frontline Oral Maintenance Therapy for Adults with Acute Myeloid Leukemia,Regulatory,21/6/2021
Novartis Presents New Data of Zolgensma in P-III Studies in Symptomatic Children with SMA at EAN2021,Clinical Trials,21/6/2021
Eisai Collaborates with BMS for the Co-Development and Co-Commercialization of MORAb-202,Biotech,21/6/2021
BeiGene's Brukinsa (zanubrutinib) Receives the NMPA's Approval for Relapsed or Refractory Waldenström's Macroglobulinemia,Regulatory,21/6/2021
FibroGen Collaborates with HiFiBiO to Advance Next-Generation Therapies for Patients with Cancer and Autoimmune Disease,Biotech,21/6/2021
Bayer Reports sNDA Submission to US FDA and MAA to EMA for Copanlisib + Rituximab to Treat B-iNHL and Relapsed MZL,Regulatory,22/6/2021
Arrowhead Signs a License Agreement with Horizon to Develop siRNA Therapeutic Targeting XDH for Uncontrolled Gout,Biotech,22/6/2021
"Innovent Publishes the Results of Sintilimab + IBI305 (bevacizumab, biosimilar) in P-II/III ORIENT-32 Study as 1L Treatment for HCC in The Lancet Oncology",Biosimilars,22/6/2021
AstraZeneca and MSD's Koselugo (selumetinib) Receive the EU's Approval for Neurofibromatosis Type 1 and Plexiform Neurofibromas,Regulatory,22/6/2021
ViiV Healthcare Signs a License Agreement with Halozyme for ENHANZE Drug Delivery Technology to Develop Ultra Long-Acting Medicines for HIV,Biotech,22/6/2021
GSK and Vir Report Results of Sotrovimab in P-III COMET-ICE Trial for High-Risk Adult Patients with Mild-To-Moderate COVID-19,Clinical Trials|COVID-19,22/6/2021
MacroGenics Signs a License Agreement with Zai Lab to Develop and Commercialize Preclinical Bispecific Antibodies in Oncology,Biotech,16/6/2021
LEO Pharma' Adtralza (tralokinumab) Receives EC's Approval for Moderate-To-Severe Atopic Dermatitis,Regulatory,23/6/2021
Novartis Reports New Data of Kesimpta (ofatumumab) in ALITHIOS Study for Multiple Sclerosis,Clinical Trials,23/6/2021
uniQure Reports 52-Week Clinical Data of Etranacogene Dezaparvovec in P-III HOPE-B Trial for Hemophilia B,Clinical Trials,23/6/2021
uniQure to Acquire Corlieve Therapeutics for $55M,Biotech|M&A,23/6/2021
Pear Therapeutics to Become Public Via THMA SPAC Merger for ~$1.6B,DigiHealth|M&A,23/6/2021
Sorrento Enters a Multi-Year Research and Development Agreement with US NAMRU-3 Against COVID-19,COVID-19,23/6/2021
Roche Report the US FDA's Acceptance of BLA for Port Delivery System with Ranibizumab to Treat Neovascular Age-Related Macular Degeneration,Regulatory,24/6/2021
Eisai and Biogen Receive FDA's Breakthrough Therapy Designation for Lecanemab (BAN2401) to Treat Alzheimer's Disease,Regulatory,24/6/2021
Bayer's Verquvo (vericiguat) Receives MHLW's Approval for Chronic Heart Failure,Regulatory,24/6/2021
Chugai's Evrysdi (risdiplam) Receives MHLW's Approval for the Treatment of Spinal Muscular Atrophy,Regulatory,24/6/2021
Janssen Reports Submission of NDA to the US FDA for Xarelto (rivaroxaban) to Prevent and Treat Blood Clots in Children,Regulatory,24/6/2021
Tecan to Acquire Paramit for ~$1B,M&A|MedTech,24/6/2021
AbbVie Acquire TeneoOne and its TNB-383B for the Treatment of Relapsed or Refractory Multiple Myeloma,M&A,25/6/2021
Lilly's Donanemab Receives the US FDA's Breakthrough Therapy Designation for the Treatment of Alzheimer's Disease,Regulatory,25/6/2021
AbbVie Receive the CHMP's Positive Opinion Recommending Approval of Rinvoq (upadacitinib) for Atopic Dermatitis,Regulatory,25/6/2021
Roche's Actemra/RoActemra (tocilizumab) Receives the US FDA's EUA for Hospitalized Patients with COVID-19,COVID-19|Regulatory,25/6/2021
Regeneron and Sanofi's Libtayo (cemiplimab) Receive the EC's Approval as 1L Treatment for Advanced NSCLC,Regulatory,25/6/2021
Regeneron and Sanofi's Libtayo (cemiplimab) Receive the EC's Approval as 1L Treatment for Advanced Basal Cell Carcinoma,Regulatory,25/6/2021
AstraZeneca Reports First Patient Vaccinating in P-II/III D7220C00001 Trial for AZD2816 to Prevent COVID-19,Clinical Trials|COVID-19,28/6/2021
Mirati's Adagrasib (MRTX849) Receives the US FDA's Breakthrough Therapy Designation for Advanced Non-Small Cell Lung Cancer,Regulatory,28/6/2021
Lilly Presents the Results of Tirzepatide in SURPASS-1 Trial for Type-2 Diabetes at ADA2021,Clinical Trials,28/6/2021
Roche's Enspryng Receives EC's Approval as First Home Subcutaneous Treatment for NMOSD,Regulatory,28/6/2021
AstraZeneca's Forxiga (dapagliflozin) Receives CHMP's Recommendation for Approval to Treat Chronic Kidney Disease in EU,Regulatory,28/6/2021
"Samsung Bioepis and Biogen Receive the CHMP's Positive Opinion Recommending Approval of Byooviz (biosimilar, ranibizumab) for Retinal Vascular Disorders",Biosimilars|Regulatory,28/6/2021
Gilead Reports Submission of NDA to the US FDA for Lenacapavir to Treat HIV-1 in People with Limited Therapy Options,Regulatory,29/6/2021
"Innovent's Tyvyt (sintilimab) + Byvasda (biosimilar, bevacizumab) Receive the NMPA's Approval as 1L Therapy for Hepatocellular Carcinoma",Biosimilars|Regulatory,29/6/2021
"Teva Signs an Exclusive Commercialization Agreement with Bioeq for FYB201 (biosimilar, ranibizumab)",Biosimilars,29/6/2021
AstraZeneca's Vaxzevria (AZD1222) Delivers Strong Immune Responses in COV001 and COV002 Trials Against COVID-19,Clinical Trials,29/6/2021
Medtronic Presents Real-World Data of InPen Smart Insulin Pen for Controlling Blood Sugar Levels at ADA2021,Clinical Trials|MedTech,29/6/2021
Sanofi Reports Results of Soliqua (insulin glargine and lixisenatide) in SoliMix Study for the Treatment of Type 2 Diabetes,Clinical Trials,29/6/2021
Medtronic Launches its First App-Based Research Study to Manage Atrial Fibrillation Disease Burden,DigiHealth,30/6/2021
BMS' Opdivo (nivolumab) + Yervoy (ipilimumab) Receive EC's Approval for dMMR or MSI-H mCRC After Prior Chemotherapy,Regulatory,30/6/2021
AbbVie Report Results of Rinvoq (upadacitinib) in P-III Maintenance Study for the Treatment of Ulcerative Colitis,Clinical Trials,30/6/2021
"Amneal Reports the US FDA's Acceptance of BLA for Alymsys (biosimilar, bevacizumab)",Biosimilars,17/6/2021
Theramex Collaborates with Enzene for the Registration and Commercialization of Biosimilar Denosumab,Biosimilars,2021-10-06
"Celltrion Launches Remsima SC (biosimilar, infliximab) for Rheumatoid Arthritis in Canada",Biosimilars,2021-07-06
Arbutus and Antios Enter into a Clinical Collaboration to Evaluate AB-729 + ATI-2173 for Chronic Hepatitis B Virus Infection,Clinical Trials,30/6/2021
Alvotech Reaches PCD in its Switching Study for AVT02 (Proposed Biosimilar to Humira),Biosimilars,15/6/2021
Vivoryon and Simcere Sign a License Agreement for N3pE Amyloid-Targeting Medicines to Treat Alzheimer's Disease in Greater China,Pharma,30/6/2021
Celltrion to Acquire Controlling Stake of Iksuda Therapeutics,Biosimilars,2021-07-06
"Formycon and Bioeq Report MAA Submission to EMA for FYB201 (biosimilar, ranibizumab)",Biosimilars|Regulatory,30/6/2021
Apellis and Beam Sign a Five-Year Research Collaboration to Discover Novel Therapies for Complement-Driven Diseases,Pharma,2021-01-07
"STADA and Xbrane's Xlucane (biosimilar, ranibizumab) Meet its Primary Endpoint in P-III Xplore Study",Biosimilars|Clinical Trials,2021-01-07
LEXEO Therapeutics' LX2006 Receives the US FDA's Rare Pediatric Disease Designation and Orphan Drug Designation to Treat Friedreich Ataxia,Regulatory,2021-01-07
Abbott's XIENCE Stent Receives the US FDA's Approval for Shortest Blood Thinner Course in Patients with High Bleeding Risk,MedTech|Regulatory,2021-01-07
Jazz's Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) Receives the US FDA's Approval for Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma,Regulatory,2021-01-07
Orchard Collaborates with Pharming to Develop and Commercialize OTL-105 for Hereditary Angioedema,Pharma,2021-01-07
Nestle and Seres Collaborate to Jointly Commercialize SER-109 for Recurrent Clostridioides difficile Infection,Biotech,2021-02-07
The US FDA Approves FoundationOne CDx for Alunbrig (brigatinib) in Patients with ALK+ NSCLC,MedTech|Regulatory,2021-02-07
Almirall and Kaken Enter into a License Agreement for the Development and Commercialization of Efinaconazole in Europe,Pharma,2021-02-07
Zydus Seeks EUA for ZyCoV-D Against COVID-19 in India,COVID-19|Regulatory,2021-02-07
Denovo In-Licenses Lundbeck's Idalopirdine for Alzheimer's Disease and Other Indications,Pharma,2021-02-07
Hutchmed Reports the US FDA's Acceptance of Surufatinib's NDA for Advanced Neuroendocrine Tumors,Regulatory,2021-02-07
GSK and Alector Sign $2.2B Collaboration to Develop Therapies for Neurodegenerative Diseases,Biotech,2021-05-07
"Gan Lee Presents P-I Results of Proposed Biosimilar Insulins Aspart, Lispro and Glargine at ADA 2021",Biosimilars|Clinical Trials,2021-05-07
Roche to Present New data of Hemlibra (emicizumab) in P-IIIb STASEY Study for Hemophilia A at ISTH 2021,Clinical Trials,2021-05-07
Ocugen and Bharat Biotech Present Results of Covaxin in P-III Study Against COVID-19,Clinical Trials|COVID-19,2021-05-07
Merck Amends Collaboration with NGM to Advance Novel Therapies for Retinal and CVM Diseases,Biotech,2021-05-07
Lupin's Solosec (secnidazole) Receives the US FDA's Approval for the Treatment of Trichomoniasis,Regulatory,2021-05-07
Spero Therapeutics Enters into a License Agreement with Pfizer for SPR206 to Treat MDR Gram Negative Infections,Biotech,2021-06-07
Immunic's IMU-838 Receives the US FDA's IND Approval to Initiate P-III ENSURE &amp; P-II CALLIPER Studies for RRMS &amp; PMS,Clinical Trials|Regulatory,2021-06-07
Abbisko Signs an Exclusive License Agreement with Sperogenix to Develop ABSK021 for ALS and Other Rare Neurological Diseases in Greater China,Pharma,2021-06-07
Hutchmed Initiates P-I Trial of HMPL 295 for the Treatment of Advanced Solid Tumors in China,Clinical Trials,2021-06-07
Roche Enter into a Collaboration with Mimetas to Develop Human Disease Models for Drug Development,Biotech,2021-06-07
Merck's Keytruda (pembrolizumab) Receives the US FDA's Approval for Expanded Indication in Patients with Locally Advanced Cutaneous Squamous Cell Carcinoma,Regulatory,2021-06-07
Sanofi Signs ~$1B Agreement with Eureka &amp; MSK for their Multiple Myeloma Candidate,Biotech,2021-07-07
Alvotech Initiates AVT04-GL-301 Study of AVT04 Proposed Biosimilar to Stelara (ustekinumab) for the Treatment of Plaque Psoriasis,Biosimilars,2021-07-07
Sorrento's Resiniferatoxin Receives the US FDA's Clearance to Initiate P-II Trial for the Treatment of Knee Pain in Patients with Osteoarthritis,Clinical Trials,2021-07-07
Merck Collaborates with OncoSec to Evaluate TAVO (tavokinogene telseplasmid) + Keytruda (pembrolizumab) in P-III KEYNOTE-C87 Trial for Late-Stage Metastatic Melanoma,Clinical Trials,2021-07-07
Y-mAbs Reports BLA Submission to the NMPA for Danyelza (naxitamab-gqgk) to Treat Relapsed/Refractory High-Risk Neuroblastoma,Regulatory,2021-07-07
Mallinckrodt Reports Results of StrataGraft in P-III STRATA2016 Study for Thermal Burns,Clinical Trials|MedTech,2021-07-07
"Teva Enters Into a Commercialization Agreement with Bioeq for FYB201 (biosimilar, ranibizumab)",Biosimilars,2021-08-07
Chugai Files an Application with MHLW for an Additional Indication of Tecentriq as an Adjuvant Treatment for NSCLC in Japan,Biotech,2021-08-07
Roche Enters into a Clinical Collaboration with Treos Bio for PolyPEPI1018 + atezolizumab in P-I/II Trial to Treat Late Stage Microsatellite Stable Metastatic Colorectal Cancer,Biotech,2021-08-07
BeiGene Signs a Supply Agreement with PureTech for LYT-200 and Tislelizumab in Patients with Difficult-to-Treat Solid Tumors,Biotech,2021-08-07
BeiGene Reports NMPA's Acceptance of sBLA for Tislelizumab to Treat Esophageal Squamous Cell Carcinoma in China,Regulatory,2021-08-07
AstraZeneca and Amgen Report the US FDA's Acceptance of BLA and Priority Review of Tezepelumab for the Treatment of Asthma,Regulatory,2021-08-07
AstraZeneca Signs an Exclusive License Agreement with F-star Therapeutics for Novel STING Inhibitors,Biotech,2021-09-07
BeiGene's Kyprolis (carfilzomib) Receives NMPA's Conditional Approval for the Treatment of Relapsed or Refractory Multiple Myeloma,Regulatory,2021-09-07
Lilly Signs a Three-Year Collaboration with Verge Genomics to Discover and Develop Novel Therapies for ALS,Biotech,2021-09-07
Janssen Collaborates with Vor to Develop Engineered Hematopoietic Stem Cell Transplants with Bi-Specific Antibody Therapy to Treat AML,Biotech,2021-09-07
Jazz's Vyxeos (daunorubicin and cytarabine liposome) for Injection Receives Health Canada Approval for the Treatment of High-risk Acute Myeloid Leukemia,Regulatory,2021-09-07
Lysogene Receives the US FDA's Fast Track Designation for LYS-GM101 Gene Therapy to Treat GM1 Gangliosidosis,Regulatory,2021-09-07
Bayer's Kerendia (finerenone) Receives the US FDA's Approval for the Treatment of Chronic Kidney Disease Associated with Type 2 Diabetes,Regulatory,2021-12-07
Takeda Presents Results of Takhzyro (lanadelumab) in P-III HELP Study Open-Label Extension to Treat Hereditary Angioedema Attacks at EAACI 2021,Clinical Trials,2021-12-07
Astellas and Seagen's Padcev (enfortumab vedotin-ejfv) Receive the US FDA's Full Approval and Expands Indication for Patients with Locally Advanced or Metastatic Urothelial Cancer,Regulatory,2021-12-07
Innovent Reports First Patient Dosing in P-I CIBI323A101 Study of IBI323 to Treat Advanced Malignant Tumors,Clinical Trials,2021-12-07
Galapagos Reports New Post-Hoc Analyses from P-III SELECTION Program of Filgotinib to Treat Ulcerative Colitis,Clinical Trials,2021-12-07
Janssen Presents Three-Year Data of Stelara (ustekinumab) in P-lll UNIFI LTE Study for the Treatment of Moderately to Severely Active Ulcerative Colitis at ECCO,Clinical Trials,2021-12-07
Scynexis' Brexafemme (ibrexafungerp tablets) Receives the US FDA's Approval as the First Oral Non-Azole Treatment for Vaginal Yeast Infections,Regulatory,2021-02-06
Chimerix's Tembexa (brincidofovir) Receives the US FDA's Approval for the Treatment of Smallpox,Regulatory,2021-04-06
Novo Nordisk to Acquire Prothena's ATTR Amyloidosis Program for ~$1.2B,Biotech,13/7/2021
Biogen Signs a License Agreement with Innocare for Orelabrutinib to Treat Multiple Sclerosis,Pharma,13/7/2021
Menagen Signs a Commercialization Agreement with CKD for Biosimilar Darbepotein Alfa,Biosimilars,13/7/2021
Janssen's Darzalex Faspro (daratumumab and hyaluronidase-fihj) + Pomalidomide and Dexamethasone Receive the US FDA's Approval to Treat Patients with Multiple Myeloma,Regulatory,13/7/2021
Hutchmed Reports First Commercial Sale of Orpathys (savolitinib) in China,Pharma,13/7/2021
Astellas and Affinivax Present Results of ASP3772 in P-II Study for Streptococcus Pneumoniae,Clinical Trials,13/7/2021
Hepion Reports Results of CRV431 in P-IIa AMBITION Trial for the Treatment of NASH,Clinical Trials,14/7/2021
Hologic Receives CE Mark to Use Saliva Samples with Aptima SARS-CoV-2 Test in EU,COVID-19|MedTech,14/7/2021
Ionis Signs an Exclusive WW License Agreement with Bicycle to Develop Targeted Oligonucleotide Therapeutics Using TfR1 Bicycle Technology,Biotech,14/7/2021
Astellas Signs a License Agreement with ExCellThera for In Vitro Use of UM171 in Pluripotent Stem Cells,Biotech,14/7/2021
Strongbridge Reports Results of Post Hoc Analyses from a One Year HYPHOP Study of Keveyis (dichlorphenamide) to Treat Primary Periodic Paralysis,Clinical Trials,14/7/2021
Caribou Reports the First Patient Dosing in P-I ANTLER Study of CB-010 to Treat Relapsed or Refractory B Cell Non-Hodgkin Lymphoma,Clinical Trials,14/7/2021
Eli Lilly to Acquire Protomer Technologies for ~$1B,M&A,15/7/2021
Galapagos Reports Results of GLPG3667 in P-Ib Study for the Treatment of Psoriasis,Clinical Trials,15/7/2021
Incyte and Novartis Publish Results of Jakafi (ruxolitinib) in P-III REACH3 Study to Treat Chronic Graft-Versus-Host Disease in NEJM,Clinical Trials,15/7/2021
Johnson &amp; Johnson Publishes Interim Results of Single-Shot COVID-19 Vaccine in P-I/IIa Sub-Study for COVID 19 in NEJM,Clinical Trials,15/7/2021
Heat Biologics Signs a Research License Agreement with ProBioGen for Transposase System and Suspension HEK293 Cell Line,Biotech,15/7/2021
Skyhawk Collaborate with Aragen to Develop Novel Small Molecule Therapeutics to Correct RNA Expression,Biotech,15/7/2021
Eton's Rezipres (ephedrine hydrochloride injection) Receives the US FDA's Approval for the Treatment of Hypotension,Regulatory,15/6/2021
Sarfez's Soaanz Receives the US FDA's Approval for the Treatment of Heart Failure and Renal Disease,Regulatory,21/6/2021
Ipsen Signs an Exclusive WW License Agreement with IRLAB for Mesdopetam to Treat Parkinson Disease,Pharma,16/7/2021
Alexion Reports Results of Ultomiris (ravulizumab-cwvz) in P-III Study for Generalized Myasthenia Gravis,Clinical Trials,16/7/2021
Vir Reports First Patient Dosing in P-II MARCH Trial for VIR-2218 + VIR-3434 as a Functional Cure Regimen for Chronic Hepatitis B Virus Infection,Clinical Trials,16/7/2021
Bio-Thera Reports First Patient Dosing in P-III Study for BAT2206 Proposed Biosimilar of Stelara (ustekinumab),Biosimilars,16/7/2021
AcelRx Signs a License Agreement with Aguettant to Commercialize Dzuveo in EU and for Two Pre-Filled Syringe Products in US,Pharma,16/7/2021
Eli Lilly Signs an Agreement with Banner Alzheimer's Institute to Evaluate Donanemab in P-III TRAILBLAZER-ALZ 3 Trial for Alzheimer's Disease,Biotech,16/7/2021
GSK Reports Results of Daprodustat in P-III ASCEND Program for the Treatment of Anemia due to Chronic Kidney Disease,Clinical Trials,19/7/2021
Merck's Vaxneuvance (pneumococcal 15-valent conjugate vaccine) Receives the US FDA's Approval for the Prevention of Invasive Pneumococcal Disease Caused by 15 Serotypes,Biotech|Regulatory,19/7/2021
Sanofi's Fexinidazole Receives the US FDA's Approval as the First Oral Treatment for Sleeping Sickness,Regulatory,19/7/2021
AstraZeneca's Imfinzi (durvalumab) Receives NMPA's Approval as a 1L Treatment of Extensive-Stage Small Cell Lung Cancer,Regulatory,19/7/2021
Gilead Reports New Data of Lenacapavir in P-II/III CAPELLA Trial for the Treatment of HIV,Clinical Trials,19/7/2021
Genentech Reports New Data of Hemlibra (emicizumab-kxwh) in P-IIIb STASEY Study to Treat Hemophilia A,Clinical Trials,19/7/2021
AstraZeneca Signs an Exclusive WW License Agreement with Aridis for Suvratoxumab to Prevent Pneumonia,Biotech,20/7/2021
Regeneron's Ronapreve Antibody Cocktail (casirivimab and imdevimab) Receives MHLW's Approval for the Treatment of Mild to Moderate COVID-19,Regulatory,20/7/2021
Samsung Bioepis Initiates P-III Clinical Trial of SB17 Proposed Biosimilar to Stelara (ustekinumab),Biosimilars,20/7/2021
Kadmon's Rezurock (belumosudil) Receives the US FDA's Approval for the Treatment of Chronic Graft Versus Host Disease,Regulatory,20/7/2021
"BioNTech Signs a Purchase Agreement to Acquire Kite's Cell Therapy, R&amp;D Platform and Manufacturing Facility in Gaithersburg, MD",Biotech,20/7/2021
"Myovant's Ryeqo (relugolix, estradiol, and norethindrone acetate) Receives EC's Approval for the Treatment of Women with Uterine Fibroids",Regulatory,20/7/2021
Merck Presents Results from P-IIa Clinical Trial of Islatravir (MK-8591) for the Prevention of HIV at IAS 2021,Clinical Trials,21/7/2021
Relmada In-Licenses Psilocybin Program from Arbormentis,Biotech,21/7/2021
Albireo's Bylvay (odevixibat) Receives the US FDA's Approval for the Treatment of Progressive Familial Intrahepatic Cholestasis,Regulatory,21/7/2021
Scilex Reports Completion of Patient Enrollment in P-III C.L.E.A.R. Program for Semdexa (SP-102) to Treat Sciatica Pain Management,Clinical Trials,21/7/2021
Genentech's Venclexta (venetoclax) + Azacitidine Receives Breakthrough Therapy Designation for the Treatment of Myelodysplastic Syndromes,Regulatory,21/7/2021
Calliditas Signs a License Agreement with STADA to Commercialize Specialty Therapy for the Treatment of IgA Nephropathy in EU,Pharma,21/7/2021
Lexeo Acquires Stelios to Expands its Gene Therapy Pipeline for Rare Cardiovascular Diseases,M&A,22/7/2021
Bayer and Merck's Verquvo (vericiguat) Receives the EC's Approval for the Treatment of Chronic Heart Failure,Regulatory,22/7/2021
IM Reports Results of IMT-002 in P-Ib MAD Trial for the Treatment of Type 1 Diabetes,Clinical Trials,22/7/2021
Mabpharm's Biobetter (CMAB008) for Infliximab Receives NMPA's Approval in China,Biosimilars|Regulatory,22/7/2021
Bluebird Bio's Skysona (elivaldogene autotemcel) Receives EC's Approval for the Treatment of Cerebral Adrenoleukodystrophy,Regulatory,22/7/2021
Merck and Eisai's Keytruda (pembrolizumab) + Lenvima (lenvatinib) Receive the US FDA's Approval for the Treatment of Advanced Endometrial Carcinoma,Regulatory,22/7/2021
"Bioeq Collaborates with Teva to Commercialize FYB201 (biosimilar, ranibizumab)",Biotech,2021-07-07
Synaffix Signs a License Agreement with ProfoundBio for ADC Technologies,Biotech,23/7/2021
NGM Reports Completion of Patient Enrollment in P-II CATALINA Study of NGM621 in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration,Clinical Trials,23/7/2021
Celltrion Collaborates with Inhalon to Develop Regdanvimab (CT-P59) for the Treatment of COVID-19 at Home,COVID-19,23/7/2021
"Meiji and Dong-A ST Sign an Exclusive License Agreement with Intas to Commercialize DMB-3115, Proposed Biosimilar to Ustekinumab",Biosimilars,23/7/2021
ImaginAb Signs a Multi-Year Non-Exclusive License Agreement with Boehringer Ingelheim for CD8 ImmunoPET Technology,Biotech,23/7/2021
AstraZeneca's Bydureon BCise (exenatide extended-release) Receives the US FDA's Approval for the Treatment of Type2 Diabetes,Regulatory,23/7/2021
Alexion's Ultomiris (ravulizumab) Receives CHMP's Positive Opinion Recommending its Approval for Children and Adolescents with PNH,Regulatory,26/7/2021
AstraZeneca's Vaxzevria Demonstrates Effectiveness After One Dose Against Beta/Gamma and Delta Variants of SARS-CoV-2 Virus,Biotech,26/7/2021
AbbVie Presents Results of AGN-190584 in P-III GEMINI 1 Study for Presbyopia at 2021 ASCRS,Clinical Trials,26/7/2021
The US FDA Declines to Approve Incyte's Retifanlimab to Treat Patients with Squamous Cell Carcinoma of the Anal Canal,Regulatory,26/7/2021
Denali Reports Results of DNL310 in P-I/II Study in Patients with the Lysosomal Storage Disease Hunter Syndrome (MPS II),Biotech|Clinical Trials,26/7/2021
PerkinElmer to Acquire BioLegend for $5.25B,M&A,26/7/2021
BeiGene's Brukinsa (Zanubrutinib) Receives Health Canada's Approval for Mantle Cell Lymphoma,Regulatory,27/7/2021
Prothena Presents Preclinical Data of its Alzheimer's Candidates at AAIC 2021,Clinical Trials,27/7/2021
GSK's Shingrix Receives the US FDA's Approval to Prevent Shingles in Immunocompromised Adults,Regulatory,27/7/2021
Adagio Collaborates with Biocon to Provide COVID-19 Ab Treatment to Patients in India and Other Emerging Markets,Biotech|COVID-19,27/7/2021
BioNTech Plans to Initiate the Clinical Study of Malaria and Tuberculosis Vaccines in 2022,Biotech|Clinical Trials,27/7/2021
"AstraZeneca and Regeneron Collaborate to Research, Develop and Commercialize Therapies for Obesity",Pharma,27/7/2021
Amgen to Acquire Teneobio for ~$2.5B,M&A,28/7/2021
PeptiDream and Takeda Expand its Research and License Agreement to Develop Peptide Drug Conjugates Targeting CNS Diseases,Biotech,28/7/2021
AbbVie and Calico Expand its Existing Collaboration to Focus on Aging and Age-Related Diseases,Biotech,28/7/2021
Sanofi's Avalglucosidase alfa Receives CHMP's Positive Opinion for Patients with Pompe Disease,Regulatory,28/7/2021
BridgeBio Enters into Clinical Collaboration with BMS to Evaluate BBP-398 + Opdivo for Advanced Solid Tumors with KRAS Mutations,Clinical Trials|Pharma,28/7/2021
Arena and Aristea Collaborate to Develop RIST4721 for Treatment of Complicated Immune-Mediated Inflammatory Diseases,Biotech,28/7/2021
BD Acquires Tepha to Boost its Surgical Mesh Portfolio,M&A|MedTech,29/7/2021
Roche Reports the US FDA's Acceptance of BLA for Faricimab to Treat Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration,Regulatory,29/7/2021
Regeneron and Sanofi Report Results of Dupixent (dupilumab) in P-III LIBERTY CUPID Clinical Program for Chronic Spontaneous Urticaria,Clinical Trials,29/7/2021
"Viatris and Biocon's Semglee (biosimilar, insulin glargine) Receive the US FDA's Approval as the First Interchangeable Biosimilar for Diabetes",Biosimilars,29/7/2021
Janssen Amends its Agreement with Protagonist to Develop and Commercialize IL-23 Antagonists,Pharma,29/7/2021
Takeda's TAK-994 Receives Breakthrough Therapy Designation for the Treatment of Narcolepsy Type 1,Regulatory,29/7/2021
"Henlius Reports First Patient Dosing in P-I Study of HLX04-O (biosimilar, bevacizumab) for Wet Age-Related Macular Degeneration",Biosimilars,19/7/2021
Lilly Collaborates with Kumquat to Develop Novel Small Molecules that Enhance Tumor-Specific Immune Responses,Biotech,30/7/2021
GSK's Nucala (mepolizumab) Receives the US FDA's Approval for the Treatment of Chronic Rhinosinusitis with Nasal Polyps,Regulatory,30/7/2021
Junshi Reports NMPA's Acceptance of sNDA for Toripalimab + CT as 1L Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma,Pharma,30/7/2021
Alnylam Signs a License Agreement with PeptiDream to Develop and Commercialize Peptide-siRNA Conjugates for Delivery of RNAi Therapeutics to a Broader Range of Extrahepatic Tissues,Biotech,30/7/2021
BeiGene Reports Results of Brukinsa (zanubrutinib) in P-III SEQUOIA Trial for the Treatment of Chronic Lymphocytic Leukemia,Clinical Trials,30/7/2021
Roche Publishes the Results of Evrysdi (risdiplam) in FIREFISH Study to Treat of Type 1 SMA at NEJM,Clinical Trials,30/7/2021
Astellas Signs a License Agreement with Minovia for Novel Mitochondrial Cell Therapy Programs,Biotech,2021-02-08
Takeda and Frazier Collaborate to Launch HilleVax (biopharma company) for the Development of Norovirus Vaccine,Biotech,2021-02-08
AstraZeneca's Saphnelo (anifrolumab-fnia) Receives the US FDA's Approval for the Treatment of Moderate to Severe Systemic Lupus Erythematosus,Regulatory,2021-02-08
Janssen's Uptravi (selexipag) Receives the US FDA's Approval for IV Use in Adults with Pulmonary Arterial Hypertension,Regulatory,2021-02-08
Ipsen Signs an Exclusive Collaboration with Exicure to Develop SNA-Based Therapeutics for Rare Neurodegenerative Disorders,Biotech,2021-02-08
Regeneron Reports the EUA Expansion for REGEN-COV (casirivimab and imdevimab) to Treat COVID 19,COVID-19,2021-02-08
"BioFactura Initiates P-I Study of BFI-751 (biosimilar, ustekinumab)",Biosimilars,25/5/2021
Abzena and BioXpress Collaborate to Develop and Manufacture Biosimilars for Third Party Customers,Biosimilars,27/7/2021
Abbott Launches Jot Dx Insertable Cardiac Monitor to Detect Abnormal Heart Rhythms in US,MedTech,2021-03-08
Sanofi to Acquire Translate Bio for ~$3.2B,M&A,2021-03-08
Roche Reports the US FDA's Acceptance of BLA and Priority Review of Tecentriq (atezolizumab) as an Adjuvant Treatment for NSCLC,Regulatory,2021-03-08
Novartis Lifts Partial Clinical Trial Hold on OAV-101 Clinical Program to Treat SMA,Clinical Trials,2021-03-08
UCB's Bimekizumab Receives NICE Recommendation for the Fast-Track Appraisal to Treat Severe Plaque Psoriasis,Regulatory,2021-03-08
Lilly and Incyte Report Results of Baricitinib in P-III COV-BARRIER Study for Patients with COVID-19 Receiving Invasive Mechanical Ventilation,Clinical Trials,2021-03-08
Marinus Signs an Agreement with Orion for the Commercialization of Ganaxolone in EU,Biotech,2021-04-08
Bayer Reports Results of Eliapixant (BAY1817080) in P-IIb Study for the Treatment of Refractory Chronic Cough,Clinical Trials,2021-04-08
Tachyon Collaborates with AbCellera to Develop Novel Antibody Therapies Targeting TGF-ß Superfamily Member for Cancer,Biotech,2021-04-08
"Celltrion to Supply Herzuma (biosimilar, trastuzumab) and Truxima (biosimilar, rituximab) in Brazil",Biosimilars,2021-04-08
Outlook Reports Results of ONS-5010 / Lytenava (bevacizumab-vikg) in P-III NORSE TWO Trial for the Treatment of Wet AMD,Clinical Trials,2021-04-08
BeyondSpring Reports Results of Plinabulin + Docetaxel in P-III DUBLIN-3 Trial for 2L and 3L Treatment of NSCLC with EGFR Wild Type,Regulatory,2021-04-08
F-star Collaborates with MSD to Evaluate FS120 + Keytruda for the Treatment of Cancer,Clinical Trials,2021-05-08
Schrödinger Signs a R&amp;D Collaboration with Zai Lab for Oncology Program Targeting DNA Damage Response,Biotech,2021-05-08
Regeneron Publishes the Results of REGEN-COV (casirivimab and imdevimab) in P-III Trial to Prevent COVID-19 at NEJM,Clinical Trials,2021-05-08
Pfizer Reports Results of Ritlecitinib in P-IIb/III Trial for the Treatment of Alopecia Areata,Clinical Trials,2021-05-08
Regeneron and Sanofi Stop P-III EMPOWER-Lung 3 Trial Early Due to Improvement in OS for 1L Treatment of NSCLC,Clinical Trials,2021-05-08
Merck's Keytruda (pembrolizumab) Receives the US FDA's Priority Review for the Adjuvant Treatment of Stage II Resected High-Risk Melanoma,Regulatory,2021-05-08
Bayer to Acquire Vividion for ~$2B,M&A,2021-06-08
AstraZeneca Signs an Exclusive License Agreement with Sierra for AZD5153 to Treat Myelofibrosis,Biotech,2021-06-08
Takeda Publishes the Results of Takhzyro (lanadelumab) in P-III HELP Study for the Prevention of Hereditary Angioedema Attacks in the Journal Allergy,Clinical Trials,2021-06-08
"Polpharma &amp; Bioeq Report BLA Submission to the US FDA for FYB201 (biosimilar, ranibizumab)",Biosimilars,2021-06-08
Kite Signs a License Agreement with Appia to Develop Allogeneic Cell Therapies for the Treatment of Cancer,Biotech,2021-06-08
Medtronic to Acquire Intersect ENT for ~$1.1B,M&A|MedTech,2021-06-08
Sanofi's Nexviazyme (avalglucosidase alfa-ngpt) Receives the US FDA's Approval for the Treatment of Late-Onset Pompe Disease,Regulatory,2021-09-08
Genentech Reports Results of Polivy (polatuzumab vedotin-piiq) + R-CHP in P-III POLARIX Trial for the Treatment of Diffuse Large B-Cell Lymphoma,Clinical Trials,2021-09-08
Eli Lilly and Innovent Report Results of Sintilimab + CT in P-III ORIENT-11 Study as 1L Treatment of NSCLC,Clinical Trials,2021-09-08
AstraZeneca's Forxiga (dapagliflozin) Receives EC's Approval for the Treatment of Chronic Kidney Disease in Patients with and without T2D,Regulatory,2021-09-08
UCB Presents Two-Year Data of Bimekizumab in BE BRIGHT Trial for the Treatment of Moderate to Severe Plaque Psoriasis at AAD 2021,Clinical Trials,2021-09-08
Calliditas Receives the US FDA's Fast Track Designation for Setanaxib to Treat Primary Biliary Cholangitis,Regulatory,2021-09-08
AbbVie Terminates its License Agreement with Molecular Partners for Abicipar Pegol,Biotech,2021-10-08
Harmony Acquires ConSynance's Asset for the Treatment of Narcolepsy and other Rare Neurological Diseases,M&A,2021-10-08
AbbVie Receives $20M Milestone in its DUB Targets Collaboration with Mission to Treat Alzheimer and Parkinson Diseases,Biotech,2021-10-08
Seagen Signs an Exclusive WW License Agreement with RemeGen to Develop and Commercialize Disitamab Vedotin,Biotech,2021-10-08
Alnylam Reports Completion of Patient Enrollment in P-III HELIOS-B Study for Vutrisiran to Treat ATTR Amyloidosis with Cardiomyopathy,Clinical Trials,2021-10-08
Merck Reports the US FDA's Acceptance of sBLA and Priority Review for Keytruda (pembrolizumab) as an Adjuvant Treatment for RCC,Regulatory,2021-10-08
Takeda to Advance FIN-524 Development Program in Ulcerative Colitis,Pharma,2021-11-08
Dermavant Reports the US FDA's Acceptance of NDA for Tapinarof Cream to Treat Plaque Psoriasis,Clinical Trials,2021-11-08
GW's Epidyolex (cannabidiol) Receives MHRA's Approval for the Treatment of Seizures Associated with Tuberous Sclerosis Complex in UK,Regulatory,2021-11-08
Merck Reports the US FDA's Acceptance of Keytruda's sBLA for Review to Treat MSI-H/dMMR Advanced Endometrial Carcinoma,Regulatory,2021-11-08
Boston's EXALT Model B Single-Use Bronchoscope Receives the US FDA's Clearance for Bronchoscopy Procedures,MedTech,2021-11-08
The US FDA's Rejects FibroGen's Roxadustat for the Treatment of Anemia Due to CKD,Regulatory,2021-11-08
Sorrento to License Dyadic's DYAI-100 and C1 Technology for Protein-Based Coronavirus Vaccines and Therapeutics,Biotech|COVID-19,2021-12-08
Merck's Keytruda (pembrolizumab) + Lenvima (lenvatinib) Receive the US FDA's Approval as 1L Treatment of Advanced Renal Cell Carcinoma,Regulatory,2021-12-08
C4T's CFT7455 Receives the US FDA's Orphan Drug designation for the Treatment of Multiple Myeloma,Regulatory,2021-12-08
Innovent's IBI306 Meets its Primary Endpoint in P-III CREDIT-2 Study for Heterozygous Familial Hypercholesterolemia,Clinical Trials,2021-12-08
I-Mab Reports Interim Data of Plonmarlimab (TJM2) in P-II/III Study to Treat COVID-19,Clinical Trials,2021-12-08
GC Publishes the Results of GC5107 in P-III Trial for the Treatment of Primary Immunodeficiency in Frontiers in Immunology,Clinical Trials,2021-12-08
Jazz' Xywav Receives the US FDA's Approval for the Treatment of Idiopathic Hypersomnia,Regulatory,13/8/2021
Aprea Reports the FDA's Hold on Clinical Trials for the Treatment Lymphoid Malignancy,Clinical Trials,13/8/2021
Wise and NYU Langone Health Publish the Results of Personal Zen App for Multiple Sclerosis in Frontiers in Neurology,DigiHealth,13/8/2021
Ipsen Reports the Withdrawal of NDA for Palovarotene to Treat Fibrodysplasia Ossificans Progressiva,Clinical Trials,13/8/2021
Celltrion's Regdanvimab (CT-P59) Receives the ANVISA's EUA for the Treatment of COVID-19 in Brazil,COVID-19|Regulatory,13/8/2021
Junshi and Coherus's Toripalimab Receive the US FDA's Breakthrough Therapy Designation as 1L Treatment of Nasopharyngeal Carcinoma,Regulatory,13/8/2021
Merck's Welireg (belzutifan) Receives the US FDA's Approval for the Treatment of Von Hippel-Lindau Disease Associated Tumors,Regulatory,16/8/2021
The US FDA Rejects Sesen Bio's Vicineum (oportuzumab monatox-qqrs) for the Treatment of BCG-Unresponsive NMIBC,Regulatory,16/8/2021
Lilly Reports Results of Lebrikizumab in P-III ADvocate 1 and 2 Studies for the Treatment of Moderate to Severe Atopic Dermatitis,Clinical Trials,16/8/2021
Pfizer's Ticovac Receives the US FDA's Approval for the Prevention of Tick-Borne Encephalitis,Regulatory,16/8/2021
Merck Reports the Initiation of Rolling Submission to Health Canada for Molnupiravir to Treat COVID-19,COVID-19|Regulatory,16/8/2021
The US FDA Lifts the Clinical Hold of Rocket's RP-A501 Clinical Trial to Treat Danon Disease,Clinical Trials,16/8/2021
Eli Lilly's Lyumjev (insulin lispro-aabc injection) Receives the US FDA's Expanded Label Approval for the Treatment of Type 1 and Type 2 Diabetes,Regulatory,17/8/2021
Incyte Signs a License Agreement with InnoCare to Develop and Commercialize Tafasitamab in Greater China,Biotech,17/8/2021
Exelixis Expands its Collaboration with Invenra to Develop Novel Biologics in Oncology,Biotech,17/8/2021
Abbott's Amplatzer Amulet Device Receives the US FDA's Approval for the Treatment of Atrial Fibrillation,MedTech,17/8/2021
Novartis' Cosentyx (secukinumab) Receives the NMPA's Approval for the Treatment of Pediatric Psoriasis in China,Regulatory,17/8/2021
BMS Reports EMA's Validation of MAA for Opdivo (nivolumab) + Yervoy (ipilimumab) and Opdivo + CT to Treat Esophageal Squamous Cell Carcinoma,Regulatory,17/8/2021
Sol-Gel Technologies' Twyneo (tretinoin/benzoyl peroxide) Cream Receives the US FDA's Approval for the Treatment of Acne Vulgaris,Regulatory,27/7/2021
GSK's Jemperli (dostarlimab-gxly) Receives the US FDA's Accelerated Approval for the Treatment of dMMR Recurrent or Advanced Solid Tumors,Regulatory,18/8/2021
Agios Reports the US FDA's Acceptance of NDA and Priority Review for Mitapivat to Treat Pyruvate Kinase Deficiency,Regulatory,18/8/2021
Verily Acquires SignalPath to Expand its Clinical Research Capabilities,M&A|MedTech,18/8/2021
BeiGene and EUSA Receive the NMPA's Approval of Qarziba (dinutuximab beta) for High-Risk Neuroblastoma,Regulatory,18/8/2021
Novartis Reports Results of Beovu (brolucizumab) in P-III KITE &amp; KINGFISHER Trials for the Treatment of Diabetic Macular Edema,Clinical Trials,18/8/2021
BMS Exercises its Option to Develop Exscientia's AI-Designed Drug Candidate,Biotech,18/8/2021
AbbVie Publishes 12-week Results of Atogepant in P-III ADVANCE Trial for the Preventive of Migraine in NEJM,Clinical Trials,19/8/2021
Boehringer Ingelheim and Eli Lilly's Jardiance (empagliflozin) Receive the US FDA's Approval for the Treatment of Heart Failure with Reduced Ejection Fraction,Regulatory,19/8/2021
Coherus and Junshi Report Interim Results of Toripalimab + CT in P-III CHOICE-01 Trial as 1L Treatment for Non-Small Cell Lung Cancer,Clinical Trials,19/8/2021
Merck Signs a Supply Agreement with Werewolf for WTX-124 INDUKINE Program to Treat Solid Tumors,Pharma,19/8/2021
Orion Signs a License and Research Agreement with Alligator to Develop Bispecific Antibody for the Treatment of Cancer,Biotech,19/8/2021
Merck Enters in Third Clinical Trial Collaboration with Adagene to Advance ADG106 + Keytruda (pembrolizumab) for Solid Tumors and Hematological Malignancies,Clinical Trials,19/8/2021
BMS' Abecma (Idecabtagene Vicleucel) Receives EC's Conditional Approval for Relapsed and Refractory Multiple Myeloma,Regulatory,20/8/2021
Gilead Reports EMA's Validation of MAA for Lenacapavir to Treat HIV-1 in People with Limited Therapy Options,Regulatory,20/8/2021
Astellas and FibroGen's Evrenzo (roxadustat) Receive EC's Approval for Symptomatic Anemia Associated with Chronic Kidney Disease,Regulatory,20/8/2021
Janssen Presents Results of Rybrevant (amivantamab-vmjw) in P-I CHRYSALIS Study for Advanced NSCLC with METex14 Mutations at WCLC,Clinical Trials,20/8/2021
AstraZeneca's AZD7442 Meets its Primary Endpoint in P-III PROVENT Study for the Prevention of COVID-19,Clinical Trials|COVID-19,20/8/2021
Roche's Ventana MMR RxDx Panel Test Receives the US FDA's Approval as First CDx to Detect dMMR Solid Tumor,MedTech|Regulatory,20/8/2021
BMS' Opdivo(nivolumab) Receives the US FDA's Approval for the Adjuvant Treatment of High-Risk Urothelial Carcinoma,Regulatory,23/8/2021
BeiGene Reports NMPA's Acceptance of sBLA for Tislelizumab (BGB-A317) to Treat Nasopharyngeal Cancer in China,Regulatory,23/8/2021
Pfizer's Xeljanz (tofacitinib citrate) Receives EC's Approval for the Treatment of Active Polyarticular JIA &amp; Juvenile PsA,Regulatory,23/8/2021
Zydus' ZyCoV-D Receives the DCGI's EUA for the Treatment of COVID-19,COVID-19|Regulatory,23/8/2021
Alexion to Discontinue its P-III CHAMPION-ALS Trial of Ultomiris (ravulizumab) for Amyotrophic Lateral Sclerosis,Clinical Trials,23/8/2021
Pfizer to Acquire Trillium for ~$2.26B,M&A,23/8/2021
Pfizer and BioNTech's Comirnaty Receive the US FDA's Approval to Prevent COVID-19 in Individuals Aged 16 Years and Older,Regulatory,24/8/2021
Takeda Signs a License Agreement with Genevant to Develop and Commercialize Novel Nonviral Gene Therapies for Liver Diseases,Pharma,24/8/2021
Theravance Reports Results of Izencitinib in P-IIb Dose-Finding Induction Study for the Treatment of Ulcerative Colitis,Clinical Trials,24/8/2021
Merck KGaA and GSK Discontinue P-II INTR@PID BTC 055 Study of Bintrafusp Alfa as 1L Treatment of Biliary Tract Cancer,Clinical Trials,24/8/2021
Novartis' Kymriah (tisagenlecleucel) Fails to Meet its Primary Endpoint in P-III BELINDA Study as 2L Treatment in Aggressive B-Cell Non-Hodgkin Lymphoma,Clinical Trials,24/8/2021
UCB's Bimzelx (bimekizumab) Receives EC's Approval for the Treatment of Moderate to Severe Plaque Psoriasis,Regulatory,24/8/2021
Roche Signs a License Agreement with Shape to Advance AAV-based RNA Editing Technology for Neuroscience and Rare Disease,Biotech,25/8/2021
AbbVie's Rinvoq (upadacitinib) Receives EC's Approval for the Treatment of Moderate to Severe Atopic Dermatitis,Regulatory,25/8/2021
Vertex Expands its 2018 Agreement with Arbor to Develop Novel Ex Vivo Engineered Cell Therapies,Biotech,25/8/2021
Takeda and Ono's Opdivo (nivolumab) + Cabometyx (cabozantinib) Receive MHLW's Approval for the Treatment of Unresectable or Metastatic Renal Cell Carcinoma,Regulatory,25/8/2021
Argenx Reports EMA's Validation of MAA for Efgartigimod to Treat Generalized Myasthenia Gravis,Regulatory,25/8/2021
Cara and Vifor's Korsuva (difelikefalin) Receive the US FDA's Approval for the Treatment of Moderate-to-Severe Pruritus Due to CKD in Patients with Hemodialysis,Regulatory,25/8/2021
Lilly Signs a License Agreement with Lycia to Develop Novel LYTAC Degraders,Biotech,#N/A
Thermo Fisher's Oncomine Dx Target Test Receives the US FDA's Approval as a CDx for the Treatment of IDH1-Mutated Cholangiocarcinoma,MedTech|Regulatory,#N/A
Merck Reports Results of Vaxneuvance (pneumococcal 15-valent conjugate vaccine) in P-III PNEU-PED Study for the Prevention of Invasive Pneumococcal Disease,Clinical Trials,#N/A
AstraZeneca's Forxiga (dapagliflozin) Receives MHLW's Approval for the Treatment of Chronic Kidney Disease in Patients with and without T2D,Regulatory,#N/A
Pfizer and BioNTech Initiate Rolling Submission of sBLA for the US FDA's Approval of Comirnaty's Booster Dose in Individuals Aged 16 Years and Older,Regulatory,#N/A
AstraZeneca's ALXN1840 Meets its Primary Endpoint in P-III FoCus Trial for the Treatment of Wilson Disease,Clinical Trials,#N/A
NovaRock Signs an Exclusive License Agreement with Flame to Co-Develop and Commercialize NBL-015,Biotech,#N/A
MorphoSys and Incyte's Minjuvi (tafasitamab) + Lenalidomide Receive EC's Approval for the Treatment of R/R DLBCL,Regulatory,#N/A
BeyondSpring Signs an Exclusive Agreement with Jiangsu Hengrui to Co- Develop &amp; Commercialize Plinabulin in Greater China,Pharma,#N/A
Innovent Collaborates with Bolt to Develop Three Oncology Boltbody ISAC Programs,Biotech,#N/A
Amgen Presents Results of Repatha (evolocumab) in P-III HUYGENS Study for the Treatment of Acute Coronary Syndrome at ESC 2021,Clinical Trials,#N/A
Ascendis' Skytrofa (lonapegsomatropin-tcgd) Receives the US FDA's Approval for Pediatric Growth Hormone Deficiency,Regulatory,#N/A
BeiGene Signs a Clinical Trial Agreement with ImmixBio to Evaluate IMX-110 + Tislelizumab in Solid Tumors,Biotech,#N/A
MicroTransponder Receives the US FDA's Approval for Vivistim System as the First Vagus Nerve Stimulation Implant for Stroke Rehabilitation,MedTech,#N/A
"Bio-Thera and Hikma Sign an Exclusive Commercialization and License Agreement for BAT2206 (biosimilar, ustekinumab) in the US",Biosimilars,#N/A
Sanofi and Regeneron's Dupixent Meets All Endpoints in P-III Study in Children with Atopic Dermatitis,Clinical Trials,#N/A
SpringWorks Collaborates with Dana-Farber to Evaluate Nirogacestat in Multiple Myeloma,Biotech,#N/A
Pfizer Reports Results of Abrocitinib in P-III JADE DARE Study to Treat Atopic Dermatitis,Clinical Trials,#N/A
Abbott Reports Head-to-Head Data for Amplatzer Amulet Against Boston Scientific's Watchman Device to Treat Atrial Fibrillation #ESC2021,MedTech,#N/A
GSK and SK Bioscience Initiate P-III Study of GBP510 Against AZ/Oxford's COVID-19 Vaccine,Clinical Trials,#N/A
Bone Therapeutics's JTA-004 Fails to Meet its All Endpoints in P-III Study for Knee Osteoarthritis,Clinical Trials,#N/A
Baxter in Talks to Acquire Hill-Rom for ~$10B,M&A,#N/A
Janssen Reports Post-Hoc Analysis of P-III GRIPHON and P-IIIb TRITON Studies of Uptravi (selexipag) for the Treatment of Pulmonary Arterial Hypertension #ESC2021,Clinical Trials,#N/A
Boehringer Ingelheim and Eli Lilly Present Results of Jardiance (empagliflozin) in P-III EMPEROR-Preserved Trial for the Treatment of HFpEF at ESC 2021,Clinical Trials,#N/A
"Centus Reports Results of FKB238 (bevacizumab, biosimilar) in P-III AVANA Trial for the Treatment of Advanced/Recurrent nonsq.NSCLC",Clinical Trials,#N/A
Cipla Collaborates with Kemwell to Form Joint Venture to Develop and Commercialize Biosimilars,Biosimilars,#N/A
"Formycon and Bioeq Report Submission of BLA to the US FDA for FYB201 (biosimilar, ranibizumab)",Biosimilars,#N/A
"Samsung Bioepis' Byooviz (biosimilar, ranibizumab) Receives EC's Approval for the Treatment of Ophthalmic in EU",Biosimilars|Regulatory,#N/A
Novartis Signs an Agreement with NHS to Commercialize Leqvio (inclisiran) for the Treatment of Cardiovascular Disease,Biotech,#N/A
AC Immune Report Results of Semorinemab in P-II Lauriet Study for the Treatment of Alzheimer's Disease,Clinical Trials,#N/A
Bayer Initiates P-III OASIS Program of Elinzanetant for the Treatment of Vasomotor Symptoms During Menopause,Clinical Trials,#N/A
Johnson &amp; Johnson Discontinues the P-IIb Imbokodo Trial of HIV Vaccine Regimen for HIV Infection,Clinical Trials,#N/A
Merck's Keytruda (pembrolizumab) Receives the US FDA's Approval for Label Update to Treat Advanced Urothelial Carcinoma,Regulatory,#N/A
Merck and Ridgeback Initiate P-III MOVe-AHEAD Study of Molnupiravir for the Prevention of COVID-19 Infection,Clinical Trials|COVID-19,#N/A
"Celltrion's Herzuma (biosimilar, trastuzumab) Overtook the Original Treatments for Cancer",Biosimilars,#N/A
Enzene Receives Marketing Authorization for Romiplostim (biosimilar) in India,Biosimilars,#N/A
Nora Signs an Exclusive Agreement Biopharmaceutical Partner to Launch a Biosimilar in Canada,Biosimilars,#N/A
AstraZeneca Signs a Multiyear Agreement with Thermo Fisher to Co-Develop NGS-based CDx for Targeted Therapies,MedTech,#N/A
CVS Dropped Sanofi's Diabetes Drugs Lantus for Biosimilars,Biosimilars,#N/A
Takeda's Pevonedistat Fails to Meet Primary Endpoints in P-III PANTHER Trial as 1L Treatment for Patients with Rare Bone Marrow Cancer,Clinical Trials,#N/A
BMS Exercised Its Option to License Evotec's EVT8683 for the Treatment of Neurodegenerative Disease,Biotech,#N/A
BeiGene's Brukinsa (zanubrutinib) Receives the US FDA's Approval for the Treatment of Waldenström's Macroglobulinemia,Regulatory,#N/A
Astellas Pauses Dosing of AT132 in ASPIRO Clinical Trial for the Treatment of X-linked Myotubular Myopathy,Clinical Trials,#N/A
Janssen's Invega Hafyera (paliperidone palmitate) Receives the US FDA's Approval for the Treatment of Schizophrenia,Regulatory,#N/A
"Sandoz Reports Results of Omnitrope (biosimilar, somatropin) in PATRO Children Study for the Treatment of Turner Syndrome",Biosimilars,#N/A
Baxter to Acquire Hillrom for ~$10.5B,M&A,#N/A
Abbott to Acquire Walk Vascular to Bolster its Peripheral Vascular Offerings,M&A|MedTech,#N/A
Alexion's Ultomiris (ravulizumab) Receives EC's Approval for Expanded Use to Treat Paroxysmal Nocturnal Haemoglobinuria,Regulatory,#N/A
Pfizer Initiates P-III RENOIR Trial of RSVpreF Vaccine for the Treatment of Respiratory Syncytial Virus,Clinical Trials,#N/A
Novartis Cosentyx (secukinumab) Receives NICE Recommendation for Patients with Plaque Psoriasis,Regulatory,#N/A
Forte's FB-401 Fails to Meet Primary Endpoints in P-II Clinical Trial For the Treatment of Atopic Dermatitis,Clinical Trials,#N/A
Novartis to Discontinue CIRRUS-1 Study of CFZ533 (iscalimab) in Kidney Transplant Patients,Clinical Trials,#N/A
Dr. Reddy's Collaborates with Citius to Sell Rights of its Anti-Cancer Agent (E7777),Pharma,#N/A
BioMarin Reports FDA's Hold on P-I/II Phearless Trial of BMN 307 in Adults with PKU,Clinical Trials,#N/A
AstraZeneca and Amgen's Tezepelumab Demonstrates 86% Reduction in Exacerbations in Patients with Asthma and Nasal Polyps,Clinical Trials,#N/A
Bayer Reports Results of Eliapixant in P-IIb PAGANINI Study for Patients with Refractory Chronic Cough,Clinical Trials,#N/A
Moderna's Spikevax Receives TGA's Provisional Approval to Treat COVID-19 in Patients Aged 12-17 Years,COVID-19|Regulatory,#N/A
JW's Relmacabtagene Autoleucel Receives the NMPA's Approval for the Treatment of R/R Large B-Cell Lymphoma in China,Regulatory,#N/A
NeuExcell Signs a Research Agreement with Spark to Develop a Novel Gene Therapy for Huntington's Disease,Biotech,#N/A
Advent and GIC to Acquire Sobi for ~$8B,M&A|Pharma,#N/A
Impel NeuroPharma's Trudhesa (dihydroergotamine mesylate) Nasal Spray Receives the US FDA's Approval for the Treatment of Migraine,Regulatory,#N/A
Sorrento Initiates Enrollment in P-II MSC-COV-202BR Study for the Treatment of Acute Respiratory Distress due to COVID-19 in Brazil,Clinical Trials,#N/A
"Hetero's Tocira (biosimilar, tocilizumab) Receives the DCGI's EUA for the Treatment of COVID-19 in Hospitalized Adults",Biosimilars,#N/A
Genentech Signs a License Agreement with Adaptimmune to Develop and Commercialize Cancer-Targeted Allogeneic T-cell Therapies,Biotech,#N/A
Sanofi to Acquire Kadmon for ~$1.9B,M&A,#N/A
Google Collaborates with Mayo Clinic to Develop AI Algorithm for the Treatment of Neurological Diseases,MedTech,#N/A
AM-Pharma Enters into an Exclusive License Agreement with Kyowa Kirin to Commercialize Ilofotase Alfa in Japan,Pharma,#N/A
United Therapeutics Presents Results of Tyvaso DPI in BREEZE Clinical Study for the Treatment of Pulmonary Arterial Hypertension at ERS 2021,Clinical Trials,#N/A
AstraZeneca Presents Results of Fasenra in P-IIIb PONENTE Study for the Treatment of Asthma at ERS 2021,Clinical Trials,#N/A
"Sandoz Enters into a Commercialization and License Agreement with Bio-Thera to Commercialize BAT1706, a Proposed Biosimilar Avastin (bevacizumab)",Biosimilars,#N/A
AstraZeneca and Hutchmed Initiate P-III SANOVO Trial for Orpathys (savolitinib) + Tagrisso (osimertinib) as a 1L Therapy for Non-small Cell Lung Cancer in China,Clinical Trials,#N/A
Sanofi Provides Update on P-III PEGASUS Trial of Rilzabrutinib for the Treatment of Pemphigus,Clinical Trials,#N/A
AstraZeneca Reports Results of PT027 (albuterol and budesonide) in P-III MANDALA and DENALI Trials for the Treatment of Asthma,Clinical Trials,#N/A
Cardiff Oncology Reports Results of Onvansertib in P-Ib/II Trial for the Treatment of KRAS-Mutated Metastatic Colorectal Cancer,Clinical Trials,#N/A
ICU Medical Commits to Acquire Smith for ~$2.35B,M&A,#N/A
Eli Lilly Signs a License and Research Agreement with ProQR to Develop &amp; Commercialize RNA Therapeutic for the Treatment of Liver and Nervous System Disorders,Biotech,#N/A
Roche to Acquire TIB Molbiol for Bolstering its Molecular Diagnostics Portfolio,M&A,#N/A
Dermavant Reports the First Patient Dosing in P-III ADORING Program of Tapinarof for the Treatment of Atopic Dermatitis,Clinical Trials,#N/A
Boehringer Ingelheim and Eli Lilly's Jardiance (empagliflozin) Receive the US FDA's Breakthrough Therapy Designation for the Treatment of Heart Failure with Preserved Ejection Fraction,Regulatory,#N/A
"Samsung Bioepis Reports Results of Post-Hoc Analysis from P-III Study of Byooviz (biosimilar, ranibizumab) for the Treatment of nAMD",Biosimilars|Clinical Trials,#N/A
Boehringer Ingelheim Signs a Research Agreement with Twist to Discover Therapeutic Antibodies Against Multiple Targets,Biotech,#N/A
BeiGene and Novartis Report the US FDA's Acceptance of BLA for Tislelizumab to Treat Esophageal Squamous Cell Carcinoma,Regulatory,#N/A
AstraZeneca Presents Results of Imfinzi (durvalumab) + Tremelimumab in P-III POSEIDON Study as 1L Treatment for Stage IV NSCLC at WCLC 2021,Clinical Trials,#N/A
ZOLL to Acquire Itamar for ~$538M,M&A|MedTech,#N/A
Hutchmed's Amdizalisib (HMPL-689) Receives Breakthrough Therapy Designation for the Treatment of R/R Follicular Lymphoma in China,Regulatory,#N/A
AbbVie Collaborates with Regenxbio to Develop and Commercialize RGX-314 for the Treatment of Retinal Diseases,Pharma,#N/A
BMS Reports Three-Year Data of Opdivo (nivolumab) + Yervoy (ipilimumab) in P-III CheckMate -743 Trial for 1L Treatment of Unresectable Malignant Pleural Mesothelioma,Clinical Trials,#N/A
Nuformix Signs an Exclusive WW License Agreement with Oxilio to Develop NXP001 for Oncology Disease,Pharma,#N/A
AzurRx Signs a Reverse Triangular Merger Agreement to Acquire First Wave Bio for ~$229M,M&A,#N/A
Coherus and Junshi Present Interim Results of Toripalimab in P-III CHOICE-01 Trial as 1L Treatment for Non-Small Cell Lung Cancer at WCLC 2021,Clinical Trials,#N/A
Everest Signs a License Agreement with Providence to Advance mRNA Vaccines,Biotech|COVID-19,#N/A
ONO and BMS Report Submission of sBLA for Opdivo (nivolumab) + Yervoy (ipilimumab) as 1L Treatment of Unresectable Advanced or Recurrent ESCC in Japan,Biotech,#N/A
Amgen's Lumakras (sotorasib) Receives Health Canada's Approval for KRAS G12C-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer,Regulatory,#N/A
Ginkgo Going Public with ~1.63B in Proceed Via Soaring Eagle SPAC Merger,M&A,#N/A
RedHill's Opaganib (ABC294640) Fails to Meet its Primary Endpoints in P-II/III Study for the Treatment of Severe COVID-19,Clinical Trials|COVID-19,#N/A
Roche Collaborates with Temedica to Launch Brisa App for the Treatment of Multiple Sclerosis,DigiHealth,#N/A
AbCellera Acquires TetraGenetics to Enhance its Capabilities for Developing Antibodies,Biotech|M&A,#N/A
MSD Enters into a Clinical Collaboration with IO to Evaluate IO102-IO103 + Keytruda as 1L Treatment of Metastatic Melanoma,Clinical Trials,#N/A
BeiGene's Brukinsa (zanubrutinib) Receives the US FDA's Accelerated Approval for the Treatment of R/R Marginal Zone Lymphoma,Regulatory,#N/A
Takeda's Exkivity (mobocertinib) Receives the US FDA's Approval as the First Oral Therapy for EGFR Exon20 Insertion+ NSCLC,Regulatory,#N/A
Biogen to Initiate P-IIIb ASCEND Study Evaluating Higher Doses of Spinraza (nusinersen) for the Treatment of Spinal Muscular Atrophy,Pharma,#N/A
Merck Enters into a Clinical Collaboration with Hookipa to Evaluate Keytruda (pembrolizumab) + HB-200 as 1L Treatment of Advanced Head and Neck Cancers,Clinical Trials,#N/A
BioCryst's Orladeyo (berotralstat) Receives NICE Recommendation as First Oral Therapy to Prevent HAE Attacks in the UK,Regulatory,#N/A
Amgen Presents Results of Lumakras (sotorasib) + Vectibix (panitumumab) in P-Ib/II CodeBreaK 101 study for KRAS G12C-Mutated Colorectal Cancer at ESMO21 2021,Clinical Trials,#N/A
BMS Reports Five-Year Data of Opdivo (nivolumab) + Yervoy (ipilimumab) in P-III CheckMate -214 for the Treatment of Advanced or Metastatic Renal Cell Carcinoma,Clinical Trials,#N/A
Boehringer Ingelheim Enters into a Clinical Collaboration with Amgen to Evaluate BI 1701963 + Lumakras (sotorasib) for Locally Advanced or Metastatic NSCLC,Clinical Trials,#N/A
Clarus Signs an Exclusive WW License Agreement with McGill University to Develop and Commercialize its Technology for Rare Conditions Due to Coenzyme-Q10 Deficiencies,Biotech,#N/A
Biogen Reports Mixed Results of Vixotrigine (BIIB074) in P-II CONVEY Study for the Treatment of Small Fiber Neuropathy,Clinical Trials,#N/A
AbbVie Submits Regulatory Applications to the US FDA and EMA for Rinvoq (upadacitinib) to Treat Active Ulcerative Colitis,Regulatory,#N/A
Coherus and Junshi Present Interim Results of Toripalimab in P-III JUPITER-06 Trial as 1L Treatment for Advanced Esophageal Squamous Cell Carcinoma at ESMO 2021,Clinical Trials,#N/A
Coave Signs an Exclusive License Agreement with Théa to Co-Development and Commercialize CTx-PDE6b for PDE6b Associated Retinitis Pigmentosa in EU,Biotech,#N/A
Everest Enter into an Exclusive License Agreement with Sinovent and SinoMab to Develop and Commercialize XNW1011 for Renal Diseases,Pharma,#N/A
Mirati Presents Results of Adagrasib (MRTX849) in P-I/II KRYSTAL–1 Study for the Treatment of KRAS G12C-Mutated Colorectal Cancer at ESMO 2021,Clinical Trials,#N/A
Regeneron and Sanofi Present Results of Libtayo (cemiplimab) in P-III EMPOWER-Lung 3 Study as 1L Treatment of Advanced NSCLC at ESMO 2021,Clinical Trials,#N/A
Merck Reports Results of Keytruda (pembrolizumab) in P-III KEYNOTE-826 Trial as 1L Treatment for Cervical Cancer,Clinical Trials,#N/A
Exelixis' Cabometyx (cabozantinib) Receives the US FDA's Approval for the Treatment of Locally Advanced or Metastatic Differentiated Thyroid Cancer,Regulatory,#N/A
AstraZeneca Presents the Updated Results of Imfinzi (durvalumab) in P-III CASPIAN Trial for the Treatment of Extensive-Stage Small Cell Lung Cancer at ESMO 2021,Clinical Trials,#N/A
"Samsung Bioepis and Biogen's Byooviz (biosimilar, ranibizumab) Receives the US FDA's Approval for the Treatment of Retinal Vascular Disorders",Biosimilars|Regulatory,#N/A
Abbott's Portico with Flexnav Tavr System Receives the US FDA's Approval for the Treatment of Aortic Valve Disease,MedTech,#N/A
Bayer Signs a License and Research Agreement with Gubra to Develop Novel Peptide Therapeutics for Cardiorenal Diseases,Biotech,#N/A
Novartis to Acquire Arctos to Boost its Optogenetics Portfolio to Treat Eye Diseases,Biotech|M&A,#N/A
Amgen Collaborates with Verastem to Evaluate VS-6766 + Lumakras (Sotorasib) in P-I/II Trial for KRAS G12C-Mutant Non-Small Cell Lung Cancer,Pharma,#N/A
Boston Scientific to Acquire Devoro for ~$336M,M&A,#N/A
Incyte's Opzelura (ruxolitinib) Receives the US FDA's Approval for the Treatment of Atopic Dermatitis,Regulatory,#N/A
Boehringer Ingelheim Acquires Abexxa to Expands its Immuno-oncology Research,M&A,#N/A
Seagen and Genmab's Tivdak (tisotumab vedotin-tftv) Receive the US FDA's Accelerated Approval for the Treatment of Recurrent or Metastatic Cervical Cancer,Regulatory,#N/A
Exelixis Presents Results of Cabometyx (cabozantinib) in P-III COSMIC-311 Trial for the Treatment of Radioactive Iodine-Refractory DTC at ESMO 2021,Clinical Trials,#N/A
Takeda Enters into an Exclusive License Agreement with Mirum to Develop and Commercialize Maralixibat for Rare Pediatric Liver Diseases in Japan,Pharma,#N/A
Vigeo Reports Completion of VT1021 in P-I/II Study for the Treatment of Recurrent Glioblastoma and Pancreatic Cancer,Clinical Trials,#N/A
AbCellera Enters into a License Agreement with Everest to Discover Antibody Therapies,Biotech,#N/A
Innovent Reports NMPA's Acceptance of sNDA for Sintilimab as 1L Treatment for Esophageal Squamous Cell Carcinoma,Regulatory,#N/A
Abbott's Epic Plus Tissue Valves Receives the US FDA's Approval for the Treatment of Mitral or Aortic Valve Replacement,MedTech,#N/A
Incyte's Jakafi (ruxolitinib) Receives the US FDA's Approval for the Treatment of Chronic Graft-Versus-Host Disease,Regulatory,#N/A
Gilead Reports Results of Veklury (remdesivir) in P-III Trial for the Treatment of COVID-19,Clinical Trials|COVID-19,#N/A
Immunic Sign a License Agreement with University Medical Center Goettingen for IMU-838 &amp; N4-Hydroxycytidine to Treat Viral Infections,Biotech|COVID-19,#N/A
Roche Presents Results of Evrysdi (risdiplam) in RAINBOWFISH Study for the Treatment of Neuromuscular Disorder at WMS 2021,Clinical Trials,#N/A
AstraZeneca Collaborates with VaxEquity to Develop and Commercialize Self-Amplifying RNA Therapeutics,Biotech,#N/A
Innovent Reports the First Patient Dosing in P-II CIBI112A201 Trial of IBI112 for the Treatment of Plaque Psoriasis,Clinical Trials,#N/A
Pfizer and BioNTech's COVID-19 Vaccine Booster Receive the US FDA's EUA for the Treatment of COVID-19,Regulatory,#N/A
GE Healthcare to Acquire BK Medical for ~ $1.45B,M&A|MedTech,#N/A
Everest's SPR206 Receives the NMPA's IND Approval for the Treatment of MDR Gram-Negative Bacterial Infections,Regulatory,#N/A
Amgen's Repatha (evolocumab) Receives the US FDA's Approval for the Treatment of Heterozygous Familial Hypercholesterolemia,Regulatory,#N/A
Innovent and AnHeart Report Interim Results of Taletrectinib (AB-106) in P-II TRUST Trial for the Treatment of ROS1-Positive NSCLC at CSCO 2021,Clinical Trials,#N/A
JW Reports One-Year Follow-Up Results of Relmacabtagene Autoleucel in P-II RELIANCE Study for the Treatment of R/R LBCL at CSCO 2021,Clinical Trials,#N/A
Boehringer Ingelheim Receives Positive Opinion for the Use of Ingelvac CircoFLEX + Ingelvac PRRSFLEX for Pig Health Management in the EU,Animal Health,#N/A
Astellas and Seagen's Padcev (enfortumab vedotin) Receive MHLW's Approval for the Treatment of Radically Unresectable Urothelial Carcinoma,Regulatory,#N/A
Takeda's Alofisel (darvadstrocel) Receives MHLW's Approval for the Treatment of Complex Perianal Fistulas with Non-active or Mildly Active Luminal CD,Regulatory,#N/A
Incyte Enters into an Exclusive WW License Agreement with Syndax to Develop and Commercialize Axatilimab for cGVHD and Other Fibrotic Diseases,Pharma,#N/A
Bio-Thera Signs a License Agreement with Intract for Soteria and Phloral Technologies to Develop Oral Antibody Therapies,Biotech,#N/A
Innovent Signs a License Agreement with Union to Develop &amp; Commercialize Orismilast for Inflammatory Dermatology Conditions in China,Biotech,#N/A
AstraZeneca's Saphnelo (anifrolumab) Receives MHLW's Approval for the Treatment of Systemic Lupus Erythematosus,Regulatory,#N/A
Eisai Initiates Rolling Submission of BLA to the US FDA for Lecanemab to Treat Alzheimer's Disease,Regulatory,#N/A
ViiV Healthcare Signs an Exclusive License Agreement with Shionogi to Develop S-365598 for HIV,Pharma,#N/A
Boehringer Ingelheim Signs an Agreement with Invetx to Develop and Commercialize Novel Veterinary Therapies,Animal Health,#N/A
The US FDA Approves New Indication for Lilly's Erbitux (cetuximab) + Braftovi (encorafenib) to Treat Metastatic Colorectal Cancer with a BRAF V600E Mutation,Regulatory,#N/A
AbbVie's Qulipta (atogepant) Receives the US FDA's Approval for the Treatment of Migraine,Regulatory,#N/A
AstraZeneca to Acquire Caelum for ~500M,M&A,#N/A
ViiV Healthcare Presents Three-Year Results of Dovato (dolutegravir/lamivudine) in P-III TANGO Study for the Treatment of HIV at IDWeek 2021,Clinical Trials,#N/A
Novartis Reports Results of ligelizumab (QGE031) in P-IIb Study for the Treatment of Chronic Spontaneous Urticaria,Clinical Trials,#N/A
Medtronic's Radial Artery Catheter Device Receives CE Mark Approval for the Treatment of Neurovascular Diseases,MedTech,#N/A
Regeneron Publishes the Results of REGEN-COV (casirivimab and imdevimab) in P-III Trial for COVID-19 in NEJM,Clinical Trials|COVID-19,#N/A
Janssen Initiates P-III EVERGREEN Study of RSV Vaccine for the Treatment of Lower Respiratory Tract Disease Due to Respiratory Syncytial Virus,Clinical Trials,#N/A
TransMedics' OCS Liver System Receives the US FDA's Approval for Liver Transplantation,MedTech|Regulatory,#N/A
Takeda Signs an Exclusive License Agreement with JCR to Commercialize JR-141 for the Treatment of Hunter Syndrome,Pharma,#N/A
Eli Lilly Reports Results of Tirzepatide in P-III SURPASS-3 MRI Sub-Study for the Treatment of Type 2 Diabetes,Clinical Trials,#N/A
Merck to Acquire Acceleron for ~$11.5B,M&A,#N/A
Otsuka Enters into a WW License Agreement with Sunovion and Sumitomo Dainippon to Develop and Commercialize Neuropsychiatric Candidates,Pharma,#N/A
Novartis Presented Results of Remibrutinib (LOU064) in P-IIb Study for the Treatment of Chronic Spontaneous Urticaria at EADV,Clinical Trials,#N/A
Dermavant Presented Long-Term Results of Tapinarof in P-III PSOARING 3 Study for the Treatment of Plaque Psoriasis at EADV,Clinical Trials,#N/A
Sanofi Presents Results of Amlitelimab (KY1005) in P-IIa Study for the Treatment of Moderate-To-Severe Atopic Dermatitis at EADV 2021,Clinical Trials,#N/A
Merck and Ridgeback Report Interim Results of Molnupiravir in P-III MOVe-OUT Trial for the Treatment of COVID-19,Clinical Trials|COVID-19,#N/A
BMS Reports EMA's Validation of MAA for Relatlimab and Nivolumab as 1L Treatment for Unresectable or Metastatic Melanoma,Regulatory,#N/A
Kite's Tecartus Receives the US FDA's Approval as the First and Only Car T for Adults with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia,Regulatory,#N/A
Merck KGaA and GSK Terminate their ~$4.2B Collaboration Due to Clinical Failures,Uncategorized,#N/A
Takeda Enters into a License Agreement with Selecta to Develop Gene Therapies for the Treatment of Lysosomal Storage Disorders,Biotech,#N/A
"Polpharma Biologics Reports the US FDA?s Acceptance of BQ201's (biosimilar, ranibizumab) BLA for Review to Treat Wet Age-Related Macular Degeneration",Biosimilars,#N/A
AstraZeneca Seeks the US FDA?s EUA for AZD7442 to Treat COVID-19,COVID-19|Regulatory,#N/A
"Coherus Report Results of CHS-201 (biosimilar, ranibizumab) in COLUMBUS-AMD Clinical Trial for the Treatment of nAMD",Biosimilars,#N/A
Xenon?s XEN1101 Meets its Primary Efficacy Endpoint in P-IIb X-TOLE Clinical Trial for the Treatment of Focal Epilepsy,Clinical Trials,#N/A
Guardant Health Initiates ORACLE Study of Guardant Reveal Blood Test for the Treatment of Early-Stage Cancers,MedTech,#N/A
Johnson &amp; Johnson Reports EUA Submission to the US FDA for Supporting the Booster of its Single Shot COVID-19 Vaccine Candidate,Regulatory,#N/A
Inotiv to Acquire Plato BioPharma for ~$15.0M,M&A,#N/A
Sage and Biogen Present Results of Zuranolone in LANDSCAPE and NEST Clinical Development Programs for the Treatment of MDD and PPD at ECNP 2021,Clinical Trials,#N/A
Novartis?s Adakveo (crizanlizumab) Receives NICE Recommendation as a New Therapy for Sickle Cell Disease,Regulatory,#N/A
Kaleido Reports Results of KB295 in Clinical and Preclinical Studies for the Treatment of Mild-to-Moderate Ulcerative Colitis,Clinical Trials,#N/A
Boston to Acquire Baylis for ~$1.75B,M&A,#N/A
"Biocad Presents Results of BCD-021 (biosimilar, bevacizumab) in P-III Study for the Treatment of Non-Squamous Non-Small Cell Lung Cancer at ESMO 2021",Biosimilars|Clinical Trials,#N/A
"Fresenius Kabi Reports Results of MSB11456 (biosimilar, tocilizumab) in Two Clinical Trials for the Treatment of Rheumatoid Arthritis",Biosimilars|Clinical Trials,#N/A
"Tanvex Presents Results of TX05 (biosimilar, trastuzumab) in P-III Study for the Treatment of HER2-Positive Early Stage Breast Cancer at ESMO 2021",Biosimilars|Clinical Trials,#N/A
Alvotech?s AVT02 (a proposed biosimilar to Humira) Receives CHMP?s Positive Opinion for the Treatment of Autoimmune Diseases,Biosimilars|Regulatory,#N/A
"Samsung Bioepis Presents Five-year Follow-up Results of Ontruzant (biosimilar, trastuzumab) in Early or Locally Advanced HER2 Positive Breast Cancer at ESMO 2021",Biosimilars|Clinical Trials,#N/A
Pfizer Signs an Option and License Agreement with Voyager to Develop and Commercialize Gene Therapies for Neurologic and Cardiovascular Diseases,Biotech,#N/A
Sanofi Reports Interim Results of Fluzone High-Dose Quadrivalent Vaccine + COVID-19 mRNA Booster Dose in First Descriptive Study for COVID-19,Clinical Trials|COVID-19,#N/A
PharmaTher Initiates P-II KET-LID Study of Ketamine for Levodopa-Induced Dyskinesia in Patients with Parkinson?s Disease,Clinical Trials,#N/A
Denali Presented Results of DNL343 and SAR443820 in P-I Clinical Studies for the Treatment of Amyotrophic Lateral Sclerosis at NEALS 2021,Clinical Trials,#N/A
BMS? Deucravacitinib Fails to Meet its Primary and Secondary Endpoints in P-II LATTICE-UC Study for the Treatment of Moderate to Severe Ulcerative Colitis,Clinical Trials,#N/A
Amgen Signs a R&amp;D Collaboration with Neumora to Advance Novel Precision Therapies for Neuropsychiatric and Neurodegenerative Diseases,Biotech,#N/A
"Apobiologix?s Bambevi (biosimilar, bevacizumab) Receives Health Canada Approval for Multiple Cancer Indications",Biosimilars|Regulatory,#N/A
"Alvotech Reports Results of AVT02 (biosimilar, adalimumab) in AVT02-GL-302 Study to Treat Chronic Diseases",Biosimilars|Clinical Trials,#N/A
AbbVie?s Rinvoq (upadacitinib) Met Primary and Secondary Endpoints in P-III SELECT-AXIS 2 Clinical Trial for Non-Radiographic Axial Spondyloarthritis,Clinical Trials,#N/A
Schr?dinger Signs a Two-Year Research Collaboration with MD Anderson to Advance its WEE1 Program,Pharma,#N/A
Sanofi Signs a Non-Exclusive Clinical Collaboration Agreement with Mirati to Evaluate Adagrasib + SAR442720 (RMC-4630) in P-I/II Study for KRAS G12C-Mutated Lung Cancer,Clinical Trials,#N/A
Allogene Reports the US FDA?s Clinical Hold on ALPHA2 Study of ALLO-501A to Treat Large B Cell Lymphoma,Clinical Trials,#N/A
Takeda Receives the US FDA Advisory Committee?s Recommendation for TAK-620 (maribavir) to Treat CMV Infection in Post-Transplant Recipients,Regulatory,#N/A
AbbVie?s Rinvoq (upadacitinib) Receives the Health Canada Approval for the Treatment of Moderate to Severe Atopic Dermatitis,Regulatory,#N/A
Janssen Report Submission of sBLA to the US FDA for the Approval of Stelara (ustekinumab) to Treat Juvenile Psoriatic Arthritis,Regulatory,#N/A
Genentech?s Gantenerumab Receives the US FDA?s Breakthrough Therapy Designation for the Treatment of Alzheimer?s Disease,Regulatory,#N/A
Turning Point Presents Results of Repotrectinib in P-I/II TRIDENT-1 Study for the Treatment of Solid Tumors at AACR-NCI-EORTC 2021,Clinical Trials,#N/A
Regenxbio Presents Results of RGX-314 in P-II ALTITUDE Trial for the Treatment of Diabetic Retinopathy at ASRS Annual Meeting,Clinical Trials,#N/A
Merck and Ridgeback Report EUA Submission to the US FDA for Molnupiravir to Treat COVID-19,COVID-19|Regulatory,#N/A
Supernus to Acquire Adamas for ~$450M,M&A,#N/A
AstraZeneca?s AZD7442 Meet its Primary Endpoints in P-III TACKLE Trial for the Treatment of COVID-19,Clinical Trials|COVID-19,#N/A
Pacira to Acquire Flexion for ~427M,M&A,#N/A
Sarepta Presents the New Analyses and Functional Data of SRP-9001 in Multiple Studies for the Treatment of DMD at SRP-9001 Micro-dystrophin Day,Clinical Trials,#N/A
AbCellera Enters into a Collaboration and License Agreement with Salipro to Boost Therapeutic Antibodies,Biotech,#N/A
Sutro Signs an Option Agreement with BioNova to Develop and Commercialize STRO-001 for Hematologic Cancers in Greater China,Pharma,#N/A
The US FDA Lifts the Clinical Hold of Protagonist?s Rusfertide Clinical Development Program,Clinical Trials,#N/A
Takeda Signs an Exclusive License Agreement with Poseida for Novel Non-Viral In Vivo Gene Therapies,Biotech,#N/A
Spark Signs an Exclusive Global Licensing Agreement with CombiGene for CG01 to Treat Focal Epilepsy,Biotech,#N/A
Ultimovacs Reports Results of 24-month Follow-up Study of UV1 + Pembrolizumab for 1L Treatment of Metastatic Malignant Melanoma,Clinical Trials,#N/A
Sanofi Presents Results of Tolebrutinib in a P-IIb LTS for Relapsing Forms of Multiple Sclerosis at ECTRIMS 2021,Clinical Trials,#N/A
Eli Lilly?s Verzenio (abemaciclib) Receives the US FDA?s Approval for People with HR+ HER2- High Risk Early Breast Cancer,Regulatory,#N/A
Sanofi's Sarclisa Combination Regimen Receives Health Canada?s Approval for Multiple Myeloma,Regulatory,#N/A
PharmaTher?s Ketamine Receives the US FDA?s Orphan Drug Designation for Complex Regional Pain Syndrome,Regulatory,#N/A
Turning Point and EQRx Collaborate to Evaluate Elzovantinib + Aumolertinib in Patients with EGFR Mutant Met-Amplified Advanced NSCLC,Pharma,#N/A
Merck?s Keytruda (pembrolizumab) Receives the US FDA?s Approval for Second Indication in Cervical Cancer,Regulatory,#N/A
Novartis Reports the US FDA and EMA Filing Acceptance of Beovu for Patients with Diabetic Macular Edema,Regulatory,#N/A
Regeneron Reports the US FDA?s Acceptance of Priority Review for REGEN-COV for the Treatment and Prophylaxis of COVID-19,Regulatory,#N/A
Asieris Receives NMPA?s IND Approval to Evaluate APL-1202 + Tislelizumab as Neoadjuvant Therapy for MIBC Patients,Regulatory,#N/A
Lilly Presents Updated Data of Verzenio (abemaciclib) in P-III monarchE Trial Presented at ESMO and Published in the Annals of Oncology,Clinical Trials,#N/A
AstraZeneca Reports Results of Imfinzi + Tremelimumab in P-III HIMALAYA Study for 1L Treatment of Unresectable Liver Cancer,Clinical Trials,#N/A
Hologic to Acquire Bolder Surgical for $160M,M&A|MedTech,#N/A
Exelixis In-Licenses Second Anti-Cancer Compound from Aurigene Following the US FDA?s Acceptance of IND for P-I Study of XL114 in Non-Hodgkin?s Lymphoma,Pharma,#N/A
Gan &amp; Lee Completes P-III Studies of GL-GLA for Patients with T1D &amp; T2D,Biosimilars,#N/A
Bristol Myers Squibb?s Zeposia (ozanimod) Receives CHMP?s Positive Opinion for Adult Patients with Moderately to Severely Active Ulcerative Colitis,Regulatory,#N/A
Genentech?s Tecentriq Receives the US FDA?s Approval as Adjuvant Treatment for Early Non-Small Cell Lung Cancer,Regulatory,#N/A
AbbVie? Skyrizi (risankizumab) Receives CHMP?s Positive Opinion for the Treatment of Adults with Active Psoriatic Arthritis in the EU,Regulatory,#N/A
"Boehringer Ingelheim?s Cyltezo (biosimilar, adalimumab) Receives the US FDA?s sBLA Approval as the 1st Interchangeable Biosimilar for Multiple Chronic Inflammatory Diseases",Biosimilars|Regulatory,#N/A
"Bio-Thera Expands its Partnership with Pharmapark to Commercialize BAT2206 (biosimilar, ustekinumab in Russia and other CIS Countries",Biosimilars,#N/A
Innovent Reports Results of Sintilimab in P-III ORIENT-31 Study for EGFR-Mutated Non squamous Non-Small Cell Lung Cancer,Clinical Trials,#N/A
Ipsen Signs an Exclusive WW Collaboration with Accent to Develop and Commercialize METTL3 Program,Pharma,#N/A
Takeda Amend its Collaboration with Wave Life Sciences to Advance CNS Programs,Pharma,#N/A
Lipocine Enters into an Exclusive License Agreement with Antares to Commercialize Tlando in the US,Pharma,#N/A
Gilead?s Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) Low-Dose Tablet Receives the US FDA?s Approval for Expanded Indication to Treat HIV-1,Regulatory,#N/A
Takeda Signs an Agreement with Calithera to Acquire Sapanisertib and Mivavotinib,Pharma,#N/A
Lilly Published Results of Tirzepatide in SURPASS-4 Study for the Treatment of Type 2 Diabetes in The Lancet,Clinical Trials,#N/A
Sanofi?s Dupixent (dupilumab) Receives NICE Recommendation for the Treatment of Severe Asthma,Regulatory,#N/A
Sana Entered into an Agreement with Beam for Non-Exclusive Commercial Rights of its CRISPR Cas12b Nuclease System for Cell Therapy Programs,Biotech,#N/A
Antios Enters into a Clinical Collaboration Agreement with Assembly Biosciences to Evaluate ATI-2173 and Vebicorvir for Chronic Hepatitis B Virus Infection,Biotech,#N/A
Boehringer Ingelheim Exercised its Option to License Oxford Biomedica?s Lentiviral Vector Technology to Commercialize BI 3720931 for CF,Pharma,#N/A
Atea Reports Results of AT-527 in P-II MOONSONG Trial for the Treatment of COVID-19,Clinical Trials|COVID-19,#N/A
Dicerna Reports Results of Nedosiran in PHYOX4 Study for the Treatment of Primary Hyperoxaluria Type 3,Clinical Trials,#N/A
SpringWorks Enters into an Exclusive WW License Agreement with Academic Institutions to Advance Portfolio of Mutation-Selective EGFR Inhibitors,Pharma,#N/A
Janssen Enters into a License and Collaboration Agreement with F-star to Develop and Commercialize Multiple Bispecific Antibody Therapeutics,Biotech,#N/A
Sumitomo Dainippon Pharma Signs a Definitive Agreement with BehaVR to Develop and Commercialize PDTs and Wellness Product for CNS Disorders,Pharma,#N/A
Regeneron and Sanofi?s Dupixent (dupilumab) Receive the US FDA?s Approval as an Add-On Maintenance Treatment to Treat Moderate-To-Severe Asthma,Regulatory,#N/A
Pfizer and BioNTech Report Results of COVID-19 Vaccine Booster in P-III Trial for the Treatment of COVID-19,Clinical Trials|COVID-19,#N/A
Pfizer?s Prevnar 20 (Pneumococcal 20-Valent Conjugate Vaccine) Receives the CDC?s Advisory Committee Recommendation for Invasive Disease and Pneumonia,Regulatory,#N/A
Antengene Enters into a Research Collaboration &amp; License Option Agreement with LegoChem Biosciences for Antibody-Drug Conjugate Candidates,Pharma,#N/A
Mirum?s Livmarli (maralixibat) Receives US FDA?s Approval as the First Approved Therapy for Cholestatic Pruritus in Patients with Alagille Syndrome,Regulatory,#N/A
Selecta Enters into an Exclusive License Agreement with Genovis to Advance IgG Protease in Gene Therapy and Autoimmune Disease,Biotech,#N/A
Incyte Enters into a Supply Agreement with Specialised Therapeutics to Launch Tafasitamab and Pemigatinib in Australia and Other Countries,Pharma,#N/A
Scynexis Reports Results of Ibrexafungerp in P-III VANISH-303 Trial for Treatment of Vaginal Yeast Infection,Clinical Trials,#N/A
Regeneron and Sanofi Report Results of Dupixent (dupilumab) in P-III PRIME2 Trial for the Treatment of Prurigo Nodularis,Clinical Trials,#N/A
LEO Reports 16-week Results of Tralokinumab in P-III ECZTRA 6 Trial for the Treatment of Moderate-to-Severe Atopic Dermatitis,Clinical Trials,#N/A
Marinomed Biotech Signs a License Agreement with Luoxin to Commercialize Budesolv (budesonide nasal spray) in Greater China,Pharma,#N/A
Agenus Reports the Withdrawal of BLA for Balstilimab to Treat Cervical Cancer,Clinical Trials,#N/A
Genentech?s Susvimo Receives the US FDA?s Approval for the Treatment of Wet Age-Related Macular Degeneration,Regulatory,#N/A
Regeneron and Sanofi Report Results of Dupixent (dupilumab) in P-III Trial for the Treatment of Eosinophilic Esophagitis,Clinical Trials,#N/A
Merck Reports Results of Doravirine/Islatravir as Fixed Dose Combination in P-III Trials for the Treatment of HIV-1 Infection,Clinical Trials,#N/A
Merck and Ridgeback Report the Initiation of EMA Rolling Review of Molnupiravir for the Treatment of COVID-19,COVID-19|Regulatory,#N/A
Novartis Reports Results of Canakinumab in P-III CANOPY-1 Study for the Treatment of Lung Cancer,Clinical Trials,#N/A
Daiichi Sankyo and AstraZeneca Entered into a Second Clinical Trial Collaboration with Merck for Datopotamab Deruxtecan (Dato-DXd) + Keytruda (pembrolizumab),Clinical Trials,#N/A
MSD Entered into a Clinical Trial Collaboration with Evaxion to Evaluate EVX-01 + Keytruda (pembrolizumab) for Metastatic Melanoma,Clinical Trials|Pharma,#N/A
AstraZeneca Reports Results of Imfinzi in P-III TOPAZ-1 Trial as 1L Treatment for Advanced Biliary Tract Cancer,Clinical Trials,#N/A
Moderna Reports Results of COVID-19 Vaccine in P-II/III KidCOVE Study for the Treatment of COVID-19,Clinical Trials|COVID-19,#N/A
Glenmark launches Remogliflozin + Vildagliptin + Metformin as Fixed Dose Combination for the Treatment of Type 2 Diabetes in India,Pharma,#N/A
Guardant Health Presents Results of LUNAR-2 Blood Test for the Treatment of Early-Stage Colorectal Cancer at ACG 2021,MedTech,#N/A
Pfizer and BioNTech?s COVID-19 Vaccine Receive the US FDA?s Advisory Committee Vote Supporting EUA Against COVID-19,Regulatory,#N/A
Selecta Collaborates with Ginkgo to Develop Therapeutic Enzymes for the Treatment of Orphan and Rare Diseases,Biotech,#N/A
Vertex Collaborates with Mammoth Biosciences to Develop In Vivo Gene-Editing Therapies for Genetic Diseases,Biotech,#N/A
Vifor and Angion?s ANG-3777 Fail to Meet its Primary and Secondary Endpoint for Patients with High-Risk Kidney Transplant,Clinical Trials,#N/A
